[
    {
        "question": "Under what conditions can either party assign their rights and obligations under this agreement?",
        "options": {
            "A": "Without consent if assigning to a successor of substantially all business assets.",
            "B": "Without consent if the agreement is executed in counterparts.",
            "C": "With consent only if the assignment is for less than half of the obligations.",
            "D": "With prior written consent from the other party."
        },
        "correct_answer": "A",
        "explanation": "Either party can assign their rights and obligations under the agreement to a successor in ownership of substantially all of the assets of the business, provided that the successor expressly assumes in writing the performance of the terms and conditions of the agreement.",
        "source": "unknown",
        "client": "Ochsner Health System",
        "document_type": "unknown",
        "context": "BH 546 \nNew Or leans, LA 70121  \nAttn: Scott Posecai  \n \nwith a copy to:   Office of Legal Affairs  \nOchsner Health Plan  \n1450 Poydras Street, Suite 2250 \nNew Orleans, LA 70112  \nAttn: General Counsel  \n \nAny notice given pursuant or with respect to this Agreement shall be deemed received (i) on the date such notice is hand -delivered to an authorized representative of the P arty receiving such \nnotice, (ii) on the first business day following the date on which such notice is sent prepaid for \nnext-day delivery by nationally rec ognized overnight delivery service, or (iii) on the third \nbusiness day following the date on which such notice is sent by prepaid registered or certified \nU.S. mail, return receipt requested. 13. ASSIGNMENT . This Agreement shall be binding on and shall inure to the benefit of the \nparties hereto, their respective successors and assigns. This Agreement may not be assigned in \nwhole or in part by either Party without the prior written consent of the other Party. Any attempted \nassignment without such prior written consent shall be void and unenforceable. Notwithstanding the foregoing, either Party, without the prior written approval of the other Party, may assign its rights and obligations hereunder to a successor  in ownership of substantially all of the assets of the \nbusiness, provided that the successor expressly assumes in writing the performance of the terms and conditions of this Agreement. 14. COUNTERPARTS\n. This Agreement may be executed in two  or more counterparts, each \nof which shall be deemed an original, but all such counterparts together shall constitute but one and the same Agreement. 15. ENTIRE AGREEMENT\n. This Agreement contains the entire agreement of and \nsupersedes any and all prior understandings, arrangements, and agreements between the P arties \nhereto, whether oral or written, with respect to the subject matter hereof . 16. MODIFICATION.",
        "id": "qa_1"
    },
    {
        "question": "What is the primary restriction on the use and disclosure of Confidential Information under the NDA between ATRIO Health Plans and the Receiving Party?",
        "options": {
            "A": "Confidential Information must be shared with all employees.",
            "B": "Confidential Information can only be used in relation to the Potential Transaction.",
            "C": "Confidential Information can be used for any business purpose.",
            "D": "Confidential Information can be disclosed to third parties without permission."
        },
        "correct_answer": "B",
        "explanation": "The NDA specifies that Confidential Information can only be used for the exercise of rights and performance of obligations under the agreement in relation to the Potential Transaction.",
        "source": "s3://ml-legal-restricted/contract-docs/68895/Atrio - Cotiviti - NDA - AR - 07192022 - Dynamics_68895.pdf",
        "client": "ATRIO Health Plans",
        "document_type": "NDA",
        "context": "\u201cConfidential Information \u201d means this Agreement and all information disclosed \nto, or otherwise acquired or observed by, a party and its emplo yees and agents (\u201c Receiving Party \u201d), from the other \nparty and its employees and agents (\u201c Disclosing Party \u201d), relating to the business of the Disclosing Party, whether \ncommunicated in writing, verbally, electronically, photographically, or in recorded or any other form, including, but \nnot limited to, original and copies of all information disclosed under other  contractual arrangements between the \nparties  and their predecessors, subsidiaries and affiliates, intellectual property and trade secrets, sales and operating \ninformation, existing and potential business and marketing plans and strategies, financial infor mation, cost and pricing \ninformation, data, media, know -how, designs, drawings, specifications, software programs, software documentation, \nsoftware source codes, technical information, concepts, inventions, reports, methods, processes, techniques, operatio ns, \ndevices and the like, whether or not the foregoing information is patented, tested, reduced to practice, or subject to \ncopyright. No information of the Disclosing Party will be considered Confidential Information to the extent that an \nexception is prov ided for it in Section 3 herein. 2. Use and Disclosure of Confidential Information. The Receiving Party acknowledges that it will have access \nto the Disclosing Party\u2019s Confidential Information. The Receiving Party agrees that it will not (i) use any such \nConf idential Information in any way, except for the exercise of its rights and performance of its obligations under this \nAgreement in relation to the Potential Transaction, or (ii) disclose any such Confidential Information to any Third Party \nwithout the Discl osing Party\u2019s prior written permission.",
        "id": "qa_2"
    },
    {
        "question": "What is required in the Disaster Recovery Plan according to the document?",
        "options": {
            "A": "Checkpoint/restart capabilities and hardware backup",
            "B": "Notification of system downtime to designated State staff",
            "C": "Routine system maintenance schedule",
            "D": "Only hardware backup for servers"
        },
        "correct_answer": "A",
        "explanation": "The Disaster Recovery Plan must include checkpoint/restart capabilities and hardware backup, as specified in the document.",
        "source": "s3://ml-legal-restricted/contract-docs/55945/Accenture - Cotiviti SubK Agmt (Jan 2017)[CURRENT].pdf",
        "client": "Accenture",
        "document_type": "MSA",
        "context": "MPC 30\n\n \n\nCPC 06\n\n \n\nCNC 20\n\n \n\n \n\n \n\n     \n\n        \n  \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \n  \n \n \n  \n  \n\n \n\n \n\n  \n\n \n\n36\n\f\nDocuSign Envelope ID: 3AF05216-675E-4233-AD34-2EA07E0611A5\n\n   \n\n \n \n\nThe State may grant a waiver of this requirement under emergency conditions, Schedule routine\nsystem maintenance during non-peak processing hours, from 3:00 a.m. to 4:00 aum., Central Standard\nTime. Notify the designated State staff when the automated inquiry and transaction systems have been down\nfor more than ten (10) consecutive minutes outside of the State-approve scheduled maintenance\nwindow. Initial notification must include a brief description of the incident and projected recovery\ntime. Submit a follow-up notice to the State within ten (10) minutes of recovery, identifying total\ndown time and resolution. Document and track all incidents and resolutions in an automated tracking\nsystem. Provide ail system and application availability according te specifications established by the State. Prepare and submit for State approval and comprehensive Disaster Recovery Plan and submit to the\nState for approval on an annual basis. The Disaster Recovery Plan must adhere to State and Federal\nlaws, rules, regulations, and guidelines and must include:\n\ns Checkpoint/restart capabilities, 278\n\n* Retention and storage of back-up files and software;\n\ne Hardware back-up for the servers:\n\n\u00a9 Hardware back-up for data entry equipment;\n\n\u00ae Neiwork back-up for telecommunications:\n\n\u00ae Telephone communications lines to the disaster back-up site;\n\n* Recovery prioritization list {hardware and software applications; and\n\n*  Telecommunication Voice Switch,\n\n \n\n \n\n \n\n    \n\n \n\n \n\nSOC 54 Coordinate with and demonstrate to the State the Vendor's disaster recover capabilities every\ncalendar year. Include recovery of any new functionality implemented during the previous year. SOC 35 in the event of a catastrophic (i.e. possibility of crimes, terrorism, hackers, intentional torts. human\n\nerror, virus, etc.)",
        "id": "qa_3"
    },
    {
        "question": "What must a user do if hardware and software requirements change according to the document?",
        "options": {
            "A": "Upgrade equipment immediately without notification",
            "B": "Receive an email notification and have the right to withdraw consent",
            "C": "Continue using outdated equipment until further notice",
            "D": "Manually check for updates on the company website"
        },
        "correct_answer": "B",
        "explanation": "If hardware and software requirements change, the user will receive an email notification and have the right to withdraw their consent to receiving electronic notices and disclosures.",
        "source": "unknown",
        "client": "Capital Health Plan, Inc.",
        "document_type": "unknown",
        "context": "send us an e -mail to legal@verscend .com and in the body of such request you must \nstate your e -mail, full name, IS Postal Address, telephone number, and account number. Required hardware and software   \nOperating Systems:  Windows2000\u00ac or WindowsXP\u00ac  \nBrowsers (for \nSENDERS):  Internet Explorer 6.0\u00ac or above  \nBrowsers (for \nSIGNERS):  Internet Explorer 6.0\u00ac, Mozilla FireFox 1.0, NetScape 7.2 (or above)  \nEmail:  Access to a valid email account  \nScreen Resolution:  800 x 600 minimum  \nEnabled Security \nSettings:  \u00f2 Allow per session cook ies \n\u00f2 Users accessing the internet behind a Proxy Server must enable HTTP \n1.1 settings via proxy connection  \n** These minimum requirements are subject to change. If these requirements change, we will \nprovide you with an email message at the email address w e have on file for you at that time \nproviding you with the revised hardware and software requirements, at which time you will have \nthe right to withdraw your consent. Acknowledging your access and consent to receive materials electronically   \nTo confirm to  us that you can access this information electronically, which will be similar to \nother electronic notices and disclosures that we will provide to you, please verify that you were \nable to read this electronic disclosure and that you also were able to print  on paper or \nelectronically save this page for your future reference and access or that you were able to e -mail \nthis disclosure and consent to an address where you will be able to print on paper or save it for \nyour future reference and access. Further, if you consent to receiving notices and disclosures \nexclusively in electronic format on the terms and conditions described above, please let us know \nby clicking the \u00e6I agree\u00c6 button below.",
        "id": "qa_4"
    },
    {
        "question": "What rights does the Business Associate Agreement (BAA) provide regarding individuals' protected health information?",
        "options": {
            "A": "The right to obtain a copy of information in an electronic format.",
            "B": "The right to terminate the agreement with immediate effect.",
            "C": "The right to receive compensation for disclosed information.",
            "D": "The right to audit and monitor financial transactions."
        },
        "correct_answer": "A",
        "explanation": "The BAA specifies individuals' rights to obtain a copy of their information in an electronic format, as well as other provisions related to protected health information.",
        "source": "unknown",
        "client": "Crumdale Partners - Better Benefits",
        "document_type": "unknown",
        "context": "The BAA will govern and supersede the terms of this Agreement with respect to any protected \nhealth information disclosed hereunder, and will include, but will not be limited to, the following provisions: \na. Individuals' rights to obtain a copy of the individual's information in an electronic format;  \nb. Individuals' rights to have the individual's information transmitted to another entity or person \ndesignated by the individual, provided the request is clear, conspicuous, and specific;  \nc. The right to audit and monitor activities that involve protected health information; and \nd. The process for notification and reporting of unauthorized disclosure or protected health information \nbreaches. 7. Term. This Agreement may be terminated with respect to subsequent disclosures upon thirty (30) days' prior \nwritten notice to the other Party. This Agreement shall automatically terminate two (2) years after its Effective Date. The rights and obligations accruing prior to termination as set forth herein shall survive the termination of this \nAgreement for a period of five (5) years provided, however, that Receiving Party\u2019s obligations respecting Disclosing \nParty\u2019s \u201ctrade secrets\u201d (as such term is defined in 18 U.S.C. 1839) shall continue for so long as such information qualifies \nas a trade secret. 8. Compensation. The Receiving Party shall not be obligated to compensate the Disclosing Party for \nConfidential Information (except as may result from a breach of this Agreement) and the Receiving Party acknowledges \nand understands that no warranties of any kind are given by the Disclosing Party with respect to the accuracy or \ncompleteness of the Confidential Information. 9. Ownership. Confidential Information shall remain the sole and exclusive property of the Disclosing Party. Nothing in this Agreement shall be construed as granting to the Receiving Party any right, title or interest in or to any \npatent, trademark, license, copyright or other right of the Disclosing Party. 10. Relationship of the parties.",
        "id": "qa_5"
    },
    {
        "question": "What is the non-competition clause in the agreement?",
        "options": {
            "A": "Licensee cannot develop similar products during the term and one year after termination.",
            "B": "Licensee cannot publicly disclose the commercial relationship with Licensor.",
            "C": "Licensee can hire third parties to develop similar products during the agreement.",
            "D": "Licensee can develop similar products immediately after termination."
        },
        "correct_answer": "A",
        "explanation": "The agreement specifies that the Licensee cannot develop or sell a product with similar functionality to the Licensed Program during the term and for one year after the agreement's termination.",
        "source": "unknown",
        "client": "Capital Health Plan, Inc.",
        "document_type": "unknown",
        "context": "Each party shall\npromptly notify the other of any unauthorized possession, use or disclosure of the other party\u2019s\nConfidential Information by such party\u2019s employees, agents or representatives. G) Licensor Marketing. Licensee acknowledges and agrees that Licensor may, subject to the\nconfidentiality requirements of this Agreement, publicly disclose the commercial relationship\nbetween Licensor and Licensee as contemplated by this Agreement, through, without limitation,\npress releases, promotional literature and references in Licensor\u2019s web site. H) Non-Competition. Licensee agrees that during the term of this Agreement and for a term of one\n: year subsequent to the termination of this Agreement, Licensee shall not develop or sell a\ni product, or hire any third party to develop a product, with the same or substantially similar\ni functionality to the Licensed Program. 9. TERMINATION EVENTS. A) Licensor\u2019s Termination Events. Licensor may terminate this Agreement and any license granted\nto Licensee hereunder, and pursue appropriate legal remedies, if:\n\ni. Licensee fails to pay Licensor any license fees or other charges as set forth in this\nAgreement;\n\nii. _ Licensee (including any employee, officer, director, partner, agent, parent or subsidiary, or\naffiliate of Licensee) uses, copies or modifies the Licensed Program or transfers possession\nof any copy, adaptation, transcription, or merged portion of the Licensed Program to any\nother party in any way not expressly authorized by this Agreement;\n\niii. Licensee is in default of any other material provision of this Agreement and such default is\nnot cured within thirty (30) days after Licensor gives Licensee written notice of that default,\nprovided that no remedy period shall be required for defaults which are not curable; or\n\niv.",
        "id": "qa_6"
    },
    {
        "question": "What is required before Cotiviti can use offshore subcontractors or employees to access PHI?",
        "options": {
            "A": "Cotiviti must receive client approval",
            "B": "Cotiviti must notify the client 30 days in advance",
            "C": "No approval is necessary",
            "D": "Cotiviti must provide detailed records of access"
        },
        "correct_answer": "A",
        "explanation": "Client approval is required for any offshore vendors, subcontractors, or employees to access PHI according to the contract.",
        "source": "unknown",
        "client": "Maryland Physicians Care (MPC)",
        "document_type": "unknown",
        "context": "Upon request, the Receiving Party sh all certify such destruction in writing to the Disclosing \nParty. Where the request for the return or destruction of Client Confidentia l Information prevents, hinders or delays \nCotiviti\u2019s performance of the Services, Cotiviti shall ha ve no liability for any partial or non-performance of its \nobligations or any delay in respect of the same. 4.6 Confidential Information as Trade Secrets. Client acknowledges and agrees that all Cotiviti Confidential \nInformation is extremely valuable to Cotiviti; that Coti viti Confidential Information is not generally known to the \npublic; and that Cotiviti Confidential Information shall be deemed to be a \u201ctrade secret\u201d pursuant to all applicable \nlaw. The following language will be placed as a legend on each page of any Cotiviti Confidential Information \nprepared for authorized submission to public sector/gov ernmental entities (including and any exhibits thereto): \n\"Proprietary Information containing trade secr ets and/or commercial and financial information \nexempt from disclosure under any applicable state or federal law including without limitation the \nfederal Freedom of Information Act (5 U.S.C.\u00a7 552) and similar state laws.\" 4.7 Use of Representatives and Subcontractors. Client understands and acknowledges that Cotiviti may utilize \nits Representatives and subcontractors, some of whom may be located outside of the Un ited States, to perform the \nServices and support the Solutions, and to conduct research  and development activities, as long as the data remains \nonshore in the United States and no vendors, subcontractors or employees will have access to protected health \ninformation (\u201cPHI\u201d). Cotiviti to provider 30 days advance notification of its intent to use said Subcontractors. Client \nmust approve all offshore vendors, subcontractors or employee access to PHI. 4.8 Inspection, Audit and Records Retention.",
        "id": "qa_7"
    },
    {
        "question": "Which type of incident does NOT require Response and Reporting measures according to section 1.1.9?",
        "options": {
            "A": "Service attacks that do not result in a server being taken offline",
            "B": "Introduction of malware that does not result in unauthorized access",
            "C": "Unauthorized acquisition of BSC Data",
            "D": "Invalid password attempts"
        },
        "correct_answer": "A",
        "explanation": "Service attacks that do not result in a server being taken offline are explicitly mentioned as incidents that do not require Response and Reporting measures.",
        "source": "unknown",
        "client": "Blue Shield of California",
        "document_type": "unknown",
        "context": "S\n\n(d) For the avoidance of doubt, the parties agree that the Response and Reporting\nmeasures described in this section 1.1.9, subsections (a)-(c), shall not apply to any\nSecurity Incident that does not result in the actual, unauthorized acquisition, access,\nuse or disclosure of BSC Data, such as \u201cpings\u201d on an information system firewall; port\nscan; attempts to log on to an information system or enter a database with an invalid\npassword or user name; service attacks that do not result in a server being taken\noffline; or introduction of malware (e.g., a worm or virus) that does not or is not likely\nto result in unauthorized access, use, disclosure, modification or destruction of BSC\nData, and that would not cause an information security analyst of ordinary prudence to\nsuspect a malicious, prolonged, or deliberate effort to adversely affect or otherwise\ninterfere with Consultant's information systems used to provide the Services. 1.1.10 Security Assessments - Consultant's Security Program shall provide for regular\nassessment of the risks to the security of BSC Data and to BSC\u2019s, Consultant's, or any\nthird party's systems, applications, and services that are used to provide the Services. (a) Security Risk Assessment - Consultant shall perform a SSAE 16 SOC1 Type II and\ncomplete the BSC provide IT Questionnaire annually and provide a copy to BSC in\naccordance with Exhibit F.\n\n(b) Vulnerability Scans - Consultant shall perform internal and external host/network\nvulnerability scans at least quarterly and after any material change in the host/network\nconfiguration. Application Security Tests & Assessments - Consultant shall perform a security\n\nassessment on all applications and systems that are used to provide the Services, and\n\nany modifications, updates, new versions or releases, or any other changes to such\napplications or systems prior to delivery to BSC or installation on any BSC or third-\nparty system.",
        "id": "qa_8"
    },
    {
        "question": "Under what circumstances is the Business Associate allowed to receive remuneration in exchange for PHI?",
        "options": {
            "A": "Without any restrictions.",
            "B": "Only for marketing purposes.",
            "C": "Only with prior written consent of MPHC and as permitted by the HITECH Act.",
            "D": "For payment related to health care operations regardless of consent."
        },
        "correct_answer": "C",
        "explanation": "The Business Associate may receive remuneration in exchange for PHI only with the prior written consent of MPHC and as permitted by the HITECH Act, according to the document.",
        "source": "unknown",
        "client": "Martin's Point Health Care",
        "document_type": "unknown",
        "context": "Business\nAssociate shall not disclose PHI to a health plan for payment or for the Health Care\nOperations of MPHC if a MPHC patient has paid in full for a health care item or service\nout-of-pocket and has requested this special restriction. g. Prohibition on Remuneration. Business Associate shall not receive remuneration\ndirectly or indirectly in exchange for PHI, except with the prior written consent of\nMPHC and as permitted by the HITECH Act. Notwithstanding the foregoing, this\nprovision shall not prohibit payment by MPHC for services provided by Business\nAssociate pursuant to a written services agreement between Business Associate and\nMPHC. h, Fundraising and Marketing. Business Associate shall not use or disclose PHI for\nfundraising or for marketing purposes unless such use or disclosure is pursuant to a\nwritten services agreement with MPHC and does not violate HIPAA and the HITECH\nAct. 2. Prohibitions on Unauthorized Requests, Use or Disclosure,\n\na. Business Associate will neither use nor disclose PHI it creates or receives from MPHC\nor from another Business Associate of MPHC, except as permitted or required by this\nAgreement or as required by law or as otherwise permitted in writing by MPHC. This\nAgreement does not authorize Business Associate to request, use, disclose, maintain or\ntransmit PHI in a manner that will violate 45 C.F.R. Parts 160-164.\n\nb. Business Associate will not develop any list, description or other grouping of\nindividuals using PHI received from or on behalf of MPHC, except as permitted by this\nAgreement or in writing by MPHC. Business Associate will not request, use or disclose\nany list, description or other grouping of individuals that is derived using such PHI,\nexcept as permitted by this Agreement or otherwise permitted in writing by MPHC.",
        "id": "qa_9"
    },
    {
        "question": "Under the MSA, which circumstance requires Cotiviti to indemnify ACA Health Benefits Fund?",
        "options": {
            "A": "Non-payment of Fees by Client",
            "B": "Failure to maintain Required Insurance",
            "C": "Consequential Loss caused by Cotiviti",
            "D": "Wilful Misconduct or Gross Negligence by Cotiviti"
        },
        "correct_answer": "D",
        "explanation": "Cotiviti is required to indemnify ACA Health Benefits Fund for any Claim arising from Wilful Misconduct, Gross Negligence, or illegal acts under the agreement.",
        "source": "s3://ml-legal-restricted/contract-docs/73278/ACA - Cotiviti Australia - MSA - JK - 10052023 - Dynamics_73278.pdf",
        "client": "ACA Health Benefits Fund",
        "document_type": "MSA",
        "context": "11.2 Cotiviti must at all times indemnify and hold harmless Clien t and its Personnel from and \nagainst any Claim for Loss (excluding Consequential Loss) or otherwise against those indemnified (whether the Claim is by Cotiviti or a third party) where the Claim arises out of \nor in relation to; \n(a) any Wilful Misconduct, Gross Negligence, or illegal or unlawful act or omission  of \nCotiviti in the supply of, or failure to supply,  Services under this Agreement ;  \n(b) a Claim made by a third party that the use by Cotiviti of any Cotiviti materials used \nby Cotiviti under this Agreement is an infringement of that third party's Intellectual \nProperty Rights or contractual rights; \n(c) any act or omission of Cotiviti which results in a Claim for Loss against Client  for \nbreach o f Privacy Laws;  \n(d) any injury to or death of any person caused by any act or omission of Cotiviti or its \nPersonnel; or \n(e) any damage to real or tangible property caused by any act or omission of Cotiviti or \nits Personnel. 11.3 A party's liability under an indemnity under this Agreement will be reduced to the extent that \nthe other party fails to take reasonable steps to mitigate its Loss, or increases its Loss, through its own acts or omissions. 12. Insurance  \n12.1 Each party must effect and maintain, at its own cost, the  Required Insurance with a reputable \ninsurer on terms consistent with prudent risk management. 12.2 If requested by one party, the other party must provide to Client  certificates of currency for each  \nRequired Insurance. 13. Suspension of Services \n13.1 Cotiviti may suspend providing the Services to Client : \n(a) for non -payment  of Fees in accordance with this Agreement ; or \n(b) as otherwise permitted under this Agreement.",
        "id": "qa_10"
    },
    {
        "question": "What is required of the Receiving Party upon termination of the agreement concerning Confidential Information?",
        "options": {
            "A": "Transfer all Confidential Information to a third-party for safekeeping.",
            "B": "Destroy or deliver all Confidential Information to the Disclosing Party, except for a single archival copy.",
            "C": "Return all Confidential Information without retaining any copies.",
            "D": "Retain all electronic and digital copies of Confidential Information indefinitely."
        },
        "correct_answer": "B",
        "explanation": "The document specifies that the Receiving Party must destroy or deliver all Confidential Information to the Disclosing Party, except for a single archival copy that may be retained by the legal department for dispute resolution purposes.",
        "source": "unknown",
        "client": "Crumdale Partners - Better Benefits",
        "document_type": "unknown",
        "context": "\u201c Latent Data \u201d refers to data that is \nstored by a party on routine back-up media, including but not limited to deleted files and other non-logical data types, \nmemory dumps, swap files, temporary files, printer spool files and metadata that can customarily be retrieved only by \ncomputer forensics experts and is generally considered inaccessible without the use of specialized tools and techniques. 5. Return of Confidential Information. Subject to Section 3, \u201cExceptions,\u201d above, promptly following the earlier \nof (i) the termination of this Agreement, or (ii) the written request of Disclosing Party, the Receiving Party shall destroy \nor deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party \nconstituting or containing Confidential Information, together with all copies thereof, including all electronic and digital \ncopies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving \nParty's legal department for dispute resolution purposes only. Upon receipt of such a request, the Receiving Party shall \ndestroy all other documents and materials constituting Confidential Information in its possession to the extent \nreasonably practicable. Upon request, the Receiving Party shall certify such destruction in writing to the Disclosing \nParty. 6. Protected Health Information. If any part of the Confidential Information disclosed hereunder is protected \nhealth information pursuant to the Federal Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191 and its implementing regulations (collectively, \u201c HIPAA\u201d), as amended by the regulations promulgated \npursuant to the Health Information Technology for Economic and Clinical Health Act, Title XIII of the American \nRecovery and Reinvestment Act of 2009 (the \u201c HITECH Act \u201d), the parties agree to enter into a Business Associate \nAgreement (the \u201c BAA\u201d).",
        "id": "qa_11"
    },
    {
        "question": "Which clause describes the effect of a force majeure event on the Licensor\u2019s performance?",
        "options": {
            "A": "Licensor\u2019s performance is terminated and considered a default",
            "B": "Licensor must renegotiate terms with Licensee",
            "C": "Licensor\u2019s performance is excused and the time for performance is extended",
            "D": "Licensor must continue performance without delay"
        },
        "correct_answer": "C",
        "explanation": "The agreement specifies that in the event of a force majeure, Licensor\u2019s performance is excused and the time for performance is extended due to the delay or inability to perform resulting from such occurrence.",
        "source": "unknown",
        "client": "Capital Health Plan, Inc.",
        "document_type": "unknown",
        "context": "In the event that any term of this Agreement is, becomes or is declared to be invalid\nor void by any court or tribunal of competent jurisdiction, such term or terms shall be null and\n\n_ void and shall be deemed severed from this Agreement and all the remaining terms of this\n\nF)\n\nG)\n\n\u2018Agreement shall remain in full force and effect. Complete Agreement. THIS AGREEMENT JIS THE COMPLETE AND EXCLUSIVE\nSTATEMENT OF EACH PARTY'S OBLIGATIONS AND RESPONSIBILITIES TO THE\nOTHER AND SUPERSEDES ANY OTHER PROPOSAL, REPRESENTATION OR OTHER\nCOMMUNICATION BY OR ON BEHALF OF THE PARTIES RELATING TO THE\nSUBJECT MATTER HEREOF. Force Majeure. In the event that Licensor\u2019s performance is delayed, prevented, obstructed or\ninhibited because of any Act of God, fire, casualty, delay or disruption in transportation, flood,\nwar, strike, lockout, epidemic, destruction or shut-down of production facilities, shortage or\ncurtailment, riot, insurrection, governmental acts or directives, or any other cause beyond the\nreasonable control of Licensor, including financial requirements or manufacturing limitations\nimposed by third-party manufacturers, suppliers, or vendors, Licensor may give notice to\nLicensee, via Email or in writing, and thereupon Licensor\u2019s performance shall be excused and the\ntime for the performance shall be extended for the period of delay or inability to perform\nresulting from such occurrence. The occurrence of such an event shall not constitute grounds for\ndefault under this Agreement. Verisk Health, Inc.\nLicense Agreement with Capital Health Plan\n\nPage 8 of 30\n\nVersion 1-23-09\n\f\nH) Survival. Afier expiration or termination of this Agreement, all provisions relating to payment\nshall survive until completion of required payments.",
        "id": "qa_12"
    },
    {
        "question": "What is required for the secure handling of service account passwords according to the document?",
        "options": {
            "A": "Passwords must be stored in a hashed format and never changed.",
            "B": "Passwords should be long, difficult-to-guess, changed periodically, and stored in a hashed or encrypted format.",
            "C": "Passwords must be changed annually and stored in plain text.",
            "D": "Passwords should be short, easy-to-remember, stored in encrypted format, and changed only when compromised."
        },
        "correct_answer": "B",
        "explanation": "The document specifies that service account passwords must be long, difficult-to-guess, changed periodically, and stored in a hashed or encrypted format for secure handling.",
        "source": "unknown",
        "client": "Blue Shield of California",
        "document_type": "unknown",
        "context": "In accordance with Sarbanes -\nOxley compliance, VH is in the \nprocess of scoping in all BU\u2019s in \norder to verify that adequate \nITGC\u2019s have been implemented. 6 Incident Response Capability  \nCapabilities and management practices to manage and resolve \ninformation security related incidents quickly are in place. 7 Secure Configurations for Hardware, Software and Network \nDevices  \nSecure configuration standards for hardware and software, including \nnetworking devices, operating systems, databases and applications \nare in place. Use of strong authentication and secure protocols is \nenforced. Although specific configurations \nare in place, Information  \nSecurity is in the process of \nverifying secure build processes \nfor each BU  and expected \ncompletion is by the end of  \n2014. 8 Perimeter D efense  \nEstablish multilayered perimeter defense by use of firewalls, proxies \nand DMZs. Implement and maintain rules for allowing inbound and \noutbound traffic. 9 Application Software Security  \nInternally developed and third -party application software is carefully \ntested for security vulne rabilities. For third -party software, enterprises \nshould verify that vendors have conducted detailed security testing of \ntheir products. For in -house developed applications, enterprises must \nconduct such testing themselves or engage an outside firm to \ncomplete the testing. Findings are remediated promptly. Developers \nshould be trained in secure coding techniques and security testing \nintegrated into the SDLC. SDLC processes are in place \nbut vary in breadth and depth. Information Security will be \nverifying secure coding \nguidelines and usi ng standards \nlike OWASP to improve \napplication security in 2014. 10 Controlled use of Administrative Privileges  \nService accounts have long  and difficult -to-guess passwords that are \nchanged on a periodic basis as is done for traditional user and \nadministrator passwords. Passwords for all systems should be stored \nin a hashed or encrypted format. Furthermore, files containing these \nencrypted or hashed passwords required for systems to authenticate \nusers should be readable only with super -user privileges.",
        "id": "qa_13"
    },
    {
        "question": "What does the agreement state regarding the creation of formal business relationships between the parties?",
        "options": {
            "A": "There is no obligation to enter into a formal business organization.",
            "B": "The parties must share profits and liabilities.",
            "C": "The parties are bound to enter into a partnership.",
            "D": "The agreement establishes a joint venture."
        },
        "correct_answer": "A",
        "explanation": "The agreement explicitly states that it is not intended to be a joint venture, partnership, or other formal business organization.",
        "source": "unknown",
        "client": "Crumdale Partners - Better Benefits",
        "document_type": "unknown",
        "context": "Nothing in this Agreement shall be deemed to create, either express or implied, \nthe power in either Party to bind the other. Neither Party shall be bound by the actions of the other, shall be liable for \nthe debts of the other, or shall have a right to share in the profits of the other. This Agreement is not intended to be a \nCotiviti, Inc. CONFIDENTIAL AND PROPRIETARY 3\njoint venture, partnership or other formal business organization, and neither Party is under any obligation to enter into \nany further agreement with the other Party. 11.Mutual Representations. Each Party represents that it has the right to disclose its Confidential Information \nin furtherance of the purpose set forth above without violating any agreement with or right of any other person. Confidential Information may include information of a third party provided that the third party has authorized such \ndisclosure. 12.No Further Obligation or Limitation. This Agreement shall not be construed in any manner to be an \nobligation to enter into a subcontract or contract or to result in any claim whatsoever by one Party against the other for \nreimbursement of cost for any efforts expended. Except as specifically set forth herein, this Agreement does not: (i) \nrestrict either Party from developing new products, improving existing products, or marketing any new, improved or \nexisting products; or (ii) commit either Party to discloseany particular information, or to develop, make, use, buy, sell, \nor otherwise dispose of any existing or future products, or to favor or recommend any product or service of the other. To be binding, any such restriction or commitment must be in writing and signed by both parties. 13.Notices. All notices or other communications contemplated by this Agreement shall be in writing and shall \nbe deemed properly delivered when (i) delivered personally or (ii) mailed by registered or certified mail, postage \nprepaid, to the address of the other Party set forth in the first paragraph of this Agreement. 14.Assignment.",
        "id": "qa_14"
    },
    {
        "question": "What must the Receiving Party do with Confidential Information upon termination of the Agreement or upon written request from the Disclosing Party?",
        "options": {
            "A": "Retain all copies for future reference",
            "B": "Deliver all copies to the Disclosing Party",
            "C": "Distribute copies to relevant departments for processing",
            "D": "Destroy all documents and materials except a single archival copy for legal purposes"
        },
        "correct_answer": "D",
        "explanation": "The legal document specifies that the Receiving Party must destroy all documents and materials containing Confidential Information except for a single archival copy that may be retained by the legal department for dispute resolution purposes.",
        "source": "unknown",
        "client": "Crumdale Partners - Better Benefits",
        "document_type": "unknown",
        "context": "\u201c Latent Data \u201d refers to data that is \nstored by a party on routine back-up media, including but not limited to deleted files and other non-logical data types, \nmemory dumps, swap files, temporary files, printer spool files and metadata that can customarily be retrieved only by \ncomputer forensics experts and is generally considered inaccessible without the use of specialized tools and techniques. 5. Return of Confidential Information. Subject to Section 3, \u201cExceptions,\u201d above, promptly following the earlier \nof (i) the termination of this Agreement, or (ii) the written request of Disclosing Party, the Receiving Party shall destroy \nor deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party \nconstituting or containing Confidential Information, together with all copies thereof, including all electronic and digital \ncopies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving \nParty's legal department for dispute resolution purposes only. Upon receipt of such a request, the Receiving Party shall \ndestroy all other documents and materials constituting Confidential Information in its possession to the extent \nreasonably practicable. Upon request, the Receiving Party shall certify such destruction in writing to the Disclosing \nParty. 6. Protected Health Information. If any part of the Confidential Information disclosed hereunder is protected \nhealth information pursuant to the Federal Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191 and its implementing regulations (collectively, \u201c HIPAA\u201d), as amended by the regulations promulgated \npursuant to the Health Information Technology for Economic and Clinical Health Act, Title XIII of the American \nRecovery and Reinvestment Act of 2009 (the \u201c HITECH Act \u201d), the parties agree to enter into a Business Associate \nAgreement (the \u201c BAA\u201d).",
        "id": "qa_15"
    },
    {
        "question": "What remedy is available to the Disclosing Party for a breach of the agreement?",
        "options": {
            "A": "Termination of the agreement",
            "B": "Money damages only",
            "C": "Arbitration",
            "D": "Specific performance and/or injunctive relief"
        },
        "correct_answer": "D",
        "explanation": "The agreement states that the Disclosing Party is entitled to specific performance and/or injunctive relief, in addition to money damages, indicating these are remedies for breach.",
        "source": "unknown",
        "client": "Wellth, Inc.",
        "document_type": "unknown",
        "context": "Subject to the foregoing sentence, each Party and its \nRepresentatives expressly disclaim any and all liability to the other and its Representatives that may be \nbased on any C onfidential Information, the use thereof, errors therein, or omissions there from. 5. Remedies . The Parties understand and agree that money damages  may not be a sufficient \nremedy for any breach of this Agreement by it or by its Representatives and that the  Disclosing Party shall \nbe entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, \nto remedy such breach. Such remedy shall not be deemed to be the exclusive remedy for any such breach \nof this Agreement bu t shall be in addition to all other remedies available at law or in equity, including but \nnot limited to money damages. The Parties further acknowledge and agree that the covenants contained \nherein are necessary for the protection of legitimate business i nterests and are reasonable in scope. No \nfailure or delay in exercising any right, power, or privilege under this Agreement shall operate as a waiver \nthereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the \nexercise of any right, power, or privilege under this Agreement. 6. Solicitation of Employees . Unless otherwise provided in any subsequent written agree -\nment regarding a Potential Transaction, for a period of two years following the Effective Date of  this \nAgreement, each Party agrees, on behalf of itself and its Representatives, not to directly hire, employ, or \notherwise contract with, any of the other Party\u2019s, including any parent companies or subsidiaries, \nemployees, agents, or other persons who the n have, or who have had within the preceding three months, \nemployment with the Party or its parent or affiliates, and with whom it has had contact or who became \nknown to it in connection with this Agreement or its consideration of a Potential Transaction.",
        "id": "qa_16"
    },
    {
        "question": "What actions must be taken if a party becomes aware of a data breach according to the MSA?",
        "options": {
            "A": "Notify the regulatory authorities immediately and cease communication with the other party.",
            "B": "Delay notifying the other party until a full investigation is complete.",
            "C": "Promptly notify the other party and meet to discuss the next steps regarding investigation and handling of the breach.",
            "D": "Promptly notify the other party and then handle the breach independently."
        },
        "correct_answer": "C",
        "explanation": "The MSA requires that the party aware of the breach must promptly notify the other party, and both parties should meet to discuss appropriate next steps for investigation and handling, including compliance with the Privacy Act.",
        "source": "s3://ml-legal-restricted/contract-docs/73278/ACA - Cotiviti Australia - MSA - JK - 10052023 - Dynamics_73278.pdf",
        "client": "ACA Health Benefits Fund",
        "document_type": "MSA",
        "context": "7.7 Data Breach  \n7.8 Where either party becomes aware of any actual or suspected Data Breach: \n(a) that party must promptly notify the other party of the Data Breach (Data Breach \nNotice); \n(b) the parties will meet as soon as practicable discuss in good faith appropriate next \nsteps regarding investigation and handling of the Data Breach, including the parties\u2019 \nrespective responsibilities including, without limitation, mandatory requirements for \ndata breach notification in accordance with the Privacy Act ; and \n(c) each party must provide all reasonable assistance to the other to ensure each party is \nin compliance with its obligations under the Privacy Act. 8. Confidentiality  \n8.1 Except to the extent expressly permitted or required by this Agreement, a party must not use \nor disclose the other party's Confidential Information. 8.2 A party may use or disclose the Confidential Information of the other party to the extent \nreasonably required to enable it to comply with its obligations or exercise its rights under this \nAgreement. 8.3 A party may disclose the Confidential Information of the other party: \n(a) when required to do so by law or any regulatory authority, including any stock \nexchange on which it or any other member of its Group is listed; and \n(b) to its Personnel whose duties reasonably require such disclosure, on condition that the party making such disclosure: \n(i) ensures that each such person to whom such disclosure is made is informed of \nthe confidentiality of the information and the obligations of confidentiality \nunder this Agreement; and \n(ii) ensures that each such person to whom such disclosure is made complies with \nthose obligations as if they were bound by them. 8.4 A party must not disclose the terms of this Agreement to any other person, except in \naccordance with this clause 8. 8.5 Each party must establish and maintain effective security measures to prevent any \nunauthorised use or disclosure of, or unauthorised access, loss or damage to, the Confidential \nInformation of the other party.",
        "id": "qa_17"
    },
    {
        "question": "Under the NDA, when do the obligations regarding Confidential Information cease to apply?",
        "options": {
            "A": "When the receiving party independently develops the information without reference to the Confidential Information",
            "B": "When the receiving party sells the information to a competitor",
            "C": "When the information is disclosed to a third party",
            "D": "When the receiving party uses the information for its own purposes"
        },
        "correct_answer": "A",
        "explanation": "The NDA specifies that obligations cease when the receiving party independently develops the information without use of or reference to the Confidential Information.",
        "source": "s3://ml-legal-restricted/contract-docs/67562/Advise Insurance - Cotiviti - NDA - SK - 03042022 - Dynamics_67562.pdf",
        "client": "Advise Insurance",
        "document_type": "NDA",
        "context": "The receiving party\u2019s obligations hereunder will not apply, \nor will cease to apply, to that Confidential Information \nwhich the receiving party can establish (i) is or hereafter \nbecomes generally known or available to the public or \ninterested persons throug h no breach of this Agreement by \nthe receiving party; (ii) is rightfully known to the receiving \nparty without restriction on disclosure at the time of its \nreceipt from the disclosing party; (iii) is rightfully \nfurnished to the receiving party by a third pa rty without \nbreach of an obligation of confidentiality; (iv) is \nindependently developed by the receiving party without \nuse of or reference to the Confidential Information; (v) is \nrequired to be disclosed pursuant to the order of a court, \nadministrative age ncy or other governmental body \n(provided that the receiving party shall give the disclosing party reasonable notice prior to such disclosure and shall \ncomply with any applicable protective order or equivalent); \nor (vi) is approved for release by written au thorization of \nthe disclosing party. 2. Obligations of receiving party . The receiving party will \nprotect Confidential Information by using at least the same \ndegree of care, but no less than a reasonable degree of care, \nto prevent the unauthorized disclosure of such Confidential \nInformation as the receiving party uses to pro tect its own \nconfidential or proprietary information. The receiving \nparty will neither disclose nor copy Confidential \nDisclosure except as necessary for its employees, agents or \ncontractors with a need to know, provided that any such \nemployee, agent or co ntractor shall have agreed in writing, \nas a condition to his or her employment or engagement or \nin order to obtain Confidential Information, to be bound by \nnon-disclosure and non -use obligations substantially \nsimilar to this Agreement.",
        "id": "qa_18"
    },
    {
        "question": "What is the permitted use of Confidential Information under the NDA?",
        "options": {
            "A": "To reverse engineer prototypes to improve own products.",
            "B": "To disclose to third parties for marketing purposes.",
            "C": "To evaluate a business relationship with the disclosing party.",
            "D": "To develop new products independently."
        },
        "correct_answer": "C",
        "explanation": "The NDA specifies that Confidential Information can only be used to assess the products/services of the disclosing party to determine if they meet the receiving party's needs, which is defined as the \"Permitted Use\".",
        "source": "s3://ml-legal-restricted/contract-docs/67562/Advise Insurance - Cotiviti - NDA - SK - 03042022 - Dynamics_67562.pdf",
        "client": "Advise Insurance",
        "document_type": "NDA",
        "context": "Any copies which ar e made will \nbe identified as belonging to the disclosing party and shall \nbe reproduced with the disclosing party\u2019s proprietary rights \nnotices in the same manner in which such notices appear in \nthe original copy provided by the disclosing party. The \nreceiv ing party will not disassemble, decompile or reverse \nengineer any prototypes, software or other tangible objects \nwhich embody Confidential Information. The receiving \nparty will not use the Confidential Information for any \npurpose except to evaluate a busi ness relationship with the \ndisclosing party or otherwise in pursuance of such a \nrelationship. The receiving party will use the Confidential \nInformation solely for the purpose of assessing the \nproducts/services of the disclosing party to determine \nwhether those products/services meet the receiving party's \nneeds (\"Permitted Use\"), and for no other purpose. The \nreceiving party will not disclose Confidential Information \nto any third party without the prior written consent of the \ndisclosing party. This Agreem ent shall not be construed in any manner to be \nan obligation to enter into a subcontract or contract or to \nresult in any claim whatsoever by one Party against the \nother for reimbursement of cost for any efforts expended. Except as specifically set forth he rein, this Agreement does \nnot: (i) restrict either Party from developing new products, \nimproving existing products, or marketing any new, \nimproved or existing products; or (ii) commit either Party \nto disclose any particular information, or to develop, make , \nDocuSign Envelope ID: 7B7BFB2B-38B6-4A1A-AD79-3B4CACB0A43A\n \nPage 2 of 3 use, buy, sell, or otherwise dispose of any existing or future \nproducts, or to favor or recommend any product or service \nof the other. To be binding, any such restriction or \ncommitment must be in writing and signed by both parties. 3.",
        "id": "qa_19"
    },
    {
        "question": "What is included in the Technical Specification Document according to the Work Order / Change Request?",
        "options": {
            "A": "Only Roles and Responsibilities",
            "B": "System Access Requirements and Data Mapping Requirements",
            "C": "Functional and Technical Design Requirements such as Scope and Business Parameters",
            "D": "B and C are both included"
        },
        "correct_answer": "D",
        "explanation": "The Technical Specification Document includes Roles and Responsibilities, System Access Requirements, Data Mapping Requirements, Functional and Technical Design Requirements such as Scope, Business Parameters, Bypasses, Custom Component Requirements, and Exclusions.",
        "source": "s3://ml-legal-restricted/contract-docs/72908/NBFHHSE - Cotiviti - WO 1 TO SOW 2 - MS - 12112023 - Dynamics_72908.pdf",
        "client": "1199 SEIU National Benefit Funds",
        "document_type": "Work Order / Change Request",
        "context": "Client  receives  clinical  chart  validation  solution  recommendation  data back from \nCotiviti;   \nc. Client  re-adjudicates  claims  back from Cotiviti  to apply  the clinical  chart  validation  \nsolution  recommendations;    \nd. Client  offsets  or collects  upon  overpayments  based  upon  the clinical  chart  validation  \nrecommendations  where  appropriate ; and  \nd. Cotiviti  receives  and processes  paid claims  history  data. Deliverables  \nDeliverables for WO#1 to SOW#2 include:  \n\u2022 High Level Workflows/Process Documents  \n\u2022 Technical Specification Document which will include:  \no Roles and Responsibilities , System Access Requirements , Data Mapping \nRequirements  and Crosswalks  \no Functional  and Technical  Design Requirements such as  Scope , Business \nParameters, Bypasses Custom Compon ent Requirements, and Exclusions  \n\u2022 Interface Code including any Custom Components / Code as per the Technical \nSpecification Document  \n\u2022 Interface Code Transition  \n \nHigh Level Roles and Respons ibility  Definition \n \nDevelopment Environment Access  \n \nTask Client  Cotiviti  \n1. Provide Access to Cotiviti Developers  \n X  \n2. Load Test Data into Development Environment, if needed  X  \n \nHigh Level Requirements / Design  \nJoint Design Sessions (7 -10 Design Meetings with Cotiviti, IT, and Business)  \n \nTask Client  Cotiviti  \n1. High level interface workflows  X X \n2. Mapping / Crosswalk requirements  X X \n3. To Be Adjudicated / Audited File requirements (Bypass, \nExclusions, etc.) X X \nDocuSign Envelope ID: 4776A02C-397E-465F-82F7-C0CBB6A8A78F\n4. Interface Design (Design Options,  Business  and Technical \nParameters, etc.) X X \n5. Operational Schedule (Job definition -Outbound and \nInbound Files)  X X \n6. Q & A Clarification (File Mapping, Reason Codes,  \nOperational Processes, etc.) X X \n7. Code Delivery Process definition  X X \n8.",
        "id": "qa_20"
    },
    {
        "question": "What is the duration of the confidentiality obligations after the expiration or termination of the agreement?",
        "options": {
            "A": "1 year after the Effective Date",
            "B": "3 years after the Effective Date",
            "C": "Until the agreement is terminated",
            "D": "2 years after the Effective Date"
        },
        "correct_answer": "B",
        "explanation": "The document states that the obligations regarding the use, protection, disclosure, return, and destruction of Confidential Information survive until three years after the Effective Date.",
        "source": "unknown",
        "client": "Ochsner Health System",
        "document_type": "unknown",
        "context": "To be binding, any such restriction or commitment must be in writing and signed by both parties. 7. NO WARRANT Y\n. Each Disclosing Party makes no representation or warranty as to the \naccuracy and completeness of any Confidential Information provided by it to the Receiving Party , \nand no liability shall result to a Disclosing Party from its use, except as set forth in a definitive agreement for the Purpose . Only the representations and warranties that are made in a definitive \nagreement for the Purpose , when, as, and if it is executed, and subject to such limitations and \nrestrictions as may be specified therein, shall  have any legal effect. 8. OWNERSHIP. Confidential Information shall remain the sole and exclusive property of \nthe Disclosing Party. Nothing in this Agreement shall be construed as granting to the Receiving Party any right, title or interest in or to any pat ent, trademark, license, copyright or other right of \nthe Disclosing Party. 9. TERM; SURVIVAL OF CERTAIN P ROVISIONS\n. Except as otherwise provided \nherein, t his Agreement shall be effective as of the Effective Date and applies to the discussions \nbetween the P arties that occur, and all Confidential Information disclosed , during its t erm. This \nAgreement shall expire on the third  (3rd) anniversary of the Effective Date. This A greement may \nbe terminated earlier by either P arty by giving the other P arty thirty (30) days advance written \nnotice of termination. Notwithstanding the foregoing, the obligations of each P arty regarding the \nuse, protection, disclosure, return and destruction of C onfidential Information of the other Party \nshall  survive until three (3) years after the Effective D ate. Any expiration or earlier termination of \nthis Agreement shall not release a P arty of breaches of this Agreement by it or its Representatives \noccurring prior thereto. 10. REMEDIES\n.",
        "id": "qa_21"
    },
    {
        "question": "What is permitted regarding the use of Confidential Information according to the agreement?",
        "options": {
            "A": "Using it in competitive products without restrictions",
            "B": "Using it for product development without restrictions",
            "C": "Sharing it freely with all employees",
            "D": "Using it for any third party\u2019s benefit with prior written approval"
        },
        "correct_answer": "D",
        "explanation": "The agreement allows the use of Confidential Information for a third party\u2019s benefit only with the prior written approval of an authorized representative.",
        "source": "unknown",
        "client": "Arthur J Gallagher & Co.",
        "document_type": "unknown",
        "context": "(c) To not use the other Party\u2019s Confidential Information directly or indirectly, in products or services \nwhich are competitive or may become competitive with the then present and foreseeable future \nproducts of the other Party. (d) Other than the limited use allowed by this Agreement, to not use the other Party\u2019s Confidential \nInformation for a Party\u2019s own or any third party\u2019s benefit without the prior written approval of an \nauthorized representative of the other Party for each such proposed use or instance. (e) To restrict access to the Confidential Information to only a Party\u2019s employees who clearly need \naccess to the Confidential Information to carry out the Purpose or obligations of this Agreement \nprovided however, said employees have signed a Confidentiality Agreement requiring substantially \nthe same restrictions and conditions contained herein. (f) To use all necessary and appropriate technical, administrative and physical safeguards to prevent \nthe use or disclosure of the other Party\u2019s Confidential Information other than as permitted hereby. PBD acknowledges that Company is obtaining the requested Information to provide Consultant with \ndata aggregation and analytics services. Notwithstanding anything to the contrary in this Agreement, \nCompany is expressly permitted to share the Information with Consultant and PBM Clients to \nprovide requested services. Furthermore, Company is expressly permitted to aggregate and de-\nidentify the data, and aggregate de-identified information for preparing commercially available \nnormative and benchmarking data, analysis and product development solely in furtherance of the \nPurpose of this Agreement and only for the benefit of PBM Client. 3. Non-Disclosure and Restriction of Use of PHI. With respect to PHI, the Parties agree as follows: \n(a) To accept and use the PHI disclosed by the Disclosing Party only for the Purpose set forth above \nand in accordance with the terms of PBD\u2019s business associate agreement with the PBM Client or \nCompany\u2019s business associate agreement with Consultant, as applicable.",
        "id": "qa_22"
    },
    {
        "question": "What does the Miscellaneous section of the MSA state regarding reliance on representations?",
        "options": {
            "A": "Parties can rely on written representations made after the Agreement.",
            "B": "Parties can rely on inducements from third parties.",
            "C": "Parties cannot rely on any representations outside of those expressly contained within the Agreement.",
            "D": "Parties can rely on oral representations made before the Agreement."
        },
        "correct_answer": "C",
        "explanation": "The Miscellaneous section states that each party acknowledges entering into the Agreement solely on the basis of the agreements and representations contained therein, and has not relied on any representations outside of those expressly contained within the Agreement.",
        "source": "s3://ml-legal-restricted/contract-docs/55945/Accenture - Cotiviti SubK Agmt (Jan 2017)[CURRENT].pdf",
        "client": "Accenture",
        "document_type": "MSA",
        "context": "12\n\f\nDocuSign Envelope ID: 3AF0521B-675E-4233-AD34-2EA07 2061145\n\n13, Miscellaneous. 13.1 Entire Agreement. As of the Effective Date, this Agreement, and any applicable Werk\nOrders, set forth the entire understanding between the parties with respect to the subject matter of\nthis Agreement and any applicable Work Order, and supersedes all prior agreements with respect\nto the subject matter of this Agreement for services performed by Subcontractor on or after the\nEffective Date. Each party acknowledges that it is entering into this Agreement solely on the\nbasis of the agrcements and representations contained herein, and that it has not relied upon any\nrepresentations, warranties, promises, or inducements of any kind, whether oral or written, and\nfrom any source, other than those that are expressly contained within this Agreement. Each\nparty acknowledges that it is a sophisticated business entity and that in entering into this\nAgreement it has had the opportunity to consult with counsel of its choosing. This Agreement\nmay be executed electronically and in any number of counterparts, each of which will be\nconsidered an original for all purposes, and all of which when taken together will constitute one\nagreement binding on the parties, notwithstanding that both parties are not signatories to the\noriginal or the same counterpart. Except as a Work Order may otherwise expressly provide, each\nWork Order will be a complete statement of its subject matter and wil! supplement and modify\nthe terms and conditions of this Agreement for the purposes of the corresponding scope of work\nonly. Nothing in this Agreement is intended or will be construed to confer on any party (other\nthan Accenture, Subcontractor, and the parties entitled to indemnification) any rights, benefits or\nremedies of any kind, and no other party will be deemed to be a third party beneficiary. 13.2. Modification.",
        "id": "qa_23"
    },
    {
        "question": "What restrictions are placed on the use of Confidential Information according to the NDA with 7-Eleven?",
        "options": {
            "A": "It must only be used for evaluating the Potential Transaction and cannot be disclosed without prior written consent.",
            "B": "It can only be used for marketing purposes related to the Potential Transaction.",
            "C": "It can be used for any commercial purpose as long as it remains confidential.",
            "D": "It can be shared with any third party if they agree to confidentiality."
        },
        "correct_answer": "A",
        "explanation": "The NDA specifies that Confidential Information must be kept strictly confidential and used only for evaluating the Potential Transaction, with disclosure requiring prior written consent.",
        "source": "s3://ml-legal-restricted/contract-docs/73385/7-Eleven - Cotiviti  - NDA - MS -  11152023 - Dynamics_73385.pdf",
        "client": "7-Eleven",
        "document_type": "NDA",
        "context": "Each  Party  agrees  as follows:  \n \n(a) Except as expressly provided in this Agreement, the Confidential \nInformation shall be kept strictly confidential and shall not, without the prior written consent of  \nthe Disclosing Party, be disclosed by the Nondisclosing Party or the Nondisclosing Party\u2019s \nRepresentatives, in any manner whatsoever, in whole or in part, and shall not be used by the \nNondisclosing Party or the Nondisclosing Party\u2019s Representatives, directly or indirectly, for any \npurpose other than evaluating the Potential  Transaction. Moreover, the Nondisclosing Party  will \ntransmit the Confidential Information only to those Representatives who need to know the Confidential Information for the purpose of evaluating the Potential Transaction, who are \ninformed by the Nondisclosing Party of the confidential nature of the Confidential Information, \nand who have agreed in writing to be bound by provisions no less restrictive than those \ncontained in  this Agreement. The Nondisclosing Party  shall be responsible for any  breach by its \nRepresentatives of the terms of this Agreement. (b) Without the prior written consent of the Disclosing Party, the \nNondisclosing Party shall not, and shall direct the Nondisclosing Party\u2019s Representatives not to, \ndisclose to any other Person (including any Affiliates or Representatives to which disclosure is \nnot expressly permitted by this Agreement) that the Confidential Information has been made \navailable, that discussions or negotiations are taking place concerning the Potential  \nTransaction, or any of the terms, conditions, or other facts with respect to the Potential Transaction, including the status thereof or the terms of this Agreement. (c) If either Party determines that it does not wish to enter into the Potential \nTransaction, it will promptly advise the other Party of that fact.",
        "id": "qa_24"
    },
    {
        "question": "What are the consequences if Accenture fails to deliver the Weekly Management Report within the prescribed time frame or with incorrect information?",
        "options": {
            "A": "$200 per calendar day for each day the report is late or incorrect",
            "B": "No penalty will be applied",
            "C": "$100 per calendar day for each day the report is late or incorrect",
            "D": "Termination of the contract"
        },
        "correct_answer": "A",
        "explanation": "The document specifies that the State may assess up to $200 per calendar day for each day the Weekly Management Report is late or contains incorrect information.",
        "source": "s3://ml-legal-restricted/contract-docs/55945/Accenture - Cotiviti SubK Agmt (Jan 2017)[CURRENT].pdf",
        "client": "Accenture",
        "document_type": "MSA",
        "context": "his report is used te moniter the Vendor's claims\nprocessing function and must be delivered to the State Agency within five (5} State Working Days\nafter the last day of the week covered by the report. The report must be ina fermat approved by\nthe State, and must include at a minimum:\n\n\u00a9 Claims received last week, month to date, and year to date; # claims processed\n\nlast week, month to date, and year to date;\n\n* Cycle time last week, month to date, and year to date;\n\n\u00ab Claims aged inventory by specialty group designated by the State;\n\ns Claims on hold or pending adjustment; and\n\n\u00ab Suspense locations. Liquidated Damages: The State may assess up to $200 per calendar day for each day the Weekly\nManagement Report is late. ifthe Report is received within the prescribed time frames but does\nnot contain one or more of the prescribed elements or if the information reported is incorrect, the\nState may assess up te $200 per calendar day until all required elements are included in the Report\nor until the data reported is accurate. General Operations-Reporting {GOC-34):\n\nPerformance Standard: Provide a monthly progress and slatus report, organized by program, with\ncontent and ina media and format approved by the State. Submit to the State by the 20th calendar\nday of the following month. Liquidated Damages: The State may assess up to $200 per calendar day for each day the Monthly\nStatus Report is late. Lf the Report is received within the prescribed time frames but does not\ncontain one or more of the prescribed elements or if the. information reported is incorrect, the State\nmay assess up to $200 per calendar day until all required elements are included in the Report or\nuntil the data reported is accurate,\n\nGeneral Operations-Reperting (GOC-36):\n\nPerformance Standard: Submit a monthly monitoring report on the performance areas listed in\nIndex A of the Prime Contract by the 15\" business day of each month.",
        "id": "qa_25"
    },
    {
        "question": "What does the NDA specify about the ownership of Confidential Information?",
        "options": {
            "A": "Confidential Information becomes joint property of both parties.",
            "B": "Ownership of Confidential Information is transferred to the Receiving Party.",
            "C": "The Receiving Party gains partial ownership of the Confidential Information.",
            "D": "Confidential Information remains the sole property of the Disclosing Party."
        },
        "correct_answer": "D",
        "explanation": "The NDA clearly states that Confidential Information shall remain the sole and exclusive property of the Disclosing Party.",
        "source": "s3://ml-legal-restricted/contract-docs/72710/Abarca Health - Cotiviti - NDA - MS - 08312023 - Dynamics_72710.pdf",
        "client": "Abarca Health LLC",
        "document_type": "NDA",
        "context": "1839) shall continue for so long as such information qualifies as a trade secret. 8. Compensation. The Receiving Party shall not be obligated to compensate the Disclosing Party for \nConfidential Information (except as may result from a breach of this Agreement) and the Receiving Party acknowledges \nand understands that no warranties of any kind are given  by the Disclosing Party with respect to the accuracy or \ncompleteness of the Confidential Information. 9. Ownership. Confidential Information shall remain the sole and exclusive property of the Disclosing Party. Nothing in this Agreement shall be construed as  granting to the Receiving Party any right, title or interest in or to any \npatent, trademark, license, copyright or other right of the Disclosing Party. 10. Relationship of the parties . Nothing in this Agreement shall be deemed to create, either express or imp lied, \nthe power in either Party to bind the other. Neither Party shall be bound by the actions of the other, shall be liable for \nDocuSign Envelope ID: 32A31026-DCD7-4F16-8BB6-2BC6BBBCBB05\nDocuSign Envelope ID: 1DEE5668-B8FB-46FA-AC28-81978C0F8267\n \n\u00a9 2018 Cotiviti , Inc. CONFIDENTIAL AND PROPRIETARY  3 \nthe debts of the other, or shall have a right to share in the profits of the other. This Agreement is not intended to be a \njoint venture, partnership or other formal business organization, and neither Party is under any obligation to enter into \nany further agreement with the other Party. 11. Mutual Representations. Each Party represents that it has the right to disclose its Confidenti al Information \nin furtherance of the purpose set forth above without violating any agreement with or right of any other person. Confidential Information may include information of a third party provided that the third party has authorized such \ndisclosure. 12. No Further Obligation  or Limitation .",
        "id": "qa_26"
    },
    {
        "question": "What actions must the contractor take when receiving a request for access or amendment of PHI?",
        "options": {
            "A": "Amend the PHI directly without involving HHS.",
            "B": "Promptly forward the request to HHS or notify HHS if forwarding violates HIPAA.",
            "C": "Immediately respond to the request without notifying HHS.",
            "D": "Forward the request to the individual who made it."
        },
        "correct_answer": "B",
        "explanation": "The contractor must promptly forward the request to HHS or notify HHS if forwarding the request would violate HIPAA, according to the legal text.",
        "source": "s3://ml-legal-restricted/contract-docs/66241/Accenture - Cotiviti - DUA - JK - 05232022 - Dynamics_66241.pdf",
        "client": "Accenture",
        "document_type": "DUA",
        "context": "C ONTRACTOR 'S DUTIES REGARDING CONFIDENTIAL INFORMATION  \nSection 3.01 Obligations of Contractor  \nContractor agrees that:  \n(A) With respect to PHI, Contractor  shall:\n(1) Make  PHI available  in a designated  record  set if requested  by HHS,  if Contractor  maintains  PHI\nin a designated record set, as defined in  HIPAA . (2) Provide to HHS data aggregation services related to the healthcare operations Contractor\nperforms for HHS pursuant to the Agreement , if requested by HHS, if Contractor provides data aggregation \nservices as defined in HIPAA . (3) Provide access to PHI to an individual who is requesting his or her own PHI, or such\nindividual\u2019s Legally Authorized Representative , in compliance with the require ments of  HIPAA . (4) Make PHI available to HHS for amendment, and incorporate any amendments to PHI that\nHHS directs, in compliance with  HIPAA. (5) Document and make available to HHS, an accounting of disclosures in compliance with the\nrequirements of  HIPAA . (6) If Con tractor receives a request for access, amendment or accounting of PHI by any\nindividual, promptly forward the request to HHS or, if forwarding the request would violate HIPAA , promptly \nnotify HHS of the request and of Contractor\u2019s response. HHS will respon d to all such requests, unless \nContractor is Required by Law  to respond or HHS has given prior written consent for Contractor to respond \nto and account for all such  requests. (B) With respect to ALL Confidential Information , Contractor  shall:\n(1) Exercise  reasonable  care and no less than the same  degree  of care Contractor  uses to protect its\nown confidential, proprietary and trade secret information to prevent Confidential Information  from being  \nused in a manner  that is not expressly  an Authorized  Purpose  or as Required  by Law.",
        "id": "qa_27"
    },
    {
        "question": "Under what circumstances can Community First request Business Associate to use or disclose PHI?",
        "options": {
            "A": "In any manner deemed necessary by Community First",
            "B": "In any manner that enhances business operations",
            "C": "Only in ways permissible under the Privacy Rule",
            "D": "Only for marketing purposes"
        },
        "correct_answer": "C",
        "explanation": "Community First is restricted by legal agreements to only request PHI usage or disclosure in ways that are permissible under the Privacy Rule, the Security Rule, HITECH, or any other applicable law.",
        "source": "unknown",
        "client": "Community First Health Plans",
        "document_type": "unknown",
        "context": "Community First shall notify Business Associate as soon \nas practicable of any restriction to the use or disclosure of PHI that Community First h as agreed to \nin accordance with 45 CFR \u00a7164.522, to the extent that such limitation may affect Business \nDocuSign Envelope ID: CC6F7891-FCD3-4A9F-B775-815EC2BFDD28\nPage  7 of 12 \nBAA  2023  -6.2023   Associate\u2019s use or disclosure of PHI. VI. Permissible  Requests  by Community  First  \n \nCommunity First shall not request Business Associate to use or disclose PHI in any manner that \nwould  not be permissible under  the Privacy Rule,  the Security  Rule,  HITECH  or any other  applicable \nlaw or regulation if done by Community First. VII. Terms  and Termination  \n \nA. Termination. This Agreement  shall  terminate  when  1) federal  and/or  state  law no longer  requires \nthe Agreement;  or 2) all of the PHI provided  by Community  First  to Business  Associate,  or created \nor received by Business Associate on behalf of Co mmunity First, is destroyed or returned to \nCommunity First, or, if it is infeasible to return or destroy PHI, protections are extended to such \ninformation, in accordance with the termination provisions in  \nDocuSign Envelope ID: CC6F7891-FCD3-4A9F-B775-815EC2BFDD28\nPage  8 of 12 \nBAA  2023  -6.2023   this Section. In the event  it is determined  that the PHI can be destroyed,  then Business Associate \nshall destroy all paper, film or other hard copy media by shredding or destruction, and destroy \nelectronic media by clearing, purging or destruction so that the PHI cannot be retrieved, and \nBusiness Associate shall certify in writing to Community First that such PHI has been destroyed  \nupon request by Community First . B. Termination  for Cause .",
        "id": "qa_28"
    },
    {
        "question": "What rights does the Business Associate have regarding the ownership of PHI?",
        "options": {
            "A": "The Business Associate shares ownership rights of PHI with MPHC",
            "B": "The Business Associate can acquire ownership rights to PHI after fulfilling obligations",
            "C": "The Business Associate has full ownership rights to PHI",
            "D": "The Business Associate has no ownership rights to PHI"
        },
        "correct_answer": "D",
        "explanation": "The document states that the PHI and any related information remain the property of MPHC, and the Business Associate acquires no ownership rights to or title in PHI.",
        "source": "unknown",
        "client": "Martin's Point Health Care",
        "document_type": "unknown",
        "context": "The respective rights and obligations of the Partics under this Agreement shall by\ntheir nature survive the expiration, cancellation or termination of all contracts, or agreements\nbetween the Parties, pursuant to which PHI is disclosed to or used by the Business Associate. Without limiting the generality of the preceding sentence, Business Associate\u2019s obligation to\nprotect the privacy and security of PHI shall be in accordance with any and all applicable law. 7. Compliance with Existing Law. Business Associate acknowledges and agrees that, as of the\neffective dates for such provisions, Business Associate shall comply with each provision of\nHIPAA, the HITECH Act, or other applicable law, that extends a HIPAA requirement to\nBusiness Associate. The Parties shall take any further action, including amendment of this\nAgreement, required to ensure continued compliance with HIPAA, the HITECH Act, and any\nother applicable federal or state law as amended. Business Associate may terminate any\nwritten services agreement upon thirty (30) days written notice in the event Business\nAssociate does not take such action to ensure compliance with applicable federal and state\nlaw as amended. 8. Ownership of PHI. The PHI and any related information created for or received from\nMPHC is, and will remain, the property of MPHC, including any and all forms thereof\ndeveloped by Business Associate in the course of fulfilling its obligations pursuant to this\nAgreement. Business Associate agrees that it acquired no ownership rights to or title in PHI\nor any related information. 9, Amendments. This Agreement may not be modified, nor shall any provision hereof be\nwaived or amended, except in a writing duly signed by an authorized representative of the\nParties. A waiver with respect to one event shall not be construed as continuing, or as a\nwaiver of any right or remedy as to any other event. The Parties agree to take such action as\nis necessary to amend this Agreement from time to time to comply with the requirements of\nHIPAA and HITECH and any other laws or regulations that apply. 10.",
        "id": "qa_29"
    },
    {
        "question": "What is the requirement for data destruction of ACS PHI or PI according to Accenture's BAA?",
        "options": {
            "A": "Data must be wiped using the US Department of Defense (DoD) 5220.22-M standard only.",
            "B": "Data must be wiped using the Gutmann standard or US Department of Defense (DoD) 5220.22-M (7 Pass) standard, or by degaussing.",
            "C": "Data must be stored indefinitely without destruction.",
            "D": "Data can be destroyed using any method without prior approval."
        },
        "correct_answer": "B",
        "explanation": "Accenture's BAA specifies that ACS PHI or PI must be wiped using the Gutmann or US Department of Defense (DoD) 5220.22-M (7 Pass) standard, or by degaussing, ensuring secure data destruction.",
        "source": "s3://ml-legal-restricted/contract-docs/55946/BAA - ACS (March 2012)[CURRENT].pdf",
        "client": "Accenture",
        "document_type": "BAA",
        "context": "Username must be promptly disabled, deleted, or the password\nchanged upon the transfer or termination of an employee with knowledge of the password,\nat maximum within 24 hours. Passwords are not to be shared. Passwords must be at least\neight characters and must be a non-dictionary word. Passwords must not be stored in\nreadable format on the computer. Passwords must be changed every 60 days, preferably\nevery 60 days. Passwords must be changed if revealed or compromised. Passwords must\nbe composed of characters from at least three of the following four groups from the standard\nkeyboard:\n\nUpper case letters (A-Z)\n\nLower case letters (a-z)\n\nArabic numerals (0-9)\n\nNon-alphanumeric characters (punctuation symbols)\n\nData Destruction. When no longer needed, all ACS PHI or Pl must be wiped using the\nGutmann or US Department of Defense (DoD) 5220.22-M (7 Pass) standard, or by\ndegaussing. Media may also be physically destroyed in accordance with NIST Special\nPublication 800-88. Other methods require prior written permission of the ACS Information\nSecurity Office. System Timeout. The system providing access to ACS PHI or Pl must provide an\nautomatic timeout, requiring re-authentication of the user session after no more than 20\nminutes of inactivity. Warning Banners. All systems providing access to ACS PHI or Pl must display a warning\nbanner stating that data is confidential, systems are logged, and system use is for business\npurposes only by authorized users. User must be directed to log off the system if they do\nnot agree with these requirements. System Logging. The system must maintain an automated audit trail which can identify the\nuser or system process which initiates a request for ACS PHI or Pl, or which alters ACS PHI\nor Pl.",
        "id": "qa_30"
    },
    {
        "question": "According to the document, how often can audits be conducted to ensure compliance with Data Protection Laws?",
        "options": {
            "A": "Annually",
            "B": "Monthly",
            "C": "Biannually",
            "D": "Quarterly"
        },
        "correct_answer": "A",
        "explanation": "The document specifies that audits can be conducted not more than once annually, unless required by applicable Data Protection Laws or in case of a security incident or reasonable suspicion of non-compliance.",
        "source": "unknown",
        "client": "Albertsons Companies, Inc.",
        "document_type": "unknown",
        "context": "5.1 Company will implement, prior to executing this DPA, and maintain current and reasonable technical and organizational security measures appropriate to the nature of the Personal Data Processed as required by applicable Data Protection Laws, or otherwise necessary to adequately protect Personal Data against Data Incidents, and in accordance with any applicable standards,  5.2 Company will treat Personal Data as confidential and ensure access by only its personnel who need to know and are contractually or legally bound to confidentiality obligations at least as protective of Personal Data as this DPA. Where there are pre-existing agreements (such as a non-disclosure agreement) or the Parties subsequently enter into an agreement containing confidentiality terms, then the agreement or terms which provide the greatest protection of Personal Data will supersede and control. 6. AUDITS AND DATA PROTECTION IMPACT ASSESSMENTS. 6.1 Unless required by applicable Data Protection Laws, or in case of a security incident or reasonable suspicion of non-compliance with this addendum, not more than once annually, Company will make all required information and records related to the product or services provided under this Agreement available to demonstrate compliance with Data Protection Laws  and the obligations set out in this DPA. Where an audit identifies any shortcomings or non-compliance, the Company agrees to remediate any agreed-upon deficiencies within the timelines agreed upon by the parties.",
        "id": "qa_31"
    },
    {
        "question": "What is the duration of the Nondisclosing Party\u2019s obligations for Confidential Information that constitutes a trade secret under applicable law according to the NDA?",
        "options": {
            "A": "Three years after disclosure",
            "B": "Indefinitely regardless of trade secret status",
            "C": "For as long as the information remains a trade secret under applicable law",
            "D": "Until all agreements between the Parties are terminated"
        },
        "correct_answer": "C",
        "explanation": "The NDA states that the Nondisclosing Party\u2019s obligations continue for as long as the information is considered a trade secret under applicable law.",
        "source": "s3://ml-legal-restricted/contract-docs/73385/7-Eleven - Cotiviti  - NDA - MS -  11152023 - Dynamics_73385.pdf",
        "client": "7-Eleven",
        "document_type": "NDA",
        "context": "The term of this Agreement shall begin on the Effective Date and end on \nthe later of (i)  three (3) years, or (ii)  the termination of all agreements between the Parties; \nprovided, however, that the Nondisclosing Party\u2019s obligations under this Agreement shall continue for three (3) years after the applicable Confidential Information is disclosed to such \nParty, or for Confidential Information that constitutes a trade secret under applicable law, the \nNondisclosing Party\u2019s obligations under this Agreement shall continue for so long as such \ninformation constitutes a trade secret under applicable law. 10. Execution of Document. The Parties agree that the execution of this document \nmay be accomplished in one or more counterparts and electronically (e.g., DocuSign) or by \nfacsimile or PDF and the Parties agree that electronic, facsimile, or PDF copies will be valid, original  documents  and that, taken together, counterparts  shall constitute  an original  copy  of this \nAgreement. 11. Severability. If any term or provision of this Agreement is invalid, illegal, or \nunenforceable in any jurisdiction, such  invalidity,  illegality,  or unenforceability  shall not affect any \nother term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. 12. Governing Law; Venue. The validity, terms, and conditions of this Agreement, \nas well as the Parties\u2019 performance hereunder, shall be governed by the laws of the State of \nTexas, exclusive of the conflict-of-laws provisions thereof or elsewhere that would cause the \napplication of the laws of any jurisdiction other than the State of Texas.",
        "id": "qa_32"
    },
    {
        "question": "What must the Receiving Party do with Confidential Information upon termination of the agreement or upon request from the Disclosing Party?",
        "options": {
            "A": "Retain all documents and materials for future reference.",
            "B": "Destroy or deliver all documents and materials, except for a single archival copy retained by the legal department.",
            "C": "Store all documents and materials indefinitely on backup media.",
            "D": "Convert all documents and materials into non-confidential information."
        },
        "correct_answer": "B",
        "explanation": "The document specifies that upon termination or request, the Receiving Party must destroy or deliver all Confidential Information, retaining only a single archival copy for legal dispute resolution purposes.",
        "source": "unknown",
        "client": "Maryland Physicians Care (MPC)",
        "document_type": "unknown",
        "context": "CONFIDENTIAL  AND  PROPRIETARY  2  \n documented  by the Receiving  Party  with written  records. Each  Party  has the right  to refuse  to accept  any trade  secret, \nConfidential Information or similar proprietary information prior to full disclosure. 4. Latent  Data. Latent  Data,  which  is Confidential  Information,  shall  be subject  to destruction  in due course  but \nshall  remain Confidential Information of  the Disclosing Party until it is  destroyed. \u201c Latent  Data\u201d refers to  data  that is \nstored  by a party  on routine  back -up media,  including  but not limited  to deleted  files and other  non-logical  data  types, \nmemory  dumps,  swap  files,  temporary  files,  printer  spool  files and metadata  that can customarily  be retrieved  only  by \ncomputer  forensics  experts  and is generally  considered  inaccessible  without  the use of specialized  tools  and techniques. 5. Return  of Confidential  Information. Subject  to Section  3, \u201cExceptions,\u201d  above,  promptly  following  the earlier \nof (i) the termination  of this Agreement,  or (ii) the written  request  of Disclosing  Party,  the Receiving  Party  shall  destroy \nor deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party \nconstituting  or containing  Confidential  Information,  together  with  all copies  thereof,  including  all electronic  and digital \ncopies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving \nParty's legal department for dispute resolution purposes only, and except for electronically -stored Confidential \nInformation contained in an archived computer system backup in accordance with Receiving Party\u2019s generally \napplicable  security  and disaster  recovery  procedures. Upon  receipt  of such  a request,  the Receiving  Party  shall  destroy \nall other documents and materials constituting Confidential Information in its possession to the extent reasonably \npracticable. Upon request, the Receiving Party shall document such destruction in writing to the Disclosing Party. 6. Protected Health Information. If any part of the Confidential Information disclosed hereunder is protected \nhealth information pursuant to the Federal Health Insurance Portability and Accountability Act of 1996, Pub. L. No.",
        "id": "qa_33"
    },
    {
        "question": "Under what conditions can a party assign its rights and obligations under this agreement without prior written consent from the other party?",
        "options": {
            "A": "Assignment is allowed if the successor in ownership expressly assumes the agreement terms in writing.",
            "B": "Assignment can occur freely without any conditions.",
            "C": "Assignment is never allowed without prior written consent.",
            "D": "Assignment is allowed only if both parties agree verbally."
        },
        "correct_answer": "A",
        "explanation": "The agreement permits assignment to a successor in ownership of substantially all assets if the successor expressly assumes the agreement terms in writing.",
        "source": "unknown",
        "client": "Ochsner Health System",
        "document_type": "unknown",
        "context": "BH 546 \nNew Or leans, LA 70121  \nAttn: Scott Posecai  \n \nwith a copy to:   Office of Legal Affairs  \nOchsner Health Plan  \n1450 Poydras Street, Suite 2250 \nNew Orleans, LA 70112  \nAttn: General Counsel  \n \nAny notice given pursuant or with respect to this Agreement shall be deemed received (i) on the date such notice is hand -delivered to an authorized representative of the P arty receiving such \nnotice, (ii) on the first business day following the date on which such notice is sent prepaid for \nnext-day delivery by nationally rec ognized overnight delivery service, or (iii) on the third \nbusiness day following the date on which such notice is sent by prepaid registered or certified \nU.S. mail, return receipt requested. 13. ASSIGNMENT . This Agreement shall be binding on and shall inure to the benefit of the \nparties hereto, their respective successors and assigns. This Agreement may not be assigned in \nwhole or in part by either Party without the prior written consent of the other Party. Any attempted \nassignment without such prior written consent shall be void and unenforceable. Notwithstanding the foregoing, either Party, without the prior written approval of the other Party, may assign its rights and obligations hereunder to a successor  in ownership of substantially all of the assets of the \nbusiness, provided that the successor expressly assumes in writing the performance of the terms and conditions of this Agreement. 14. COUNTERPARTS\n. This Agreement may be executed in two  or more counterparts, each \nof which shall be deemed an original, but all such counterparts together shall constitute but one and the same Agreement. 15. ENTIRE AGREEMENT\n. This Agreement contains the entire agreement of and \nsupersedes any and all prior understandings, arrangements, and agreements between the P arties \nhereto, whether oral or written, with respect to the subject matter hereof . 16. MODIFICATION.",
        "id": "qa_34"
    },
    {
        "question": "What is required before a Provider can file a legal proceeding against Blue Cross and Blue Shield of Nebraska?",
        "options": {
            "A": "A peer-to-peer discussion involving the Provider, Client, and Cotiviti",
            "B": "Cotiviti providing testimony at State Fair Hearings",
            "C": "Immediate filing without any discussions",
            "D": "Approval of process documented via email"
        },
        "correct_answer": "A",
        "explanation": "The contract requires a peer-to-peer discussion between the Provider, Client, and Cotiviti before the Provider can file a legal proceeding, including arbitration.",
        "source": "unknown",
        "client": "Blue Cross and Blue Shield of Nebraska",
        "document_type": "unknown",
        "context": "CONFIDENTIAL AND PROPRIETARY  Page 8  of 16 \nWhenever Client\u2019s contract with a Provider allows, Client will process overpayment claims as \noffsets to the provider\u2019s future remittances within thirty (30) days of validation by Client using \nsystem -generated offset scripting or other method as deemed acceptable by Client. Client shall require Providers to participate in, and Client will use reasonable efforts to facilitate, a \npeer-to-peer discussion between the Provider, Client, and Cotiviti prior to the Provider filing a legal \nproceeding, including, but not limited to, arbitration. Cotiviti support services will be performed remotely and Cotiviti knowledgeable resources shall not \nbe required to travel. Upon Client\u2019s reasonable request Cotiviti will provide, to the extent available, \nadditional knowledgeable resource support at the rat es set forth in the Additional Services fee table. Cotiviti support does not include providing testimony at State Fair Hearings, arbitration proceedings, \nor other similar proceedings (such testimony shall be provided by Client\u2019s in -house resources, such \nas a Client -employed medical director) . 7. Reconsiderations:  Cotiviti will support up to two (2) levels of Provider reconsiderations support and \ndeterminations on behalf of Client. Cotiviti will have a minimum of thirty (30) business days from \nthe date the reconsideration was provided to Cotiviti to complete review . The parties will agree on \na process, if required, for Client to provide to Cotiviti Provider reconsiderations information that \nProviders send to Client , which approval of process may be documented via email to the primary \ncontact on file .",
        "id": "qa_35"
    },
    {
        "question": "Under the agreement, how may the Receiving Party use the Disclosing Party's Confidential Information?",
        "options": {
            "A": "For personal use",
            "B": "Only for exercising rights and performing obligations related to the Potential Transaction",
            "C": "For disclosure to any Third Party without restriction",
            "D": "For any business purpose"
        },
        "correct_answer": "B",
        "explanation": "The agreement specifies that the Receiving Party may only use the Confidential Information for exercising its rights and performing obligations under the agreement related to the Potential Transaction.",
        "source": "unknown",
        "client": "Crumdale Partners - Better Benefits",
        "document_type": "unknown",
        "context": "\u201cConfidential Information \u201d means this Agreement and all information disclosed \nto, or otherwise acquired or observed by, a party and its employees and agents (\u201c Receiving Party \u201d), from the other \nparty and its employees and agents (\u201c Disclosing Party \u201d), relating to the business of the Disclosing Party, whether \ncommunicated in writing, verbally, electronically, photographically, or in recorded or any other form, including, but \nnot limited to, original and copies of all information disclosed under other contractual arrangements between the \nparties and their predecessors, subsidiaries and affiliates, intellectual property and trade secrets, sales and operating \ninformation, existing and potential business and marketing plans and strategies, financial information, cost and pricing \ninformation, data, media, know-how, designs, drawings, specifications, software programs, software documentation, \nsoftware source codes, technical information, concepts, inventions, reports, methods, processes, techniques, operations, \ndevices and the like, whether or not the foregoing information is patented, tested, reduced to practice, or subject to \ncopyright. No information of the Disclosing Party will be considered Confidential Information to the extent that an \nexception is provided for it in Section 3 herein. 2. Use and Disclosure of Confidential Information. The Receiving Party acknowledges that it will have access \nto the Disclosing Party\u2019s Confidential Information. The Receiving Party agrees that it will not (i) use any such \nConfidential Information in any way, except for the exercise of its rights and performance of its obligations under this \nAgreement in relation to the Potential Transaction, or (ii) disclose any such Confidential Information to any Third Party \nwithout the Disclosing Party\u2019s prior written permission. The Receiving Party agrees that it will not allow any \nunauthorized person access to the Disclosing Party\u2019s Confidential Information, and that the Receiving Party will take \nall action reasonably necessary to protect the confidentiality of such Confidential Information, including implementing \nand enforcing procedures to minimize the possibility of unauthorized use or copying of such Confidential Information.",
        "id": "qa_36"
    },
    {
        "question": "What is required from Vendor and/or Consultant when accessing the benefit administration systems?",
        "options": {
            "A": "Use commercially reasonable security measures",
            "B": "Share their access with other entities",
            "C": "Ignore the Company\u2019s security measures",
            "D": "Transfer their access rights to another party"
        },
        "correct_answer": "A",
        "explanation": "The document specifies that Vendor and/or Consultant must use commercially reasonable security measures to protect the confidentiality of user identification, passwords, and data accessed through the systems.",
        "source": "unknown",
        "client": "Boston Benefit Partners",
        "document_type": "unknown",
        "context": "Confidential Information shall not include\ninformation: G) generally available to the public prior to or during the time of the Services through authorized\ndisclosure; or (if) obtained from:a third party who is under no obligation to Company not to disclose such information\n\nC.. Systems Aevess: If Company grants Vendor and/or Consultant the right t\u00e9 access the benefit administration systems\nthat Company makes available to facilltate the transfer of Confidential Information (\u201cSystems\u201d) the following\nconditions apply. The Systems, and any documentation with respect-to the Systems, shall be treated as Proprietary\nInformation as defined in.this Agreement and subject to the sane confidentiality restrictions contained herein. This right\nis nonexclusive and nontransferable, and all rights, title and interest In the Systems remain Company\u2019s. Vendor and\nConsultant shall not share, lease or otherwise transfer. its right to access and tise the Systems to any other person or\nentity\n\ntn ateyssiny and using dhe Systems, Voodur and/or Consulint shall use commercially reasunable security micasuics,\nincluding, measures to protect: (a) the confidentiality of user Mentification and passwords and (b) data accessed through\nthe Systems from unauthorized access or damage, inchiding damage by computer viruses. Vender and/or Consultant\nalso agree to comply with our security measures of which we notify you. Vendor and/or Consultant will contact\nCompany immediately if (a) any breach of the security procedures is sispected or has oGeurred and/or (b) an employee\nno longer needs Systems access due to termination of employment, or otherwise, so that Company may deactivate the\nemployee's identification number or password\n\nCompany reserves the right to terminate the Vendor's and/or Consultant\u2019s Systems access at any time.",
        "id": "qa_37"
    },
    {
        "question": "Under the MSA agreement, to whom may the Client disclose Confidential Information, and under what conditions?",
        "options": {
            "A": "To any third party without restrictions",
            "B": "To employees of Advantmed India LLP and Optum Health \u2013 CDO with specific conditions",
            "C": "Only to Optum Health \u2013 CDO with no conditions",
            "D": "To any subcontractors without any prior permissions"
        },
        "correct_answer": "B",
        "explanation": "The Client may disclose Confidential Information to employees of Advantmed India LLP to the minimum extent necessary for SOW #1, and Optum Health \u2013 CDO only under specific conditions agreed upon in the MSA.",
        "source": "s3://ml-legal-restricted/contract-docs/74579/Advantmed, LLC - Cotiviti - MSA - DM - 08302024 - Dynamics_74579.pdf",
        "client": "AdvantMed",
        "document_type": "MSA",
        "context": "The Receiving Party agrees that it will not (i) use any such \nConfi dential Information in any way,  except for the exercise of its rights and performance of its obligations under \nthis Agreement  or for the purpose for which it was disclosed , or (ii) disclose any such Confidential Information to \nany third party  without the Disclosing Party\u2019s prior written permission . Notwithstanding the preceding sentence , (i) Cotiviti may disclose  Confidentia l Information to its  Representatives  \nand subcontractors who are required to have access to the Confidential Information in connection with the provision \nof a Solution  to or on behalf of Client , provided each  has agreed to restrictions no less stringent than Cotiviti  with \nregard to the use and disclosure of such Confidential Information , and (ii) Client may disclose Confidential \nInformation to employees of its wholly -owned subsidiary Advantmed India LLP  to the minimum extent necessary \nfor implementation and provision of the services under Statement of Work #1 for Risk Adjustment between the \nparties, to be executed contemporaneously herewith (\u201c SOW #1\u201d), provided such Advantmed India LLP employees \nhave agreed to restrictions no less stringent than Client  with regard to the use and disclosure of such Confidential \nInformation . Notwithstanding anything herein to the contrary, except for permitted disclos ures to Advantmed India LL P \nemployees pursuant to the preceding sentence, Client  may disclose only to the Optum Health \u2013 CDO business \nsegment only the following information: (i) periodic status reports  for the services performed under SOW #1 , strictly \nlimited to the number of records retrieved by Cotiviti under SOW #1  at a given point in time ; (ii) the minimum \nvolume commitment under SOW #1 ; and (iii) fees set forth in SOW #1 , provide d that Optum Health -CDO agrees to \nhold such pricing in strict confidence within the business segment and agrees  not further disclose such pricing.",
        "id": "qa_38"
    },
    {
        "question": "What must occur when either party becomes aware of a data breach according to the MSA?",
        "options": {
            "A": "The party must promptly notify the other party and meet to discuss next steps.",
            "B": "The party must immediately fix the breach without notifying the other party.",
            "C": "The party must ensure all personnel are informed of the breach before notifying the other party.",
            "D": "The party must notify the regulatory authorities before informing the other party."
        },
        "correct_answer": "A",
        "explanation": "The MSA specifies that the party must promptly notify the other party of the data breach and meet to discuss appropriate next steps.",
        "source": "s3://ml-legal-restricted/contract-docs/73278/ACA - Cotiviti Australia - MSA - JK - 10052023 - Dynamics_73278.pdf",
        "client": "ACA Health Benefits Fund",
        "document_type": "MSA",
        "context": "7.7 Data Breach  \n7.8 Where either party becomes aware of any actual or suspected Data Breach: \n(a) that party must promptly notify the other party of the Data Breach (Data Breach \nNotice); \n(b) the parties will meet as soon as practicable discuss in good faith appropriate next \nsteps regarding investigation and handling of the Data Breach, including the parties\u2019 \nrespective responsibilities including, without limitation, mandatory requirements for \ndata breach notification in accordance with the Privacy Act ; and \n(c) each party must provide all reasonable assistance to the other to ensure each party is \nin compliance with its obligations under the Privacy Act. 8. Confidentiality  \n8.1 Except to the extent expressly permitted or required by this Agreement, a party must not use \nor disclose the other party's Confidential Information. 8.2 A party may use or disclose the Confidential Information of the other party to the extent \nreasonably required to enable it to comply with its obligations or exercise its rights under this \nAgreement. 8.3 A party may disclose the Confidential Information of the other party: \n(a) when required to do so by law or any regulatory authority, including any stock \nexchange on which it or any other member of its Group is listed; and \n(b) to its Personnel whose duties reasonably require such disclosure, on condition that the party making such disclosure: \n(i) ensures that each such person to whom such disclosure is made is informed of \nthe confidentiality of the information and the obligations of confidentiality \nunder this Agreement; and \n(ii) ensures that each such person to whom such disclosure is made complies with \nthose obligations as if they were bound by them. 8.4 A party must not disclose the terms of this Agreement to any other person, except in \naccordance with this clause 8. 8.5 Each party must establish and maintain effective security measures to prevent any \nunauthorised use or disclosure of, or unauthorised access, loss or damage to, the Confidential \nInformation of the other party.",
        "id": "qa_39"
    },
    {
        "question": "What is the requirement for Business Associate when receiving a request, subpoena, or order to disclose PHI?",
        "options": {
            "A": "Business Associate must notify Covered Entity within 30 days.",
            "B": "Business Associate must notify Covered Entity within 5 days.",
            "C": "Business Associate must challenge the validity independently.",
            "D": "Business Associate must comply immediately without notification."
        },
        "correct_answer": "B",
        "explanation": "The legal document specifies that Business Associate must notify the Covered Entity within five (5) days of receipt of any request, subpoena, or order to disclose PHI.",
        "source": "unknown",
        "client": "Sierra Health Plan of Nevada",
        "document_type": "unknown",
        "context": "BusinessAssociate (and its agents or subcontractors) shall only request, use and disclose the\nminimum amount of PHI necessary to accomplish the purpose of the request, use or disclosure. 3.11 Notice of Request for Data. Business Associate agrees to notify Covered Entity within five (5) days of Business Associate\u2019s\n\nreceipt of any request, subpoena, or judicial or administrative order to disclose PHI. To the extent\nthe Covered Entity decides to assume responsibility for challenging the validity of such request,\n\nsubpoena or order, Business Associate agrees to cooperate with Covered Entity in such challenge. 4. Covered Entity\u2019s Obligations. 4.1 Notice of Privacy Practices. Covered Entity shall provide Business Associate with the notice of any privacy practices that\nCovered Entity produces in accordance with 45 CFR Section 64.520, as well as any changes to\nsuch notice. Business Associate shall not distribute its own notice, if any, to Individuals, without\nthe prior written consent of Covered Entity. 4.2 Revocation of Authorization by Individual. Covered Entity agrees to inform Business Associate of any change to, or revocation of, an\nIndividual\u2019s Authorization to use or disclose PHI to the extent that such change may affect\nBusiness Associate\u2019s use or disclosure of PHI, within a reasonable period of time after Covered\nEntity becomes aware of such change. 4.3 Restrictions on Use and Disclosure. Covered Entity agrees to notify Business Associate of any restrictions to the use or disclosure of\nPHI agreed to by Covered Entity in accordance with 45 CFR Section 164.522, to the extent that\nsuch restriction may affect Business Associate\u2019s use or disclosure of PHI. 4.4 Permissible Requests. Covered Entity shall not request Business Associate to use or disclose PHI in any manner that\nwould not be permissible under the Privacy Rule if done by Covered Entity. 4.5 Safeguards.",
        "id": "qa_40"
    },
    {
        "question": "What action must a user take if hardware and software requirements change for electronic disclosures?",
        "options": {
            "A": "Manually check the website for updated requirements without notification",
            "B": "Update their system according to the new requirements without notification",
            "C": "Continue using the current system without any changes",
            "D": "Receive an email notification and have the right to withdraw consent"
        },
        "correct_answer": "D",
        "explanation": "The document specifies that if hardware and software requirements change, users will receive an email notification and have the right to withdraw their consent.",
        "source": "unknown",
        "client": "Self Insured Services Co",
        "document_type": "unknown",
        "context": "send us an e -mail to legal@verscend .com and in the body of such request you must \nstate your e -mail, full name, IS Postal Address, telephone number, and account number. Required hardware and software   \nOperating Systems:  Windows2000\u00ac or WindowsXP\u00ac  \nBrowsers (for \nSENDERS):  Internet Explorer 6.0\u00ac or above  \nBrowsers (for \nSIGNERS):  Internet Explorer 6.0\u00ac, Mozilla FireFox 1.0, NetScape 7.2 (or above)  \nEmail:  Access to a valid email account  \nScreen Resolution:  800 x 600 minimum  \nEnabled Security \nSettings:  \u00f2 Allow per session cook ies \n\u00f2 Users accessing the internet behind a Proxy Server must enable HTTP \n1.1 settings via proxy connection  \n** These minimum requirements are subject to change. If these requirements change, we will \nprovide you with an email message at the email address w e have on file for you at that time \nproviding you with the revised hardware and software requirements, at which time you will have \nthe right to withdraw your consent. Acknowledging your access and consent to receive materials electronically   \nTo confirm to  us that you can access this information electronically, which will be similar to \nother electronic notices and disclosures that we will provide to you, please verify that you were \nable to read this electronic disclosure and that you also were able to print  on paper or \nelectronically save this page for your future reference and access or that you were able to e -mail \nthis disclosure and consent to an address where you will be able to print on paper or save it for \nyour future reference and access. Further, if you consent to receiving notices and disclosures \nexclusively in electronic format on the terms and conditions described above, please let us know \nby clicking the \u00e6I agree\u00c6 button below.",
        "id": "qa_41"
    },
    {
        "question": "What is the Receiving Party required to do with the Confidential Information upon request by the Disclosing Party?",
        "options": {
            "A": "Retain all Confidential Information but cease its use.",
            "B": "Destroy all Confidential Information except automatically generated backups.",
            "C": "Destroy all copies, including automatically generated backups.",
            "D": "Continue using Confidential Information but with increased security measures."
        },
        "correct_answer": "B",
        "explanation": "The Receiving Party must destroy all Confidential Information except for automatically generated computer backups, which must not be used and must be protected as per the agreement.",
        "source": "unknown",
        "client": "Wellth, Inc.",
        "document_type": "unknown",
        "context": "At any time upon the request \nof the Disclosing Party, the Receiving Party shall promptly (and in no event later than five business days \nafter such request) (i) destroy or cause to be destroyed all Confidential Infor mation in the possession or \ncontrol of the Receiving Party or its Representa tives confirm such destruction in writing to the Disclosing \nParty, provided, however, that the obligation to destroy such Confidential Information does not extend to \nautomatically generated computer back -up or archival copies generated in the ordinary cour se of Receiving \nParty\u2019s information systems procedures, provided that Receiving Party shall make no further use of such \ncopies and shall extend the protections of this Agreement to such Confidential Information for so long as \nthe Receiving Party maintains such Confidential Information. Notwithstanding the destruction of \nConfidential Information hereunder, the Receiving Party and its Representatives shall continue to be bound \nby their confidentiality and other obligations hereunder relating to such confident iality for the term of this \nAgreement and thereafter, without limitation. 4. No Representations or Warranties . Both Parties understand that the other has endeavored \nto include in the Confidential Information the information that it believes to be reliable a nd relevant for the \npurposes of the others use and consideration. The Parties acknowledge and agree that (a) no representation \nor warranty, express or implied, is made by the Disclosing Party or any of its Representatives as to the \naccuracy or completenes s of the Confidential Information, and (b)  the Receiving Party shall be entitled to \nrely only on those representations and warranties (if any) that may be made in a subsequent written \nagreement regarding a transaction, signed and delivered by both Parties , and then only to the extent, and \nsubject to the limitations, provided therein.",
        "id": "qa_42"
    },
    {
        "question": "What rights are included in the Business Associate Agreement regarding individuals' protected health information?",
        "options": {
            "A": "The right to obtain PHI in a paper format only",
            "B": "The right to audit and monitor activities involving PHI",
            "C": "The right to prevent any disclosure of PHI",
            "D": "The right to delete personal information permanently"
        },
        "correct_answer": "B",
        "explanation": "The Business Associate Agreement includes provisions for auditing and monitoring activities that involve protected health information (PHI), among other rights.",
        "source": "s3://ml-legal-restricted/contract-docs/72710/Abarca Health - Cotiviti - NDA - MS - 08312023 - Dynamics_72710.pdf",
        "client": "Abarca Health LLC",
        "document_type": "NDA",
        "context": "104-191 and its implementing regulations (collectively, \u201c HIPAA \u201d), as amended by the regulations promulgated \npursuant to the Health Information Technology for Economic and Clinical Health Act, Title XIII of the Americ an \nRecovery and Reinvestment Act of 2009 (the \u201c HITECH Act \u201d), the parties  agree to enter into a Business Associate \nAgreement (the \u201c BAA \u201d). The BAA will govern and supersede the terms of this Agreement with respect to any protected \nhealth information disclose d hereunder, and will include, but will not be limited to, the following provisions:  \na. Individuals' rights to obtain a copy of the individual's information in an electronic format;  \nb. Individuals' rights to have the individual's information transmitted to anot her entity or person \ndesignated by the individual, provided the request is clear, conspicuous, and specific;  \nc. The right to audit and monitor activities that involve protected health information; and \nd. The process for notification and reporting of unauthorized disclosure or protected health information \nbreaches. 7. Term. This Agreement  may  be terminated with respect to subsequent disclosures upon thirty (30) days' prior \nwritten notice to the other Party. This Agreement terminates automatically at the conclusion of the Parties\u2019 discussions \nregarding whether to enter into a formal business relationship with each other or, if the business relationship is \nformalized, at the commencement or effective date of th e contract formalizing that business relationship if said \nagreement contains provisions that are stricter for the Receiving Party than those contained in the contract. Termination \nof this Agreement does not relieve the Receiving Party of any of the obligat ions set forth in this Agreement with respect \nto the Confidential Information, and the Parties acknowledge and agree that those obligations remain in full force and \neffect  for a period of five (5) years provided, however, that Receiving Party\u2019s obligations respecting Disclosing Party\u2019s  \n\u201ctrade secrets\u201d (as such term is defined in 18 U.S.C.",
        "id": "qa_43"
    },
    {
        "question": "How is Confidential Information defined in the agreement between the Parties?",
        "options": {
            "A": "Information shared only through electronic communication.",
            "B": "Only information shared in written form marked as confidential.",
            "C": "Only Proprietary Information and Third Party Information explicitly marked as confidential.",
            "D": "All non-public information concerning the Disclosing Party or its business, including oral, visual, written, electronic, or other forms."
        },
        "correct_answer": "D",
        "explanation": "The agreement defines Confidential Information as all non-public information concerning the Disclosing Party or its business, including various forms such as oral, visual, written, electronic, and marked as confidential.",
        "source": "unknown",
        "client": "Wellth, Inc.",
        "document_type": "unknown",
        "context": "As a condition to the commencement of discussions concerning a Potential Transaction, \nthe Parties acknowledge and agree that any Confidential Information as defined below, that a Party, (a \n\u201cDisclosing Party\u201d) may disclose, or already may have disclosed to the other Party (a \u201cReceiving Party\u201d), \nwill be tre ated in accordance with the terms of this Agreement. 2. Definitions . (a) Confidential Information . The term \u201cConfidential Information\u201d means all non -\npublic information concerning the Disclosing Party or its business (including Proprietary Information and \nThird Party Information, as defined below), contracts, whether in oral, visual, written, electronic, or other \nform, or any material specifically marked as confidential, that is made available by HMS or the Company \nto the other Party or any of its Representati ves (\u201cPrimary Confidential Information\u201d), together, in each case, \nwith all notes, memoranda, summaries, analyses, studies, compilations, and other writings relating thereto \nor based thereon prepared by the Receiving Party  or any of its Representatives (\u201cD erivative Confidential \nInformation\u201d). Neither Party shall have an obligation to specifically identify any information as to which \nthe protection of this Agreement is desired by any notice or other action, and each Party hereby agrees that \nall information r eceived by it relating to the other Party in connection with discussions relating to a Potential \nDocuSign Envelope ID: 4E0396A3-CE17-4863-AFA6-699C2E79FDDE\nNDA -Mutual (12 -19-2017) - CONFIDENTIAL   2 \n Transaction shall be deemed to be Confidential Information covered by this Agreement.",
        "id": "qa_44"
    },
    {
        "question": "What is the duration of the Nondisclosing Party\u2019s obligations concerning Confidential Information that is considered a trade secret under the NDA?",
        "options": {
            "A": "Until the Confidential Information no longer constitutes a trade secret",
            "B": "Three (3) years after disclosure",
            "C": "Until the termination of all agreements between the Parties",
            "D": "Indefinitely"
        },
        "correct_answer": "A",
        "explanation": "The NDA specifies that obligations for Confidential Information considered a trade secret continue for as long as the information remains a trade secret under applicable law.",
        "source": "s3://ml-legal-restricted/contract-docs/73385/7-Eleven - Cotiviti  - NDA - MS -  11152023 - Dynamics_73385.pdf",
        "client": "7-Eleven",
        "document_type": "NDA",
        "context": "The term of this Agreement shall begin on the Effective Date and end on \nthe later of (i)  three (3) years, or (ii)  the termination of all agreements between the Parties; \nprovided, however, that the Nondisclosing Party\u2019s obligations under this Agreement shall continue for three (3) years after the applicable Confidential Information is disclosed to such \nParty, or for Confidential Information that constitutes a trade secret under applicable law, the \nNondisclosing Party\u2019s obligations under this Agreement shall continue for so long as such \ninformation constitutes a trade secret under applicable law. 10. Execution of Document. The Parties agree that the execution of this document \nmay be accomplished in one or more counterparts and electronically (e.g., DocuSign) or by \nfacsimile or PDF and the Parties agree that electronic, facsimile, or PDF copies will be valid, original  documents  and that, taken together, counterparts  shall constitute  an original  copy  of this \nAgreement. 11. Severability. If any term or provision of this Agreement is invalid, illegal, or \nunenforceable in any jurisdiction, such  invalidity,  illegality,  or unenforceability  shall not affect any \nother term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. 12. Governing Law; Venue. The validity, terms, and conditions of this Agreement, \nas well as the Parties\u2019 performance hereunder, shall be governed by the laws of the State of \nTexas, exclusive of the conflict-of-laws provisions thereof or elsewhere that would cause the \napplication of the laws of any jurisdiction other than the State of Texas.",
        "id": "qa_45"
    },
    {
        "question": "What must Vendor and Consultant do with Proprietary Information at the conclusion of services?",
        "options": {
            "A": "Relinquish or destroy the information",
            "B": "Store the information securely for 5 years",
            "C": "Share the information with authorized third parties",
            "D": "Transfer ownership to Employer"
        },
        "correct_answer": "A",
        "explanation": "The document states that Vendor and Consultant must either relinquish to Company or destroy all Proprietary Information at the conclusion of services.",
        "source": "unknown",
        "client": "Boston Benefit Partners",
        "document_type": "unknown",
        "context": "applicable laws\nand/or tegulations, including, but not limited to the privacy and security provisions of HIPAA, for any Confidential\nInformation it-receives including, but not limited to, the amendment of any Plan: documents in accordance with the Privacy\nRule; and {c) prohibit access to the Confidential Information by any employee, agent or other designee other than an\nemployee, agent or designee designated by Employer in writing to participate in the activities described herein\n\nWith respect \u2018to the facilides of Employer where Corifidential Information is created, received, maintained or\ntransmitted, including, but not limited to electronic personal health information received from Company, Vendor and\nConsultant, respectively, shall implement the administrative, physical and technical safeguards that reasonably and\nappropriately protect ihe confidentiality, integrity and availability of such, Confidential jaformation as required by, and\nas more specifically set forth ji, the Final Scoutity Regulations issued under the HIPAA. Employer will provide to\nCompany copies of their respective contidentiality and information security policies upon the request of Company In\naddition, Employer will report in writing to Company any security incident of which it becomes aware relating to the\nConfidential Information inchiding, but not limited to, any attempted er successful unauthorized use or disclosure of the\nConfidential Information\n\nG Conclusion of Services: At the conclusion of the Services or upon request by Company, Vendar and Consultant\nshall either relinquish to Company or destroy (with such destruction to be certified to Company) all Proprietary\nInformation\n\nH. Breach: If during the course of providing the Services it is discovered that this Agreement has been breached by\nVendor andor Conswitant then al] Confidential Information shail be relinquished to Company upon dermand\n\n{.",
        "id": "qa_46"
    },
    {
        "question": "Under what conditions can the Recipient disclose Confidential Information?",
        "options": {
            "A": "If the Recipient has prior knowledge before receiving it from the Owner",
            "B": "If required by law, with prompt notification to the Owner",
            "C": "If the information becomes generally known by third parties",
            "D": "If the information is independently developed by the Recipient"
        },
        "correct_answer": "B",
        "explanation": "The document specifies that the Recipient may disclose Confidential Information if required by law, provided that the Recipient promptly notifies the Owner so that protective measures can be sought.",
        "source": "unknown",
        "client": "The Standard",
        "document_type": "unknown",
        "context": "These obligations do not apply to information or materials that: (i) are or become \ngenerally known b y third parties other than as a result of an act or omission by the \nRecipient; (ii) were already independently known by the Recipient prior to receiving them \nfrom the Owner; (iii) are developed independently by the Recipient. Recipient may disclose \nConfide ntial Information if required by law, provided that Recipient promptly notifies the \nOwner of such requirement so that the Owner can seek to obtain a protective order or \nDocusign Envelope ID: B527775C-3F59-4071-AFAF-15FC96A5A319\n \n \n similar remedy. The Recipient shall promptly notify the Owner of any breaches of \nconfid entiality under this Agreement, to the extent Recipient has obtained knowledge of \nsuch breach. 3. Termination . Either party may terminate this Agreement with respect to future disclosure of \nConfidential Information by sending the other party 30 days prior written notice. This \nAgreement shall automatically terminate two (2) years after its Effective Date. The rights and \nobligations accruing prior to termination as set forth herein shall survive the termination of \nthis Agreement for a period of three  (3) year s.   \n4. Return of Confidential Information . Upon written request, the Recipient: (a) will exercise \ncommercially reasonable efforts either to return to the Owner all documents and materials \n(and all copies thereof), to the extent that it can legally do so, c ontaining any Confidential \nInformation of the Owner, or to destroy all such items, again to the extent that it can legally \ndo so, and (b) will certify  the same  in writing . Latent Data, which is Confidential Information \nshall be subject to destruction in du e course but shall remain Confidential Information of the \nDisclosing Party until it is destroyed.",
        "id": "qa_47"
    },
    {
        "question": "What does the term \"Sensitive Personal Information\" include according to the document?",
        "options": {
            "A": "First name or initial and last name with credit card information",
            "B": "Only driver\u2019s license number",
            "C": "Just the social security number",
            "D": "Any combination of first name and last name"
        },
        "correct_answer": "A",
        "explanation": "Sensitive Personal Information includes an individual\u2019s first name or initial and last name in combination with items like social security number, driver\u2019s license number, or credit/debit card information with security codes.",
        "source": "unknown",
        "client": "Community First Health Plans",
        "document_type": "unknown",
        "context": "Sensitive Personal Information means an individual\u2019s first name or first in itial and last name in \ncombination with any one or more of the following items: a) social security number; driver\u2019s \nlicense  number  or government -issued  identification  number;  or account  number  or credit  or debit \ncard  number  in combination  with  any required  security  code,  access  code,  or password  that would \npermit access to an individual\u2019s financial account; or b) information that identifies an individual \nand relates  to: the physical  or mental  health  or condition  of the individual;  the provision  of health \ncare to the individual; or payment for the provision of health care to the individual. J. Use means, with respect to PHI, the sharing, employment, application, utilization, examination, or \nanalysis of such information within the entity that maintains it. II. Purposes  for which  PHI May  Be Disclosed  to Business  Associate  \n \nIn connection with the services provided by Business Associate to or on behalf of Community First \ndescribed  in this Agreement,  Community  First  may  disclose  PHI to Business  Associate  for the purposes \ndescribed in the underlying Agreement executed by and between the Parties. III. Obligations  and Activities  of Business  Associate  \n \nA. Legal Obligations . Business Associate is required by law to comply with the applicable \nrequirements of: (1) HIPAA Securit y Rule (45 CFR 164.302 through 164.318), (2) the use and \ndisclosure provisions of HIPAA Privacy Rule (45 CFR 164.502, 164.504) and (3) the applicable  \nDocuSign Envelope ID: CC6F7891-FCD3-4A9F-B775-815EC2BFDD28\nPage  3 of 12 \nBAA  2023  -6.2023   provisions of the HITECH Act.",
        "id": "qa_48"
    },
    {
        "question": "What security measures must COMPANY implement for network security according to the document?",
        "options": {
            "A": "Utilizing only wireless connections without firewalls",
            "B": "Using a switched-network topology without password protection",
            "C": "Establishing thresholds and alarms to notify personnel of potential problems or outages",
            "D": "Allowing unrestricted access to network scan results"
        },
        "correct_answer": "C",
        "explanation": "The document specifies that COMPANY must establish thresholds and alarms to notify personnel of potential problems or outages as part of their network security measures.",
        "source": "unknown",
        "client": "Humana",
        "document_type": "unknown",
        "context": "2) Network Security: \na) If COMPANY uses a switched-network topology, monitoring ports on the switches shall be password protected by \nCOMPANY. b) COMPANY shall ensure that interconnections within the COMPANY, with other companies, and with the Internet (\"Access \nPoints\") , whether wired or wireless, into the COMPANY network are protected by using firewalls, secure tunnels, or access \nlists on routers . . . c) .. COMPANY shall ensme that a networkmanagement:systemis used to monitor-:its:local networkand servers. Threshulds=and \u00b7\u00b7 \nalarms shall be established to notify COMPANY and Humana personnel of potential problems or outages. d) COMPANY shall implement either host-based or network-based Intrusion Detection Solution (IDS) or Intrusion Protection \nSolution (IPS) with response and recovery plans to monitor potential unauthorized access to COMPANY network and \nsystems. e) Upon Humana's request, COMPANY shall make available internal and external network scan results to Humana for review. 3) Transmission Security: \na) COMPANY shall ensure that any business-to-business connectivity between COMPANY and Humana shall be protected by \nfirewall, PGP encryption, and access list controls. b) COMPANY shall require all transmissions of PHI to be secure and encrypted, including but not limited to: e-mail, web-mail, \nBlackbeny e-mail and other mobile device e-mail, FTP, chat and instant messaging, web services etc. NOTE: The PHiitselfmust be enc1ypted such that only the intended recipient can decrypt it. Simply using an encrypted \ntunnel is not sufficient.",
        "id": "qa_49"
    },
    {
        "question": "What rights are provided to individuals under the BAA regarding their protected health information?",
        "options": {
            "A": "The right to transmit their information to another entity or person",
            "B": "The right to delete their information permanently",
            "C": "The right to receive compensation for data usage",
            "D": "The right to obtain a copy of information in paper format"
        },
        "correct_answer": "A",
        "explanation": "The BAA includes provisions for individuals' rights to have their information transmitted to another entity or person designated by them.",
        "source": "unknown",
        "client": "Crumdale Partners - Better Benefits",
        "document_type": "unknown",
        "context": "The BAA will govern and supersede the terms of this Agreement with respect to any protected \nhealth information disclosed hereunder, and will include, but will not be limited to, the following provisions: \na. Individuals' rights to obtain a copy of the individual's information in an electronic format;  \nb. Individuals' rights to have the individual's information transmitted to another entity or person \ndesignated by the individual, provided the request is clear, conspicuous, and specific;  \nc. The right to audit and monitor activities that involve protected health information; and \nd. The process for notification and reporting of unauthorized disclosure or protected health information \nbreaches. 7. Term. This Agreement may be terminated with respect to subsequent disclosures upon thirty (30) days' prior \nwritten notice to the other Party. This Agreement shall automatically terminate two (2) years after its Effective Date. The rights and obligations accruing prior to termination as set forth herein shall survive the termination of this \nAgreement for a period of five (5) years provided, however, that Receiving Party\u2019s obligations respecting Disclosing \nParty\u2019s \u201ctrade secrets\u201d (as such term is defined in 18 U.S.C. 1839) shall continue for so long as such information qualifies \nas a trade secret. 8. Compensation. The Receiving Party shall not be obligated to compensate the Disclosing Party for \nConfidential Information (except as may result from a breach of this Agreement) and the Receiving Party acknowledges \nand understands that no warranties of any kind are given by the Disclosing Party with respect to the accuracy or \ncompleteness of the Confidential Information. 9. Ownership. Confidential Information shall remain the sole and exclusive property of the Disclosing Party. Nothing in this Agreement shall be construed as granting to the Receiving Party any right, title or interest in or to any \npatent, trademark, license, copyright or other right of the Disclosing Party. 10. Relationship of the parties.",
        "id": "qa_50"
    },
    {
        "question": "What requirement must be met before the disclosure of PHI to a Business Associate as per the HIPAA Privacy Rule?",
        "options": {
            "A": "Business Associate must undergo a HIPAA compliance audit.",
            "B": "Business Associate must sign a contract containing specific requirements.",
            "C": "Business Associate must provide proof of data encryption.",
            "D": "Business Associate must be registered with the U.S. Department of Health and Human Services."
        },
        "correct_answer": "B",
        "explanation": "The HIPAA Privacy Rule requires the Business Associate to enter into a contract containing specific requirements before the disclosure of PHI, as outlined in Title 45, Sections 164.502(e) and 164.504(e) of the CFR.",
        "source": "unknown",
        "client": "Sierra Health Plan of Nevada",
        "document_type": "unknown",
        "context": "The Parties intend to protect the privacy and provide for the security of PHI disclosed to Business\nAssociate pursuant to the Master Agreement in compliance with the Health Insurance Portability\nand Accountability Act of 1996, Public Law 104-191 (\u201cHIPAA\u201d) and regulations promulgated\nthereunder by the U.S. Department of Health and Human Services (the \u201cHIPAA Regulations\u201d)\nand other applicable laws. As part of the HIPAA Regulations, the Privacy Rule (defined below) requires Business Associate\nto enter into a contract containing specific requirements with Business Associate prior to the\n\ndisclosure of PHI, as set forth in, but not limited to, Title 45, Sections 164.502(e) and 164.504(e)\nof the Code of Federal Regulations (\u201cCFR\u201d) and contained in this Agreement. 2. DEFINITIONS\n\nAuthorization shall have the meaning given to the term under the Privacy Rule, including, but\nnot limited to, 45 CFR Section 164.508. Data Aggregation shall have the meaning given to the term under the Privacy Rule, including,\nbut not limited to, 45 CFR Section 164.501. Designated Record Set shall have the meaning given to the term under the Privacy Rule,\nincluding, but not limited to, 45 CFR Section 164.501. Health Care Operations shall have the meaning given to the term under the Privacy Rule,\nincluding, but not limited to, 45 CFR Section 164.501. Page 1 of 6\n\n \n\n \n\n \n\n \n\n \n\f\nIndividual shall have the meaning given to the term under the Privacy Rule, including, but not\nlimited to, 45 CFR Section 164.501. It shall also include a person who qualifies as a personal\nrepresentative in accordance with 45 CFR Section 164.502(g).",
        "id": "qa_51"
    },
    {
        "question": "What is the main purpose of the Work Order (WO) #1 executed between Cotiviti, Inc. and the 1199 SEIU National Benefit Funds?",
        "options": {
            "A": "To outline the process for data interface between the Client and Cotiviti.",
            "B": "To provide payment details and deadlines for services rendered.",
            "C": "To confirm legal binding and execution of signatures.",
            "D": "To establish roles and responsibilities for IT deliverables."
        },
        "correct_answer": "A",
        "explanation": "The scope of the Work Order specifies that Cotiviti will design, build, test, and operationalize the data interface processes between the Client and Cotiviti.",
        "source": "s3://ml-legal-restricted/contract-docs/72908/NBFHHSE - Cotiviti - WO 1 TO SOW 2 - MS - 12112023 - Dynamics_72908.pdf",
        "client": "1199 SEIU National Benefit Funds",
        "document_type": "Work Order / Change Request",
        "context": "This WO #1 may be executed in two or more counterparts, each of which shall be \ndeemed to be an original as against any Party whose signature appears thereon, but all of which \ntogether shall constitute one and the same instrument. IN WITNESS WHEREOF, the undersigned, intending to be legally bound, have executed this \nWO #1 as of the date of last signature below. Cotiviti,\u00a0Inc.   \n1199SEIU\u00a0National\u00a0Benefit\u00a0Fund\u00a0for\u00a0Health\u00a0\nand\u00a0Human\u00a0Service\u00a0Employees \n1199SEIU\u00a0Greater\u00a0New\u00a0York\u00a0Benefit\u00a0Fund \n1199SEIU\u00a0National\u00a0Benefit\u00a0Fund\u00a0for\u00a0Home\u00a0\nCare\u00a0Employees \n \nBy:       By:  \nName:       Name:  \nTitle:       Title:  \nDate:       Date:  \n     \n\u00a0 \u00a0 \u00a0 \u00a0\n\u00a0 \u00a0 \u00a0\u00a0\u00a0\n\u00a0 \u00a0 \u00a0\u00a0\u00a0\n\u00a0 \u00a0 \u00a0\u00a0\u00a0\n\u00a0 \u00a0 \u00a0\u00a0\u00a0\n \n \n \nAngela Scott\nChief of Benefit Operations\n12 / 11 / 2023\nDocuSign Envelope ID: 4776A02C-397E-465F-82F7-C0CBB6A8A78F\nCheri Moehring\nSVP Clinical Chart Validation\nDecember 11, 2023 | 5:25 PM EST\nEXHIBIT A  \n \n \n \n \n \n \n \nHigh Level IT Ro les and \nResponsib ilities \nwith Deliverables  \n \n \n \n \n \n \n \n \nPrepared  for:  1199SEIU NATIONAL BENEFIT FUND  \nFOR HEALTH AND HUMAN SERVICE EMPLOYEES , \n1199SEIU GREATER NEW YORK BENEFIT FUND , \n1199SEIU NATIONAL BENEFIT FUND FOR HOME CARE  \nEMPLOYEES  \n \n \n \n \nAugust 22, 2023\nDocuSign Envelope ID: 4776A02C-397E-465F-82F7-C0CBB6A8A78F\n \n \n \n \n \n \n \nScope  \n \nCotiviti  will assign  employees  and/or  subcontractors  to design,  build,  test, and \noperationalization  of the data interface  between  Client  and Cotiviti. Such  data interface  \nprocesses  shall include:  \na. Cotiviti  receives  and processes  both the Client\u2019s  prepay,  post adjudication  and paid \nclaim  data;   \nb.",
        "id": "qa_52"
    },
    {
        "question": "What must the Receiving Party do with Confidential Information upon termination of the agreement or upon Disclosing Party\u2019s request?",
        "options": {
            "A": "Retain all Confidential Information indefinitely",
            "B": "Backup all Confidential Information and delete all original copies",
            "C": "Transfer all Confidential Information to a third party",
            "D": "Destroy or return all Confidential Information, except for a single archival copy for dispute resolution"
        },
        "correct_answer": "D",
        "explanation": "The legal document specifies that upon termination or request, the Receiving Party must destroy or return all Confidential Information, while retaining a single archival copy for dispute resolution purposes.",
        "source": "unknown",
        "client": "Maryland Physicians Care (MPC)",
        "document_type": "unknown",
        "context": "CONFIDENTIAL  AND  PROPRIETARY  2  \n documented  by the Receiving  Party  with written  records. Each  Party  has the right  to refuse  to accept  any trade  secret, \nConfidential Information or similar proprietary information prior to full disclosure. 4. Latent  Data. Latent  Data,  which  is Confidential  Information,  shall  be subject  to destruction  in due course  but \nshall  remain Confidential Information of  the Disclosing Party until it is  destroyed. \u201c Latent  Data\u201d refers to  data  that is \nstored  by a party  on routine  back -up media,  including  but not limited  to deleted  files and other  non-logical  data  types, \nmemory  dumps,  swap  files,  temporary  files,  printer  spool  files and metadata  that can customarily  be retrieved  only  by \ncomputer  forensics  experts  and is generally  considered  inaccessible  without  the use of specialized  tools  and techniques. 5. Return  of Confidential  Information. Subject  to Section  3, \u201cExceptions,\u201d  above,  promptly  following  the earlier \nof (i) the termination  of this Agreement,  or (ii) the written  request  of Disclosing  Party,  the Receiving  Party  shall  destroy \nor deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party \nconstituting  or containing  Confidential  Information,  together  with  all copies  thereof,  including  all electronic  and digital \ncopies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving \nParty's legal department for dispute resolution purposes only, and except for electronically -stored Confidential \nInformation contained in an archived computer system backup in accordance with Receiving Party\u2019s generally \napplicable  security  and disaster  recovery  procedures. Upon  receipt  of such  a request,  the Receiving  Party  shall  destroy \nall other documents and materials constituting Confidential Information in its possession to the extent reasonably \npracticable. Upon request, the Receiving Party shall document such destruction in writing to the Disclosing Party. 6. Protected Health Information. If any part of the Confidential Information disclosed hereunder is protected \nhealth information pursuant to the Federal Health Insurance Portability and Accountability Act of 1996, Pub. L. No.",
        "id": "qa_53"
    },
    {
        "question": "Which of the following is considered \"Confidential Information\" according to the NDA?",
        "options": {
            "A": "Publicly available marketing strategies",
            "B": "General industry knowledge",
            "C": "Information disclosed before the Effective Date",
            "D": "Pricing and terms under agreements"
        },
        "correct_answer": "D",
        "explanation": "The NDA defines \"Confidential Information\" as including terms and pricing under agreements, among other specific types of non-public information.",
        "source": "s3://ml-legal-restricted/contract-docs/73385/7-Eleven - Cotiviti  - NDA - MS -  11152023 - Dynamics_73385.pdf",
        "client": "7-Eleven",
        "document_type": "NDA",
        "context": "(b) \u201cConfidential Information\u201d shall mean and include all confidential, non- \npublic, or proprietary information, whether or not such information is labeled or otherwise \nidentified as confidential, including that obtained through documents (whether written or \nelectronic), observations, inspection of facilities, or discussions with the Disclosing Party or its Representatives, and all analyses, compilations, data studies, or other documents prepared by \nthe Nondisclosing Party or its Representatives containing or based upon, in whole or in part,  \nany such furnished information or reflecting the Nondisclosing Party\u2019s or its Representatives\u2019 \nreview of, or interest in, the Potential Transaction; whether disclosed before, on, or after the Effective Date, including but not limited to (i)  the terms of and pricing under any agreement \nbetween the Parties or between Vendor and one of 7-Eleven\u2019s Affiliates; (ii)  business and \nmarketing plans, strategies, and programs; (iii)  financial information, budgets, projections, and \nresults; (iv) employee and contractor lists and records; (v)  business methods and operating and \nproduction procedures; (vi) product information, product development specifications, or technical, engineering, and scientific research, devices, and processes (for example, recipes, ingredient lists, formulas, chemical compositions, blueprints, designs, drawings, trade secrets, and software development tools and documentation); (vii) pricing, sales data, prospect, and \ncustomer  lists  and   information;  (viii) supplier   and   vendor  lists  and  information;  and \n(ix) information about franchisees  or licensees  or a franchise or licensing program. (c) \u201cDisclosing Party\u201d shall mean the Party (or, in the case of 7-Eleven, its \nAffiliate, if applicable) that supplies Confidential Information to the Nondisclosing Party.",
        "id": "qa_54"
    },
    {
        "question": "Under the NDA between Abarca Health LLC and Cotiviti, Inc., what is the status of ownership of the Confidential Information?",
        "options": {
            "A": "Ownership rights are shared equally between both parties.",
            "B": "The Receiving Party gains joint ownership with the Disclosing Party.",
            "C": "The Disclosing Party retains sole and exclusive ownership of the Confidential Information.",
            "D": "The Receiving Party gains full ownership of the Confidential Information."
        },
        "correct_answer": "C",
        "explanation": "The NDA specifies that the Confidential Information shall remain the sole and exclusive property of the Disclosing Party, with no rights granted to the Receiving Party.",
        "source": "s3://ml-legal-restricted/contract-docs/72710/Abarca Health - Cotiviti - NDA - MS - 08312023 - Dynamics_72710.pdf",
        "client": "Abarca Health LLC",
        "document_type": "NDA",
        "context": "1839) shall continue for so long as such information qualifies as a trade secret. 8. Compensation. The Receiving Party shall not be obligated to compensate the Disclosing Party for \nConfidential Information (except as may result from a breach of this Agreement) and the Receiving Party acknowledges \nand understands that no warranties of any kind are given  by the Disclosing Party with respect to the accuracy or \ncompleteness of the Confidential Information. 9. Ownership. Confidential Information shall remain the sole and exclusive property of the Disclosing Party. Nothing in this Agreement shall be construed as  granting to the Receiving Party any right, title or interest in or to any \npatent, trademark, license, copyright or other right of the Disclosing Party. 10. Relationship of the parties . Nothing in this Agreement shall be deemed to create, either express or imp lied, \nthe power in either Party to bind the other. Neither Party shall be bound by the actions of the other, shall be liable for \nDocuSign Envelope ID: 32A31026-DCD7-4F16-8BB6-2BC6BBBCBB05\nDocuSign Envelope ID: 1DEE5668-B8FB-46FA-AC28-81978C0F8267\n \n\u00a9 2018 Cotiviti , Inc. CONFIDENTIAL AND PROPRIETARY  3 \nthe debts of the other, or shall have a right to share in the profits of the other. This Agreement is not intended to be a \njoint venture, partnership or other formal business organization, and neither Party is under any obligation to enter into \nany further agreement with the other Party. 11. Mutual Representations. Each Party represents that it has the right to disclose its Confidenti al Information \nin furtherance of the purpose set forth above without violating any agreement with or right of any other person. Confidential Information may include information of a third party provided that the third party has authorized such \ndisclosure. 12. No Further Obligation  or Limitation .",
        "id": "qa_55"
    },
    {
        "question": "According to the NDA, what is required for the Nondisclosing Party to share Confidential Information with its Representatives?",
        "options": {
            "A": "Verbal consent from the Disclosing Party",
            "B": "Notification to the Disclosing Party",
            "C": "Written agreement from Representatives to be bound by confidentiality provisions",
            "D": "Prior written consent from the Disclosing Party"
        },
        "correct_answer": "C",
        "explanation": "The NDA stipulates that the Nondisclosing Party can share Confidential Information with its Representatives only if they are informed of the confidential nature and have agreed in writing to be bound by provisions no less restrictive than those in the Agreement.",
        "source": "s3://ml-legal-restricted/contract-docs/73385/7-Eleven - Cotiviti  - NDA - MS -  11152023 - Dynamics_73385.pdf",
        "client": "7-Eleven",
        "document_type": "NDA",
        "context": "Each  Party  agrees  as follows:  \n \n(a) Except as expressly provided in this Agreement, the Confidential \nInformation shall be kept strictly confidential and shall not, without the prior written consent of  \nthe Disclosing Party, be disclosed by the Nondisclosing Party or the Nondisclosing Party\u2019s \nRepresentatives, in any manner whatsoever, in whole or in part, and shall not be used by the \nNondisclosing Party or the Nondisclosing Party\u2019s Representatives, directly or indirectly, for any \npurpose other than evaluating the Potential  Transaction. Moreover, the Nondisclosing Party  will \ntransmit the Confidential Information only to those Representatives who need to know the Confidential Information for the purpose of evaluating the Potential Transaction, who are \ninformed by the Nondisclosing Party of the confidential nature of the Confidential Information, \nand who have agreed in writing to be bound by provisions no less restrictive than those \ncontained in  this Agreement. The Nondisclosing Party  shall be responsible for any  breach by its \nRepresentatives of the terms of this Agreement. (b) Without the prior written consent of the Disclosing Party, the \nNondisclosing Party shall not, and shall direct the Nondisclosing Party\u2019s Representatives not to, \ndisclose to any other Person (including any Affiliates or Representatives to which disclosure is \nnot expressly permitted by this Agreement) that the Confidential Information has been made \navailable, that discussions or negotiations are taking place concerning the Potential  \nTransaction, or any of the terms, conditions, or other facts with respect to the Potential Transaction, including the status thereof or the terms of this Agreement. (c) If either Party determines that it does not wish to enter into the Potential \nTransaction, it will promptly advise the other Party of that fact.",
        "id": "qa_56"
    },
    {
        "question": "What must a party do when they become aware of a Data Breach according to the MSA with ACA Health Benefits Fund?",
        "options": {
            "A": "Ignore the breach and continue business as usual.",
            "B": "Notify the other party and discuss next steps regarding investigation and handling.",
            "C": "Immediately terminate the agreement with the other party.",
            "D": "Disclose all confidential information related to the breach publicly."
        },
        "correct_answer": "B",
        "explanation": "The MSA requires the party aware of the Data Breach to notify the other party and discuss next steps regarding investigation and handling in accordance with the Privacy Act.",
        "source": "s3://ml-legal-restricted/contract-docs/73278/ACA - Cotiviti Australia - MSA - JK - 10052023 - Dynamics_73278.pdf",
        "client": "ACA Health Benefits Fund",
        "document_type": "MSA",
        "context": "7.7 Data Breach  \n7.8 Where either party becomes aware of any actual or suspected Data Breach: \n(a) that party must promptly notify the other party of the Data Breach (Data Breach \nNotice); \n(b) the parties will meet as soon as practicable discuss in good faith appropriate next \nsteps regarding investigation and handling of the Data Breach, including the parties\u2019 \nrespective responsibilities including, without limitation, mandatory requirements for \ndata breach notification in accordance with the Privacy Act ; and \n(c) each party must provide all reasonable assistance to the other to ensure each party is \nin compliance with its obligations under the Privacy Act. 8. Confidentiality  \n8.1 Except to the extent expressly permitted or required by this Agreement, a party must not use \nor disclose the other party's Confidential Information. 8.2 A party may use or disclose the Confidential Information of the other party to the extent \nreasonably required to enable it to comply with its obligations or exercise its rights under this \nAgreement. 8.3 A party may disclose the Confidential Information of the other party: \n(a) when required to do so by law or any regulatory authority, including any stock \nexchange on which it or any other member of its Group is listed; and \n(b) to its Personnel whose duties reasonably require such disclosure, on condition that the party making such disclosure: \n(i) ensures that each such person to whom such disclosure is made is informed of \nthe confidentiality of the information and the obligations of confidentiality \nunder this Agreement; and \n(ii) ensures that each such person to whom such disclosure is made complies with \nthose obligations as if they were bound by them. 8.4 A party must not disclose the terms of this Agreement to any other person, except in \naccordance with this clause 8. 8.5 Each party must establish and maintain effective security measures to prevent any \nunauthorised use or disclosure of, or unauthorised access, loss or damage to, the Confidential \nInformation of the other party.",
        "id": "qa_57"
    },
    {
        "question": "Under what circumstances is the Confidential Information not protected by the NDA?",
        "options": {
            "A": "If the information becomes public due to actions of the Disclosing Party.",
            "B": "If the information is known to the Nondisclosing Party before disclosure.",
            "C": "If the information is available from a public source and the Nondisclosing Party is unaware of any confidentiality obligation.",
            "D": "If the Nondisclosing Party discloses the information to the public."
        },
        "correct_answer": "B",
        "explanation": "The NDA specifies that Confidential Information is not protected if it was known to the Nondisclosing Party on a non-confidential basis prior to disclosure by the Disclosing Party.",
        "source": "s3://ml-legal-restricted/contract-docs/73385/7-Eleven - Cotiviti  - NDA - MS -  11152023 - Dynamics_73385.pdf",
        "client": "7-Eleven",
        "document_type": "NDA",
        "context": "This Agreement shall be inoperative as to such \nportions of the Confidential Information that: (i) are or become generally available to the public, \nother than as a result of a disclosure by the Nondisclosing Party or the Nondisclosing Party\u2019s Representatives; (ii)  become available to the Nondisclosing Party on a non-confidential basis \nfrom a source other than the Disclosing Party or its Representatives, provided that such source \nis not, to the knowledge of the Nondisclosing Party, bound by a confidentiality agreement with \nthe Disclosing Party or its Representatives or is otherwise prohibited from transmitting the \nConfidential Information to the Nondisclosing Party or the Nondisclosing Party\u2019s  \nRepresentatives by a contractual, legal, or fiduciary obligation; (iii)  were known to the \nNondisclosing Party on a non-confidential basis prior to their disclosure to the Nondisclosing Party by the Disclosing Party or its Representatives; or (iv) are developed independently by the \npersonnel of the Nondisclosing Party or any of its Representatives who have not had access to \nthe Disclosing Party\u2019s Confidential Information. 5. No Offer. This Agreement is not an offer, an acceptance, or a contract to \nnegotiate or enter into the Potential Transaction or any other transaction, nor is it intended to \nrequire the Parties to proceed with or continue such negotiations, the Potential Transaction, or \nDocuSign Envelope ID: 86A93AC8-1F25-4263-BD06-DE620137B060\nConfidentiality  and \nNon-Disclosure  Agreement  \n143467808.3  4 \u00a9 2019  7-Eleven,  Inc.  any other transaction. This Agreement shall not give rise to any obligation for either Party to \ndisclose any information, including the Confidential Information, to the other Party or its \nRepresentatives.",
        "id": "qa_58"
    },
    {
        "question": "What is the time frame within which the Business Associate must report improper use or disclosure of PHI?",
        "options": {
            "A": "Within 30 days of becoming aware",
            "B": "Within 60 days of becoming aware",
            "C": "Within 15 days of discovery",
            "D": "Immediately upon discovery"
        },
        "correct_answer": "A",
        "explanation": "The legal document specifies that the Business Associate must report any improper use or disclosure of PHI within 30 days of becoming aware of it.",
        "source": "unknown",
        "client": "Sierra Health Plan of Nevada",
        "document_type": "unknown",
        "context": "3.3 Mitigation of Harmful Effects. Business Associate agrees to mitigate, to the extent practicable, any harmful effect that is known\nto Business Associate of a use or disclosure of PHI by Business Associate in violation of the\n\nrequirements of this Agreement. 3.4 Reporting of Improper Use or Disclosure. Business Associate shall, within thirty (30) days of becoming aware of any use or disclosure or\n\nPHI in violation of this Agreement by Business Associate or any of its officers, directors,\nemployees, contractors or agents, report such use or disclosure to the Covered Entity. Page 2 of 6\n\n \n\f\n3.5 Associate\u2019s Agents. Business Associate agrees to ensure that any agent, including a subcontractor, to whom it\nprovides PHI received from, or created or received by Business Associate on behalf of Covered\nEntity agrees to the same restrictions and conditions that apply through this Agreement to\nBusiness Associate with respect to such information. 3.6 Access to PHI. Within ten (10) days of a request by Covered Entity for access to PHI about an Individual\ncontained in a Designated Record Set, Business Associate shall make available to Covered Entity\nsuch PHI in order to enable Covered Entity to meet the requirements of 45 CFR Section 164.524. 3.7 Availability of PHI for Amendment. Within thirty (30) days of receipt of a request from Covered Entity for the amendment of an\nIndividual\u2019s PHI or a record regarding an individual contained in a Designated Record Set,\nBusiness Associate shall provide such information to Covered Entity for amendment and shall\nincorporate any such amendments in the PHI as required by 45 CFR Section 164.526. Any\ndenials of requested amendments shall be the responsibility of Covered Entity. 3.8 Accounting Rights.",
        "id": "qa_59"
    },
    {
        "question": "What must users do if the hardware and software requirements change for accessing electronic disclosures?",
        "options": {
            "A": "Immediately upgrade their systems without notification",
            "B": "Continue using the old requirements",
            "C": "Withdraw consent if not agreeable to new requirements",
            "D": "Ignore the email notification about the changes"
        },
        "correct_answer": "C",
        "explanation": "Users have the right to withdraw their consent if the revised hardware and software requirements are not agreeable.",
        "source": "unknown",
        "client": "Self Insured Services Co",
        "document_type": "unknown",
        "context": "send us an e -mail to legal@verscend .com and in the body of such request you must \nstate your e -mail, full name, IS Postal Address, telephone number, and account number. Required hardware and software   \nOperating Systems:  Windows2000\u00ac or WindowsXP\u00ac  \nBrowsers (for \nSENDERS):  Internet Explorer 6.0\u00ac or above  \nBrowsers (for \nSIGNERS):  Internet Explorer 6.0\u00ac, Mozilla FireFox 1.0, NetScape 7.2 (or above)  \nEmail:  Access to a valid email account  \nScreen Resolution:  800 x 600 minimum  \nEnabled Security \nSettings:  \u00f2 Allow per session cook ies \n\u00f2 Users accessing the internet behind a Proxy Server must enable HTTP \n1.1 settings via proxy connection  \n** These minimum requirements are subject to change. If these requirements change, we will \nprovide you with an email message at the email address w e have on file for you at that time \nproviding you with the revised hardware and software requirements, at which time you will have \nthe right to withdraw your consent. Acknowledging your access and consent to receive materials electronically   \nTo confirm to  us that you can access this information electronically, which will be similar to \nother electronic notices and disclosures that we will provide to you, please verify that you were \nable to read this electronic disclosure and that you also were able to print  on paper or \nelectronically save this page for your future reference and access or that you were able to e -mail \nthis disclosure and consent to an address where you will be able to print on paper or save it for \nyour future reference and access. Further, if you consent to receiving notices and disclosures \nexclusively in electronic format on the terms and conditions described above, please let us know \nby clicking the \u00e6I agree\u00c6 button below.",
        "id": "qa_60"
    },
    {
        "question": "What is the definition of \"Medically Necessary\" under the provisions of this SOW?",
        "options": {
            "A": "Services or supplies determined to be appropriate and necessary for the symptoms, diagnosis, or treatment of the medical condition.",
            "B": "Services or supplies provided primarily for the convenience of the Participant's physician.",
            "C": "Services or supplies within good medical practice standards, regardless of necessity.",
            "D": "Services or supplies that are convenient for the Participant."
        },
        "correct_answer": "A",
        "explanation": "Medically Necessary services or supplies are those determined through Client\u2019s Utilization Management to be appropriate and necessary for the symptoms, diagnosis, or treatment of the medical condition.",
        "source": "unknown",
        "client": "Maryland Physicians Care (MPC)",
        "document_type": "unknown",
        "context": "Medically Necessary means covered services or supplies which, under the provisions of this SOW, \nare determined through Client\u2019s Utilization Management to be (i) appropriate and necessary for the \nsymptoms, diagnosis or treatment of the medical condition; (ii) provided for diagnosis or direct care and treatment of the specific medical condition; (iii) within standards of good medical practice within \nthe organized medical community; and (iv) not primarily for the convenience of the Participant, the \nParticipant's physician or another provider. NCQA  means the National Committee for Quality Assurance. Paid Claim Data  refers to Claims data after it has been finalized in Client\u2019s transaction system , also \nreferenced as a history file. Participant means an individual or eligible dependent of such individual, whether referred to as \n\u201cInsured,\u201d \u201cSubscriber,\u201d \u201cMember,\u201d \u201cParticipant,\u201d \u201cEnrollee,\u201d \u201cDependent\u201d or otherwise, who is \neligible for Covered Services pursuant to a Service Agreement. Payment Variance  means, the amount Client would have paid on an individ ual claim using Client\u2019s \nprevailing provider fee schedule and methodology at the time the claim is reviewed, less the actual \namount reimbursed to providers after the Services are provided pursuant to this SOW. Prepayment Claim Data  refers to Claims data be fore it has been finalized in Client\u2019s transaction \nsystem, also referenced as a to-be-adjudicated or TBA file. \u0010\u001a\u0014\u001d\u001c\u0017\u0016\u0019\u0001\u0011\u0019\u001e\u0015\u0018\u001a\u001b\u0015\u0001\u0013\u0010\r\u0001\u0006\u000b\u000e\u000e\u0006\f\u0011\b\u0002\n\u0007\u0004\u000b\u0002\u0007\u0004\u0011\u0010\u0002\u000b\u0011\t\n\u0002\u0005\u0012\u0011\u000f\n\u0005\u0012\u0003\f\t\u0005\u0011\n\u00a9 2024 Cotiviti, Inc. CONFIDENTIAL AND PROPRIETARY Page 5  of 16 \nProgram means the Medicare or commercial health maintenance organization, preferred provider \norganization or other types of health care or admi nistrative services, which are provided or arranged \nby Client or Client Affiliates. Program Requirements means the rules and procedures that establish conditions followed by \nProviders with respect to Programs. Provider  means a hospital, a physician or any other health care practitioner, contracted or otherwise, \nthat provides services to a Participant.",
        "id": "qa_61"
    },
    {
        "question": "What is the procedure to withdraw consent for receiving electronic notices and disclosures via DocuSign?",
        "options": {
            "A": "Mail a written request to Self Insured Services Co.",
            "B": "Call customer service for Self Insured Services Co.",
            "C": "Send an email request to Self Insured Services Co.",
            "D": "Use the DocuSign \"Withdraw Consent\" form on the signing page."
        },
        "correct_answer": "D",
        "explanation": "The document specifies that the withdrawal of consent must be done using the DocuSign \"Withdraw Consent\" form on the signing page of your DocuSign account.",
        "source": "unknown",
        "client": "Self Insured Services Co",
        "document_type": "unknown",
        "context": "To indicate to us that you are changing your mind, you must \nwithdraw your consent  using the DocuSign \u00f4Withdraw Consent\u00f6 form on the signing page of \nyour DocuSign account. This will indicate to us that you have withdrawn your consent to receive \nrequired notices and disclosures electronically from us and you will no longer be able to use  your \nDocuSign Express user account to receive required notices and consents electronically from us \nor to sign electronically documents from us. All notices and disclosures will be sent to you electronically   \nUnless you tell us otherwise in accordance wit h the procedures described herein, we will provide \nelectronically to you through your DocuSign user account all required notices, disclosures, \nauthorizations, acknowledgements, and other documents that are required to be provided or made \navailable to you d uring the course of our relationship with you. To reduce the chance of you \ninadvertently not receiving any notice or disclosure, we prefer to provide all of the required \nnotices and disclosures to you by the same method and to the same address that you hav e given \nus. Thus, you can receive all the disclosures and notices electronically or in paper format through \nthe paper mail delivery system. If you do not agree with this process, please let us know as \ndescribed below. Please also see the paragraph immediat ely above that describes the \nconsequences of your electing not to receive delivery of the notices and disclosures \nelectronically from us.",
        "id": "qa_62"
    },
    {
        "question": "Which of the following statements about virtual visit restrictions in the provided document is correct?",
        "options": {
            "A": "Restrictions on virtual visits for hypertension diagnosis have been removed.",
            "B": "Virtual visits are not considered appropriate settings for BP readings.",
            "C": "Restrictions on virtual visits have been added for all diagnoses mentioned.",
            "D": "Restrictions on virtual visits for rheumatoid arthritis diagnosis have been added."
        },
        "correct_answer": "A",
        "explanation": "The document states that restrictions on virtual visits for a hypertension diagnosis have been removed, allowing both visits to be outpatient telehealth, telephone visits, e-visits, or virtual check-ins.",
        "source": "unknown",
        "client": "Martin's Point Health Care",
        "document_type": "unknown",
        "context": "APP  Use of First -Line Psychosocial Care for \nChildren and A dolescents on Antipsychotics  \u2022 Added telephone visits and e -visits or \nvirtual check -ins to the \nevent/diagnosis (step 4 required \nexclusions). ART  Disease -Modifying Anti -Rheumatic Drug \nTherapy for Rheumatoid Arthritis -Scheduled \nfor Retirement  \u2022 Removed the rest riction that only one \nof the two visits with a rheumatoid \narthritis diagnosis be an outpatient \ntelehealth, telephone visit, e -visit or \nvirtual check -in when identifying the \nevent/diagnosis. \u2022 Added telephone visits, e -visits and \nvirtual check -ins to the adv anced \nillness exclusion. DocuSign Envelope ID: 931D3F57-B345-43BF-A0F3-75C51EFC4B69\n \n\u00a9 20 20 Cotiviti , Inc. CONFIDENTIAL AND PROPRIETARY  4 \nBCS, BSC -E Breast Cancer Screening  \u2022 Added telephone visits, e -visits and \nvirtual check -ins to the advanced \nillness exclusion. CBP  Controlling for High Blood Pressure  \u2022 Removed the restriction that only one \nof the two visits with a hypertension \ndiagnosis be an outpatient telehealth, \ntelephone visit, e -visit or virtual \ncheck -in when identifying the \nevent/diagnosis. \u2022 Added telephone visits, e -visits and \nvirtual check -ins to  the advanced \nillness exclusion. \u2022 In the Administrative Specification, \nadded telephone visits, e -visits and \nvirtual check -ins as appropriate \nsettings for BP readings. CDC  Comprehensive Diabetes Care  \u2022 Removed the restriction that only one \nof the two visits with a diabetes \ndiagnosis be an outpatient telehealth, \ntelephone visit, e -visit or virtual \ncheck -in when identifying the \nevent/diagnosis. \u2022 Added telephone visits, e -visits and \nvirtual check -ins to the advanced \nillness exclusion. \u2022 Added telephone visits, e -visits and \nvirtual check -ins to the \nAdministrative Specification as \nappropriate settings for BP readings.",
        "id": "qa_63"
    },
    {
        "question": "What is the minimum period for which Vendor is required to perform a criminal conviction check on Vendor Personnel?",
        "options": {
            "A": "5 years",
            "B": "7 years",
            "C": "Indefinite",
            "D": "10 years"
        },
        "correct_answer": "B",
        "explanation": "The document specifies that the criminal conviction check will cover at a minimum a seven (7) year period.",
        "source": "unknown",
        "client": "Blue Cross and Blue Shield of Nebraska",
        "document_type": "unknown",
        "context": "Vendor  represents and warrants that Vendor  Personnel are legally able to  work in the \nUnited States in compliance with the Immigration Reform and Control Act of 1986.  \n \niii. Vendor  will perform a criminal conviction check on Vendor  Personnel through an \nauthorized background reporting agency. To the extent permitted by law, this criminal \nconviction check will cover at a minimum a seven (7) year period, will check for all \nfelony convictions and misdemeanor convictions for crimes of dishonesty and violence \n(both State and Federal). iv. If Vendor controls access of Vendor Personnel to BCBSNE Systems and Data and \nVendor Personnel are terminated or removed from providing Servi ces, Vendor will \npromptly disable that Vendor  Personnel\u2019s access . v. In the event Vendor is authorized by BCBSNE to provision access for Vendor Personnel \nto BCBSNE Systems, Vendor  represents and warrants that Vendor  will provide Vendor  \nPersonnel with only th e minimum access required to perform their duties for the Services \ndefined in the Agreement  where Vendor  controls System access  in accordance with \nBCBSNE\u2019s Policies regarding logical access . Vendor  Personnel access to BCBSNE \nfacilities, Systems and data ma y be monitored, reviewed and revoked by BCBSN E at any \ntime for any reason. Provided, however, if Vendor Personnel access results in a delay in \nthe performance of the Services, Vendor shall not be liable for any such delay. 4. Security of BCBSNE Systems and Information  \na. In the event that services specified under this Agreement or any associated agreement includes \nVendor \u2019s access to BCBSNE infrastructure Systems or information computing Systems (the \n\u201cSystems\u201d), or BCBSNE\u2019s  Confidential Information, the followi ng Security Requirements will \napply:  \ni.",
        "id": "qa_64"
    },
    {
        "question": "What is the permitted use of Confidential Information according to the NDA with Advise Insurance?",
        "options": {
            "A": "To enter into a subcontract or contract automatically",
            "B": "To develop new products independently",
            "C": "To disclose information to third parties without consent",
            "D": "To evaluate a business relationship with the disclosing party"
        },
        "correct_answer": "D",
        "explanation": "The NDA specifies that the Confidential Information may only be used to evaluate a business relationship with the disclosing party and not for any other purpose.",
        "source": "s3://ml-legal-restricted/contract-docs/67562/Advise Insurance - Cotiviti - NDA - SK - 03042022 - Dynamics_67562.pdf",
        "client": "Advise Insurance",
        "document_type": "NDA",
        "context": "Any copies which ar e made will \nbe identified as belonging to the disclosing party and shall \nbe reproduced with the disclosing party\u2019s proprietary rights \nnotices in the same manner in which such notices appear in \nthe original copy provided by the disclosing party. The \nreceiv ing party will not disassemble, decompile or reverse \nengineer any prototypes, software or other tangible objects \nwhich embody Confidential Information. The receiving \nparty will not use the Confidential Information for any \npurpose except to evaluate a busi ness relationship with the \ndisclosing party or otherwise in pursuance of such a \nrelationship. The receiving party will use the Confidential \nInformation solely for the purpose of assessing the \nproducts/services of the disclosing party to determine \nwhether those products/services meet the receiving party's \nneeds (\"Permitted Use\"), and for no other purpose. The \nreceiving party will not disclose Confidential Information \nto any third party without the prior written consent of the \ndisclosing party. This Agreem ent shall not be construed in any manner to be \nan obligation to enter into a subcontract or contract or to \nresult in any claim whatsoever by one Party against the \nother for reimbursement of cost for any efforts expended. Except as specifically set forth he rein, this Agreement does \nnot: (i) restrict either Party from developing new products, \nimproving existing products, or marketing any new, \nimproved or existing products; or (ii) commit either Party \nto disclose any particular information, or to develop, make , \nDocuSign Envelope ID: 7B7BFB2B-38B6-4A1A-AD79-3B4CACB0A43A\n \nPage 2 of 3 use, buy, sell, or otherwise dispose of any existing or future \nproducts, or to favor or recommend any product or service \nof the other. To be binding, any such restriction or \ncommitment must be in writing and signed by both parties. 3.",
        "id": "qa_65"
    },
    {
        "question": "Under the agreement, what happens if a party fails to exercise its rights due to a Force Majeure event?",
        "options": {
            "A": "The party can have its performance obligations extended by a reasonable period.",
            "B": "The party can exercise its rights after notifying the other party within 30 days.",
            "C": "The party forfeits its rights permanently.",
            "D": "The party must terminate the agreement immediately."
        },
        "correct_answer": "A",
        "explanation": "The contract states that in case of Force Majeure, the party\u2019s performance obligations will be extended by a reasonable period of time corresponding to the delay caused by the Force Majeure.",
        "source": "unknown",
        "client": "Maryland Physicians Care (MPC)",
        "document_type": "unknown",
        "context": "The failure of either party to \u0010\u0019\u0013\u001c\u001b\u0016\u0015\u0018\u0001\u0011\u0018\u001d\u0014\u0017\u0019\u001a\u0014\u0001\u0012\u0010\f\u0001\u0011\u000b\u000f\u0005\u0003\n\u000b\u0011\u0002\u000b\u000f\u000e\u000e\u0002\u0006\u0011\u0004\t\u0002\u000b\u0004\u0011\u000f\u0002\u000e\b\u000e\n\u0007\r\u0003\n\b\u0011\u0007\u000e\n \n\u00a9 2018 Cotiviti, Inc. CONFIDENTIAL AND PROPRIETARY  Page 13 of 16 \n \nexercise any rights or options under th e terms or conditions of this Agreement  will not preclude or prejudice the \nexercising of the same or any other right under this Agreement. 10.4 Force Majeure. Neither party will be liable for delay or damages if prevented from fulfilling its obligations \nby reason of events beyond its reasonable control, foreseeabl e, or unforeseeable, including but not limited to acts of \nGod, criminal acts, acts of war (whether declared or undecl ared), insurrection, terrorism, or acts of hostilities (such \nas invasion or bombing), lockouts, strikes, riots, communica tion line failure, floods, fires, governmental restrictions \ncovering the use of internet-based application and support services, priority given to U.S. Government work, export \nrestrictions imposed by any Government, mobilization of te chnical personnel in general, or any other cause beyond \nthe control of such party. In case of  Force Majeure, the party\u2019s performanc e obligations will be extended by a \nreasonable period of time corresponding to the delay caus ed by the Force Majeure. T he party experiencing the Force \nMajeure will inform the other party in writing within fifteen (15) days after a fact or event of Force Majeure has been \nrecognized to have occurred. In the ev ent of any variance in or inconsistenc y between this Section and the BAA will \nbe resolved in favor of the BAA. 10.5 Schedule Delay.",
        "id": "qa_66"
    },
    {
        "question": "What must the company do to protect Personal Data according to the document?",
        "options": {
            "A": "Maintain any security measures regardless of relevance.",
            "B": "Implement and maintain current and reasonable security measures.",
            "C": "Implement outdated security measures.",
            "D": "Ignore Data Protection Laws when processing Personal Data."
        },
        "correct_answer": "B",
        "explanation": "The document specifies that the company must implement and maintain current and reasonable technical and organizational security measures appropriate to the nature of the Personal Data processed, as required by applicable Data Protection Laws.",
        "source": "unknown",
        "client": "Albertsons Companies, Inc.",
        "document_type": "unknown",
        "context": "5.1 Company will implement, prior to executing this DPA, and maintain current and reasonable technical and organizational security measures appropriate to the nature of the Personal Data Processed as required by applicable Data Protection Laws, or otherwise necessary to adequately protect Personal Data against Data Incidents, and in accordance with any applicable standards,  5.2 Company will treat Personal Data as confidential and ensure access by only its personnel who need to know and are contractually or legally bound to confidentiality obligations at least as protective of Personal Data as this DPA. Where there are pre-existing agreements (such as a non-disclosure agreement) or the Parties subsequently enter into an agreement containing confidentiality terms, then the agreement or terms which provide the greatest protection of Personal Data will supersede and control. 6. AUDITS AND DATA PROTECTION IMPACT ASSESSMENTS. 6.1 Unless required by applicable Data Protection Laws, or in case of a security incident or reasonable suspicion of non-compliance with this addendum, not more than once annually, Company will make all required information and records related to the product or services provided under this Agreement available to demonstrate compliance with Data Protection Laws  and the obligations set out in this DPA. Where an audit identifies any shortcomings or non-compliance, the Company agrees to remediate any agreed-upon deficiencies within the timelines agreed upon by the parties.",
        "id": "qa_67"
    },
    {
        "question": "What remedies are available to the Disclosing Party in case of a breach of the NDA?",
        "options": {
            "A": "Specific performance and termination of the agreement",
            "B": "Specific performance, injunctive relief, and money damages",
            "C": "Money damages and termination of the agreement",
            "D": "Only money damages"
        },
        "correct_answer": "B",
        "explanation": "The NDA specifies that the Disclosing Party can seek specific performance and/or injunctive relief, in addition to money damages, for breaches of the agreement.",
        "source": "s3://ml-legal-restricted/contract-docs/63453/19902_ACTmd HMS MNDA 05302019.pdf",
        "client": "ACT.md",
        "document_type": "NDA",
        "context": "5. Remedies . The Parties understand and agree that money damages  may not be a sufficient \nremedy for any breach of this Agreement by it or by its Representatives and that the Disclosing Party shall \nbe entitled to specific performance and/or in junctive relief, either temporary or permanent, as appropriate, \nto remedy such breach. Such remedy shall not be deemed to be the exclusive remedy for any such breach \nof this Agreement but shall be in addition to all other remedies available at law or in e quity, including but \nnot limited to money damages. The Parties further acknowledge and agree that the covenants contained \nherein are necessary for the protection of legitimate business interests and are reasonable in scope. No \nfailure or delay in exercis ing any right, power, or privilege under this Agreement shall operate as a waiver \nthereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the \nexercise of any right, power, or privilege under this Agreemen t. \n6. Solicitation of Employees . Unless otherwise provided in any subsequent written agree -\nment regarding a Potential Transaction, for a period of two years following the Effective Date of this \nAgreement, each Party agrees, on behalf of itself and its Repre sentatives, not to directly hire, employ, or \notherwise contract with, any of the other Party\u2019s, including any parent companies or subsidiaries, \nemployees, agents, or other persons who then have, or who have had within the preceding three months, \nemployment  with the Party or its parent or affiliates, and with whom it has had contact or who became \nknown to it in connection with this Agreement or its consideration of a Potential Transaction.",
        "id": "qa_68"
    },
    {
        "question": "What happens to the obligations regarding Confidential Information when the NDA is terminated?",
        "options": {
            "A": "Obligations are immediately terminated",
            "B": "Obligations remain indefinitely",
            "C": "Obligations remain for 1 year",
            "D": "Obligations remain for 5 years"
        },
        "correct_answer": "D",
        "explanation": "The document specifies that obligations regarding Confidential Information remain in full force and effect for a period of five years after the termination of the NDA.",
        "source": "s3://ml-legal-restricted/contract-docs/72710/Abarca Health - Cotiviti - NDA - MS - 08312023 - Dynamics_72710.pdf",
        "client": "Abarca Health LLC",
        "document_type": "NDA",
        "context": "104-191 and its implementing regulations (collectively, \u201c HIPAA \u201d), as amended by the regulations promulgated \npursuant to the Health Information Technology for Economic and Clinical Health Act, Title XIII of the Americ an \nRecovery and Reinvestment Act of 2009 (the \u201c HITECH Act \u201d), the parties  agree to enter into a Business Associate \nAgreement (the \u201c BAA \u201d). The BAA will govern and supersede the terms of this Agreement with respect to any protected \nhealth information disclose d hereunder, and will include, but will not be limited to, the following provisions:  \na. Individuals' rights to obtain a copy of the individual's information in an electronic format;  \nb. Individuals' rights to have the individual's information transmitted to anot her entity or person \ndesignated by the individual, provided the request is clear, conspicuous, and specific;  \nc. The right to audit and monitor activities that involve protected health information; and \nd. The process for notification and reporting of unauthorized disclosure or protected health information \nbreaches. 7. Term. This Agreement  may  be terminated with respect to subsequent disclosures upon thirty (30) days' prior \nwritten notice to the other Party. This Agreement terminates automatically at the conclusion of the Parties\u2019 discussions \nregarding whether to enter into a formal business relationship with each other or, if the business relationship is \nformalized, at the commencement or effective date of th e contract formalizing that business relationship if said \nagreement contains provisions that are stricter for the Receiving Party than those contained in the contract. Termination \nof this Agreement does not relieve the Receiving Party of any of the obligat ions set forth in this Agreement with respect \nto the Confidential Information, and the Parties acknowledge and agree that those obligations remain in full force and \neffect  for a period of five (5) years provided, however, that Receiving Party\u2019s obligations respecting Disclosing Party\u2019s  \n\u201ctrade secrets\u201d (as such term is defined in 18 U.S.C.",
        "id": "qa_69"
    },
    {
        "question": "What is the timeframe within which BUSINESS ASSOCIATE must make available information for accounting of disclosures to COVERED ENTITY?",
        "options": {
            "A": "Within 10 days of notice",
            "B": "Within 5 days of notice",
            "C": "Within 15 days of notice",
            "D": "Within 20 days of notice"
        },
        "correct_answer": "A",
        "explanation": "The document specifies that BUSINESS ASSOCIATE must provide the information within ten (10) days of notice by COVERED ENTITY.",
        "source": "unknown",
        "client": "Inogen",
        "document_type": "unknown",
        "context": "2.10 Within ten (10) days of notice by COVERED ENTITY of a request for an\n\n2.13\n\n2.14\n\naccounting of disclosures of Protected Information, BUSINESS ASSOCIATE and\nits agents or subcontractors shall make available to COVERED ENTITY the\ninformation required to provide an accounting of disclosures to enable\nCOVERED ENTITY to fulfill its obligations under the Privacy Rule, including,\nbut not limited to, 45 CFR Section 164.528. Such accounting shall be provided to\nCOVERED ENTITY at the address, and to the attention of, the department\nspecified by COVERED ENTITY at the time that such request for accounting is\nmade by COVERED ENTITY. BUSINESS ASSOCIATE need not provide an\naccounting of disclosures made (i) to carry out treatment, payment or Health Care\nOperations; (ii) to Individuals of their own Protected Information; (iii) to persons\ninvolved in the Individual\u2019s care (iv) for national security or intelligence purposes\nas set forth in 45 CFR 164.512(k)(2); (vi) to correctional institutions or law\nenforcement officials as set forth in 45 CFR Section 164.512(k)(5); or (vii) prior\nto the compliance date. BUSINESS ASSOCIATE will implement a process that\nallows for an accounting to be collected and maintained by BUSINESS\nASSOCIATE and its agents or subcontractors for at least six (6) years. Ata\nminimum, BUSINESS ASSOCIATE shall record (i) the date of disclosure; (ii) the\nname of the entity or person who received Protected Information and, if known,\nthe address of the entity or person; (iii) a brief description of Protected\nInformation disclosed; and (iv) a brief statement of purpose for the disclosure that\nreasonably informs the Individual of the basis for the disclosure. In the event that\nthe request for an accounting is delivered directly to BUSINESS ASSOCIATE or\nits agents or subcontractors, BUSINESS ASSOCIATE shall within five business\n(5) days of a request notify COVERED ENTITY about such request.",
        "id": "qa_70"
    },
    {
        "question": "Under what circumstances can a party assign its rights and obligations according to the NDA?",
        "options": {
            "A": "To a successor in ownership of substantially all assets, with written assumption of terms",
            "B": "Without any approval or notification",
            "C": "Only through a court order",
            "D": "With prior written approval from the other party"
        },
        "correct_answer": "A",
        "explanation": "The NDA allows assignment to a successor in ownership of substantially all assets, provided the successor expressly assumes the terms in writing.",
        "source": "s3://ml-legal-restricted/contract-docs/67562/Advise Insurance - Cotiviti - NDA - SK - 03042022 - Dynamics_67562.pdf",
        "client": "Advise Insurance",
        "document_type": "NDA",
        "context": "Notwithstanding the foregoing, either \nParty, without the prior written approval of the other Party, \nmay assign its r ights and obligations hereunder to a \nsuccessor in ownership of substantially all of the assets of \nDocuSign Envelope ID: 7B7BFB2B-38B6-4A1A-AD79-3B4CACB0A43A\n \nPage 3 of 3 the business, provided that the successor expressly assumes \nin writing the performance of the terms and conditions of \nthis Agreement. 12. General. This Agreement  constitutes the entire agreement \nbetween the parties with respect to the subject matter \nhereof and supersedes any prior or contemporaneous \nagreements or understandings, written or oral, concerning \nthe subject matter hereof. This Agreement may be \namended,  modified or revoked only by a written instrument \nexecuted by all parties hereto. Failure to enforce any \nprovision of this Agreement shall not constitute a waiver \nof any term hereof, and no waiver of any other provision(s) \nor of the same provision on anot her occasion. This \nAgreement shall be binding upon and inure to the benefit \nof the parties hereto and their respective heirs, legal \nrepresentatives, successors and assigns. 13. Notices. Any notice or communication from   one party to \nthe other party concern ing the terms of this Agreement \nshall be in writing and shall be sent Certified Mail, return \nreceipt requested and postage prepaid or by National \ncommercial overnight courier, such as Federal Express, \nUPS, or Airborne Express, to the address specified belo w.  \nNotices sent by certified mail shall be deemed received on \nthe third business day after mailing; notices sent by \ncommercial overnight courier shall be deemed received \naccording to the records of the courier. If to Holdings :  \nAdvise Health Holdings,  LLC \n1331 S. Curry Pike  \nBloomington, IN 4740 3 \n \n If to the Participant:  \n10701 S River Front Parkway, Unit 200, \nSouth Jordan, UT 84095  \n \n \n14. Governing Law .",
        "id": "qa_71"
    },
    {
        "question": "What is the legal status of the confidential information according to the NDA between Abarca Health LLC and the Receiving Party?",
        "options": {
            "A": "The confidential information becomes public upon disclosure.",
            "B": "The Receiving Party is required to compensate the Disclosing Party for the confidential information.",
            "C": "The Receiving Party gains ownership rights to the confidential information.",
            "D": "The confidential information remains the sole property of the Disclosing Party."
        },
        "correct_answer": "D",
        "explanation": "The NDA explicitly states that confidential information remains the sole and exclusive property of the Disclosing Party.",
        "source": "s3://ml-legal-restricted/contract-docs/72710/Abarca Health - Cotiviti - NDA - MS - 08312023 - Dynamics_72710.pdf",
        "client": "Abarca Health LLC",
        "document_type": "NDA",
        "context": "1839) shall continue for so long as such information qualifies as a trade secret. 8. Compensation. The Receiving Party shall not be obligated to compensate the Disclosing Party for \nConfidential Information (except as may result from a breach of this Agreement) and the Receiving Party acknowledges \nand understands that no warranties of any kind are given  by the Disclosing Party with respect to the accuracy or \ncompleteness of the Confidential Information. 9. Ownership. Confidential Information shall remain the sole and exclusive property of the Disclosing Party. Nothing in this Agreement shall be construed as  granting to the Receiving Party any right, title or interest in or to any \npatent, trademark, license, copyright or other right of the Disclosing Party. 10. Relationship of the parties . Nothing in this Agreement shall be deemed to create, either express or imp lied, \nthe power in either Party to bind the other. Neither Party shall be bound by the actions of the other, shall be liable for \nDocuSign Envelope ID: 32A31026-DCD7-4F16-8BB6-2BC6BBBCBB05\nDocuSign Envelope ID: 1DEE5668-B8FB-46FA-AC28-81978C0F8267\n \n\u00a9 2018 Cotiviti , Inc. CONFIDENTIAL AND PROPRIETARY  3 \nthe debts of the other, or shall have a right to share in the profits of the other. This Agreement is not intended to be a \njoint venture, partnership or other formal business organization, and neither Party is under any obligation to enter into \nany further agreement with the other Party. 11. Mutual Representations. Each Party represents that it has the right to disclose its Confidenti al Information \nin furtherance of the purpose set forth above without violating any agreement with or right of any other person. Confidential Information may include information of a third party provided that the third party has authorized such \ndisclosure. 12. No Further Obligation  or Limitation .",
        "id": "qa_72"
    },
    {
        "question": "What must happen to latent data according to the NDA between Abarca Health LLC and the Receiving Party?",
        "options": {
            "A": "Latent data must be subject to destruction in due course but remains confidential until destroyed.",
            "B": "Latent data can be freely shared with third parties.",
            "C": "Latent data must be immediately destroyed upon request.",
            "D": "Latent data must be kept permanently as confidential information."
        },
        "correct_answer": "A",
        "explanation": "The NDA specifies that latent data, which is considered confidential, should be destroyed in due course but remains confidential until it is destroyed.",
        "source": "s3://ml-legal-restricted/contract-docs/72710/Abarca Health - Cotiviti - NDA - MS - 08312023 - Dynamics_72710.pdf",
        "client": "Abarca Health LLC",
        "document_type": "NDA",
        "context": "Each Party has the right to refuse to accept any trade secret, \nConfidential Informa tion or similar proprietary information prior to full disclosure. 4. Latent Data. Latent Data , which is Confidential Information shall be subject to destruction in due course but \nshall remain Confidential Information of the Disclosing Party until it is destr oyed. \u201cLatent Data\u201d refers to  data that is \nstored by a party on routine back -up media, including but not limited to deleted files and other non -logical data types, \nmemory dumps, swap files, temporary files, printer spool files and metadata that can customarily be retrieved only by \ncomputer forensics experts and is generally considered inaccessible without the use of specialized tools and techniques. 5. Return of Confidential Information. Subject to Section 3, \u201cExceptions,\u201d above, promptly following the earlier \nof (i) the termination of t his Agreement, or (ii) the written request of Disclosing Party, the Receiving Party shall destroy \nor deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party constituting or containing Confidential I nformation, together with all copies thereof, including all electronic and digital \ncopies in the possession of the Receiving Party . Upon receipt of such a request, the Receiving Party shall destroy all \nother documents and materials constituting Confidential Information in its possession to the extent reasonably practicable. Upon request, the Receiving Party shall certify such d estruction in writing to the Disclosing Party. 6. Protected Health Information. If any part of the Confidential Information disclosed hereunder is protected \nhealth information pursuant to the Federal Health Insurance Portability and Accountability Act of 1996, Pub. L. No.",
        "id": "qa_73"
    },
    {
        "question": "What is required in the Disaster Recovery Plan according to the Accenture MSA?",
        "options": {
            "A": "Adhere to State and Federal laws, rules, regulations, and guidelines.",
            "B": "Include only a recovery prioritization list for software applications.",
            "C": "Include recovery capabilities for telecommunications equipment only.",
            "D": "Submit the Disaster Recovery Plan for approval bi-annually."
        },
        "correct_answer": "A",
        "explanation": "The Disaster Recovery Plan must adhere to State and Federal laws, rules, regulations, and guidelines according to the document.",
        "source": "s3://ml-legal-restricted/contract-docs/55945/Accenture - Cotiviti SubK Agmt (Jan 2017)[CURRENT].pdf",
        "client": "Accenture",
        "document_type": "MSA",
        "context": "MPC 30\n\n \n\nCPC 06\n\n \n\nCNC 20\n\n \n\n \n\n \n\n     \n\n        \n  \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \n  \n \n \n  \n  \n\n \n\n \n\n  \n\n \n\n36\n\f\nDocuSign Envelope ID: 3AF05216-675E-4233-AD34-2EA07E0611A5\n\n   \n\n \n \n\nThe State may grant a waiver of this requirement under emergency conditions, Schedule routine\nsystem maintenance during non-peak processing hours, from 3:00 a.m. to 4:00 aum., Central Standard\nTime. Notify the designated State staff when the automated inquiry and transaction systems have been down\nfor more than ten (10) consecutive minutes outside of the State-approve scheduled maintenance\nwindow. Initial notification must include a brief description of the incident and projected recovery\ntime. Submit a follow-up notice to the State within ten (10) minutes of recovery, identifying total\ndown time and resolution. Document and track all incidents and resolutions in an automated tracking\nsystem. Provide ail system and application availability according te specifications established by the State. Prepare and submit for State approval and comprehensive Disaster Recovery Plan and submit to the\nState for approval on an annual basis. The Disaster Recovery Plan must adhere to State and Federal\nlaws, rules, regulations, and guidelines and must include:\n\ns Checkpoint/restart capabilities, 278\n\n* Retention and storage of back-up files and software;\n\ne Hardware back-up for the servers:\n\n\u00a9 Hardware back-up for data entry equipment;\n\n\u00ae Neiwork back-up for telecommunications:\n\n\u00ae Telephone communications lines to the disaster back-up site;\n\n* Recovery prioritization list {hardware and software applications; and\n\n*  Telecommunication Voice Switch,\n\n \n\n \n\n \n\n    \n\n \n\n \n\nSOC 54 Coordinate with and demonstrate to the State the Vendor's disaster recover capabilities every\ncalendar year. Include recovery of any new functionality implemented during the previous year. SOC 35 in the event of a catastrophic (i.e. possibility of crimes, terrorism, hackers, intentional torts. human\n\nerror, virus, etc.)",
        "id": "qa_74"
    },
    {
        "question": "What discretion does the Client have regarding the inclusion of Outpatient Claims in the Scope?",
        "options": {
            "A": "Outpatient Claims are automatically included in the Scope.",
            "B": "Client must include Outpatient Claims in the Scope.",
            "C": "Client has no discretion and must follow Cotiviti's decision.",
            "D": "Client has the sole discretion to add Outpatient Claims during the policy selection process."
        },
        "correct_answer": "D",
        "explanation": "The legal document specifies that the Client has the sole discretion to add Outpatient Claims to the Scope before or during the policy selection process during implementation.",
        "source": "unknown",
        "client": "Maryland Physicians Care (MPC)",
        "document_type": "unknown",
        "context": "The Services are \nfurther described in Schedule A, incorp orated herein and made a part hereof. \u0708  Payment Policy Management (\u201cPPM Services\u201d)  \n\u0708 Coding Validation ( \u201cCV Services\u201d ) \n3. Implementation  \na. Scope. Following the Go Live Date and throughout the Term of this SOW, Client shall submit to \nCotiviti for editing all of Client\u2019s Professional claims with the required data elements on all \nplatforms for Client\u2019s Medicaid line of business (the \u201c Scope \u201d), subject t o reasonable exclusions \nso long as the Basis of the Bargain requirements in Schedule B are met. As of the Effective Date, the parties are in discussions related to adding Outpatient Claims to the \nScope (which may include Outpatient Claims, as the parties may agree). Client will have the sole \ndiscretion whether to add Outpatient Claims. So long as Client agrees to add Outpatient Claims \nbefore or during the policy selection process that takes place during the Implementation, the parties will implement Outpatient Claims as part of the Scope. No further Work Order or \namendments will be required under this SOW. Should  Client decide not to implement Outpatient \nClaims before or during the policy selection pr ocess that takes place during the Implementation, \u0010\u001a\u0014\u001d\u001c\u0017\u0016\u0019\u0001\u0011\u0019\u001e\u0015\u0018\u001a\u001b\u0015\u0001\u0013\u0010\r\u0001\u0006\u000b\u000e\u000e\u0006\f\u0011\b\u0002\n\u0007\u0004\u000b\u0002\u0007\u0004\u0011\u0010\u0002\u000b\u0011\t\n\u0002\u0005\u0012\u0011\u000f\n\u0005\u0012\u0003\f\t\u0005\u0011\n \n\u00a9 2024 Cotiviti, Inc. CONFIDENTIAL AND PROPRIETARY Page 2  of 16 \nthen a Work Order will be required to add such Outpatient Claims at a later date, which might \ninclude new implementation fees. Client may add additional populations or platform s to this SOW by requesting a Work Order or \notherwise as may be agreed, which may be subject to reasonable additional implementation fees \nand will be subject to the same Payment Variance rates. b. Integration Method. The Services will be provided in a: \u0708 Real Time Integration \nIntegration includes one production environment and one test environment. Additional \nenvironments may be requested in a Work Order and will be subject to additional fees. c. Team.",
        "id": "qa_75"
    },
    {
        "question": "What must the Receiving Party do with Confidential Information upon termination of the Agreement or upon request by the Disclosing Party?",
        "options": {
            "A": "Destroy or deliver all documents containing Confidential Information, except for a single archival copy for dispute resolution.",
            "B": "Only destroy electronic copies and return physical documents.",
            "C": "Return all documents and materials without retaining any copies.",
            "D": "Retain all documents and materials indefinitely."
        },
        "correct_answer": "A",
        "explanation": "The NDA requires the Receiving Party to destroy or deliver all documents containing Confidential Information, except for a single archival copy that may be retained by the legal department for dispute resolution purposes.",
        "source": "s3://ml-legal-restricted/contract-docs/68895/Atrio - Cotiviti - NDA - AR - 07192022 - Dynamics_68895.pdf",
        "client": "ATRIO Health Plans",
        "document_type": "NDA",
        "context": "Subject to Section 3, \u201cExceptions,\u201d  above, promptly following the earlier \nof (i) the termination of this Agreement, or (ii) the written request of Discl osing Party, the Receiving Party shall destroy \nor deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party \nconstituting or containing Confidential Information, together with all copies thereof, inclu ding all electronic and digital \ncopies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving \nParty's legal department for dispute resolution purposes only. Upon receipt of such a request, the Receiving  Party shall \ndestroy all other documents and materials constituting Confidential Information in its possession to the extent \nreasonably practicable. Upon request, the Receiving Party shall certify such destruction in writing to the Disclosing \nParty. 6. Prote cted Health Information. If any part of the Confidential Information disclosed hereunder is protected \nhealth information pursuant to the Federal Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191 and its implementing regulatio ns (collectively, \u201c HIPAA\u201d), as amended by the regulations promulgated \npursuant to the Health Information Technology for Economic and Clinical Health Act, Title XIII of the American \nRecovery and Reinvestment Act of 2009 (the \u201c HITECH Act \u201d), the parties  agree to enter into a Business Associate \nAgreement (the \u201c BAA\u201d). The BAA will govern and supersede the terms of this Agreement with respect to any protected \nhealth information disclosed hereunder, and will include, but will not be limited to, the following  provisions:  \na. Individuals' rights to obtain a copy of the individual's information in an electronic format;  \nb.",
        "id": "qa_76"
    },
    {
        "question": "Under the MSA, to whom can Client disclose Confidential Information related to SOW #1?",
        "options": {
            "A": "Optum Health - CDO business segment with confidentiality agreement",
            "B": "Advantmed India LLP without restrictions",
            "C": "Any employees of Client without restrictions",
            "D": "Any third party without restrictions"
        },
        "correct_answer": "A",
        "explanation": "The MSA specifies that Client may disclose certain information to the Optum Health - CDO business segment, provided they agree to hold such pricing in strict confidence and not further disclose it.",
        "source": "s3://ml-legal-restricted/contract-docs/74579/Advantmed, LLC - Cotiviti - MSA - DM - 08302024 - Dynamics_74579.pdf",
        "client": "AdvantMed",
        "document_type": "MSA",
        "context": "The Receiving Party agrees that it will not (i) use any such \nConfi dential Information in any way,  except for the exercise of its rights and performance of its obligations under \nthis Agreement  or for the purpose for which it was disclosed , or (ii) disclose any such Confidential Information to \nany third party  without the Disclosing Party\u2019s prior written permission . Notwithstanding the preceding sentence , (i) Cotiviti may disclose  Confidentia l Information to its  Representatives  \nand subcontractors who are required to have access to the Confidential Information in connection with the provision \nof a Solution  to or on behalf of Client , provided each  has agreed to restrictions no less stringent than Cotiviti  with \nregard to the use and disclosure of such Confidential Information , and (ii) Client may disclose Confidential \nInformation to employees of its wholly -owned subsidiary Advantmed India LLP  to the minimum extent necessary \nfor implementation and provision of the services under Statement of Work #1 for Risk Adjustment between the \nparties, to be executed contemporaneously herewith (\u201c SOW #1\u201d), provided such Advantmed India LLP employees \nhave agreed to restrictions no less stringent than Client  with regard to the use and disclosure of such Confidential \nInformation . Notwithstanding anything herein to the contrary, except for permitted disclos ures to Advantmed India LL P \nemployees pursuant to the preceding sentence, Client  may disclose only to the Optum Health \u2013 CDO business \nsegment only the following information: (i) periodic status reports  for the services performed under SOW #1 , strictly \nlimited to the number of records retrieved by Cotiviti under SOW #1  at a given point in time ; (ii) the minimum \nvolume commitment under SOW #1 ; and (iii) fees set forth in SOW #1 , provide d that Optum Health -CDO agrees to \nhold such pricing in strict confidence within the business segment and agrees  not further disclose such pricing.",
        "id": "qa_77"
    },
    {
        "question": "What information must psychologists include in the records for an initial examination according to New Jersey Medicaid/NJ FamilyCare requirements?",
        "options": {
            "A": "Date of service, signature, chief complaints, historical data, evaluation reports, diagnosis, intended treatment course",
            "B": "Diagnosis, intended treatment, and prognosis",
            "C": "Signature and chief complaints only",
            "D": "Only the date of service and diagnosis"
        },
        "correct_answer": "A",
        "explanation": "The legal text specifies that for the initial examination, psychologists must record at least the date of service, signature, chief complaints, pertinent historical data, evaluation reports, diagnosis, and the intended course of treatment and tentative prognosis.",
        "source": "unknown",
        "client": "Horizon Blue Cross Blue Shield of New Jersey",
        "document_type": "unknown",
        "context": "h. If the laboratory uploads, transcribes or enters test requisition or authorization  \ninformation into a record system or a laboratory information system, the laboratory \nmust ensure that the information is transcribed or entered  accurately. 3. Services Provided by a  Psychologist  \na. Psychologists shall keep such individual records as may be necessary to disclose \nfully the kind and extent of services provided and shall make such information \navailable when requested by the New Jersey Medicaid/NJ FamilyCare program or \nits agents. The recordkeeping shall document the services provided as they relate to \nthe procedure code(s) used for reimbursement purposes (see N.J.A.C. 10:67- 3, \nHealthcare Common Procedure Coding System). b. For the initial examination, the record shall include, as a minimum, the  following:  \ni. Date(s) of service rendered;  \nii. Signature of the  psychologist;  \niii. Chief  complaint(s);  \niv. Pertinent historical, social, emotional, and additional  data;  \nv. Reports of evaluation procedures undertaken or ordered;   \nvi. Diagnosis;  and \nvii. The intended course of treatment and tentative  prognosis. c. For subsequent progress notes made for each Medicaid/ NJ FamilyCare patient  \ncontact, the following shall be included on the psychotherapeutic progress  note:  \ni. Date(s) and duration of service (for example, hour, half -hour);  \nii. Signature of the  psychologist;  \niii. Name(s) of modality used, such as individual, group, or family therapy;  \niv. Notations of progress, impediments, or treatment complications;  and \nv. Other components, such as dates or information not included in (c)1 \nthrough 4 above, which may be important to the clinical description and \nprognosis. vi. One or more of the following components shall be recorded to delineate  \nthe visit and establish its uniqueness.",
        "id": "qa_78"
    },
    {
        "question": "What action must a user take to withdraw consent for receiving electronic notices and disclosures via DocuSign?",
        "options": {
            "A": "Send a written request via email",
            "B": "Use the DocuSign \"Withdraw Consent\" form",
            "C": "Call customer service to withdraw consent",
            "D": "Submit a request through the company website"
        },
        "correct_answer": "B",
        "explanation": "The document specifies that consent can be withdrawn by using the DocuSign \"Withdraw Consent\" form on the signing page of the user's DocuSign account.",
        "source": "unknown",
        "client": "Self Insured Services Co",
        "document_type": "unknown",
        "context": "To indicate to us that you are changing your mind, you must \nwithdraw your consent  using the DocuSign \u00f4Withdraw Consent\u00f6 form on the signing page of \nyour DocuSign account. This will indicate to us that you have withdrawn your consent to receive \nrequired notices and disclosures electronically from us and you will no longer be able to use  your \nDocuSign Express user account to receive required notices and consents electronically from us \nor to sign electronically documents from us. All notices and disclosures will be sent to you electronically   \nUnless you tell us otherwise in accordance wit h the procedures described herein, we will provide \nelectronically to you through your DocuSign user account all required notices, disclosures, \nauthorizations, acknowledgements, and other documents that are required to be provided or made \navailable to you d uring the course of our relationship with you. To reduce the chance of you \ninadvertently not receiving any notice or disclosure, we prefer to provide all of the required \nnotices and disclosures to you by the same method and to the same address that you hav e given \nus. Thus, you can receive all the disclosures and notices electronically or in paper format through \nthe paper mail delivery system. If you do not agree with this process, please let us know as \ndescribed below. Please also see the paragraph immediat ely above that describes the \nconsequences of your electing not to receive delivery of the notices and disclosures \nelectronically from us. How to contact Cotiviti:   \nElectronic Record and Signature Disclosure created on: 1/10/2019 11:10:15 AM\nParties agreed to: Hawley, Matthew J.",
        "id": "qa_79"
    },
    {
        "question": "What rights does the Receiving Party have concerning the Disclosing Party's Confidential Information according to the agreement?",
        "options": {
            "A": "The Receiving Party is automatically granted a license to all disclosed intellectual property.",
            "B": "The Receiving Party can receive ownership and copy Confidential Information freely.",
            "C": "The Receiving Party must receive a title and ownership of the Confidential Information.",
            "D": "The Receiving Party has no rights to copy or reproduce Confidential Information without written permission."
        },
        "correct_answer": "D",
        "explanation": "The agreement states that the Receiving Party may not copy or reproduce the Disclosing Party\u2019s Confidential Information without express written permission, except as necessary for the Purpose contemplated.",
        "source": "unknown",
        "client": "Horizon Blue Cross Blue Shield of New Jersey",
        "document_type": "unknown",
        "context": "The Receiving Party will not receive any title, ownership, license, property or other right or interest in any\nDisclosing Party's Confidential Information, and the Receiving Party may not copy or reproduce the Disclosing\nParty\u2019s Confidential Information without the express written permission of the Disclosing Party except for such\ncopies as may be necessary for the Purpose contemplated hereunder, and any copies made shall include any\ncopyright or proprietary notices included thereon. 4. Rights. No rights or obligations other than those expressly recited herein are implied by this Agreement. This\nAgreement does not require either Party to disclose any particular information, or enter into any business\nrelationship, nor does it grant Receiving Party a license to any disclosed patents, trademarks, copyrights, or\nother intellectual property. 5. No Warranty. It is understood that no representations or warranties are being made as to the completeness\nor accuracy of any information and that any and all representations and warranties made by each Party shall\nbe set forth in a signed acquisition agreement or purchase contract and be subject to the provisions thereof. 6. Term. Either Party may terminate this Agreement for any reason by giving thirty (30) days written notice to\nthe other Party. The obligations of the Receiving Party regarding Confidential Information are as stated in\nSection 2 and shall survive the termination of this Agreement. 7. Dispute Resolution. Both Parties agree that a breach of this Agreement may give rise to irreparable injury to\nthe other Party that may not be adequately compensated for by damages and, consequently, the Disclosing\nParty shall be entitled, in addition to all other remedies available to it, to injunctive and other equitable relief\nwithout the posting of a bond to prevent a breach of this Agreement and to secure the enforcement of this\nAgreement. This Agreement shall be interpreted and construed under the laws of the State of New Jersey\nwithout regard to conflict of laws principles.",
        "id": "qa_80"
    },
    {
        "question": "What is the consequence of withdrawing consent to receive notices and disclosures electronically?",
        "options": {
            "A": "Slower transaction speed",
            "B": "No impact on transaction speed",
            "C": "Additional fees for electronic documents",
            "D": "Increased transaction speed"
        },
        "correct_answer": "A",
        "explanation": "Withdrawing consent to receive notices and disclosures electronically will slow down the transaction process as the documents will need to be sent in paper format, requiring acknowledgment of receipt.",
        "source": "unknown",
        "client": "Self Insured Services Co",
        "document_type": "unknown",
        "context": "Described below are the terms and conditions for providing \nto you such notices and disclosures electronically through your DocuSign, Inc. (DocuSign) \nExpress user account. Please read the information below carefully and thoroughly, and if you can \naccess this information electr onically to your satisfaction and agree to these terms and \nconditions, please confirm your agreement by clicking the agree button at the bottom of this \ndocument. Getting paper copies   \nAt any time, you may request from us a paper copy of any record provide d or made available \nelectronically to you by us. For such copies, as long as you are an authorized user of the \nDocuSign system you will have the ability to download and print any documents we send to you \nthrough your DocuSign user account for a limited per iod of time (usually 30 days) after such \ndocuments are first sent to you. After such time, if you wish for us to send you paper copies of \nany such documents from our office to you, you will be charged a $0 per -page fee. You may \nrequest delivery of such pap er copies from us by following the procedure described below. Withdrawing your consent  \nIf you decide to receive notices and disclosures from us electronically, you may at any time \nchange your mind and tell us that thereafter you want to receive required notices and disclosures \nonly in paper format. How you must inform us of your decision to receive future notices and \ndisclosure in paper format and withdraw your consent to receive notices and disclosures \nelectronically is described below. Consequences of changing your mind   \nIf you elect to receive required notices and disclosures only in paper format, it will slow the \nspeed at which we can complete certain steps in transactions with you and delivering services to \nyou because we will need first to send the required notices or disclosures to you in paper format, \nand then wait until we receive back from you your acknowledgment of your receipt of such \npaper notices or disclosures.",
        "id": "qa_81"
    },
    {
        "question": "What remedy is available for a breach of the NDA according to the document?",
        "options": {
            "A": "Only money damages",
            "B": "Only temporary injunctive relief",
            "C": "Specific performance and/or injunctive relief",
            "D": "No remedy available"
        },
        "correct_answer": "C",
        "explanation": "The document states that the Disclosing Party is entitled to specific performance and/or injunctive relief, either temporary or permanent, in addition to money damages, as a remedy for a breach of the NDA.",
        "source": "s3://ml-legal-restricted/contract-docs/63453/19902_ACTmd HMS MNDA 05302019.pdf",
        "client": "ACT.md",
        "document_type": "NDA",
        "context": "5. Remedies . The Parties understand and agree that money damages  may not be a sufficient \nremedy for any breach of this Agreement by it or by its Representatives and that the Disclosing Party shall \nbe entitled to specific performance and/or in junctive relief, either temporary or permanent, as appropriate, \nto remedy such breach. Such remedy shall not be deemed to be the exclusive remedy for any such breach \nof this Agreement but shall be in addition to all other remedies available at law or in e quity, including but \nnot limited to money damages. The Parties further acknowledge and agree that the covenants contained \nherein are necessary for the protection of legitimate business interests and are reasonable in scope. No \nfailure or delay in exercis ing any right, power, or privilege under this Agreement shall operate as a waiver \nthereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the \nexercise of any right, power, or privilege under this Agreemen t. \n6. Solicitation of Employees . Unless otherwise provided in any subsequent written agree -\nment regarding a Potential Transaction, for a period of two years following the Effective Date of this \nAgreement, each Party agrees, on behalf of itself and its Repre sentatives, not to directly hire, employ, or \notherwise contract with, any of the other Party\u2019s, including any parent companies or subsidiaries, \nemployees, agents, or other persons who then have, or who have had within the preceding three months, \nemployment  with the Party or its parent or affiliates, and with whom it has had contact or who became \nknown to it in connection with this Agreement or its consideration of a Potential Transaction.",
        "id": "qa_82"
    },
    {
        "question": "What is the duration for which rights and obligations survive after the termination of the NDA agreement?",
        "options": {
            "A": "2 years",
            "B": "Indefinitely",
            "C": "5 years",
            "D": "10 years"
        },
        "correct_answer": "C",
        "explanation": "The NDA specifies that the rights and obligations accruing prior to termination survive for a period of five (5) years after termination.",
        "source": "s3://ml-legal-restricted/contract-docs/68895/Atrio - Cotiviti - NDA - AR - 07192022 - Dynamics_68895.pdf",
        "client": "ATRIO Health Plans",
        "document_type": "NDA",
        "context": "Individuals' rights to have the individual's information transmitted to another entity or person \ndesignated by the individual, provided the request is clear, conspicuous, and specific;  \nc. The right to audit and monitor activities that involve protected health information; and \nd. The process for notification and reporting of unauthorized disclosure or protected health information \nbreaches. 7. Term. This Agree ment  may  be terminated with respect to subsequent disclosures upon thirty (30) days' prior \nwritten notice to the other Party. This Agreement shall automatically terminate two (2) years after its Effective Date. The rights and obligations accruing prior to termination as set forth herein shall survive the termination of this \nAgreement for a period of five (5) years provided, however, that Receiving Party\u2019s obligations respecting Disclosing \nParty\u2019s \u201ctrade secrets\u201d (as such term is defined in 18 U.S.C. 1839) s hall continue for so long as such information qualifies \nas a trade secret. 8. Compensation. The Receiving Party shall not be obligated to compensate the Disclosing Party for \nConfidential Information (except as may result from a breach of this Agreement) and t he Receiving Party acknowledges \nand understands that no warranties of any kind are given by the Disclosing Party with respect to the accuracy or \ncompleteness of the Confidential Information. 9. Ownership. Confidential Information shall remain the sole and exc lusive property of the Disclosing Party. Nothing in this Agreement shall be construed as granting to the Receiving Party any right, title or interest in or to any \npatent, trademark, license, copyright or other right of the Disclosing Party. 10. Relationship of  the parties . Nothing in this Agreement shall be deemed to create, either express or implied, \nthe power in either Party to bind the other.",
        "id": "qa_83"
    },
    {
        "question": "Which of the following is considered an exception to the definition of \"Confidential Information\" under the agreement?",
        "options": {
            "A": "Information disclosed to the Receiving Party by a third party, regardless of confidentiality obligation",
            "B": "Information developed by the Receiving Party with reference to the Disclosing Party\u2019s Confidential Information",
            "C": "Information publicly known before disclosure by the Disclosing Party",
            "D": "Personal information of customers and employees"
        },
        "correct_answer": "C",
        "explanation": "Confidential Information does not include information that was publicly known and made generally available in the public domain prior to the time of disclosure by the Disclosing Party.",
        "source": "unknown",
        "client": "Albertsons Companies, Inc.",
        "document_type": "unknown",
        "context": "The Purpose, the existence of this Agreement and any \nnegotiations and agreements entered into by the parties in connection with the Purpose shall also be \nconsid ered \u201cConfidential Information.\u201d  \n3. Exceptions . Confidential Information shall not include any information that the Receiving Party  \ncan establish : (i) was publicly known and made generally available in the public domain prior to the time of \ndisclosure by the Disclosing Party; (ii)  becomes publicly known and made generally available after \ndisclosure by the Disclosing Party to the Receiving Party throu gh no breach of this Agreement by the \nReceiving Party; (iii)  is already known by or legally in the possession of the Receiving Party , without \nconfidentiality obligation,  at the time of disclosure by the Disclosing Party; (iv)  is lawfully disclosed to the \nReceiving Party , without confidentiality obligation,  by a third party; or (v)  is independently developed by the \nReceiving Party without use of or reference to the Disclosing Party\u2019s Confidential Information ; provided that , \nnotwithstanding the foregoing exce ptions,  personal information of customers and employees of either party \nshall be deemed Confidential Information hereunder to the full extent required by applicable law, and \nprovided further that no damages shall accrue with respect to information unlawful ly provided by a third \nparty unless the Disclosing Party can demonstrate that the Receiving Party knew or should have known \nthat such disclosure was unlawful . 4. Non-use and Non -disclosure . The Receiving Party agrees: (i) to use Confidential Information \nsolely for the Purpose, and for no other purpose;  (ii) not to disclose any Confidential Information except as \nexpressly permitted by, or to enforce, this Agreement and (iii) to disclose Co nfidential Information only to \nits Representatives who need to know the Confidential Information for the Purpose and who are bound to \nkeep such Confidential Information confidential consistent with the obligations of this Agreement.",
        "id": "qa_84"
    },
    {
        "question": "Under the agreement, when is the Business Associate allowed to disclose Protected Health Information (PHI)?",
        "options": {
            "A": "Under no circumstances",
            "B": "Only with explicit permission from the client",
            "C": "Only as permitted by the Agreement or as Required by Law",
            "D": "Any time the Business Associate deems it necessary"
        },
        "correct_answer": "C",
        "explanation": "The agreement specifies that the Business Associate may not use or disclose PHI other than as permitted or required by the Agreement or as Required by Law.",
        "source": "unknown",
        "client": "Blue Cross and Blue Shield of Nebraska",
        "document_type": "unknown",
        "context": "The purpose of this Agreement is to set forth the terms and \nconditions deemed necessary by the parties hereto to en sure \ncompliance with the requirements applicable to Business Associate's \nhandling of Protected Health Information (\"PHI\") under the Security \nRegulations (45 CFR Part 160 and 164, Part C, hereinafter Security \nStandards) and Implementation Specifications (45  CFR part 160 and \n164, subpart C, hereinafter the Security Rule); and the Standards for \nPrivacy  of Individually Identifiable Health Information  (45 CFR part 160 \nand 164 subparts A and E , here inafter the \"Privacy Rule\") prom ulgated \nunder HIPAA and the requ irements of the Health Information Technology \nfor Economic and Clinical Health Act, as incorporated in the American \nRecovery and Reinvestment Act of 2009 (the \u201cHITECH Act\u201d), that are \napplicable to business associates, along with any guidance and/or \nregulat ions issu ed by DHHS. Capitalized terms set forth in this  \nAgreement  shall have that meaning set forth in HIPAA , the Privacy Rule , \nthe Security Rule and/or in the HITECH Act . The HIPAA Breach \nNotification Rule is the Notification in the Case of Breach of Un secured \nProtected Health Information, as set forth at 45 CFR Part 164 Subpart D. \nIn the event of any inconsistency between this Agreement and the \nPrivacy  or Security Rules, the requirements set forth in the Rule shall \ncontrol. 2. Business Associate agr ees to not use or disclose PHI other \nthan as permitted or required by this Agreement or as Required by Law. 3. Business Associate agrees to use appropriate safeguards to \nprevent use or disclosure of the PHI other than as provided for by this \nAgreement .",
        "id": "qa_85"
    },
    {
        "question": "Who is considered an Authorised User according to the MSA?",
        "options": {
            "A": "Any member of the public authorized by Client",
            "B": "Any individual with access to the internet",
            "C": "Any employee of Cotiviti",
            "D": "An employee, agent, or independent contractor of Client authorized by Client"
        },
        "correct_answer": "D",
        "explanation": "An Authorised User is defined as an employee, agent, or independent contractor of the Client who is authorized by the Client to access the SaaS Platform and use the Services.",
        "source": "s3://ml-legal-restricted/contract-docs/73278/ACA - Cotiviti Australia - MSA - JK - 10052023 - Dynamics_73278.pdf",
        "client": "ACA Health Benefits Fund",
        "document_type": "MSA",
        "context": "Authorised User means an employee, agent and ind ependent contractor of Client  who is \nauthorised by Client  (either on a restricted or unrestricted basis) to access the SaaS Platform \nand use the Services. Business Day means a day that is not a weekend or a public holiday in New South Wales or \nSouth Austra lia. Business Hours means between the hours of 9am to 6pm Sydney time each Business Day. Business Terms means these Business Terms including the Commercial Principles and any \nvariation or amendment agreed in writing by Cotiviti and the Client . Claim means any claim, demand, allegation, suit, action, cause of action, proceeding or \njudgment of any kind however made or caused. Commencement Date for any  Services has the meaning set out in the Service Schedule for \nthose Services. Commercial Principles me ans the table set out  at the start of these Business Terms. Commissioner has the meaning given in the Privacy Act . Confidential Information  means, in relation to a party: \n(a) all information relating to or used by the party or any other member of its Group, \nincluding know-how, trade secrets, ideas, marketing strategies and operational \ninformation; \n(b) all information concerning the business affairs (including products, services, licensees \nand licensors) or property of the party or any other member of its Group, including \nany business, property or transaction in which the party or any other member of its \nGroup may be or may have been concerned or interested; and \n(c) any other information disclosed by or on behalf of the party or any other member of its Group which, by its nature or by the circumstances of its disclosure, is or could \nreasonably be expected to be regarded as confidential;  \nincluding any such information made available to the party or any other member of its Group by a third party. Client 's Confidential Information includes the Client  Data. Cotiviti's \nConfidential Information includes the SaaS Platform.",
        "id": "qa_86"
    },
    {
        "question": "What must a Receiving Party do if legally required to disclose Confidential Information?",
        "options": {
            "A": "Notify the Disclosing Party promptly and seek a protective order.",
            "B": "Disclose the information immediately without notifying the Disclosing Party.",
            "C": "Request additional information from the legal entity requiring disclosure.",
            "D": "Destroy the Confidential Information before disclosure."
        },
        "correct_answer": "A",
        "explanation": "The agreement specifies that the Receiving Party must provide prompt written notice to the Disclosing Party and cooperate fully to seek a protective order before disclosing any Confidential Information.",
        "source": "unknown",
        "client": "Ochsner Health System",
        "document_type": "unknown",
        "context": "Further, without prior written consent of the other \nParty, neither P arty will, and each will direct its Representatives not to, disclose to any person (a) \nthe fact that the Confidential Information has been made available;  and (b) the fact that discussions \nor negotiations are taking place or have taken place concer ning a business relationship between \nthe Parties. 2.2 If a Receiving Party  is requested or required (by deposition, interrogatories, \nrequests for information or documents, subpoena, civil investigative demand or any other form of \nlegal process) to disclose an y Confidential Information, it is agreed that the Receiving Party  will \nprovide the Disclosing Party with prompt written notice of such request and cooperate fully so that \nthe Disclosing Party may seek an appropriate protective order and/or waive its compli ance with \nthe provisions of this Agreement. If in the absence of an enforceable protective order, the Receiving Party  is nonetheless compelled to disclose Confidential Information, the Receiving \nParty  shall take reasonable and lawful actions to avoid and/ or minimize the extent of such \ndisclosure; provided, however, that the Receiving Party  gives the Disclosing Party written notice \nof the information to be disclosed as far in advance of its disclosure as is practicable and, upon the \nDocuSign Envelope ID: F4BFD935-23CB-491D-B17B-E978018BAD5B\nConfidentiality and Non- Disclosure Agreement  \nPage 3 of 7 \n \nDisclosing Party\u2019s reque st, uses reasonable efforts to obtain assurances that confidential treatment \nwill be accorded to such information. 2.3 Latent Data. Latent Data, which is Confidential Information shall be subject to \ndestruction in due course but shall remain Confidential Info rmation of the Disclosing Party until \nit is destroyed.",
        "id": "qa_87"
    },
    {
        "question": "What are the limitations on the Client\u2019s rights to use Cotiviti Applications as per the agreement?",
        "options": {
            "A": "Client can make Cotiviti Applications available on public electronic bulletin boards.",
            "B": "Client can frame or deep-link into any page of Cotiviti Applications without permission.",
            "C": "Client can use Cotiviti Applications within and for the benefit of its own internal business operations.",
            "D": "Client can transfer possession of Cotiviti Applications freely."
        },
        "correct_answer": "C",
        "explanation": "The agreement specifies that Cotiviti grants the Client a personal, nontransferable, and nonexclusive right to use the Software, Application, or Application Service for the benefit of the Client\u2019s own internal business operations.",
        "source": "unknown",
        "client": "Maryland Physicians Care (MPC)",
        "document_type": "unknown",
        "context": "Client may be requ ired to seek written approval for all Approved Authorized \nUsers on an annual basis, the timing of which may be determined by Cotiviti. (iv) Each Authorized User account will be used by one and only one individual. (v) Client will be responsible for the acts and om issions of its Authorized Users and Approved \nAuthorized Users with respect to the provisions of th is Agreement and the Statement of Work and use of an \nApplication Service. (vi) The parties agree to abide by restrictions, as described in the Business Associate \nAgreement, on the use of protected health information. (b) Rights in Application Se rvice Use (if Applicable) \n(i) Subject to the terms and conditions of this Ag reement, Cotiviti grants to Client a personal, \nnontransferable and nonexclusive right to use the Software , Application, or Application Service identified in any \nStatement of Work within and for the benefit of Client\u2019s  own internal business operations, and for no other \npurpose. (ii) Limitations on Client\u2019s rights: \n(A) The right to Application Service Use will not extend to any third party or any \nbusiness or operation of a third party, unless and until (i) Cotiviti is notified in writing of the desire for such \nextension, and (ii) Cotiviti and Client agree in writing as to appropriate increases, if any, in the payments required \nunder this Agreement. (B) No right is granted to Client to (i) make  Cotiviti Applications available in any \npublic electronic bulletin board, public computer based info rmation system, or the equivalent; (ii) publish, translate \nor transfer possession of Cotiviti Applications or copy an y portion thereof; or (iii) without prior written permission \nfrom Cotiviti, frame or deep-link into any page of any Cotiviti Application, or otherwise mask the appearance of \nCotiviti -identifying information on such page.",
        "id": "qa_88"
    },
    {
        "question": "How can you withdraw your consent to receive electronic notices and disclosures from Cotiviti?",
        "options": {
            "A": "Send a letter via US Postal Service",
            "B": "Call Cotiviti customer service",
            "C": "Send an email to legal@verscend.com",
            "D": "Decline to sign a document within your DocuSign account and select a checkbox"
        },
        "correct_answer": "D",
        "explanation": "The document specifies that you can withdraw consent by declining to sign a document within your DocuSign account and selecting the checkbox indicating you wish to withdraw your consent.",
        "source": "unknown",
        "client": "Self Insured Services Co",
        "document_type": "unknown",
        "context": "You may contact us to let us know of your changes as to how we may contact you electronical ly, \nto request paper copies of certain information from us, and to withdraw your prior consent to \nreceive notices and disclosures electronically as follows:  \nTo contact us by email, send messages to : legal@verscend.com  \nTo advise Cotiviti of your new e -mail address  \nTo let us know of a change in your e -mail address where we should send notices and disclosures \nelectronically to you, you must send an email message to us at Katerina.Koliovska -\nTobaygo@verscend.com and in the body of such request you must state:  your previous e -mail \naddress, your new e -mail address. We do not require any other information to change your email \naddress. In addition, you must notify DocuSign, Inc to arrange for your new email address to be reflected \nin your DocuSign account by fo llowing the process for changing e -mail in DocuSign. To request paper copies from Cotiviti   \nTo request delivery from us of paper copies of the notices and disclosures previously provided \nby us to you electronically, you must send us an e -mail to Katerina. Koliovska -\nTobaygo@verscend.com and in the body of such request you must state your e -mail address, full \nname, US Postal address, and telephone number. To withdraw your consent with Cotiviti   \nTo inform us that you no longer want to receive future notices a nd disclosures in electronic \nformat you may:  \ni. decline to sign a document from within your DocuSign account, and on the subsequent \npage, select the check -box indicating you wish to withdraw your consent, or you may;  \nii.",
        "id": "qa_89"
    },
    {
        "question": "What actions may the non-breaching party take upon knowledge of a material breach according to the legal document?",
        "options": {
            "A": "Report the violation to the Secretary immediately without attempting to cure the breach.",
            "B": "Terminate the agreement immediately regardless of the possibility of curing the breach.",
            "C": "Ignore the breach if it cannot be cured.",
            "D": "Provide a reasonable opportunity for the breaching party to cure the breach or end the violation, and terminate the agreement if cure is not possible."
        },
        "correct_answer": "D",
        "explanation": "The document specifies that the non-breaching party may provide a reasonable opportunity to cure the breach or end the violation and terminate the agreement if cure is not possible. If neither termination nor cure is feasible, reporting the violation to the Secretary may be required by the HIPAA Rules.",
        "source": "unknown",
        "client": "Community First Health Plans",
        "document_type": "unknown",
        "context": "Upon  knowledge  of a material  breach,  the non-breaching  party  may:  \n \n1. Provide  a reasonable  opportunity  for the other  party  to cure  the breach  or end the \nviolation and terminate this Agreement if cure is not possible; or,  \n \n2. Immediately  terminate  this Agreement  if cure  is not possible;  or, \n \n3. If neither  termination  nor cure  is feasible,  report  the violation  to the Secretary  if required \nby the HIPAA Rules. C. Effect of Termination. Except as provided in the second bullet of the foregoing section, upon \ntermination  of this Agreement  for any reason,  Business  Associate  shall,  if feasible,  within  one \nhundred eighty (180)  days return or destroy  all PHI received from Community First, or created or \nreceived by Business Associate on behalf of Community First that the Business Associate maintains \nin any form and retain no copies of such information. In the event that Business  Associate \ndetermines that returning or destroying the PHI is infeasible, Business Associate shall provide to  \nCommunity First notification of the conditions that make return or destruction infeasible  and \nBusiness Associate shall extend the protections of t his Agreement to such PHI and limit further \nuses and disclosures of such PHI to those purposes that make the return or destruction infeasible, \nfor so long as Business Associate maintains such PHI. This section shall apply to PHI that is in the possession of subcontractors or agents of Business \nAssociate. VIII. Miscellaneous  \n \nA. Regulatory References . A reference in this Agreement to a section in the HIPAA Rules or the \nHITECH Act means the section currently in effect or as it may be amended, and for which \ncompliance is required. B. Amendment. The Parties  agree  to take  such  action  as is necessary  to amend  this Agreement  from \ntime  to time  as necessary  for compliance  with  the requirements  of the HIPAA  Rules  and any other \napplicable  law. This Agreement  may  not be modified,  nor shall  any provision  hereof  be waived  or \namended,  except  in writing  duly  signed  and agreed  to by Business  Associate  and Community  First. C. Survival.",
        "id": "qa_90"
    },
    {
        "question": "What must the Recipient do with Discloser\u2019s Confidential Information upon expiration or termination of the Agreement?",
        "options": {
            "A": "Publish a press release about the termination",
            "B": "Keep the information for five years",
            "C": "Return all tangible information and delete electronic information",
            "D": "Destroy all electronic and tangible copies"
        },
        "correct_answer": "C",
        "explanation": "Upon expiration or termination, the Recipient must securely return all tangible Confidential Information and either return or delete electronic Confidential Information, as per the Discloser's discretion.",
        "source": "unknown",
        "client": "Albertsons Companies, Inc.",
        "document_type": "unknown",
        "context": "9.2  Each Party\u2019s confidentiality obligations shall survive  for a period of five (5) years provided, however, that \nRecipient \u2019s obligations respecting  Discloser\u2019s  \u201ctrade secrets\u201d (as such term is defined in 18 U.S.C. 1839) shall \ncontinue for so long as such information qualifies as a trade secret. Notwithstanding the foregoing obligations, \nhowever, any trade secret disclosed hereunder shall be properly marked as same . 10. EFFECT OF TERMINATIO N.   \n  \n10.1  Upon expiration or termination of this Agreement or upon written request from Discloser, Recipient will \nsecurely and immediately return to Discloser all tangible Confidential Information of Discloser, including but \nnot limited to all reports, media, documentation, notes, plans, drawings, materials, and all copies of the \nsame. With respect to Discloser\u2019s Confidential Inf ormation stored in electronic form, Recipient will securely, \nat Discloser\u2019s sole discretion, either (i) promptly return or (ii) delete all such Confidential Information from its \nand its Recipient Personnel\u2019s systems pursuant to its electronic records archi val policy and certify in writing to \nDiscloser that such information has been so returned or deleted. Company agrees to transfer Albertsons \nConfidential Information to Albertsons, or a third party as designated by Albertsons, at no additional cost to \nAlber tsons, upon expiration or termination of this Agreement or upon Albertsons\u2019 request. 11. PUBLICITY . 11.1   Neither Party may make any press release or other public disclosure regarding this Agreement or the Purposes \nwithout the prior written consent of the other Party. 12. REMEDIES .",
        "id": "qa_91"
    },
    {
        "question": "What is the minimum retrieval rate for medical records in a risk adjustment campaign as specified in the SOW?",
        "options": {
            "A": "95%",
            "B": "90%",
            "C": "87%",
            "D": "75%"
        },
        "correct_answer": "C",
        "explanation": "The SOW specifies that Cotiviti shall retrieve a minimum of 87% of Retrievable Medical Records per campaign.",
        "source": "s3://ml-legal-restricted/contract-docs/74838/Advantmed - Cotiviti - SOW 1 - DM - 08302024 - Dynamics_74838.pdf",
        "client": "AdvantMed",
        "document_type": "SOW",
        "context": "Following the Effective Date, the parties will work together to develop and agree to \nan operational calendar, which sets forth a schedule for the delivery, intake, processing, and delivery of files, \nand which the parties shall review, and update as necessa ry (the \u201c Operational Calendar \u201d). The parties hereby \nagree to abide by the Operational Calendar and shall undertake all necessary efforts required to do so. F. Acceptance. Acceptance will be deemed to be made as of the date Cotiviti has the Chase List. G. Offshore Backoffice Services. The pricing contained in this SOW is conditioned upon Cotiviti performing \nthe back office functions offshore, including intake and association work that is manual in nature. 4. Client Responsibilities  \n \nA. Provide Chase List. Client shall provide Cotiviti its Chase List for each project via SFTP . B. Respond to Questions. Client shall provide all necessary information or approvals as requested by Cotiviti. C. Intentionally omitted. D. Client Staff. Client shall dedicate appropriate staff to fulfill Client\u2019s obligations in this SOW, including but \nnot limited to appropriate subject matter experts and appropriate technical and IT resources. 5. Additional Performance Standards. A. Risk Adjustment Retrieval Rate. For each campaign for risk adjustment retrieval that is at least 12 weeks \nlong beginning on the date of active retrieval and for which Client complies with the deadlines in section 3.C., \nabove, Cotiviti shall retrieve a minimum of 87% of Retrievable Medical Records per campaign. The retrieval \nrate will be calculated with the following equation: total number of Medical Records Retrieved, divided by \nthe total number of Retrievable Medical Records. \u201c Retrievable Medical Records \u201d refers to all medical records \nin the Chase List, except for duplicate Medical Records, Chase IDs cancelled by Client, and any Chase ID \nending in a \u201cno patient\u201d or \u201cno record\u201d status.",
        "id": "qa_92"
    },
    {
        "question": "What is the duration for which Eliza must maintain records to verify performance and compliance according to the agreement?",
        "options": {
            "A": "For ninety days after the Term",
            "B": "For two years after the Term",
            "C": "During the Term only",
            "D": "For five years after the Term"
        },
        "correct_answer": "B",
        "explanation": "The agreement specifies that Eliza shall maintain records for the duration of the Term and for two years thereafter or as required by law, whichever is greater.",
        "source": "unknown",
        "client": "Inogen",
        "document_type": "unknown",
        "context": "CUSTOMER REPRESENTS AND WARRANTS THAT IT HAS AGREEMENTS\nAND EXISTING BUSINESS RELATIONSHIPS IN PLACE WITH ITS PLANS AND/OR WITH ITS\nPATIENT MEMBERS THAT ALLOW PATIENT DATA TO BE USED FOR THE SERVICES AND\nPROGRAMS CONTEMPLATED HEREUNDER CONSISTENT WITH THE REQUIREMENTS OF ALL\nAPPLICABLE LAWS WITHOUT FURTHER CONSENTS BEING OBTAINED. Customer shall indemnify, defend and hold harmless Eliza, its directors, officers, employees and agents from\nand against any and all claims, liabilities, actions, demands, losses, damages, judgments, settlements, costs and\nexpenses (including reasonable attorneys' fees) in connection with or arising out of (a) the collection, accuracy,\ndelivery, and use of data pursuant to this Agreement, or (b) Customer's breach of this Agreement. Records: During the Term and for two (2) years thereafter or as required by law, whichever is greater, Eliza\nshall maintain records necessary to verify its performance and compliance with this Agreement. Programs and\nrelated records will be considered closed after ninety (90) days of inactivity. Entire Agreement: This Agreement, together with the Exhibits hereto, constitutes the entire agreement\nbetween the parties concerning the subject matter hereof and merges and supersedes all prior and\ncontemporaneous agreements and communications, whether written or oral, concerning such subject matter. If\nCustomer issues a purchase order or other document purporting to relate to this Agreement or the Programs,\neither as an original contract or as an amendment of this Agreement, such document issued by Customer shall\nbe considered to be for Customer's internal use only, and the provisions contained therein shall not amend this\nAgreement except as may be expressly agreed to by Eliza in writing. Amendments: This Agreement may be modified or amended only in writing specified to be amendments or\nmodifications and signed by a duly authorized representative of each party.",
        "id": "qa_93"
    },
    {
        "question": "What are the requirements for retaining Aetna\u2019s Business Records according to the amendment?",
        "options": {
            "A": "Records must be retained permanently.",
            "B": "Supplier must retain records as per the retention period in the specific Schedule.",
            "C": "Records must be retained until the termination of the Agreement.",
            "D": "Supplier must retain records for 5 years."
        },
        "correct_answer": "B",
        "explanation": "The amendment specifies that Supplier shall retain Aetna\u2019s Business Records in accordance with the retention period set forth in the specific Schedule.",
        "source": "s3://ml-legal-restricted/contract-docs/55195/Aetna - Amendment No. 12 to PSA (April 2015) [55195].pdf",
        "client": "Aetna Life Insurance Company",
        "document_type": "Amendment",
        "context": "The receiving party shall take all necessary steps to immediately cure or prevent such \nbreach and to ensure no further release of any Confidential Information. G. Records Retention. To the extent specific types of Aetna  Business Records are described in a Schedule  \nSupplier  shall retain Aetna\u2019s  Business Records in accordance with the retention period set forth in said \nSchedule. \u201cAetna Business Records\u201d may include  information created or received by Supplier in connection  \nwith the work performed under this Agreement and in support of Aetna business activities that evidence \nSupplier\u2019s functions, operations, and obligations, including but not limited to, as applicable: data and \ninformation on internal or external transaction s, financial results, strategic and operational plans, policies and \nprocedures; correspondence/communicatio ns with members, plan sponsors,  producers, providers, \nsubcontractors and/or regulators, and internal copies of legall y required reports or forms . H. Survivability. It is expressly agreed by the parties that the provisions of this Section shall survive the \ntermination, for any reason, of this Agreement and shall be binding on each party, its successors and assigns for \nthe benefit of the other party a nd its Affiliates, successors and assigns. The effective date of this Amendment No. 12 is April 30 , 2015 . The Agreement shall remain in full force and effect, and except as hereby amended, is ratified and confirmed. IN WITNESS WHEREOF , the Parties hav e hereto by their duly authorized representatives executed this Agreement.",
        "id": "qa_94"
    },
    {
        "question": "What does the NDA between ATRIO Health Plans and Cotiviti Inc. specify about the nature of the relationship between the parties?",
        "options": {
            "A": "The NDA establishes a joint venture between the parties.",
            "B": "The NDA does not establish a joint venture, partnership, or formal business organization between the parties.",
            "C": "The NDA creates a formal business organization between the parties.",
            "D": "The NDA implies a partnership between the parties."
        },
        "correct_answer": "B",
        "explanation": "The NDA explicitly states that it is not intended to be a joint venture, partnership, or other formal business organization between the parties.",
        "source": "s3://ml-legal-restricted/contract-docs/68895/Atrio - Cotiviti - NDA - AR - 07192022 - Dynamics_68895.pdf",
        "client": "ATRIO Health Plans",
        "document_type": "NDA",
        "context": "Neither Party shall be bound by the actions of the other, shall be liable for \nthe debts of the other, or shall have a  right to share in the profits of the other. This Agreement is not intended to be a \nDocuSign Envelope ID: 97A67F5D-7AEA-4DA0-8A31-39BDF4A1B710\n \n\u00a9 2018 Cotiviti , Inc. CONFIDENTIAL AND PROPRIETARY  3 \njoint venture, partnership or other formal business organization, and neither Party is under any obligation to enter into \nany further agreement with the other Party. 11. Mutual  Representations. Each Party represents that it has the right to disclose its Confidential Information \nin furtherance of the purpose set forth above without violating any agreement with or right of any other person. Confidential Information may include inf ormation of a third party provided that the third party has authorized such \ndisclosure. 12. No Further Obligation  or Limitation . This Agreement shall not be construed in any manner to be an \nobligation to enter into a subcontract or contract or to result in any  claim whatsoever by one Party against the other for \nreimbursement of cost for any efforts expended. Except as specifically set forth herein, this Agreement does not: (i) \nrestrict either Party from developing new products, improving existing products, or m arketing any new, improved or \nexisting products; or (ii) commit either Party to disclose any particular information, or to develop, make, use, buy, sell, \nor otherwise dispose of any existing or future products, or to favor or recommend any product or servi ce of the other. To be binding, any such restriction or commitment must be in writing and signed by both parties . 13. Notices.",
        "id": "qa_95"
    },
    {
        "question": "What is the required timeframe for installing critical security patches on systems processing Company PHI?",
        "options": {
            "A": "Within 30 days of vendor release",
            "B": "Within 7 days of vendor release",
            "C": "Within 14 days of vendor release",
            "D": "Within 60 days of vendor release"
        },
        "correct_answer": "A",
        "explanation": "The document specifies that all applicable patches must be installed within thirty (30) days of vendor release based on risk assessment and vendor recommendations.",
        "source": "s3://ml-legal-restricted/contract-docs/63497/46088_Aetna CA Compliance Addendum 052720.pdf",
        "client": "Aetna Life Insurance Company",
        "document_type": "Addendum",
        "context": "All workstations,  laptops and other systems that process and/or store Company PHI \nmust install and actively use comprehensive anti -virus software solution with automatic updates scheduled \nat least daily. F. Patch Management. All workstations, laptops and other systems that pr ocess and/or store Company PHI \nmust have critical security patches applied, with system reboot if necessary. There must be a documented \npatch management process which determines installation timeframe based on risk assessment and vendor \nrecommendations. At  a maximum, all applicable patches must be installed within thirty (30) days of \nvendor release. G. User IDs and Password Controls. All users must be issued a unique user name for accessing Company \nPHI Username must be promptly disabled, deleted, or the passwo rd changed upon the transfer or \ntermination of an employee with knowledge of the password, at maximum within twenty -four (24) hours. Passwords are not to be shared. Passwords must be at least eight (8) characters and must be a non -\ndictionary word. Password s must not be stored in readable format on the computer. Passwords must be \nchanged every ninety (90) days, preferably every sixty (60) days. Passwords must be changed if revealed \nor compromised. Passwords must be composed of characters from at least three of the following four \ngroups from the standard keyboard:  \n\uf0a7 Upper case letters (A -Z)  \n\uf0a7 Lower case letters (a -z) \n\uf0a7 Arabic numerals (0 -9) \n\uf0a7 Non-alphanumeric characters (punctuation symbols)  \nH. Data Destruction. When no longer needed, all Company PHI must be wiped using  the Gutmann or US \nDepartment of Defense (DOD) 5220.22 M (7 Pass) standard, or by degaussing. Media may also be \nphysically destroyed in accordance with NIST Special Publication 800 -88. Other methods require prior \nwritten permission of Company. I. System Timeo ut.",
        "id": "qa_96"
    },
    {
        "question": "What actions are prohibited regarding prototypes, software, or other tangible objects that embody a party\u2019s Confidential Information?",
        "options": {
            "A": "Exporting, selling, and marketing",
            "B": "Exporting, disassembling, and distributing",
            "C": "Exporting, reverse engineering, and disassembling",
            "D": "Exporting, reverse engineering, and selling"
        },
        "correct_answer": "C",
        "explanation": "The document specifies that neither party shall export, reverse engineer, disassemble, or decompile any prototypes, software, or other tangible objects that embody the other party\u2019s Confidential Information.",
        "source": "unknown",
        "client": "Albertsons Companies, Inc.",
        "document_type": "unknown",
        "context": "Neither \nDocuSign Envelope ID: 8C793239-188D-4F97-84B8-3A353BD94257\n2/24/2022 | 13:21 EST\n10897 S River Front Pkwy, South Jordan, UT Cotiviti, Inc.\n \n3 | P a g e     V020520  \n party shall ex port, reverse engineer, disassemble or decompile any prototypes, software or other tangible \nobjects that embody the other party\u2019s Confidential Information. 5. Disclosure Required by Law . In the event any Confidential Information is required to be disclosed \nby the Receiving Party under the terms of a valid and effective subpoena or order issued by a court of \ncompetent jurisdiction, or by a demand or information request from an executive or administrative agency \nor other governmental authority, the Receiving P arty shall, unless prohibited by the terms of a subpoena, \norder or demand : (i) notify the Disclosing Party of the prospective disclosure as soon as practicable; (ii) \ncooperate with the Disclosing Party, as appropriate  and at the Disclosing Party\u2019s expense , in seeking such \nprotective orders or relief from such disclosure as may be available; (iii) request the highest level of \nconfidentiality available for such information under the terms of the production order and any applicable \nprotective order; and (iv) m aintain the confidentiality of such Confidential Information in accordance with \nthe terms hereof to the fullest extent practicable under the circumstances. Disclosure in accordance with \nthis paragraph shall not, by itself, vitiate the status of such infor mation as Confidential Information. 6. Maintenance of Confidentiality . The Receiving Party agrees that it shall take commercially \nreasonable measures to protect the secrecy of , and to prevent unauthorized disclosure and/or use of , the \nConfidential Information of the Disclosing Party.",
        "id": "qa_97"
    },
    {
        "question": "What must the Business Associate do with PHI upon termination of the agreement?",
        "options": {
            "A": "Return or destroy all PHI in its possession.",
            "B": "Encrypt the PHI and keep it for future use.",
            "C": "Transfer the PHI to a third party for safekeeping.",
            "D": "Retain all copies of PHI indefinitely."
        },
        "correct_answer": "A",
        "explanation": "Upon termination of the agreement, the Business Associate is required to return or destroy all PHI in its possession or in the possession of its agents or subcontractors, and must not retain any copies.",
        "source": "unknown",
        "client": "Sierra Health Plan of Nevada",
        "document_type": "unknown",
        "context": "Covered Entity shall use appropriate safeguards to ensure the security of PHI provided to\n\nBusiness Associate pursuant to the arrangement and this Agreement, in accordance with the\nPrivacy Rule, until such PHI is received by Business Associate. Page 4 of 6\n\n \n\n \n\n \n\n \n\f\n5.Termination\n5.1 Term. This Agreement shall be effective from the Effective Date until all PHI provided by or received\nor created for Covered Entity is destroyed or returned to Covered Entity, or if it is infeasible to\nreturn or destroy PHI, protections are extended to such PHI in accordance with the terms of this\nAgreement. The term of this Agreement shall also end upon termination of the underlying Master\nAgreement, subject, however, to the requirements of this section 5 for return or destruction of all\nPHI. 5.2 Termination Upon Breach of Provisions Applicable to PHI. Any other provision of this Agreement notwithstanding, this Agreement and the Master\nAgreement may be terminated by Covered Entity upon ten (10) days prior written notice to\nBusiness Associate in the event that Business Associate materially breaches any obligation of this\nAgreement and fails to cure the breach within such ten (10) day period; provided, however, that\nin the event that termination of this Agreement and the Master Agreement is not feasible, then\nCovered Entity shall have the right to report Business Associate\u2019s breach to the Secretary of the\nDepartment of Health and Human Services. 5.3 Return or Destruction of PHI Upon Termination. Upon termination of this Agreement and the Master Agreement, Business Associate shall either\nreturn to Covered Entity or destroy all PHI in Business Associate\u2019s possession or in the\npossession of its agents or subcontractors. Business Associate shall not retain any copies of PHI. Notwithstanding the foregoing, if Business Associate determines that returning or destroying PHI\nis infeasible, Business Associate shall provide to Covered Entity notification of the conditions\nthat make return or destruction infeasible.",
        "id": "qa_98"
    },
    {
        "question": "Which federal act must the party receiving Confidential Information comply with according to the document?",
        "options": {
            "A": "The Fair Credit Reporting Act of 1970",
            "B": "The Gramm-Leach-Bliley Act of 1999",
            "C": "The Privacy Act of 1974",
            "D": "The Data Protection Act of 1998"
        },
        "correct_answer": "B",
        "explanation": "The document specifies the Gramm-Leach-Bliley Act of 1999 as one of the laws governing the privacy, confidentiality, and non-disclosure of Confidential Information.",
        "source": "unknown",
        "client": "Capital Health Plan, Inc.",
        "document_type": "unknown",
        "context": "The party receiving the Confidential Information shall\nbe solely responsible for maintaining the security of such Confidential Information and for\ncomplying with all federal, state, provincial and local laws, regulations, or other requirements\nincluding the Gramm-Leach-Bliley Act of 1999, 15 U.S.C., Section 6801, as amended from time\nto time governing the privacy, confidentiality and non-disclosure of such information and\n\u201cHIPAA\u201d ~ the Health Insurance Portability and Accountability Act of 1996. Confidential Information shall not include information which is: (i) already known by the\nrecipient party prior to receipt and of which it did not learn through its contact with the disclosing\nparty; (ii) publicly known or becomes publicly known through no wrongful act of the recipient,\nGii) rightfully received from a third party; (iv) independently developed without use of the other\n\nVerisk Health, Inc.\nLicense Agreement with Capital Health Plan\n\nPage 4 of 30\n\nVersion 1-23-09\n\f\nparty\u2019s Confidential Information; (v) disclosed without similar restrictions to a third party by the\nparty owning the Confidential Information; (vi) approved by the other party for disclosure; (vii)\nrequired to be disclosed pursuant to a requirement of a government agency, court order, or law so\nlong as the disclosing party provides the other party with reasonable and sufficient notice of such\nrequirement prior to any such disclosure to allow the disclosing party to take action to protect its\nconfidential information. i F) Each party will notify its employees who have access to Confidential Information of the other\nparty of such party\u2019s obligations hereunder and will require that such employees comply with the\nobligations hereunder. If any party is permitted to disclose Confidential Information of the other\nto agents or representatives, then the disclosing party will require such agents or representatives\nto be bound by confidentiality provisions similar to those in this Section.",
        "id": "qa_99"
    },
    {
        "question": "What is required for a waiver of a provision or right under the MSA to be binding?",
        "options": {
            "A": "It must be notarized by a third party.",
            "B": "It must be given in writing and signed by the party granting the waiver.",
            "C": "It must be approved by the court.",
            "D": "It must be verbally agreed upon by both parties."
        },
        "correct_answer": "B",
        "explanation": "The MSA specifies that a waiver is binding only if it is given in writing and signed by the party or an authorized officer of the party granting the waiver.",
        "source": "s3://ml-legal-restricted/contract-docs/73278/ACA - Cotiviti Australia - MSA - JK - 10052023 - Dynamics_73278.pdf",
        "client": "ACA Health Benefits Fund",
        "document_type": "MSA",
        "context": "Indemnities \n18.7 The indemnities in this Agreement are: \n(a) continui ng obligations of the parties, separate and independent from their other \nobligations and survive the termination or expiry of this Agreement; and \n(b) absolute and unconditional and unaffected by anything, other than the terms of this \nAgreement,  that might have  the effect of prejudicing, releasing, discharging or \naffecting in any other way the liability of the party giving the indemnity. 18.8 It is not necessary for a party to incur expense or make payment before enforcing a right of indemnity under this Agreement. Costs \n18.9 Each party must pay its own costs in respect of this Agreement and the documents and \ntransactions contemplated by this Agreement, except that Client  must pay any stamp duty \nchargeable on this Agreement, and any other documents contemplated by this Agreement. Invalid or unenforceable provisions  \n18.10 If a provision of this Agreement is invalid or unenforceable in a jurisdiction: \n(a) it is to be read down or severed in that jurisdiction to the extent of the invalidity or \nunenforceability; and \n(b) that fact does not af fect the validity or enforceability of that provision in another \njurisdiction or the remaining provisions. Waiver and exercise of rights  \n18.11 A waiver by a party of a provision of or of a right under this Agreement is binding on the party granting the waiver on ly if it is given in writing and is signed by the party or an \nauthorised officer of the party granting the waiver. Amendment \n18.12 This Agreement may be amended only by a document signed by both parties. Counterparts \n18.13 This Agreement may be signed in counterparts and all counterparts taken together constitute \none document.",
        "id": "qa_100"
    },
    {
        "question": "What restrictions are imposed on the Client regarding the Verisk IP?",
        "options": {
            "A": "Client can copy Verisk IP for internal use.",
            "B": "Client can reverse engineer Verisk IP.",
            "C": "Client can create derivative works from Verisk IP.",
            "D": "Client cannot distribute or sublicense Verisk IP."
        },
        "correct_answer": "D",
        "explanation": "The document specifies that the Client may not copy, distribute, market, sell, lease, sublicense or otherwise transfer the Licensed Programs or Services to third parties.",
        "source": "unknown",
        "client": "Martin's Point Health Care",
        "document_type": "unknown",
        "context": "Without limiting the foregoing,\nClient shall not, and shall cause its employees or authorized\nusers to not: 1) reverse engineer, decompile, reverse compile,\not disassemble the Verisk IP; 2) create a derivative work or\ncompilation of the Verisk IP, including without limitation\nany product or service derived or compiled from or based on,\nin whole or in part, any Verisk services or products. Client\nmay not copy, distribute, market, sell, lease, sublicense or\notherwise transfer the Licensed Programs or Services to third\nparties. (c) Notwithstanding the above, in no way shall Client\nbe prevented from implementing changes to its systems,\nprocesses, or contracts that are done in the ordinary course of\nbusiness or were otherwise arrived at independent of and\nwithout reliance on or benefit of the results of the Licensed\nPrograms or Services provided herein. (d) As between the Parties, Verisk and its licensors are\nthe owners of all right, title and interest, including all\nintellectual property rights, in and to Verisk Applications,\nComparative Data and Ancillary Verisk Services. Except as\nexpressly provided herein, Verisk and its licensors reserve all\nrights with respect to Verisk Applications and Client will not\nhave or exercise any such rights not expressly granted. (e) As between the Parties, unless otherwise specified\nin a Statement of Work, Verisk will be the owner of all right,\ntitle and interest, including all intellectual property rights, in\nand to any code required to provide Deliverables, and Client\nwill be the owner of all right, title and interest, including all\nintellectual property rights, in and to Application Data and\nprinted or displayed output from Deliverables that includes\nApplication Data. General VH Master Services Agreement 2012. [END OF TEXT]\n\n=\n\n \n\nPage |\n\f\nAPPENDIX A-1D\u2014PERFORMANCE MEASUREMENT SOFTWARE LICENSE (INSTALLED)\n\nA1D.1.",
        "id": "qa_101"
    },
    {
        "question": "What type of information is excluded from being disclosed during discussions of a Potential Transaction according to the agreement?",
        "options": {
            "A": "Proprietary information",
            "B": "Trade secrets",
            "C": "Intellectual property rights",
            "D": "Protected Health Information (PHI)"
        },
        "correct_answer": "D",
        "explanation": "The agreement specifies that information disclosed during discussions shall not include PHI, unless it has been de-identified according to federal regulations.",
        "source": "unknown",
        "client": "Wellth, Inc.",
        "document_type": "unknown",
        "context": "The Parties agree that \ninformation disclosed and received in the course of di scussions concerning a Potential Transaction shall \nnot include information defined as Protected Health Information (PHI) under federal regulations at 45 \nC.F.R. \u00a7 160.103, except insofar as such PHI may have been de -identified within the meaning of regulati ons \nat 45 C.F.R. \u00a7 164.514. 8. Miscellaneous . (a) No License . The disclosure of information under this Agreement shall not be \ndeemed a grant of a license, by implication or otherwise, under any of the Disclosing Party\u2019s trade secrets, \nproprietary or other inte llectual property rights. (b) Entire Agreement . This Agreement contains the sole and entire agreement \nbetween the Parties with respect to the confidentiality of the Confidential Information and the con -\nfidentiality of all matters concerning a Potential Transa ction. This Agreement may be amended, modified, \nor waived only by a separate written instrument duly signed and delivered by or on behalf of both Parties. (c) Severability . If all or part of any term or condition of this Agreement, or the \napplication of any term or condition of this Agreement, is determined by any court of competent jurisdiction \nto be invalid or unenforceable to any extent, the remainder of the terms and conditions of this Agreement \n(other than those portions determined to be invalid or unenf orceable) shall not be affected, and the \nremaining terms and conditions (or portions of terms and conditions) shall be valid and enforceable to the \nfullest extent permitted by law. If a judicial determination prevents the accomplishment of the purpose of \nthis Agreement, the invalid term or condition (or portion of terms or conditions) shall be restated to conform \nto applicable law and to reflect as nearly as possible the original intention of the Parties. (d) Attorneys\u2019 Fees .",
        "id": "qa_102"
    },
    {
        "question": "What is the obligation of the Receiving Party regarding the destruction of Confidential Information upon request by the Disclosing Party?",
        "options": {
            "A": "Destroy all Confidential Information within 5 business days and confirm destruction in writing.",
            "B": "Destroy all Confidential Information within 30 days and confirm destruction in writing.",
            "C": "Destroy all Confidential Information within 3 business days and confirm destruction in writing.",
            "D": "Destroy all Confidential Information within 10 business days and confirm destruction in writing."
        },
        "correct_answer": "A",
        "explanation": "The NDA specifies that the Receiving Party must destroy all Confidential Information within 5 business days upon request and confirm the destruction in writing.",
        "source": "s3://ml-legal-restricted/contract-docs/63453/19902_ACTmd HMS MNDA 05302019.pdf",
        "client": "ACT.md",
        "document_type": "NDA",
        "context": "At any time upon the request \nof the Disclosing Party, the Receiving Party shall promptly (and in no event  later than five business days \nafter such request) (i) destroy or cause to be destroyed all Confidential Infor mation in the possession or \ncontrol of the Receiving Party or its Representatives confirm such destruction in writing to the Disclosing \nParty, pr ovided, however, that the obligation to destroy such Confidential Information does not extend to \nautomatically generated computer back -up or archival copies generated in the ordinary course of Receiving \nParty\u2019s information systems procedures, provided that  Receiving Party shall make no further use of such \ncopies and shall extend the protections of this Agreement to such Confidential Information for so long as \nthe Receiving Party maintains such Confidential Information. Notwithstanding the destruction of \nConfidential Information hereunder, the Receiving Party and its Representatives shall continue to be bound \nby their confidentiality and other obligations hereunder relating to such confidentiality for the term of this \nAgreement and thereafter, without limitat ion. 4. No Representations or Warranties . Both Parties understand that the other has endeavored \nto include in the Confidential Information the information that it believes to be reliable and relevant for the \npurposes of the others use and consideration. Th e Parties acknowledge and agree that (a) no representation \nor warranty, express or implied, is made by the Disclosing Party or any of its Representatives as to the \naccuracy or completeness of the Confidential Information, and (b)  the Receiving Party shall  be entitled to \nrely only on those representations and warranties (if any) that may be made in a subsequent written \nagreement regarding a transaction, signed and delivered by both Parties, and then only to the extent, and \nsubject to the limitations, provid ed therein. Subject to the foregoing sentence, each Party and its \nRepresentatives expressly disclaim any and all liability to the other and its Representatives that may be \nbased on any Confidential Information, the use thereof, errors therein, or omission s there from.",
        "id": "qa_103"
    },
    {
        "question": "Under what conditions does the NDA become inoperative regarding Confidential Information?",
        "options": {
            "A": "When the information is already known to the Nondisclosing Party independently.",
            "B": "When Confidential Information is disclosed by the Nondisclosing Party.",
            "C": "When the information is disclosed in the course of a negotiation.",
            "D": "When the information becomes available from a source bound by confidentiality."
        },
        "correct_answer": "A",
        "explanation": "The NDA becomes inoperative when the Confidential Information was already known to the Nondisclosing Party on a non-confidential basis before disclosure by the Disclosing Party.",
        "source": "s3://ml-legal-restricted/contract-docs/73385/7-Eleven - Cotiviti  - NDA - MS -  11152023 - Dynamics_73385.pdf",
        "client": "7-Eleven",
        "document_type": "NDA",
        "context": "This Agreement shall be inoperative as to such \nportions of the Confidential Information that: (i) are or become generally available to the public, \nother than as a result of a disclosure by the Nondisclosing Party or the Nondisclosing Party\u2019s Representatives; (ii)  become available to the Nondisclosing Party on a non-confidential basis \nfrom a source other than the Disclosing Party or its Representatives, provided that such source \nis not, to the knowledge of the Nondisclosing Party, bound by a confidentiality agreement with \nthe Disclosing Party or its Representatives or is otherwise prohibited from transmitting the \nConfidential Information to the Nondisclosing Party or the Nondisclosing Party\u2019s  \nRepresentatives by a contractual, legal, or fiduciary obligation; (iii)  were known to the \nNondisclosing Party on a non-confidential basis prior to their disclosure to the Nondisclosing Party by the Disclosing Party or its Representatives; or (iv) are developed independently by the \npersonnel of the Nondisclosing Party or any of its Representatives who have not had access to \nthe Disclosing Party\u2019s Confidential Information. 5. No Offer. This Agreement is not an offer, an acceptance, or a contract to \nnegotiate or enter into the Potential Transaction or any other transaction, nor is it intended to \nrequire the Parties to proceed with or continue such negotiations, the Potential Transaction, or \nDocuSign Envelope ID: 86A93AC8-1F25-4263-BD06-DE620137B060\nConfidentiality  and \nNon-Disclosure  Agreement  \n143467808.3  4 \u00a9 2019  7-Eleven,  Inc.  any other transaction. This Agreement shall not give rise to any obligation for either Party to \ndisclose any information, including the Confidential Information, to the other Party or its \nRepresentatives.",
        "id": "qa_104"
    },
    {
        "question": "What must the Receiving Party do with Confidential Information upon termination of the Agreement or upon request by the Disclosing Party?",
        "options": {
            "A": "Destroy or return all documents except for a single archival copy for dispute resolution purposes.",
            "B": "Transfer all Confidential Information to a third party.",
            "C": "Delete only electronic copies and retain physical copies indefinitely.",
            "D": "Retain all documents for future reference."
        },
        "correct_answer": "A",
        "explanation": "The document specifies that the Receiving Party must destroy or deliver all materials containing Confidential Information except for a single archival copy retained by the legal department for dispute resolution purposes.",
        "source": "unknown",
        "client": "Crumdale Partners - Better Benefits",
        "document_type": "unknown",
        "context": "\u201c Latent Data \u201d refers to data that is \nstored by a party on routine back-up media, including but not limited to deleted files and other non-logical data types, \nmemory dumps, swap files, temporary files, printer spool files and metadata that can customarily be retrieved only by \ncomputer forensics experts and is generally considered inaccessible without the use of specialized tools and techniques. 5. Return of Confidential Information. Subject to Section 3, \u201cExceptions,\u201d above, promptly following the earlier \nof (i) the termination of this Agreement, or (ii) the written request of Disclosing Party, the Receiving Party shall destroy \nor deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party \nconstituting or containing Confidential Information, together with all copies thereof, including all electronic and digital \ncopies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving \nParty's legal department for dispute resolution purposes only. Upon receipt of such a request, the Receiving Party shall \ndestroy all other documents and materials constituting Confidential Information in its possession to the extent \nreasonably practicable. Upon request, the Receiving Party shall certify such destruction in writing to the Disclosing \nParty. 6. Protected Health Information. If any part of the Confidential Information disclosed hereunder is protected \nhealth information pursuant to the Federal Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191 and its implementing regulations (collectively, \u201c HIPAA\u201d), as amended by the regulations promulgated \npursuant to the Health Information Technology for Economic and Clinical Health Act, Title XIII of the American \nRecovery and Reinvestment Act of 2009 (the \u201c HITECH Act \u201d), the parties agree to enter into a Business Associate \nAgreement (the \u201c BAA\u201d).",
        "id": "qa_105"
    },
    {
        "question": "What is the non-competition clause duration mentioned in the agreement between Licensor and Licensee?",
        "options": {
            "A": "No non-competition clause is specified",
            "B": "During the term of the agreement only",
            "C": "For one year after termination of the agreement",
            "D": "For five years after termination of the agreement"
        },
        "correct_answer": "C",
        "explanation": "The agreement specifies that the Licensee shall not develop or sell a product with similar functionality to the Licensed Program for one year after the termination of the agreement.",
        "source": "unknown",
        "client": "Capital Health Plan, Inc.",
        "document_type": "unknown",
        "context": "Each party shall\npromptly notify the other of any unauthorized possession, use or disclosure of the other party\u2019s\nConfidential Information by such party\u2019s employees, agents or representatives. G) Licensor Marketing. Licensee acknowledges and agrees that Licensor may, subject to the\nconfidentiality requirements of this Agreement, publicly disclose the commercial relationship\nbetween Licensor and Licensee as contemplated by this Agreement, through, without limitation,\npress releases, promotional literature and references in Licensor\u2019s web site. H) Non-Competition. Licensee agrees that during the term of this Agreement and for a term of one\n: year subsequent to the termination of this Agreement, Licensee shall not develop or sell a\ni product, or hire any third party to develop a product, with the same or substantially similar\ni functionality to the Licensed Program. 9. TERMINATION EVENTS. A) Licensor\u2019s Termination Events. Licensor may terminate this Agreement and any license granted\nto Licensee hereunder, and pursue appropriate legal remedies, if:\n\ni. Licensee fails to pay Licensor any license fees or other charges as set forth in this\nAgreement;\n\nii. _ Licensee (including any employee, officer, director, partner, agent, parent or subsidiary, or\naffiliate of Licensee) uses, copies or modifies the Licensed Program or transfers possession\nof any copy, adaptation, transcription, or merged portion of the Licensed Program to any\nother party in any way not expressly authorized by this Agreement;\n\niii. Licensee is in default of any other material provision of this Agreement and such default is\nnot cured within thirty (30) days after Licensor gives Licensee written notice of that default,\nprovided that no remedy period shall be required for defaults which are not curable; or\n\niv.",
        "id": "qa_106"
    },
    {
        "question": "What is required to confirm consent for receiving electronic notices and disclosures?",
        "options": {
            "A": "Sending a text message to a provided number",
            "B": "Clicking the \"I agree\" button after accessing and verifying the electronic disclosure",
            "C": "Sending a signed physical letter to the company",
            "D": "Calling the company's customer service number"
        },
        "correct_answer": "B",
        "explanation": "The document specifies that consent to receive electronic notices and disclosures can be confirmed by clicking the \"I agree\" button after verifying access to the electronic disclosure.",
        "source": "unknown",
        "client": "Self Insured Services Co",
        "document_type": "unknown",
        "context": "send us an e -mail to legal@verscend .com and in the body of such request you must \nstate your e -mail, full name, IS Postal Address, telephone number, and account number. Required hardware and software   \nOperating Systems:  Windows2000\u00ac or WindowsXP\u00ac  \nBrowsers (for \nSENDERS):  Internet Explorer 6.0\u00ac or above  \nBrowsers (for \nSIGNERS):  Internet Explorer 6.0\u00ac, Mozilla FireFox 1.0, NetScape 7.2 (or above)  \nEmail:  Access to a valid email account  \nScreen Resolution:  800 x 600 minimum  \nEnabled Security \nSettings:  \u00f2 Allow per session cook ies \n\u00f2 Users accessing the internet behind a Proxy Server must enable HTTP \n1.1 settings via proxy connection  \n** These minimum requirements are subject to change. If these requirements change, we will \nprovide you with an email message at the email address w e have on file for you at that time \nproviding you with the revised hardware and software requirements, at which time you will have \nthe right to withdraw your consent. Acknowledging your access and consent to receive materials electronically   \nTo confirm to  us that you can access this information electronically, which will be similar to \nother electronic notices and disclosures that we will provide to you, please verify that you were \nable to read this electronic disclosure and that you also were able to print  on paper or \nelectronically save this page for your future reference and access or that you were able to e -mail \nthis disclosure and consent to an address where you will be able to print on paper or save it for \nyour future reference and access. Further, if you consent to receiving notices and disclosures \nexclusively in electronic format on the terms and conditions described above, please let us know \nby clicking the \u00e6I agree\u00c6 button below.",
        "id": "qa_107"
    },
    {
        "question": "What security measure is required when Humana requests remote access to COMPANY network?",
        "options": {
            "A": "Password protection only",
            "B": "Single-factor authentication",
            "C": "2-factor or dual authentication",
            "D": "Biometric authentication"
        },
        "correct_answer": "C",
        "explanation": "The document specifies that COMPANY shall require 2-factor or dual authentication for remote access to Humana Confidential Information.",
        "source": "unknown",
        "client": "Humana",
        "document_type": "unknown",
        "context": "If Humana remote access into COMPANY network is required, \nCOMPANY shall require 2-factor, or dual authentication prior to allowing access to Humana Confidential Information .. \n22 of 41 \nMASTER SERVICES AGREEMENT \ng) IfHumana Confidential Information is resident on COMPANY-controlled systems, COMPANY shall logically segregate \nHum ana Confidential Information or data from all other COMPANY customer data. COMPANY shall logically isolate \nHumana Confidential Information or data to prevent any physical access to unauthorized users. h) COMPANY shall log historical access to, and use of, COMPANY-controlled systems as that access or use applies to PHI \nand, upon Humana's request, shall provide Humana with access to review such logs. i) COMPANY shall employ electronic key access to the COMPANY offices. Any Humana-specific processing area shall \nhave a separate electronic door lock. COMPANY shall be responsible for limiting access to the Humana processing area to \nauthorized Personnel only. 1) Enterprise Vulnerability Management (\"EVM\"): \na) COMPANY shall adhere universally-accepted best practice standards for patch management criticality ranking and \npatching time frame requirements for all IT systems, switches, routers, appliances, servers, and workstation PC's. b) COMPANY shall ensure that trusted, commercially available anti-virus software is installed, enabled, and kept current at \nall times on all COMPANY servers and workstations used in processing Humana Confidential Information. COMPANY \nshall configure all inbound servers to scan all e-mail and net usage for known viruses. There are two parts to such updates, \nthe anti virus software engine and the data files. COMPANY shall update the engine to the latest engine published by the \nantivirus software vendor within thirty (30) days of the new engine release. COMPANY shall update the data files to \ncurrent status within ten (10) business days of availability. c) COMPANY shall implement trusted commercially available, up-to-date spyware protection on all PC's used for accessing \nHumana Confidential Information.",
        "id": "qa_108"
    },
    {
        "question": "What is the fee for application enhancement and off-hour testing according to the legal document?",
        "options": {
            "A": "$500 per application",
            "B": "$0.10 per record",
            "C": "$250 per hour",
            "D": "$55 per hour"
        },
        "correct_answer": "C",
        "explanation": "The document specifies that application enhancement and off-hour testing fees are $250 per hour.",
        "source": "unknown",
        "client": "Inogen",
        "document_type": "unknown",
        "context": "Line of Business (LOB) Fee: One (1) included, $2,000 per additional LOB I\nOne (1) LOB included in the set-up and configuration fee. Additional LOBs will incur a fee. This fee includes: quality\nassurance testing, one (1) caller ID tag, one (1) toll-free inbound number, one (1) transfer number (if applicable) and\nstandard data support fees. Telephone Append Fee: $0.10 per record or $500 per application, whichever is greater Oo\n\nTranscription Fee: $55 per hour as needed x\n\nOther Application Fees\n\nIL.2.a\n\n11.2.b\n\nIL2.c\n\nApplication Enhancement and Off-Hour Testing Fees: $250 per hour Rl\nAny change after customer has approved the Program Overview Document will incur an application enhancement fee\ndepending on the number of hours to implement. In addition, if off-hour testing of application is requested, hourly fees\nwill be charged. Written approval will be obtained from Customer. Custom Financial Reporting and Custom Data Fees: $250 per hour &\nCovers any non-standard financial reporting. Any data request outside of what is specified in the Program Overview\nDocument (including but not limited to the expiration of data files sent and replaced). Written approval will be obtained\nfrom Customer. Standard Analytic Reporting Fee: Included via ElizaLive i\nApplication level analytic reporting through the Eliza online reporting portal, Eliza PhD. Additional reports will be\nprovided on an agreed upon schedule and following completion of program logic. Deliverables may include progress to\ngoal, year-over-year performance, performance relative to comparable programs and will include analysis and\nrecommendations on how to optimize outcomes. Written approval will be obtained from Customer. In the event of any conflict between the terms of the Agreement or the SOW, this SOW shall prevail. ereto have caused this SOW to be duly executed, effective as of the Effective Date.",
        "id": "qa_109"
    },
    {
        "question": "What is included as part of the License Agreement for the Licensed Program?",
        "options": {
            "A": "Limited technical support during normal business hours",
            "B": "All travel and out-of-pocket expenses covered",
            "C": "Unlimited technical support during business hours",
            "D": "Free on-site training and consulting services"
        },
        "correct_answer": "A",
        "explanation": "The License Agreement includes limited technical support with installation and operation of the Licensed Program during normal business hours at the Licensor\u2019s reasonable discretion.",
        "source": "unknown",
        "client": "Capital Health Plan, Inc.",
        "document_type": "unknown",
        "context": "Operating system: Please identify the operating system and release number under which the Licensed\nProgram will be run (e.g., Windows 98/NT, MVS, Solaris 5.6). 1. Estimated number of Unique Individuals to which the Licensed Program will be applied:\n\n \n\nEmail... 2 PASS @ QR ORG ocr\n\nVerisk Health, Inc.\n\nLicense Agreement with Capital Health Plan\nPage 12 of 30\n\nVersion 1-23-09\n\f\nAttachment C\n\nCONTRACT SERVICE RATES\n\n \n\nLimited technical support with installation and operation of the Licensed Program during normal business\nhours is included as part of the License Agreement, at Licensor\u2019s reasonable discretion. The rates indicated\nbelow are the current, all-inclusive professional service rates for any additional services sought by Licensee\n(e.g., programming support, file preparation, training, analytic and other consulting services). Travel and out-\nof-pocket expenses are additional and billed at cost. Programmer/Processor $150 per hour\nAnalyst $200 per hour\nSenior Scientist $350 per hour\nPrincipal $350 per hour\nOn-site Training $5,000 per day\n\nThese rates are subject to change by Licensor without prior notice. Verisk Health, Inc.\n\nLicense Agreement with Capital Health Plan\nPage 13 of 30\n\nVersion 1-23-09\n\f\nAttachment D\n\nUSAGE REPORT\n(To be submitted to Verisk prior to each anniversary date of the Execution Date of the Agreement)\n\n1. For the license year ended\n\n2. Number of Unique Individuals on which the Licensed Program\nwas used during the license year: :\n\n3. Annual Fee for the license year, calculated pursuant to the Annual Fee Schedule in Attachment A:\n$ :\n\n4.",
        "id": "qa_110"
    },
    {
        "question": "What document contains the sole and exclusive terms and conditions governing the parties' rights with respect to the Services?",
        "options": {
            "A": "Attachments",
            "B": "Business Associate Agreement",
            "C": "Statements of Work",
            "D": "Master Agreement"
        },
        "correct_answer": "D",
        "explanation": "The Master Agreement contains the sole and exclusive terms and conditions that govern the rights, responsibilities, and obligations of the parties with respect to the Services.",
        "source": "unknown",
        "client": "Maryland Physicians Care (MPC)",
        "document_type": "unknown",
        "context": "This agreement consists of the cover page and the terms and conditions (together, the \u201c Master \nAgreement \u201d), any Attachments to the Master Agreement, any St atements of Work executed between the parties \nreferencing this Master Agreement, an d any amendments to the Master Agreement, Attachments, or Statements of \nWork, any Business Associate Agreement execut ed between the parties (together, the \u201c Agreement \u201d). This Agreement \ncontains the sole and exclusive terms and conditions that will govern the rights, responsibilities, and obligations of \nthe parties with respect to the Services. 2.2 Attachments. The terms of this Agreement include any at tachments containing additional terms and \nconditions that are attached to this Master Agreement or a Statement of Work at the time of execution or are later \nattached by an amendment, which may be specifically referred to as schedules, exhibits, or the like (\u201c Attachments \u201d). 2.3 Statements of Work. Cotiviti and Client may enter into statements  of work, which refer to this Agreement, \ncontaining additional terms and conditions agreed to by the parties instructing Cotiviti to provide Client specific \nSolutions for specific fees (together with an y Attachments to the Statements of Work, \u201c Statements of Work \u201d (SOW)). 2.4 Business Associate Agreement. Cotiviti and Client may enter into a business associates agreement, \ncontaining additional terms and conditions agreed to by the parties instructing Covere d Entities to provide each \nother with access to, or have Business Associate  create, maintain, transmit (including to/from Covered Entity) and/or receive \ncertain Protected Health Information (as defined below), thus  necessitating a written agreement that meets the applicable \nrequirements of the Privacy and Security Rules. 2.5 Order of Precedence .",
        "id": "qa_111"
    },
    {
        "question": "What security measure is required for business-to-business connectivity between COMPANY and Humana?",
        "options": {
            "A": "Firewall only",
            "B": "Firewall, PGP encryption, and access list controls",
            "C": "Access list controls only",
            "D": "PGP encryption only"
        },
        "correct_answer": "B",
        "explanation": "The legal document specifies that business-to-business connectivity between COMPANY and Humana must be protected by firewall, PGP encryption, and access list controls.",
        "source": "unknown",
        "client": "Humana",
        "document_type": "unknown",
        "context": "2) Network Security: \na) If COMPANY uses a switched-network topology, monitoring ports on the switches shall be password protected by \nCOMPANY. b) COMPANY shall ensure that interconnections within the COMPANY, with other companies, and with the Internet (\"Access \nPoints\") , whether wired or wireless, into the COMPANY network are protected by using firewalls, secure tunnels, or access \nlists on routers . . . c) .. COMPANY shall ensme that a networkmanagement:systemis used to monitor-:its:local networkand servers. Threshulds=and \u00b7\u00b7 \nalarms shall be established to notify COMPANY and Humana personnel of potential problems or outages. d) COMPANY shall implement either host-based or network-based Intrusion Detection Solution (IDS) or Intrusion Protection \nSolution (IPS) with response and recovery plans to monitor potential unauthorized access to COMPANY network and \nsystems. e) Upon Humana's request, COMPANY shall make available internal and external network scan results to Humana for review. 3) Transmission Security: \na) COMPANY shall ensure that any business-to-business connectivity between COMPANY and Humana shall be protected by \nfirewall, PGP encryption, and access list controls. b) COMPANY shall require all transmissions of PHI to be secure and encrypted, including but not limited to: e-mail, web-mail, \nBlackbeny e-mail and other mobile device e-mail, FTP, chat and instant messaging, web services etc. NOTE: The PHiitselfmust be enc1ypted such that only the intended recipient can decrypt it. Simply using an encrypted \ntunnel is not sufficient.",
        "id": "qa_112"
    },
    {
        "question": "What actions must a Receiving Party take if compelled to disclose Confidential Information by legal process?",
        "options": {
            "A": "Immediately disclose the information without notifying the Disclosing Party.",
            "B": "Ignore the request and refuse to disclose any information.",
            "C": "Provide prompt written notice to the Disclosing Party and seek a protective order.",
            "D": "Disclose the information and notify the Disclosing Party after disclosure."
        },
        "correct_answer": "C",
        "explanation": "The agreement requires the Receiving Party to provide prompt written notice to the Disclosing Party, cooperate fully to seek a protective order, and take reasonable steps to minimize disclosure if compelled.",
        "source": "unknown",
        "client": "Ochsner Health System",
        "document_type": "unknown",
        "context": "Further, without prior written consent of the other \nParty, neither P arty will, and each will direct its Representatives not to, disclose to any person (a) \nthe fact that the Confidential Information has been made available;  and (b) the fact that discussions \nor negotiations are taking place or have taken place concer ning a business relationship between \nthe Parties. 2.2 If a Receiving Party  is requested or required (by deposition, interrogatories, \nrequests for information or documents, subpoena, civil investigative demand or any other form of \nlegal process) to disclose an y Confidential Information, it is agreed that the Receiving Party  will \nprovide the Disclosing Party with prompt written notice of such request and cooperate fully so that \nthe Disclosing Party may seek an appropriate protective order and/or waive its compli ance with \nthe provisions of this Agreement. If in the absence of an enforceable protective order, the Receiving Party  is nonetheless compelled to disclose Confidential Information, the Receiving \nParty  shall take reasonable and lawful actions to avoid and/ or minimize the extent of such \ndisclosure; provided, however, that the Receiving Party  gives the Disclosing Party written notice \nof the information to be disclosed as far in advance of its disclosure as is practicable and, upon the \nDocuSign Envelope ID: F4BFD935-23CB-491D-B17B-E978018BAD5B\nConfidentiality and Non- Disclosure Agreement  \nPage 3 of 7 \n \nDisclosing Party\u2019s reque st, uses reasonable efforts to obtain assurances that confidential treatment \nwill be accorded to such information. 2.3 Latent Data. Latent Data, which is Confidential Information shall be subject to \ndestruction in due course but shall remain Confidential Info rmation of the Disclosing Party until \nit is destroyed.",
        "id": "qa_113"
    },
    {
        "question": "What is required of the Vendor before using an external network connection for transmitting Customer Information?",
        "options": {
            "A": "Obtain Customer\u2019s prior written approval",
            "B": "Assess the connection for risk",
            "C": "Review firewall logs regularly",
            "D": "Implement a secure communications protocol"
        },
        "correct_answer": "A",
        "explanation": "The Vendor must obtain Customer\u2019s prior written approval before using any external network connection for the transmission of Customer Information.",
        "source": "s3://ml-legal-restricted/contract-docs/70684/Lorica Health - Services Agreement (final) 11.2020 (1).pdf",
        "client": "AIA Health Insurance Pty Ltd",
        "document_type": "MSA",
        "context": "Data Communications Security \nThis section applies if Vendor uses its own or subcontracted IT systems to access, manage or \nprocess Customer Information  \n8.1 Vendor shall:- \na. configure and manage networks to maintain security for the s ystems and applications \nusing the network (fixed / wire less, internal / external and Vo IP); \nb. implement adequate and effective network level segregation a nd policy-based filtering \nmechanisms, to consistently protect Customer Information agains t unauthorised access \nor disclosure through networks; \nc. configure firewalls to produce logs and implement as \u201cdeny a ll traffic except that which is \nspecifically permitted\u201d, review  regularly and b e subject to cha nge control; \nd. ensure each external network connection is assessed for risk , logged, governed by a \ncontract and obtain Customer\u2019s prior written approval before it s use for the transmission \nof any Customer Information;  \ne. utilise a current and secure communications protocol for dat a transfers involving sensitive \ninformation across public or untrusted networks; and \nf. establish and maintain a log that captures any transfer of C ustomer Information including \nbut not limited to approvals , frequency, mode o f transfer, and confirmation of delivery and \nreceipt. 9. Cloud services \nWhere relevant to the services provided to Customer, Vendor sha ll have cloud security \nstandards and controls in place covering Vendor\u2019s use of cloud services (on demand \ncomputing services which are de livered across networks, typical ly using the internet, such as \nSoftware as a Service (SaaS), platform as a service (PaaS), inf rastructure as a service (IaaS)) \nand other variants) which shall be made available to Customer f or review before written \napproval. 10.",
        "id": "qa_114"
    },
    {
        "question": "What does the NDA between ATRIO Health Plans and the other party specify regarding the nature of their relationship?",
        "options": {
            "A": "It is a formal business organization.",
            "B": "It specifies that neither party is bound by the actions of the other.",
            "C": "It creates a partnership.",
            "D": "It establishes a joint venture."
        },
        "correct_answer": "B",
        "explanation": "The NDA explicitly states that neither party shall be bound by the actions of the other, nor liable for the debts of the other, and does not establish a joint venture, partnership, or formal business organization.",
        "source": "s3://ml-legal-restricted/contract-docs/68895/Atrio - Cotiviti - NDA - AR - 07192022 - Dynamics_68895.pdf",
        "client": "ATRIO Health Plans",
        "document_type": "NDA",
        "context": "Neither Party shall be bound by the actions of the other, shall be liable for \nthe debts of the other, or shall have a  right to share in the profits of the other. This Agreement is not intended to be a \nDocuSign Envelope ID: 97A67F5D-7AEA-4DA0-8A31-39BDF4A1B710\n \n\u00a9 2018 Cotiviti , Inc. CONFIDENTIAL AND PROPRIETARY  3 \njoint venture, partnership or other formal business organization, and neither Party is under any obligation to enter into \nany further agreement with the other Party. 11. Mutual  Representations. Each Party represents that it has the right to disclose its Confidential Information \nin furtherance of the purpose set forth above without violating any agreement with or right of any other person. Confidential Information may include inf ormation of a third party provided that the third party has authorized such \ndisclosure. 12. No Further Obligation  or Limitation . This Agreement shall not be construed in any manner to be an \nobligation to enter into a subcontract or contract or to result in any  claim whatsoever by one Party against the other for \nreimbursement of cost for any efforts expended. Except as specifically set forth herein, this Agreement does not: (i) \nrestrict either Party from developing new products, improving existing products, or m arketing any new, improved or \nexisting products; or (ii) commit either Party to disclose any particular information, or to develop, make, use, buy, sell, \nor otherwise dispose of any existing or future products, or to favor or recommend any product or servi ce of the other. To be binding, any such restriction or commitment must be in writing and signed by both parties . 13. Notices.",
        "id": "qa_115"
    },
    {
        "question": "Under what circumstances can a party assign its rights and obligations under the Agreement without prior written consent from the other party?",
        "options": {
            "A": "Only with mutual agreement and consent",
            "B": "To a successor owning substantially all business assets",
            "C": "When assigning to any third party",
            "D": "When assigning a minor part of the Agreement"
        },
        "correct_answer": "B",
        "explanation": "The Agreement allows assignment without prior consent to a successor in ownership of substantially all business assets, provided the successor assumes the Agreement\u2019s terms in writing.",
        "source": "unknown",
        "client": "Ochsner Health System",
        "document_type": "unknown",
        "context": "BH 546 \nNew Or leans, LA 70121  \nAttn: Scott Posecai  \n \nwith a copy to:   Office of Legal Affairs  \nOchsner Health Plan  \n1450 Poydras Street, Suite 2250 \nNew Orleans, LA 70112  \nAttn: General Counsel  \n \nAny notice given pursuant or with respect to this Agreement shall be deemed received (i) on the date such notice is hand -delivered to an authorized representative of the P arty receiving such \nnotice, (ii) on the first business day following the date on which such notice is sent prepaid for \nnext-day delivery by nationally rec ognized overnight delivery service, or (iii) on the third \nbusiness day following the date on which such notice is sent by prepaid registered or certified \nU.S. mail, return receipt requested. 13. ASSIGNMENT . This Agreement shall be binding on and shall inure to the benefit of the \nparties hereto, their respective successors and assigns. This Agreement may not be assigned in \nwhole or in part by either Party without the prior written consent of the other Party. Any attempted \nassignment without such prior written consent shall be void and unenforceable. Notwithstanding the foregoing, either Party, without the prior written approval of the other Party, may assign its rights and obligations hereunder to a successor  in ownership of substantially all of the assets of the \nbusiness, provided that the successor expressly assumes in writing the performance of the terms and conditions of this Agreement. 14. COUNTERPARTS\n. This Agreement may be executed in two  or more counterparts, each \nof which shall be deemed an original, but all such counterparts together shall constitute but one and the same Agreement. 15. ENTIRE AGREEMENT\n. This Agreement contains the entire agreement of and \nsupersedes any and all prior understandings, arrangements, and agreements between the P arties \nhereto, whether oral or written, with respect to the subject matter hereof . 16. MODIFICATION.",
        "id": "qa_116"
    },
    {
        "question": "What must the Receiving Party do with Confidential Information upon request from the Disclosing Party?",
        "options": {
            "A": "Transfer all Confidential Information to a secure database",
            "B": "Send all Confidential Information back to the Disclosing Party within 10 business days",
            "C": "Preserve the Confidential Information for future reference",
            "D": "Destroy all Confidential Information within 5 business days and confirm destruction in writing"
        },
        "correct_answer": "D",
        "explanation": "The NDA requires the Receiving Party to destroy all Confidential Information within 5 business days of the request and confirm the destruction in writing, except for automatically generated backups.",
        "source": "s3://ml-legal-restricted/contract-docs/63453/19902_ACTmd HMS MNDA 05302019.pdf",
        "client": "ACT.md",
        "document_type": "NDA",
        "context": "At any time upon the request \nof the Disclosing Party, the Receiving Party shall promptly (and in no event  later than five business days \nafter such request) (i) destroy or cause to be destroyed all Confidential Infor mation in the possession or \ncontrol of the Receiving Party or its Representatives confirm such destruction in writing to the Disclosing \nParty, pr ovided, however, that the obligation to destroy such Confidential Information does not extend to \nautomatically generated computer back -up or archival copies generated in the ordinary course of Receiving \nParty\u2019s information systems procedures, provided that  Receiving Party shall make no further use of such \ncopies and shall extend the protections of this Agreement to such Confidential Information for so long as \nthe Receiving Party maintains such Confidential Information. Notwithstanding the destruction of \nConfidential Information hereunder, the Receiving Party and its Representatives shall continue to be bound \nby their confidentiality and other obligations hereunder relating to such confidentiality for the term of this \nAgreement and thereafter, without limitat ion. 4. No Representations or Warranties . Both Parties understand that the other has endeavored \nto include in the Confidential Information the information that it believes to be reliable and relevant for the \npurposes of the others use and consideration. Th e Parties acknowledge and agree that (a) no representation \nor warranty, express or implied, is made by the Disclosing Party or any of its Representatives as to the \naccuracy or completeness of the Confidential Information, and (b)  the Receiving Party shall  be entitled to \nrely only on those representations and warranties (if any) that may be made in a subsequent written \nagreement regarding a transaction, signed and delivered by both Parties, and then only to the extent, and \nsubject to the limitations, provid ed therein. Subject to the foregoing sentence, each Party and its \nRepresentatives expressly disclaim any and all liability to the other and its Representatives that may be \nbased on any Confidential Information, the use thereof, errors therein, or omission s there from.",
        "id": "qa_117"
    },
    {
        "question": "What action must a user take if the hardware and software requirements change?",
        "options": {
            "A": "Receive an email notification and withdraw consent if desired",
            "B": "Automatically update their system to meet new requirements",
            "C": "Continue using the system without any action",
            "D": "Send a physical letter to request changes"
        },
        "correct_answer": "A",
        "explanation": "The document specifies that users will receive an email notification about any changes in requirements, at which point they have the right to withdraw consent.",
        "source": "unknown",
        "client": "Martin's Point Health Care",
        "document_type": "unknown",
        "context": "send us an e -mail to legal@verscend .com and in the body of such request you must \nstate your e -mail, full name, IS Postal Address, telephone number, and account number. Required hardware and software   \nOperating Systems:  Windows2000\u00ac or WindowsXP\u00ac  \nBrowsers (for \nSENDERS):  Internet Explorer 6.0\u00ac or above  \nBrowsers (for \nSIGNERS):  Internet Explorer 6.0\u00ac, Mozilla FireFox 1.0, NetScape 7.2 (or above)  \nEmail:  Access to a valid email account  \nScreen Resolution:  800 x 600 minimum  \nEnabled Security \nSettings:  \u00f2 Allow per session cook ies \n\u00f2 Users accessing the internet behind a Proxy Server must enable HTTP \n1.1 settings via proxy connection  \n** These minimum requirements are subject to change. If these requirements change, we will \nprovide you with an email message at the email address w e have on file for you at that time \nproviding you with the revised hardware and software requirements, at which time you will have \nthe right to withdraw your consent. Acknowledging your access and consent to receive materials electronically   \nTo confirm to  us that you can access this information electronically, which will be similar to \nother electronic notices and disclosures that we will provide to you, please verify that you were \nable to read this electronic disclosure and that you also were able to print  on paper or \nelectronically save this page for your future reference and access or that you were able to e -mail \nthis disclosure and consent to an address where you will be able to print on paper or save it for \nyour future reference and access. Further, if you consent to receiving notices and disclosures \nexclusively in electronic format on the terms and conditions described above, please let us know \nby clicking the \u00e6I agree\u00c6 button below.",
        "id": "qa_118"
    },
    {
        "question": "What must the Receiving Party do with the Confidential Information after the termination of the Agreement or upon written request by the Disclosing Party?",
        "options": {
            "A": "Retain a single archival copy and destroy all other copies",
            "B": "Deliver all copies to the Disclosing Party and retain no copies",
            "C": "Destroy all copies including electronic and digital copies",
            "D": "Retain all copies for archival purposes"
        },
        "correct_answer": "A",
        "explanation": "The document specifies that the Receiving Party must destroy or deliver all copies of Confidential Information but may retain a single archival copy for dispute resolution purposes.",
        "source": "unknown",
        "client": "Crumdale Partners - Better Benefits",
        "document_type": "unknown",
        "context": "\u201c Latent Data \u201d refers to data that is \nstored by a party on routine back-up media, including but not limited to deleted files and other non-logical data types, \nmemory dumps, swap files, temporary files, printer spool files and metadata that can customarily be retrieved only by \ncomputer forensics experts and is generally considered inaccessible without the use of specialized tools and techniques. 5. Return of Confidential Information. Subject to Section 3, \u201cExceptions,\u201d above, promptly following the earlier \nof (i) the termination of this Agreement, or (ii) the written request of Disclosing Party, the Receiving Party shall destroy \nor deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party \nconstituting or containing Confidential Information, together with all copies thereof, including all electronic and digital \ncopies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving \nParty's legal department for dispute resolution purposes only. Upon receipt of such a request, the Receiving Party shall \ndestroy all other documents and materials constituting Confidential Information in its possession to the extent \nreasonably practicable. Upon request, the Receiving Party shall certify such destruction in writing to the Disclosing \nParty. 6. Protected Health Information. If any part of the Confidential Information disclosed hereunder is protected \nhealth information pursuant to the Federal Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191 and its implementing regulations (collectively, \u201c HIPAA\u201d), as amended by the regulations promulgated \npursuant to the Health Information Technology for Economic and Clinical Health Act, Title XIII of the American \nRecovery and Reinvestment Act of 2009 (the \u201c HITECH Act \u201d), the parties agree to enter into a Business Associate \nAgreement (the \u201c BAA\u201d).",
        "id": "qa_119"
    },
    {
        "question": "What must the Vendor obtain before using an external network connection for transmitting Customer Information?",
        "options": {
            "A": "An internal audit approval",
            "B": "A risk assessment report",
            "C": "A verbal confirmation from the Customer",
            "D": "Customer\u2019s prior written approval"
        },
        "correct_answer": "D",
        "explanation": "According to the document, the Vendor must obtain Customer\u2019s prior written approval before using an external network connection for the transmission of any Customer Information.",
        "source": "s3://ml-legal-restricted/contract-docs/70684/Lorica Health - Services Agreement (final) 11.2020 (1).pdf",
        "client": "AIA Health Insurance Pty Ltd",
        "document_type": "MSA",
        "context": "Data Communications Security \nThis section applies if Vendor uses its own or subcontracted IT systems to access, manage or \nprocess Customer Information  \n8.1 Vendor shall:- \na. configure and manage networks to maintain security for the s ystems and applications \nusing the network (fixed / wire less, internal / external and Vo IP); \nb. implement adequate and effective network level segregation a nd policy-based filtering \nmechanisms, to consistently protect Customer Information agains t unauthorised access \nor disclosure through networks; \nc. configure firewalls to produce logs and implement as \u201cdeny a ll traffic except that which is \nspecifically permitted\u201d, review  regularly and b e subject to cha nge control; \nd. ensure each external network connection is assessed for risk , logged, governed by a \ncontract and obtain Customer\u2019s prior written approval before it s use for the transmission \nof any Customer Information;  \ne. utilise a current and secure communications protocol for dat a transfers involving sensitive \ninformation across public or untrusted networks; and \nf. establish and maintain a log that captures any transfer of C ustomer Information including \nbut not limited to approvals , frequency, mode o f transfer, and confirmation of delivery and \nreceipt. 9. Cloud services \nWhere relevant to the services provided to Customer, Vendor sha ll have cloud security \nstandards and controls in place covering Vendor\u2019s use of cloud services (on demand \ncomputing services which are de livered across networks, typical ly using the internet, such as \nSoftware as a Service (SaaS), platform as a service (PaaS), inf rastructure as a service (IaaS)) \nand other variants) which shall be made available to Customer f or review before written \napproval. 10.",
        "id": "qa_120"
    },
    {
        "question": "What is excluded from Comparative Data according to the General VH Master Services Agreement?",
        "options": {
            "A": "Membership Information",
            "B": "Application Data",
            "C": "Utilization Management Data",
            "D": "Protected Health Information"
        },
        "correct_answer": "D",
        "explanation": "The document specifies that Protected Health Information is excluded from Comparative Data.",
        "source": "unknown",
        "client": "Martin's Point Health Care",
        "document_type": "unknown",
        "context": "1.8 \u201cStatement of Work\u201d means any additional\nterms and conditions agreed to by the Parties and addended\nto this Agreement containing instructions for Verisk to\nprovide one or more specific Deliverables for specific fees. 1.9 \u201cTerm\u201d has the meaning ascribed to it in Section\n8.1 of this Agreement. 1.10 \u201cThird Party\u201d means a Person other than Client\nor Verisk. 1.11 \u201cApplication Data\u201d Includes but is not limited to\nindividuals' personal, medical, pharmacy, disability,\nprovider or insurance claim information provided by Client\nor Client\u2019s business partners, including without limitation,\nthird party administrators, pharmacy benefit companies\nand utilization management companies, to Verisk to create\nan Application Service, pursuant to the Applications\n\nGeneral VH Master Services Agreement 2011. Agreement. Application Data includes, but is not\nnecessarily limited to, claims and membership information\nfor Client insurance plan members. 1.12 \u201cApplication Service\u201d means any Deliverable\nwhereby users gain access, via an interface provided by\nVerisk, to information compiled by Verisk, in any Internet-\navailable or private data network. 1.13 \u201cVerisk Applications\u201d means any and all\nApplication Services, the software source, object and\nexecutable code used to implement such Application\nServices, any reports generated from data available\nthrough such Application Services, and any modifications\nor enhancements thercto, but not including any stored\nApplication Data provided by Client to Verisk hereunder. 1.14. \u201cComparative Data\u201d will mean aggregated data,\nincluding De-identified Data and that provided by other\nVerisk clients, compiled by Verisk, which allows Client to\ncompare its calculated values against the calculated values\nof a broader base of similar clients. For purposes of\nexplanation and not exclusion, Protected Health\nInformation will be excluded from Comparative Data.",
        "id": "qa_121"
    },
    {
        "question": "Under what conditions can the Supplier use or disclose PHI according to the agreement?",
        "options": {
            "A": "For any purpose as long as it is de-identified.",
            "B": "For research purposes without any restrictions.",
            "C": "Only for marketing purposes with individual authorization.",
            "D": "As directed by the Company to carry out obligations or as required by law."
        },
        "correct_answer": "D",
        "explanation": "The agreement states that PHI can be used or disclosed only as directed by the Company to carry out obligations or as required by law.",
        "source": "unknown",
        "client": "Blue Shield of California",
        "document_type": "unknown",
        "context": "Supplier shall neither use nor disclose PHI for the purpose of creating de -identified \ninformation that w ill be used for any purpose other than as directed by Company to carry out the \nobligations of Supplier set forth in this Agreement or the applicable Supplier Agreements, or as \nrequired by  law. 4. To the extent that, pursuant to this Agreement or any applica ble Supplier Agreements, \nSupplier is required to carry out any obligation of Company which is addressed by Subpart E of \nthe HIPAA Privacy Rule \u2013 Privacy of Individually Identifiable Health Information, then in the \nperformance of such obligations Supplier s hall comply with the requirements of Subpart E that \napply to Company as a HIPAA Covered  Entity. B. Limited Dataset or Minimum Necessary  Standard  \n \nIn using,  requesting  and/or  disclosing  PHI, Supplier  shall comply  with any and all applicable  laws, \nincluding implementing guidance and regulations, in determining what constitutes \u201cminimum \nnecessary.\u201d Supplier shall limit the use, disclosure, or request of Individuals\u2019 PHI, to the extent \npracticable, to the Limited Dataset (as defined in 45 C.F.R. \u00a7164.514(e)(2)) or to the minimum \nnecessary  amount  of PHI to accomplish  the intended  purpose  of such use, disclosure,  or request \nand to perform its obligations under this Agreement and/or the Supplier Agreements. Supplier \nshall determine what constitutes the minimum necessary to accomplish the intended purpose of \nsuch disclosure. Supplier\u2019s obligations under this provision shall be subject to modification to \ncomply with guidance issued by the  Secretary. C. Sale of PHI Prohibited  \n \nThe sale of PHI, as defined  by 45 C.F.R. 164.502(a)(5)(ii)(B), is prohibited and Supplier is \nprohibited from seeking an individual\u2019s authorization to sell such individual\u2019s PHI.",
        "id": "qa_122"
    },
    {
        "question": "What restriction does the agreement place on the disclosure of Protected Health Information (PHI)?",
        "options": {
            "A": "PHI cannot be disclosed at all under any circumstances.",
            "B": "PHI can be disclosed if it is part of the Potential Transaction.",
            "C": "PHI can be disclosed if it is de-identified according to federal regulations.",
            "D": "PHI can be disclosed with a written amendment to the agreement."
        },
        "correct_answer": "C",
        "explanation": "The agreement specifies that PHI can only be disclosed if it has been de-identified within the meaning of regulations at 45 C.F.R. \u00a7 164.514.",
        "source": "unknown",
        "client": "Wellth, Inc.",
        "document_type": "unknown",
        "context": "The Parties agree that \ninformation disclosed and received in the course of di scussions concerning a Potential Transaction shall \nnot include information defined as Protected Health Information (PHI) under federal regulations at 45 \nC.F.R. \u00a7 160.103, except insofar as such PHI may have been de -identified within the meaning of regulati ons \nat 45 C.F.R. \u00a7 164.514. 8. Miscellaneous . (a) No License . The disclosure of information under this Agreement shall not be \ndeemed a grant of a license, by implication or otherwise, under any of the Disclosing Party\u2019s trade secrets, \nproprietary or other inte llectual property rights. (b) Entire Agreement . This Agreement contains the sole and entire agreement \nbetween the Parties with respect to the confidentiality of the Confidential Information and the con -\nfidentiality of all matters concerning a Potential Transa ction. This Agreement may be amended, modified, \nor waived only by a separate written instrument duly signed and delivered by or on behalf of both Parties. (c) Severability . If all or part of any term or condition of this Agreement, or the \napplication of any term or condition of this Agreement, is determined by any court of competent jurisdiction \nto be invalid or unenforceable to any extent, the remainder of the terms and conditions of this Agreement \n(other than those portions determined to be invalid or unenf orceable) shall not be affected, and the \nremaining terms and conditions (or portions of terms and conditions) shall be valid and enforceable to the \nfullest extent permitted by law. If a judicial determination prevents the accomplishment of the purpose of \nthis Agreement, the invalid term or condition (or portion of terms or conditions) shall be restated to conform \nto applicable law and to reflect as nearly as possible the original intention of the Parties. (d) Attorneys\u2019 Fees .",
        "id": "qa_123"
    },
    {
        "question": "How long do the obligations regarding trade secrets survive after the termination of the agreement?",
        "options": {
            "A": "3 years",
            "B": "For as long as the information qualifies as a trade secret",
            "C": "1 year",
            "D": "5 years"
        },
        "correct_answer": "B",
        "explanation": "The document states that obligations regarding trade secrets continue for as long as the information qualifies as a trade secret.",
        "source": "unknown",
        "client": "Maryland Physicians Care (MPC)",
        "document_type": "unknown",
        "context": "The rights and obligations accru ing prior to termination as set forth herein shall \nsurvive the termination of this Agreement for a period of five (5) years provided, however, that Receivin g Party\u2019s \nobligations respecting Disclosing Party\u2019s \u201ctrade secrets\u201d (as such term is defined in 18 U .S.C. 1839) shall continue \nfor so long as such information qualifies as a trade secret. 13. Protected Health Information. If any part of the Confidential Information disclosed hereunder is \nprotected health information pursuant to the Federal Health Insuran ce Portability and Accountability Act of 1996, \nPub. L. No. 104191 and its implementing regulations (collectively, \u201cHIPAA\u201d), as amended by the regulations \npromulgated pursuant to the Health Information Technology for Economic and Clinical Health Act, Title XIII of the \nAmerican Recovery and Reinvestment Act of 2009 (the \u201cHITECH Act\u201d), the parties agree to enter into a Business \nAssociate Agreement (the \u201cBAA\u201d). The BAA will govern and supersede the terms of this Agreement with respect to \nany protected health in formation disclosed hereunder . 14. This Agreement may not be assigned in whole or in part by either Party without the prior written \nconsent of the other Party. Any attempted assignment without such prior written consent shall be void and \nunenforceable. No twithstanding the foregoing, either Party, without the prior written approval of the other Party, \nmay assign its rights and obligations hereunder to a successor in ownership of substantially all of the assets of the \nbusiness, provided that the successor ex pressly assumes in writing the p erformance of the terms and conditions of \nthis Agreement.",
        "id": "qa_124"
    },
    {
        "question": "What are the minimum browser requirements for signers according to the legal document?",
        "options": {
            "A": "NetScape 6.0",
            "B": "Mozilla Firefox 1.0",
            "C": "Internet Explorer 5.0",
            "D": "Google Chrome"
        },
        "correct_answer": "B",
        "explanation": "The document specifies that signers must use Internet Explorer 6.0, Mozilla Firefox 1.0, or NetScape 7.2 (or above) as minimum browser requirements.",
        "source": "unknown",
        "client": "Self Insured Services Co",
        "document_type": "unknown",
        "context": "send us an e -mail to legal@verscend .com and in the body of such request you must \nstate your e -mail, full name, IS Postal Address, telephone number, and account number. Required hardware and software   \nOperating Systems:  Windows2000\u00ac or WindowsXP\u00ac  \nBrowsers (for \nSENDERS):  Internet Explorer 6.0\u00ac or above  \nBrowsers (for \nSIGNERS):  Internet Explorer 6.0\u00ac, Mozilla FireFox 1.0, NetScape 7.2 (or above)  \nEmail:  Access to a valid email account  \nScreen Resolution:  800 x 600 minimum  \nEnabled Security \nSettings:  \u00f2 Allow per session cook ies \n\u00f2 Users accessing the internet behind a Proxy Server must enable HTTP \n1.1 settings via proxy connection  \n** These minimum requirements are subject to change. If these requirements change, we will \nprovide you with an email message at the email address w e have on file for you at that time \nproviding you with the revised hardware and software requirements, at which time you will have \nthe right to withdraw your consent. Acknowledging your access and consent to receive materials electronically   \nTo confirm to  us that you can access this information electronically, which will be similar to \nother electronic notices and disclosures that we will provide to you, please verify that you were \nable to read this electronic disclosure and that you also were able to print  on paper or \nelectronically save this page for your future reference and access or that you were able to e -mail \nthis disclosure and consent to an address where you will be able to print on paper or save it for \nyour future reference and access. Further, if you consent to receiving notices and disclosures \nexclusively in electronic format on the terms and conditions described above, please let us know \nby clicking the \u00e6I agree\u00c6 button below.",
        "id": "qa_125"
    },
    {
        "question": "What is the time frame within which the Business Associate must notify BCBSNE of a discovered or suspected HIPAA Breach?",
        "options": {
            "A": "Within 72 hours after discovery",
            "B": "Within 7 days after discovery",
            "C": "Immediately after discovery",
            "D": "Within 24 hours after discovery"
        },
        "correct_answer": "A",
        "explanation": "The document specifies that the Business Associate must notify BCBSNE of a discovered or suspected HIPAA Breach without unreasonable delay and in no event more than 72 hours after the discovery.",
        "source": "unknown",
        "client": "Blue Cross and Blue Shield of Nebraska",
        "document_type": "unknown",
        "context": "Notwithstanding the \nforeg oing, trivial and unsuccessful attempts to penetrate \nBusiness Associate\u2019s networks or systems, such as scans, \n\u201cpings\u201d , or similar events, need not be reported. c. Business Associate shall comply with the Security Rule \nto the extent required by HITECH. 10. Compliance with Breach Notification Rule. If Business \nAssociate discovers an actual or suspected HIPAA Breach, \nBusiness Associate shall notify BCBSNE  without \nunreasonable delay and in no event more than 72 hours  after \nthe discovery. Such notice shall i nclude identification of each \nIndividual whose PHI Business Associate reasonably  \nbelieves  to have been accessed, acquired, or disclosed \nduring the actual or suspected HIPAA Breach. No later than \n72 hours  thereafter, and to the extent known, Business \nAsso ciate shall also provide BCBSNE  with a description of  \n(i) what happened, including the date of the actual or \nsuspected HIPAA Breach and the date of the discovery, (ii) \nthe types of unsecured PHI involved in the actual or \nsuspected HIPAA Breach, iii) any st eps individuals should \ntake to protect themselves from potential harm from the \nactual or suspected HIPAA breach , and (iv) what Business \nAssociate is doing to investigate the actual or suspected \nHIPAA Breach, to mitigate harm to individuals, and to protect \nagainst any further HIPAA Breaches. For purposes of this \nparagraph, a HIPAA Breach shall be treated as discovered  \nas of the first day on which the HIPAA Breach is known or \nshould reasonably have been known to Business Associate \n(including any person, other than the one committing the \nHIPAA Breach that is an employee, officer, or other agent of \nthe Business Associate. Business Associate shall be \nresponsible for all notifications and mitigation costs and \nexpenses for all HIPAA Breaches caused solely by the \nconduct of Business Associate, its affiliates, and/or its \nsubcontrators .",
        "id": "qa_126"
    },
    {
        "question": "Under what circumstances may the Business Associate use PHI without violating the Privacy Rule?",
        "options": {
            "A": "For personal use",
            "B": "For marketing purposes",
            "C": "For the proper management and administration of Business Associate",
            "D": "For selling to third parties"
        },
        "correct_answer": "C",
        "explanation": "The legal document specifies that the Business Associate may use PHI for the proper management and administration of Business Associate, among other specified purposes, without violating the Privacy Rule.",
        "source": "unknown",
        "client": "Sierra Health Plan of Nevada",
        "document_type": "unknown",
        "context": "Further, Business Associate shall not use PHI in any manner that would constitute a \nviolation of the Privacy Rule if so used by Covered Entity, except that Associate may use PHI (i) \nfor the proper management and administration of Business Associate, (ii) to carry out the legal \nresponsibilities of Business Associate, or (iii) for Data Aggregation purposes on behalf of \nCovered Entity. [45 CFR \u00a7\u00a7 164.504(e)(2)(i), 164.504(e)(2)(ii)(A) and 164.504(e)(4)(i)] \n3.2 Safeguards Against Misuse of Information. Business Associate agrees to use appropriate safeguards to prevent use or disclosure of PHI other \nthan as provided for by this Agreement. 3.3 Mitigation of Harmful Effects. Business Associate agrees to mitigate, to the extent practicable, any harmful effect that is known \nto Business Associate of a use or disclosure of PHI by Business Associate in violation of the \nrequirements of this Agreement. 3.4 Reporting of Improper Use or Disclosure. Business Associate shall, within thirty (30) days of becoming aware of any use or disclosure or \nPHI in violation of this Agreement by Business Associate or any of its officers, directors, \nemployees, contractors or agents, report such use or disclosure to the Covered Entity. Page2of6 I \n3.5 Associate's Agents. Business Associate agrees to ensure that any agent, including a subcontractor, to whom it \nprovides PHI received from, or created or received by Business Associate on behalf of Covered \nEntity agrees to the same restrictions and conditions that apply through this Agreement to \nBusiness Associate with respect to such information. 3.6 Access to Pm.",
        "id": "qa_127"
    },
    {
        "question": "Under what circumstances may both parties use or disclose Confidential Information according to the agreement?",
        "options": {
            "A": "Only if it is necessary for marketing purposes",
            "B": "Only if required by the agreement terms",
            "C": "Only if both parties agree in writing",
            "D": "If required by any government authority or law"
        },
        "correct_answer": "D",
        "explanation": "The agreement allows the use or disclosure of Confidential Information if required by any government authority, law, or necessary to establish rights under the agreement, with prior notification to the other party.",
        "source": "unknown",
        "client": "Blue Cross and Blue Shield of Nebraska",
        "document_type": "unknown",
        "context": "In addition, both parties may use or disclose Confidential Information if and to the extent: a) required by\nany request or order of any government authority; b) otherwise required by law; or c) necessary to\nestablish rights under this Agreement; provided that, in each case each party will first notify the other\nparty of such requirement, permit the other party to contest such requirement if reasonably appropriate,\nand cooperate with the other party in limiting the scope of the proposed use or disclosure. lV. Return of Confidential Information\n\nUpon termination of this Agreement or upon request, both parties shall promptly return all documents and\nother tangible materials representing Confidential Information\n\nV. Remedies\n\nIt is agreed that the unauthorized use or disclosure of any Confidential Information by either could cause\nsevere and irreparable damage. In the event of such unauthorized disclosure, the non-breaching party is\nentitled to obtain from any court of competent jurisdiction preliminary and/or permanent injunctive relief,\nas well as any other form of relief permitted by applicable law. The disclosing party shall notify the non-\nbreaching party immediately upon discovery of any loss or compromise of Confidential Information. Vi. Entire Agreement\n\n \n\f\nThis Agreement constitutes the entire agreement between the parties and may not be amended except in\na writing executed by both parties. This Agreement shall be governed by the laws of the State of\nNebraska. Vil. Relationship of the Parties\n\nBCBSNE and COMPANY are independent entities and nothing in this Agreement shall be interpreted to\ncreate any type of partnership, joint venture, or other similar business relationship. Vill. Term and Termination\nThis Agreement shall commence as of the date set forth above and shall remain in force until terminated\n\nin writing by either party.",
        "id": "qa_128"
    },
    {
        "question": "What is the required procedure for managing user IDs and passwords according to the Aetna Life Insurance Company Addendum?",
        "options": {
            "A": "Passwords must be shared among users for efficiency.",
            "B": "Usernames must be disabled or deleted within 24 hours of employee termination.",
            "C": "Passwords must be changed every 30 days.",
            "D": "Passwords must consist solely of dictionary words."
        },
        "correct_answer": "B",
        "explanation": "The addendum specifies that usernames must be disabled, deleted, or the password changed within 24 hours upon employee transfer or termination.",
        "source": "s3://ml-legal-restricted/contract-docs/59280/Aetna Life Insurance Company - Cotiviti - Addendum - JK - 06012020 - Dynamics 59280.pdf",
        "client": "Aetna Life Insurance Company",
        "document_type": "Addendum",
        "context": "USB thumb drives, floppies, CD/DVD, Blackberry, \nbackup tapes etc.). Encryption must be a FIPS 140 -2 certified algorithm which is 128 bit or higher, such \nas AES. E. Antivirus software. All workstations, laptops and other systems that process and/or store Company PHI \nmust install and actively use comprehensive anti -virus software solution with automatic updates scheduled \nat least daily. F. Patch Management. All workstations, laptops and oth er systems that process and/or store Company PHI \nmust have critical security patches applied, with system reboot if necessary. There must be a documented \npatch management process which determines installation timeframe based on risk assessment and vendor \nrecommendations. At a maximum, all applicable patches must be installed within thirty (30) days of \nvendor release. G. User IDs and Password Controls. All users must be issued a unique user name for accessing Company \nPHI Username must be promptly disabled, dele ted, or the password changed upon the transfer or \ntermination of an employee with knowledge of the password, at maximum within twenty -four (24) hours. Passwords are not to be shared. Passwords must be at least eight (8) characters and must be a non -\ndiction ary word. Passwords must not be stored in readable format on the computer. Passwords must be \nchanged every ninety (90) days, preferably every sixty (60) days. Passwords must be changed if revealed \nor compromised. Passwords must be composed of characters fr om at least three of the following four \ngroups from the standard keyboard:  \n\u25aa Upper case letters (A -Z)  \n\u25aa Lower case letters (a -z) \n\u25aa Arabic numerals (0 -9) \n\u25aa Non-alphanumeric characters (punctuation symbols)  \nH. Data Destruction.",
        "id": "qa_129"
    },
    {
        "question": "What is the required timeframe to correct data extract problems according to the State-approved System Deficiency and Notification Process?",
        "options": {
            "A": "Within 10 business days",
            "B": "Within 5 business days",
            "C": "Within 3 business days",
            "D": "Within 1 business day"
        },
        "correct_answer": "B",
        "explanation": "The legal document specifies that all data extract problems must be corrected within five (5) business days of problem identification.",
        "source": "s3://ml-legal-restricted/contract-docs/55945/Accenture - Cotiviti SubK Agmt (Jan 2017)[CURRENT].pdf",
        "client": "Accenture",
        "document_type": "MSA",
        "context": "MAC 06 | Prepare and submit a corrective action plan to the State, in accordance with State-approved corrective\n\naction plan guidelines, when a problem has been identified that impacts MAR reporting. AHC 11 Produce and deliver accurate and verified ad hoc query results, with content and in media and format. and within a timeframe approved by the State,\n\nAHC 16 Notify and State within one-(1) business day of the identification of any data extract problems in\naccordance with the State-approved System Deficiency and Notification Process. Correct all data\nextract problems within five (5) business days of problem identification and notify the State of\ncorrection. AHC 17 If data extract problems cannot be corrected within five (5) business days, develop and submit a\ncorrective action plan for State approval within five (5) business days of the date it was identified the\nproblems could not be resolved. Correct the data extract problems in aceordance with the State-\n\n| approved corrective action plan. Establish and maintain an online data report repository which identifies version history of each report. Maintain the capacity to complete interactive inquires (submit a request and return requested data)\n\nwithin bventy (20) seconds, 99% of the time. An interim response of \u201cwaiting\u201d or \u201cyour request is\n\nbeimg processed\u201d does not meet the State's definition of complete. Provide automated access, twenty-three (23) hours per day, seven (7) days per week, to client\n\neligibility and other State-approved information and transactions, 98% of the lime. Ne more than two\n\n(2), one-hour periods of unscheduled downtime may occur within a thirty (30) day monitoring period.",
        "id": "qa_130"
    },
    {
        "question": "Under the agreement, what is the Business Associate allowed to do with de-identified Protected Health Information?",
        "options": {
            "A": "Use it for internal training purposes only",
            "B": "De-identify it and then store it indefinitely without further use",
            "C": "Use it to enrich current services and create new offerings",
            "D": "Use it solely for data aggregation services to the Covered Entity"
        },
        "correct_answer": "C",
        "explanation": "The agreement allows the Business Associate to de-identify Protected Health Information and use such de-identified information to enrich their current services and create new offerings.",
        "source": "unknown",
        "client": "Community First Health Plans",
        "document_type": "unknown",
        "context": "Except as otherwise limited in this Agreement, Business Associate may use or \ndisclose  PHI and implementation  of safeguards  to secure  ePHI  to perform  contracted  professional \nservices  for or on behalf  of Community  First  in which  an applicable  HIPAA  exception  does  not apply, \nif such use or disclosure of PHI would not violate the Privacy Rule if done by Community First or \nthe minimum necessary policies and procedures of the Community First and to the extent \nminimally necessary to accomplish the intended purpose of such use, disclosure or request in \naccordance with 45 C.F.R. \u00a7164.502(b). DocuSign Envelope ID: CC6F7891-FCD3-4A9F-B775-815EC2BFDD28\nPage  6 of 12 \nBAA  2023  -6.2023    \nB. de-identify Protected Health Information provided to it in accordance with 45 C.F.R. \u00a7 164.514(a) -\n(c), and use such de -identified information in order to enrich their current services and create new \nofferings. De -identified data will be the sole property of Business Associate. C. use Protected Health Information to provide data ag gregation services to Covered Entity as \npermitted by 42 C.F.R. \u00a7 164.504(e)(2)(i)(B) including (a)  outcomes data aggregation; (b) profiling of \nutilization patterns, outcomes, and prescribing patterns of providers; and (c) geographic profiling \nof patterns o f care. D. Specific  Use and Disclosure  Provisions  \n \n1. Except as otherwise limited in this Agreement, Business Associate may use PHI, if \nnecessary, for the proper management and administration of the Business Associate or \nto carry out the legal responsibilities of the Business Associate.",
        "id": "qa_131"
    },
    {
        "question": "What action must a user take to confirm their consent to receive materials electronically according to the legal document?",
        "options": {
            "A": "Call the company via telephone",
            "B": "Click the \"I agree\" button",
            "C": "Post a message on the company's social media",
            "D": "Send a physical letter to the company address"
        },
        "correct_answer": "B",
        "explanation": "The document specifies that consent is confirmed by clicking the \"I agree\" button to receive notices and disclosures electronically.",
        "source": "unknown",
        "client": "Self Insured Services Co",
        "document_type": "unknown",
        "context": "send us an e -mail to legal@verscend .com and in the body of such request you must \nstate your e -mail, full name, IS Postal Address, telephone number, and account number. Required hardware and software   \nOperating Systems:  Windows2000\u00ac or WindowsXP\u00ac  \nBrowsers (for \nSENDERS):  Internet Explorer 6.0\u00ac or above  \nBrowsers (for \nSIGNERS):  Internet Explorer 6.0\u00ac, Mozilla FireFox 1.0, NetScape 7.2 (or above)  \nEmail:  Access to a valid email account  \nScreen Resolution:  800 x 600 minimum  \nEnabled Security \nSettings:  \u00f2 Allow per session cook ies \n\u00f2 Users accessing the internet behind a Proxy Server must enable HTTP \n1.1 settings via proxy connection  \n** These minimum requirements are subject to change. If these requirements change, we will \nprovide you with an email message at the email address w e have on file for you at that time \nproviding you with the revised hardware and software requirements, at which time you will have \nthe right to withdraw your consent. Acknowledging your access and consent to receive materials electronically   \nTo confirm to  us that you can access this information electronically, which will be similar to \nother electronic notices and disclosures that we will provide to you, please verify that you were \nable to read this electronic disclosure and that you also were able to print  on paper or \nelectronically save this page for your future reference and access or that you were able to e -mail \nthis disclosure and consent to an address where you will be able to print on paper or save it for \nyour future reference and access. Further, if you consent to receiving notices and disclosures \nexclusively in electronic format on the terms and conditions described above, please let us know \nby clicking the \u00e6I agree\u00c6 button below.",
        "id": "qa_132"
    },
    {
        "question": "What encryption standard must be used for workstations and laptops processing Company PHI according to the Aetna Life Insurance Company Addendum?",
        "options": {
            "A": "SHA-256",
            "B": "DES 56 bit",
            "C": "RSA 1024 bit",
            "D": "FIPS 140-2 certified algorithm 128 bit or higher"
        },
        "correct_answer": "D",
        "explanation": "The document specifies that all workstations and laptops processing Company PHI must use a FIPS 140-2 certified algorithm that is 128 bit or higher, such as Advanced Encryption Standard (AES).",
        "source": "s3://ml-legal-restricted/contract-docs/63497/46088_Aetna CA Compliance Addendum 052720.pdf",
        "client": "Aetna Life Insurance Company",
        "document_type": "Addendum",
        "context": "Befo re a member of the workforce may access Company PHI, a thorough background \ncheck of that worker must be conducted, with evaluation of the results to assure that there is no indication \nthat the worker may present a risk to the security or integrity of confi dential data or a risk for theft or \nmisuse of confidential data. The Vendor  shall retain each workforce member\u2019s background check \ndocumentation for a period of three (3) years following termination of the Agreement . F. Security Officer Designation . Vendor  shall designate a Security Officer to oversee its data  security \nprogram who shall be responsible for carrying out the requirements  of this section and for communicating \non security matters with Company . Technical Security Controls  \nA. Workstation/Laptop encryption. All workstations and laptops that process and/or store Company PHI \nmust be encrypted using a FIPS 140 -2 certified algorithm which is 128 bit or higher, such as Advanced \nEncryption Standard (AES). The encryption solution must be full disk unless approved by the Company. ABH CA Compliance Addendum - Vendor  Page 17 of 18 Confidential  \nV.2.10.20;  \nProprietary  B. Server Security. Servers containing unencrypted Company PHI must have sufficient administrative, \nphysical, and technical controls in place to protect that data, based upon a risk assessment/system security \nrevie w. \nC. Minimum Necessary. Only the minimum necessary amount of Company PHI required to perform \nnecessary business functions may be copied, downloaded, or exported. D. Removable media devices. All electronic files that contain Company PHI data must be encrypted wh en \nstored on any removable media or portable device (i.e. USB thumb drives, floppies, CD/DVD, Blackberry, \nbackup tapes etc.). Encryption must be a FIPS 140 -2 certified algorithm which is 128 bit or higher, such \nas AES. E. Antivirus software.",
        "id": "qa_133"
    },
    {
        "question": "What is the governing law for this Agreement according to the document?",
        "options": {
            "A": "The laws of the State of New York",
            "B": "The laws of the State of Delaware",
            "C": "Federal laws of the United States",
            "D": "The laws of the State of California"
        },
        "correct_answer": "B",
        "explanation": "The document states that the Agreement shall be governed by the laws of the State of Delaware, without regard to its principles of conflicts of laws.",
        "source": "unknown",
        "client": "The Standard",
        "document_type": "unknown",
        "context": "The Owner will not be liable for any damages \narising out of the Recipient\u2019s use of any Confidential Information, and the Recipient uses the \nOwner\u2019s Confidential Information at the Recipient\u2019s own risk. 7. Governing Law . This Agreement shall be g overned by the laws of the State of Delaware , \nwithout regard to its principles of conflicts of laws. Any litigation concerning this Agreement \nshall occur in the relevant State or Federal court located in Delaware . By executing this \nAgreement Consultant c onsents to the in personam jurisdiction of those courts. 8. Injunctive Relief . The parties agree that disclosure or use of Confidential Information \ncontrary to the terms of this Agreement may cause the disclosing party irreparable harm, for \nwhich damages ma y not be adequate compensation. Therefore , the parties agree that they \nmay be entitled to seek equitable relief, including an injunction, in order to stop any breach \nor threatened breach of this Agreement. Docusign Envelope ID: B527775C-3F59-4071-AFAF-15FC96A5A319\n \n \n 9. Legal Fees . In the event that either party shall b ring any action to enforce or protect any of \nits rights under this Agreement, the prevailing party shall be entitled to recover, in addition to \nits damages, its reasonable legal fees and costs (including those of in -house counsel) \nincurred in connection th erewith. 10. Duplicate Originals . This Agreement may be executed in one or more counterparts, each \nof which when executed shall be deemed to be an original, but all of which taken together \nshall constitute one and the same instrument. 11.",
        "id": "qa_134"
    },
    {
        "question": "What should you do if the hardware and software requirements for accessing electronic disclosures change?",
        "options": {
            "A": "Ignore the changes and continue using the current setup.",
            "B": "Update your hardware and software immediately without notification.",
            "C": "Automatically agree to the new requirements.",
            "D": "Wait for a notification email and then decide whether to withdraw your consent."
        },
        "correct_answer": "D",
        "explanation": "The document states that if the requirements change, you will receive an email with the new details, and at that point, you have the right to withdraw your consent.",
        "source": "s3://ml-legal-restricted/contract-docs/68895/Atrio - Cotiviti - NDA - AR - 07192022 - Dynamics_68895.pdf",
        "client": "ATRIO Health Plans",
        "document_type": "NDA",
        "context": "send us an e -mail to legal@verscend .com and in the body of such request you must \nstate your e -mail, full name, IS Postal Address, telephone number, and account number. Required hardware and software   \nOperating Systems:  Windows2000\u00ac or WindowsXP\u00ac  \nBrowsers (for \nSENDERS):  Internet Explorer 6.0\u00ac or above  \nBrowsers (for \nSIGNERS):  Internet Explorer 6.0\u00ac, Mozilla FireFox 1.0, NetScape 7.2 (or above)  \nEmail:  Access to a valid email account  \nScreen Resolution:  800 x 600 minimum  \nEnabled Security \nSettings:  \u00f2 Allow per session cook ies \n\u00f2 Users accessing the internet behind a Proxy Server must enable HTTP \n1.1 settings via proxy connection  \n** These minimum requirements are subject to change. If these requirements change, we will \nprovide you with an email message at the email address w e have on file for you at that time \nproviding you with the revised hardware and software requirements, at which time you will have \nthe right to withdraw your consent. Acknowledging your access and consent to receive materials electronically   \nTo confirm to  us that you can access this information electronically, which will be similar to \nother electronic notices and disclosures that we will provide to you, please verify that you were \nable to read this electronic disclosure and that you also were able to print  on paper or \nelectronically save this page for your future reference and access or that you were able to e -mail \nthis disclosure and consent to an address where you will be able to print on paper or save it for \nyour future reference and access. Further, if you consent to receiving notices and disclosures \nexclusively in electronic format on the terms and conditions described above, please let us know \nby clicking the \u00e6I agree\u00c6 button below.",
        "id": "qa_135"
    },
    {
        "question": "What restriction is placed on the Licensee regarding product development during and after the term of the Agreement?",
        "options": {
            "A": "Licensee is restricted from developing similar products for two years after the Agreement.",
            "B": "Licensee may develop similar products at any time.",
            "C": "Licensee may hire third parties to develop similar products during the term of the Agreement.",
            "D": "Licensee is restricted from developing similar products for one year after the termination of the Agreement."
        },
        "correct_answer": "D",
        "explanation": "The document specifies that the Licensee agrees not to develop or sell a product with similar functionality to the Licensed Program during the term of the Agreement and for one year after its termination.",
        "source": "unknown",
        "client": "Capital Health Plan, Inc.",
        "document_type": "unknown",
        "context": "Each party shall\npromptly notify the other of any unauthorized possession, use or disclosure of the other party\u2019s\nConfidential Information by such party\u2019s employees, agents or representatives. G) Licensor Marketing. Licensee acknowledges and agrees that Licensor may, subject to the\nconfidentiality requirements of this Agreement, publicly disclose the commercial relationship\nbetween Licensor and Licensee as contemplated by this Agreement, through, without limitation,\npress releases, promotional literature and references in Licensor\u2019s web site. H) Non-Competition. Licensee agrees that during the term of this Agreement and for a term of one\n: year subsequent to the termination of this Agreement, Licensee shall not develop or sell a\ni product, or hire any third party to develop a product, with the same or substantially similar\ni functionality to the Licensed Program. 9. TERMINATION EVENTS. A) Licensor\u2019s Termination Events. Licensor may terminate this Agreement and any license granted\nto Licensee hereunder, and pursue appropriate legal remedies, if:\n\ni. Licensee fails to pay Licensor any license fees or other charges as set forth in this\nAgreement;\n\nii. _ Licensee (including any employee, officer, director, partner, agent, parent or subsidiary, or\naffiliate of Licensee) uses, copies or modifies the Licensed Program or transfers possession\nof any copy, adaptation, transcription, or merged portion of the Licensed Program to any\nother party in any way not expressly authorized by this Agreement;\n\niii. Licensee is in default of any other material provision of this Agreement and such default is\nnot cured within thirty (30) days after Licensor gives Licensee written notice of that default,\nprovided that no remedy period shall be required for defaults which are not curable; or\n\niv.",
        "id": "qa_136"
    },
    {
        "question": "What happens to the obligations related to trade secrets after the termination of the agreement?",
        "options": {
            "A": "They survive for 5 years",
            "B": "They survive for 1 year",
            "C": "They continue indefinitely as long as the information qualifies as a trade secret",
            "D": "They are void immediately after termination"
        },
        "correct_answer": "C",
        "explanation": "The obligations regarding trade secrets continue for as long as the information qualifies as a trade secret, according to the agreement.",
        "source": "unknown",
        "client": "Maryland Physicians Care (MPC)",
        "document_type": "unknown",
        "context": "The rights and obligations accru ing prior to termination as set forth herein shall \nsurvive the termination of this Agreement for a period of five (5) years provided, however, that Receivin g Party\u2019s \nobligations respecting Disclosing Party\u2019s \u201ctrade secrets\u201d (as such term is defined in 18 U .S.C. 1839) shall continue \nfor so long as such information qualifies as a trade secret. 13. Protected Health Information. If any part of the Confidential Information disclosed hereunder is \nprotected health information pursuant to the Federal Health Insuran ce Portability and Accountability Act of 1996, \nPub. L. No. 104191 and its implementing regulations (collectively, \u201cHIPAA\u201d), as amended by the regulations \npromulgated pursuant to the Health Information Technology for Economic and Clinical Health Act, Title XIII of the \nAmerican Recovery and Reinvestment Act of 2009 (the \u201cHITECH Act\u201d), the parties agree to enter into a Business \nAssociate Agreement (the \u201cBAA\u201d). The BAA will govern and supersede the terms of this Agreement with respect to \nany protected health in formation disclosed hereunder . 14. This Agreement may not be assigned in whole or in part by either Party without the prior written \nconsent of the other Party. Any attempted assignment without such prior written consent shall be void and \nunenforceable. No twithstanding the foregoing, either Party, without the prior written approval of the other Party, \nmay assign its rights and obligations hereunder to a successor in ownership of substantially all of the assets of the \nbusiness, provided that the successor ex pressly assumes in writing the p erformance of the terms and conditions of \nthis Agreement.",
        "id": "qa_137"
    },
    {
        "question": "What are Cotiviti's obligations regarding Client Confidential Information upon termination of the agreement?",
        "options": {
            "A": "Cotiviti has no obligations regarding Confidential Information once the agreement is terminated.",
            "B": "Cotiviti must return or destroy the Confidential Information unless it is not reasonably feasible or desirable to Client.",
            "C": "Cotiviti must immediately destroy all Confidential Information.",
            "D": "Cotiviti can continue to use the Confidential Information indefinitely."
        },
        "correct_answer": "B",
        "explanation": "Upon termination, Cotiviti must return or destroy the Confidential Information unless it is not reasonably feasible or desirable to Client, ensuring confidentiality and ceasing use unless required by law.",
        "source": "unknown",
        "client": "AxialHealthcare",
        "document_type": "unknown",
        "context": "Where the request for the return or destruction of Client \nConfidential Information prevents, hinders or delays Cotiviti\u2019s performance of the \nServices, Cotiviti shall have no liability for any partial or non -performance of its \nobligations o r any delay in respect of the same .\u201d \n \nSection 9.3 of the MSA : \u201cRights and Obligations Upon Termination . Upon any \ntermination of this Agreement, and except as expressly provided in section 4.3 \n[Exceptions] and 4.4 [Latent Data] of this Agreement, each party will return to the \nTERMINATION SUMMARY  \nCONFIDENTIAL INFORMATION FOR COTIVITI, INC. INTERNAL USE ONLY   \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n other party any Confidential Information of such other party which is in its \npossess ion. If return or destruction is not reasonably feasible, or desirable to Client \nfor each and every original and copy in every media of all Confidential Information \nin Cotiviti's possession, custody or control, Cotiviti warrants that it shall ensure the \nconfidentiality of the Confidential Information and it shall not use or disclose any \nConfidential Information after termination of this Agreement, except as required by \napplicable law. Upon such termination, all rights and obligations of the parties \nunder th is Agreement will cease except that Cotiviti will be entitled to recover \npayment for (i) all Solutions rendered through the date of termination (including for \nwork in progress); (ii) those reasonable costs incurred in anticipation of \nperformance or provisi on of the Solutions to the extent they cannot reasonably be \neliminated) .\u201d \nDue Date for Data Destruction:  None. Data Destruction Statement Required:  No. Due Date  for Data Destruction Statement:  None.",
        "id": "qa_138"
    },
    {
        "question": "What restrictions are placed on the use of Confidential Information by the Vendor and Consultant?",
        "options": {
            "A": "They can only use it for purposes related to the Services.",
            "B": "They can duplicate and modify it freely as long as it is kept secure.",
            "C": "They can share it with anyone as long as it is for business purposes.",
            "D": "They can use it freely for any purpose."
        },
        "correct_answer": "A",
        "explanation": "The document specifies that the Vendor and Consultant shall not use Confidential Information except for purposes of the Services.",
        "source": "unknown",
        "client": "Boston Benefit Partners",
        "document_type": "unknown",
        "context": "E. Permitted Uses: Vendor and Consultant: (a) shall not use (deemed to include, but not be limited to, using,\nexploiting, duplicating, recreating, modifying, decompiling, disassembling, reverse engineering, translating, creating\nderivative works, adding to a Vendor and/or Consultant database, or disclosing Confidential Information to another\nperson or permitting any other person to do so) Confidential Information except for purposes of the Services; (b)\nshall limit use of Confidential Information only to its authorized employees (deemed to include employees as well as\nindividuals who are agents or independent contractors of Vendor or Consultant) who have a need to know for\npurposes of providing the Services and who have been advised of the existence and terms of this Agreement and the\nobligations of confidentiality herein; (c) shall comply with all applicable laws and regulations governing the use and\ndisclosure of information; including, but not limited to, the privacy and security provisions of the Health Insurance\nand Portability and Accountability Act of 1996 (HIPAA); (d) shall use and require its employees to use, at least the\nsame degree of care to protect the Confidential Information as is used with Vendor\u2019s or Consultant\u2019s own\nproprietary and confidential information; and (e) may release Confidential Information in response to a subpoena or\nother legal process to disclose Confidential Information, after giving Company reasonable prior notice of such. disclosure and providing Company within opportunity to seek a protective judicial order or other commitment to\nmaintain the confidentiality of such Confidential Information prior to disclosure thereof.",
        "id": "qa_139"
    },
    {
        "question": "What must Covered Entity do when there is a change or revocation of an Individual's Authorization regarding PHI?",
        "options": {
            "A": "Do not inform Business Associate at all",
            "B": "Inform Business Associate immediately",
            "C": "Inform Business Associate within a reasonable period of time after becoming aware",
            "D": "Wait until the next quarterly report to inform Business Associate"
        },
        "correct_answer": "C",
        "explanation": "Covered Entity is required to inform Business Associate of any change or revocation of an Individual's Authorization to use or disclose PHI within a reasonable period of time after becoming aware of such change, as it may affect the Business Associate's use or disclosure of PHI.",
        "source": "unknown",
        "client": "Sierra Health Plan of Nevada",
        "document_type": "unknown",
        "context": "Covered Entity agrees to inform Business Associate of any change to, or revocation of, an \nIndividual's Authorization to use or disclose PHI to the extent that such change may affect \nBusiness Associate's use or disclosure of PHI, within a reasonable period of time after Covered \nEntity becomes aware of such change. 4.3 Restrictions on Use and Disclosure. Covered Entity agrees to notify Business Associate of any restrictions to the use or disclosure of \nPHI agreed to by Covered Entity in accordance with 45 CFR Section 164.522, to the extent that \nsuch restriction may affect Business Associate's use or disclosure of PHI. 4.4 Permissible Requests. Covered Entity shall not request Business Associate to use or disclose PHI in any manner that \nwould not be permissible under the Privacy Rule if done by Covered Entity. 4.5 Safeguards. Covered Entity shall use appropriate safeguards to ensure the security of PHI provided to \nBusiness Associate pursuant to the arrangement and this Agreement, in accordance with the \nPrivacy Rule, until such PHI is received by Business Associate. Page 4 of6 \n5. Termination \n5.1 Term. This Agreement shall be effective from the Effective Date until all PHI provided by or received \nor created for Covered Entity is destroyed or returned to Covered Entity, or if it is infeasible to \nreturn or destroy PHI, protections are extended to such PHI in accordance with the terms of this \nAgreement. The term of this Agreement shall also end upon termination of the underlying Master \nAgreement, subject, however, to the requirements of this section 5 for return or destruction of all \nPHI. 5.2 Termination Upon Breach of Provisions Applicable to PHI.",
        "id": "qa_140"
    },
    {
        "question": "What is required for remote computing sessions that involve access to Customer Confidential Information according to the document?",
        "options": {
            "A": "Use of a simple password authentication system",
            "B": "Access via a secure Virtual Private Network (VPN)",
            "C": "Use of unencrypted remote desktop access",
            "D": "Prohibited use of any remote computing sessions"
        },
        "correct_answer": "B",
        "explanation": "The document specifies that remote computing sessions must be performed via a secure Virtual Private Network (VPN) or other appropriate security measures.",
        "source": "unknown",
        "client": "Humana",
        "document_type": "unknown",
        "context": "2.10.13. Vendors will use an accountability system that keeps track of each access  to symmetric and private  \nkeys in plaintext  form. 2.10.14. In the event that tapes  are used for system backup, such tapes shall be encrypted  and appropriately \ninventoried and logged  as to location and planned destruction date. 2.11. Remote Computing  Requirements\n2.11.1. All permitted and authorized remote  computing sessions that may entail access  to Customer \nConfidential Information shall only be performed via a secure Virtual Private  Network (\u201cVPN\u201d) or other \nsecurity measure that  is appropriate given the type of computer access  being  employed. 2.11.2. Vendor  agrees to work toward implementing a requirement for remote access  to Vendor  environments \nwhere Customer Confidential  Information  is stored,  processed, transmitted,  accessed, or viewed  to have  \nmultifactor authentication (MFA). 2.11.3. Access  to Remote  Desktop Protocol (\u201cRDP\u201d)  shall be prohibited except while on Vendor\u2019s VPN and \nshall be limited to a minimal  level access required standard. 2.12. Malware Protection\n2.12.1. Vendor  shall install, enable and keep current reputable, commercially available anti-malware software \non all Vendor  servers and Personal Computers used in accessing,  storing, processing,  transmitting, or \ncreating Customer  Confidential  Information. 2.13. Password, Access and Identity Management\n2.13.1. Vendor  shall require  that all Vendor Representatives with access  to Customer Confidential  \nInformation use a unique username and password (collectively \u201cLogin Credentials\u201d). Each  password \nshall have  an effective use period of no more than ninety  (90) days. Said password  shall be a minimum \nof eight (8) characters in length and include  at least three (3) of the following: alpha, numeric,  special \ncharacter, and case sensitivity.",
        "id": "qa_141"
    },
    {
        "question": "What does the License Agreement specify regarding changes to professional service rates?",
        "options": {
            "A": "Rates are only adjusted annually.",
            "B": "Rates can be changed by Licensor with prior notice.",
            "C": "Rates may change without prior notice.",
            "D": "Rates are fixed for the duration of the agreement."
        },
        "correct_answer": "C",
        "explanation": "The License Agreement states that the rates are subject to change by Licensor without prior notice, indicating flexibility in adjusting rates without notifying the Licensee beforehand.",
        "source": "unknown",
        "client": "Capital Health Plan, Inc.",
        "document_type": "unknown",
        "context": "Operating system: Please identify the operating system and release number under which the Licensed\nProgram will be run (e.g., Windows 98/NT, MVS, Solaris 5.6). 1. Estimated number of Unique Individuals to which the Licensed Program will be applied:\n\n \n\nEmail... 2 PASS @ QR ORG ocr\n\nVerisk Health, Inc.\n\nLicense Agreement with Capital Health Plan\nPage 12 of 30\n\nVersion 1-23-09\n\f\nAttachment C\n\nCONTRACT SERVICE RATES\n\n \n\nLimited technical support with installation and operation of the Licensed Program during normal business\nhours is included as part of the License Agreement, at Licensor\u2019s reasonable discretion. The rates indicated\nbelow are the current, all-inclusive professional service rates for any additional services sought by Licensee\n(e.g., programming support, file preparation, training, analytic and other consulting services). Travel and out-\nof-pocket expenses are additional and billed at cost. Programmer/Processor $150 per hour\nAnalyst $200 per hour\nSenior Scientist $350 per hour\nPrincipal $350 per hour\nOn-site Training $5,000 per day\n\nThese rates are subject to change by Licensor without prior notice. Verisk Health, Inc.\n\nLicense Agreement with Capital Health Plan\nPage 13 of 30\n\nVersion 1-23-09\n\f\nAttachment D\n\nUSAGE REPORT\n(To be submitted to Verisk prior to each anniversary date of the Execution Date of the Agreement)\n\n1. For the license year ended\n\n2. Number of Unique Individuals on which the Licensed Program\nwas used during the license year: :\n\n3. Annual Fee for the license year, calculated pursuant to the Annual Fee Schedule in Attachment A:\n$ :\n\n4.",
        "id": "qa_142"
    },
    {
        "question": "What does the legal document specify about the use of a party\u2019s name or trade names in publicity releases?",
        "options": {
            "A": "They can be used freely without any restrictions.",
            "B": "They can be used as long as the other party is informed.",
            "C": "They can be used if the information is not confidential.",
            "D": "They can be used only after securing the party\u2019s written approval."
        },
        "correct_answer": "D",
        "explanation": "The legal document specifies that a party\u2019s name or trade names cannot be used in publicity releases or advertising without securing written approval from the other party.",
        "source": "unknown",
        "client": "The Standard",
        "document_type": "unknown",
        "context": "\u201cLatent Data\u201d refers to data that is stored by a party on \nroutine back -up media, including but not limited to deleted files and other non -logical data \ntypes, memory dumps, swap files, temporary files, printer spool files and metadata that can \ncustomarily be retrieved only by computer forensics experts and is generally considered \ninaccessible without the use of specialized tools and techniques. 5. Non-disclosure of Other Information . Except for the occurrence of an event that would \npermit disclosure of Confidential Information under Section 2, neither party shall disclose the \nfact that the parties are engaged in discussions related to the Purpose, the fact that on e \nparty\u2019s Confidential information has been made available to the other party, and the terms of \nany proposal, offer or indication of interest by either party. Notwithstanding the foregoing,  \neither party shall not use the name or trade names of the other  party or its affiliates in \npublicity releases or advertising, including customer lists, or for other promotional purposes, \nwithout first securing such part y\u2019s written approval. 6. No License or Representation . This Agreement does not require either party to  disclose \nany Confidential Information. All Confidential Information shall remain the sole property of \nthe Owner. By entering into this Agreement or by providing the Recipient with its \nConfidential Information, the Owner grants no license, either express o r implied, to the \nRecipient in any trademark, patent, copyright, or any other intellectual property right in the \nConfidential Information. All Confidential Information is disclosed by Owner AS IS, and by \ndisclosing the Confidential Information, the Owner m akes no representation, warranty or \nassurance with respect to the Confidential Information\u2019s completeness, accuracy, or non -\ninfringement of any trademarks, patents, copyrights, trade secrets or any other intellectual \nproperty rights or other rights of thir d parties.",
        "id": "qa_143"
    },
    {
        "question": "Under which jurisdiction is the Agreement governed?",
        "options": {
            "A": "State of California",
            "B": "Federal laws of the United States",
            "C": "State of New York",
            "D": "State of Delaware"
        },
        "correct_answer": "D",
        "explanation": "The Agreement is specifically governed by the laws of the State of Delaware, as stated in the document.",
        "source": "unknown",
        "client": "The Standard",
        "document_type": "unknown",
        "context": "The Owner will not be liable for any damages \narising out of the Recipient\u2019s use of any Confidential Information, and the Recipient uses the \nOwner\u2019s Confidential Information at the Recipient\u2019s own risk. 7. Governing Law . This Agreement shall be g overned by the laws of the State of Delaware , \nwithout regard to its principles of conflicts of laws. Any litigation concerning this Agreement \nshall occur in the relevant State or Federal court located in Delaware . By executing this \nAgreement Consultant c onsents to the in personam jurisdiction of those courts. 8. Injunctive Relief . The parties agree that disclosure or use of Confidential Information \ncontrary to the terms of this Agreement may cause the disclosing party irreparable harm, for \nwhich damages ma y not be adequate compensation. Therefore , the parties agree that they \nmay be entitled to seek equitable relief, including an injunction, in order to stop any breach \nor threatened breach of this Agreement. Docusign Envelope ID: B527775C-3F59-4071-AFAF-15FC96A5A319\n \n \n 9. Legal Fees . In the event that either party shall b ring any action to enforce or protect any of \nits rights under this Agreement, the prevailing party shall be entitled to recover, in addition to \nits damages, its reasonable legal fees and costs (including those of in -house counsel) \nincurred in connection th erewith. 10. Duplicate Originals . This Agreement may be executed in one or more counterparts, each \nof which when executed shall be deemed to be an original, but all of which taken together \nshall constitute one and the same instrument. 11.",
        "id": "qa_144"
    },
    {
        "question": "What is the procedure for handling a Force Majeure Event according to the agreement?",
        "options": {
            "A": "The unaffected party must suspend all obligations indefinitely.",
            "B": "Both parties must continue performing their obligations without any changes.",
            "C": "The affected party must immediately terminate the agreement.",
            "D": "The affected party must give notice and attempt to resume performance."
        },
        "correct_answer": "D",
        "explanation": "The agreement specifies that the affected party must immediately give notice and do everything commercially reasonable to resume performance. Obligations are suspended upon notice.",
        "source": "unknown",
        "client": "Blue Cross and Blue Shield of Nebraska",
        "document_type": "unknown",
        "context": "In the event that either Party is unable to perform any of its obligations under this \nAgreement, or to enjoy any of its benefits because of (or if loss of the Services is caused by) \nnatural disaster, actions or decrees of governmental bodies or agencies, war, civil disturbances, \nterrorism or communication line failure, or other cause not the fault of the affected  party (a \n\u201cForce Majeure Event \u201d), the Party who has been so affected shall immediately give notice to the \nother party and shall do everything commercially reasonable possible to resume performance. Upon receipt of such notice, all obligations under this Ag reement shall be immediately \nsuspended. If the period of nonperformance exceeds thirty (30) days from the receipt of notice of \nthe Force Majeure Event, the Party whose ability has not been so affected, may, by giving written \nnotice, terminate this Agreemen t or cancel, without cancellation charge, any unfilled commitment \nto purchase or provide Services. e. No Publicity . Neither party shall issue or release any statement, article, advertising, or other \npublicity material relating to this Agreement or services to  be provided under this Agreement and \nneither party shall use the name or any trademark or logo of the other party without the prior written \nconsent of the other party. f. Severability . If any provision of this Agreement shall be held to be invalid, illegal or unenforceable, \nthe validity, legality and enforceability of the remaining provisions shall in no way be affected or \nimpaired thereby . g. Governing Law and Jurisdiction . This Agreement and performance hereunder shall be governed by \nthe laws of the state of Connecticut without regard to conflicts of laws principles of such \njurisdiction. h. Notices .",
        "id": "qa_145"
    },
    {
        "question": "What type of information is considered \"Confidential Information\" under the agreement?",
        "options": {
            "A": "Trade secrets and methodologies",
            "B": "Information available to the public",
            "C": "Expired or terminated agreements",
            "D": "Information shared orally only"
        },
        "correct_answer": "A",
        "explanation": "Confidential Information includes trade secrets, methodologies, and other non-public information as defined in the agreement.",
        "source": "unknown",
        "client": "Albertsons Companies, Inc.",
        "document_type": "unknown",
        "context": "Purpose . The parties wish to share information  for the purpose of evaluating the suitability of \nentering into a business relationship  or in furtherance of an existing business relationship  (\u201cPurpose \u201d) and \nin connection therewith, the disclosing party  or its Representati ves, hereinafter defined  (collectively, \n\u201cDisclosing Party \u201d) desires that the receiving party  or its Representatives  (collectively, \u201cReceiving Party \u201d) \ntreat such  information as confidential. As used in this Agreement, \u201c Representatives \u201d shall mean the \napplicable party \u2019s parent, affiliates and subsidiaries, and its and their officers, directors, employees, \ncontractors, consultants, agents and representatives. 2. \u201cConfidential Information \u201d means any and all information of the Disclosing Party and each of its \nparent, affiliates and subsidiaries that is not available to the public, including , but not limited to : trade \nsecrets; techniques; methods; methodologies; product and manufacturing specifications; purchase or sales \nvolume , manufacturing, marketing, development, customer  (personal and aggregate  data, including \nhousehold and alternative IDs and tracking cookies  and tags ), employee, supplier, financial or operations \ninformation; technical, scientific, laboratory, experimental, research or statistical data; tooling; machinery; \ndiagrams; drawings; forecasting; business and new product and service plans; reports; procedures; \ndesigns; formulae; recipes; improvements;  records; processes ; any and all current and future product \ninforma tion; facilities tours;  know -how; data or any third party information and contracts that Disclosing \nParty is obligated to treat as confidential that is disclosed  or made accessible  to the Receiving Party  directly \nor indirectly, in any form, whether written, oral, photographic, electronic, magnetic, computer, by inspection \nof tangible objects, or otherwise (including materials, records, reports, documents, prototypes, samples, \nplant and equipment ) and information that has been subject to confidential treatment under a terminated or \nexpired agreement  between the parties .",
        "id": "qa_146"
    },
    {
        "question": "What are the requirements for a Business Associate regarding the use or disclosure of Protected Health Information (PHI) under the Agreement?",
        "options": {
            "A": "Use or disclose PHI only with the consent of the individuals involved",
            "B": "Use or disclose PHI as desired",
            "C": "Use or disclose PHI only as permitted or required by the Agreement or as Required by Law",
            "D": "Use or disclose PHI without any safeguards"
        },
        "correct_answer": "C",
        "explanation": "The Business Associate is required to not use or disclose PHI other than as permitted or required by the Agreement or as Required by Law, reflecting compliance with legal regulations.",
        "source": "unknown",
        "client": "Blue Cross and Blue Shield of Nebraska",
        "document_type": "unknown",
        "context": "The purpose of this Agreement is to set forth the terms and \nconditions deemed necessary by the parties hereto to en sure \ncompliance with the requirements applicable to Business Associate's \nhandling of Protected Health Information (\"PHI\") under the Security \nRegulations (45 CFR Part 160 and 164, Part C, hereinafter Security \nStandards) and Implementation Specifications (45  CFR part 160 and \n164, subpart C, hereinafter the Security Rule); and the Standards for \nPrivacy  of Individually Identifiable Health Information  (45 CFR part 160 \nand 164 subparts A and E , here inafter the \"Privacy Rule\") prom ulgated \nunder HIPAA and the requ irements of the Health Information Technology \nfor Economic and Clinical Health Act, as incorporated in the American \nRecovery and Reinvestment Act of 2009 (the \u201cHITECH Act\u201d), that are \napplicable to business associates, along with any guidance and/or \nregulat ions issu ed by DHHS. Capitalized terms set forth in this  \nAgreement  shall have that meaning set forth in HIPAA , the Privacy Rule , \nthe Security Rule and/or in the HITECH Act . The HIPAA Breach \nNotification Rule is the Notification in the Case of Breach of Un secured \nProtected Health Information, as set forth at 45 CFR Part 164 Subpart D. \nIn the event of any inconsistency between this Agreement and the \nPrivacy  or Security Rules, the requirements set forth in the Rule shall \ncontrol. 2. Business Associate agr ees to not use or disclose PHI other \nthan as permitted or required by this Agreement or as Required by Law. 3. Business Associate agrees to use appropriate safeguards to \nprevent use or disclosure of the PHI other than as provided for by this \nAgreement .",
        "id": "qa_147"
    },
    {
        "question": "Which type of visits were added to the advanced illness exclusion according to the legal document?",
        "options": {
            "A": "Telephone visits only",
            "B": "In-person visits only",
            "C": "Telephone visits, e-visits, and virtual check-ins",
            "D": "E-visits and virtual check-ins only"
        },
        "correct_answer": "C",
        "explanation": "The document specifies that telephone visits, e-visits, and virtual check-ins were added to the advanced illness exclusion.",
        "source": "unknown",
        "client": "Martin's Point Health Care",
        "document_type": "unknown",
        "context": "\u2022 Deleted redundant value sets from \nthe Telehealth section  \nOMW  Osteoporosis Management in Women Who \nHad a Fracture  \u2022 Added telephone visits, e -visits and \nvirtual check -ins to the advanced \nillness exclusion. PBH  Persistence of Beta -Blocker Treatment After a \nHeart Attack  \u2022 Added telephone visits, e -visits and \nvirtual check -ins to the advanced \nillness exclusion. PCR  Plan All -Cause Readmissions  \u2022 Added telephone visits to Risk \nAdjustment Comorbidi ty Category \nDetermination in step 1  \nPDS -E Postpartum Depression Screening and Follow -\nup \u2022 Added online assessments to \nNumerator 2 (added online \nassessment codes to the Follow Up \nVisits Value Set). DocuSign Envelope ID: 931D3F57-B345-43BF-A0F3-75C51EFC4B69\n \n\u00a9 20 20 Cotiviti , Inc. CONFIDENTIAL AND PROPRIETARY  6 \nPND -E Prenatal Depression Screening and Follow -up \u2022 Added online assessments to \nNumerator 2 (added online \nassessment codes to the Follow Up \nVisits Value Set). PPC  Prenatal and Postpartum Care  \u2022 Added telephone visits (Telephone \nVisits Value Set) e -visits and virtual \ncheck -ins (Online Assessments Value \nSet) t o the Timeliness of Prenatal Care \nrate (administrative specification) and \nclarified in the Notes that services \nprovided via telephone, e -visit or \nvirtual check -in are eligible for use in \nreporting both rates. SAA  Adherence to Antipsychotic Medications fo r \nIndividuals with Schizophrenia  \u2022 Added telephone visits, e -visits and \nvirtual check -ins to step 1 of the \nevent/diagnosis. \u2022 Added telephone visits, e -visits and \nvirtual check -ins to the advanced \nillness exclusion. SMC  Cardiovascular Monitoring for People with \nCardiovascular Disease and Schizophrenia  \u2022 Added telephone visits, e -visits and \nvirtual check -ins to step 1 of the \nevent/diagnosis.",
        "id": "qa_148"
    },
    {
        "question": "What measure must the Vendor implement to prevent Customer Information leakage when dealing with email and messaging systems?",
        "options": {
            "A": "Encrypt all email communications",
            "B": "Use only technical security controls",
            "C": "Employ a combination of policy, awareness, procedural, and technical security controls",
            "D": "Block all outbound emails"
        },
        "correct_answer": "C",
        "explanation": "The document specifies that the Vendor must protect email and messaging systems by using a combination of policy, awareness, procedural, and technical security controls to prevent Customer Information leakage.",
        "source": "s3://ml-legal-restricted/contract-docs/70684/Lorica Health - Services Agreement (final) 11.2020 (1).pdf",
        "client": "AIA Health Insurance Pty Ltd",
        "document_type": "MSA",
        "context": "utilising encrypt ed protocols or VPN tunnels) \nfor system, network and security administration activities to m itigate the risk from unauthorised \ninterception and eavesdropping threats. 4.7 Vendor shall, for purp oses inclu ding preventing C ustomer Inform ation leakage,:- \na. protect email and messaging systems by a combination of poli cy, awareness, procedural \nand technical security controls; \nb. screen and restrict outbound email containing unencrypted Cu stomer Information where \nsuch information comprises hospital, medical or HCP data (and h ave suitable policies in \nplace to restrict outbound email  containing other Customer Info rmation);  \nc. in relation to systems on which Customer Information compris ing hospital, medical or HCP \ndata is processed and stored, rest rict and monitor the sharing of that data fr om the system \nto: \n(i) external websites that provide web-based email, social \nnetworking and online storage facilities; \n(ii) online meeting and collaboration services. d. have suitable policie s in place regarding: \nDocuSign Envelope ID: 91DF90F9-CA35-4758-BD71-ADE44095F63F\n \n \n#224395v1 (i) access by employees and contractors during the performance \nof work duties to external websites that provide web-based \nemail, social networking and online storage facilities; and  \n(ii) use by employees and contractors during the performance of  \nwork duties of online meeting and collaboration services. 5. Cryptography \n5.1 Where a cryptographic mechanism such as encryption or hashing i s used by Vendor, Vendor \nshall use current and publicly proven cryptographic algorithms,  protocols and key lengths with \na long term protection outlook.",
        "id": "qa_149"
    },
    {
        "question": "What change was made to the use of virtual check-ins in the context of diagnosing advanced illnesses according to the document?",
        "options": {
            "A": "Virtual check-ins were completely removed as a tool for diagnosis.",
            "B": "Virtual check-ins are now mandatory for all diagnoses.",
            "C": "Virtual check-ins were added to the advanced illness exclusion.",
            "D": "Virtual check-ins can only be used for in-person visits."
        },
        "correct_answer": "C",
        "explanation": "The document states that telephone visits, e-visits, and virtual check-ins were added to the advanced illness exclusion, indicating a greater flexibility in using these methods for diagnosis.",
        "source": "unknown",
        "client": "Martin's Point Health Care",
        "document_type": "unknown",
        "context": "APP  Use of First -Line Psychosocial Care for \nChildren and A dolescents on Antipsychotics  \u2022 Added telephone visits and e -visits or \nvirtual check -ins to the \nevent/diagnosis (step 4 required \nexclusions). ART  Disease -Modifying Anti -Rheumatic Drug \nTherapy for Rheumatoid Arthritis -Scheduled \nfor Retirement  \u2022 Removed the rest riction that only one \nof the two visits with a rheumatoid \narthritis diagnosis be an outpatient \ntelehealth, telephone visit, e -visit or \nvirtual check -in when identifying the \nevent/diagnosis. \u2022 Added telephone visits, e -visits and \nvirtual check -ins to the adv anced \nillness exclusion. DocuSign Envelope ID: 931D3F57-B345-43BF-A0F3-75C51EFC4B69\n \n\u00a9 20 20 Cotiviti , Inc. CONFIDENTIAL AND PROPRIETARY  4 \nBCS, BSC -E Breast Cancer Screening  \u2022 Added telephone visits, e -visits and \nvirtual check -ins to the advanced \nillness exclusion. CBP  Controlling for High Blood Pressure  \u2022 Removed the restriction that only one \nof the two visits with a hypertension \ndiagnosis be an outpatient telehealth, \ntelephone visit, e -visit or virtual \ncheck -in when identifying the \nevent/diagnosis. \u2022 Added telephone visits, e -visits and \nvirtual check -ins to  the advanced \nillness exclusion. \u2022 In the Administrative Specification, \nadded telephone visits, e -visits and \nvirtual check -ins as appropriate \nsettings for BP readings. CDC  Comprehensive Diabetes Care  \u2022 Removed the restriction that only one \nof the two visits with a diabetes \ndiagnosis be an outpatient telehealth, \ntelephone visit, e -visit or virtual \ncheck -in when identifying the \nevent/diagnosis. \u2022 Added telephone visits, e -visits and \nvirtual check -ins to the advanced \nillness exclusion. \u2022 Added telephone visits, e -visits and \nvirtual check -ins to the \nAdministrative Specification as \nappropriate settings for BP readings.",
        "id": "qa_150"
    },
    {
        "question": "What is the definition of \"Latent Data\" according to the legal document?",
        "options": {
            "A": "Data stored in easily accessible formats for routine use",
            "B": "Data that is routinely shared between parties in discussions",
            "C": "Data stored on routine backup media, considered inaccessible without specialized tools",
            "D": "Data that can be retrieved by anyone using standard tools"
        },
        "correct_answer": "C",
        "explanation": "Latent Data refers to data stored on routine backup media that is generally considered inaccessible without the use of specialized tools and techniques, typically retrievable only by computer forensics experts.",
        "source": "unknown",
        "client": "The Standard",
        "document_type": "unknown",
        "context": "\u201cLatent Data\u201d refers to data that is stored by a party on \nroutine back -up media, including but not limited to deleted files and other non -logical data \ntypes, memory dumps, swap files, temporary files, printer spool files and metadata that can \ncustomarily be retrieved only by computer forensics experts and is generally considered \ninaccessible without the use of specialized tools and techniques. 5. Non-disclosure of Other Information . Except for the occurrence of an event that would \npermit disclosure of Confidential Information under Section 2, neither party shall disclose the \nfact that the parties are engaged in discussions related to the Purpose, the fact that on e \nparty\u2019s Confidential information has been made available to the other party, and the terms of \nany proposal, offer or indication of interest by either party. Notwithstanding the foregoing,  \neither party shall not use the name or trade names of the other  party or its affiliates in \npublicity releases or advertising, including customer lists, or for other promotional purposes, \nwithout first securing such part y\u2019s written approval. 6. No License or Representation . This Agreement does not require either party to  disclose \nany Confidential Information. All Confidential Information shall remain the sole property of \nthe Owner. By entering into this Agreement or by providing the Recipient with its \nConfidential Information, the Owner grants no license, either express o r implied, to the \nRecipient in any trademark, patent, copyright, or any other intellectual property right in the \nConfidential Information. All Confidential Information is disclosed by Owner AS IS, and by \ndisclosing the Confidential Information, the Owner m akes no representation, warranty or \nassurance with respect to the Confidential Information\u2019s completeness, accuracy, or non -\ninfringement of any trademarks, patents, copyrights, trade secrets or any other intellectual \nproperty rights or other rights of thir d parties.",
        "id": "qa_151"
    },
    {
        "question": "What type of relationship is explicitly not intended by the NDA between ATRIO Health Plans and Cotiviti, Inc.?",
        "options": {
            "A": "All of the above",
            "B": "Joint venture",
            "C": "Formal business organization",
            "D": "Partnership"
        },
        "correct_answer": "A",
        "explanation": "The NDA specifically states that it is not intended to be a joint venture, partnership, or other formal business organization, indicating that all these types of relationships are not intended.",
        "source": "s3://ml-legal-restricted/contract-docs/68895/Atrio - Cotiviti - NDA - AR - 07192022 - Dynamics_68895.pdf",
        "client": "ATRIO Health Plans",
        "document_type": "NDA",
        "context": "Neither Party shall be bound by the actions of the other, shall be liable for \nthe debts of the other, or shall have a  right to share in the profits of the other. This Agreement is not intended to be a \nDocuSign Envelope ID: 97A67F5D-7AEA-4DA0-8A31-39BDF4A1B710\n \n\u00a9 2018 Cotiviti , Inc. CONFIDENTIAL AND PROPRIETARY  3 \njoint venture, partnership or other formal business organization, and neither Party is under any obligation to enter into \nany further agreement with the other Party. 11. Mutual  Representations. Each Party represents that it has the right to disclose its Confidential Information \nin furtherance of the purpose set forth above without violating any agreement with or right of any other person. Confidential Information may include inf ormation of a third party provided that the third party has authorized such \ndisclosure. 12. No Further Obligation  or Limitation . This Agreement shall not be construed in any manner to be an \nobligation to enter into a subcontract or contract or to result in any  claim whatsoever by one Party against the other for \nreimbursement of cost for any efforts expended. Except as specifically set forth herein, this Agreement does not: (i) \nrestrict either Party from developing new products, improving existing products, or m arketing any new, improved or \nexisting products; or (ii) commit either Party to disclose any particular information, or to develop, make, use, buy, sell, \nor otherwise dispose of any existing or future products, or to favor or recommend any product or servi ce of the other. To be binding, any such restriction or commitment must be in writing and signed by both parties . 13. Notices.",
        "id": "qa_152"
    },
    {
        "question": "What is the definition of \"Latent Data\" according to the legal document?",
        "options": {
            "A": "Data that is readily accessible and can be easily retrieved without specialized tools.",
            "B": "Data stored on routine backup media that can only be retrieved by computer forensics experts.",
            "C": "Data that is publicly available and does not require permission to disclose.",
            "D": "Data that is intentionally hidden and cannot be retrieved by any means."
        },
        "correct_answer": "B",
        "explanation": "Latent Data refers to data stored on routine backup media, including deleted files and other non-logical data types, which can only be retrieved by computer forensics experts using specialized tools and techniques.",
        "source": "unknown",
        "client": "The Standard",
        "document_type": "unknown",
        "context": "\u201cLatent Data\u201d refers to data that is stored by a party on \nroutine back -up media, including but not limited to deleted files and other non -logical data \ntypes, memory dumps, swap files, temporary files, printer spool files and metadata that can \ncustomarily be retrieved only by computer forensics experts and is generally considered \ninaccessible without the use of specialized tools and techniques. 5. Non-disclosure of Other Information . Except for the occurrence of an event that would \npermit disclosure of Confidential Information under Section 2, neither party shall disclose the \nfact that the parties are engaged in discussions related to the Purpose, the fact that on e \nparty\u2019s Confidential information has been made available to the other party, and the terms of \nany proposal, offer or indication of interest by either party. Notwithstanding the foregoing,  \neither party shall not use the name or trade names of the other  party or its affiliates in \npublicity releases or advertising, including customer lists, or for other promotional purposes, \nwithout first securing such part y\u2019s written approval. 6. No License or Representation . This Agreement does not require either party to  disclose \nany Confidential Information. All Confidential Information shall remain the sole property of \nthe Owner. By entering into this Agreement or by providing the Recipient with its \nConfidential Information, the Owner grants no license, either express o r implied, to the \nRecipient in any trademark, patent, copyright, or any other intellectual property right in the \nConfidential Information. All Confidential Information is disclosed by Owner AS IS, and by \ndisclosing the Confidential Information, the Owner m akes no representation, warranty or \nassurance with respect to the Confidential Information\u2019s completeness, accuracy, or non -\ninfringement of any trademarks, patents, copyrights, trade secrets or any other intellectual \nproperty rights or other rights of thir d parties.",
        "id": "qa_153"
    },
    {
        "question": "Under the agreement, what is one permitted use of Confidential Information?",
        "options": {
            "A": "To publicly disclose for marketing purposes",
            "B": "To perform services for authorized third parties under the Primary Agreement in accordance with applicable law",
            "C": "To share with competitors",
            "D": "To sell to third parties for profit"
        },
        "correct_answer": "B",
        "explanation": "The agreement allows the use or disclosure of Confidential Information to perform services for authorized third parties under the Primary Agreement in accordance with applicable law, including HIPAA.",
        "source": "unknown",
        "client": "Blue Shield of California",
        "document_type": "unknown",
        "context": "Title to the Confidential Information shal l remain solely with Discloser  to the \nextent it had title to the Co nfidential Information at th e time of the disclosure  \n2.6. Nothing in this Agreement is intended to limit any permitted uses and disclosures \nof a Party in respect of Conf idential Information that ar e consistent with the terms \nof this Agreement, includi ng, without limitation, the ri ght to use or disclose \nConfidential Information: \n2.6.1.  to perform services for authorized th ird parties under the Primary Agreement \nin accordance with applicable law, including HIPAA; \n2.6.2.  for the proper management and administ ration of a Party or to carry out the \nlegal responsibilities of such Party in  accordance with applicable Business \nAssociate Agreements; \n2.6.3.  for the purpose of de-identifying th e Personal Information in accordance \nwith applicable Business Associate Agreements. 2.7. Security Assessment Once per calendar year or in the ev ent of a security breach \nincident, BSC has the right to perform a s ecurity assessment on the Consultant (a \n\"Security Assessment \"). Upon BSC's request, Consultant shall provide \ninformation and documentation in Consulta nt\u2019s  electronic data room on the \nsecurity of its environment and of any Services to BSC under the Primary \nAgreement, so as to allow BSC to perform such a Security Assessment, and to determine the overall security of the Consu ltant and Consultant's ability to comply \nwith NIST 800-53 or HITRUS T. If BSC determines that  such initial Security \nAssessment indicates security concerns or issues which require mitigation, in BSC's \nsole but reasonable opinion, BSC shall noti fy Consultant in writing of any such \nconcerns and/or issues with a request for Consultant to provid e an action plan for \nmitigation and/or correction of such concerns and/or issues.",
        "id": "qa_154"
    },
    {
        "question": "What is the permitted use of Confidential Information according to the NDA?",
        "options": {
            "A": "For marketing purposes",
            "B": "To develop new products independently",
            "C": "For any business purpose",
            "D": "To evaluate a business relationship with the disclosing party"
        },
        "correct_answer": "D",
        "explanation": "The NDA specifies that Confidential Information can only be used to evaluate a business relationship with the disclosing party, or in pursuance of such a relationship, and not for other purposes.",
        "source": "s3://ml-legal-restricted/contract-docs/67562/Advise Insurance - Cotiviti - NDA - SK - 03042022 - Dynamics_67562.pdf",
        "client": "Advise Insurance",
        "document_type": "NDA",
        "context": "Any copies which ar e made will \nbe identified as belonging to the disclosing party and shall \nbe reproduced with the disclosing party\u2019s proprietary rights \nnotices in the same manner in which such notices appear in \nthe original copy provided by the disclosing party. The \nreceiv ing party will not disassemble, decompile or reverse \nengineer any prototypes, software or other tangible objects \nwhich embody Confidential Information. The receiving \nparty will not use the Confidential Information for any \npurpose except to evaluate a busi ness relationship with the \ndisclosing party or otherwise in pursuance of such a \nrelationship. The receiving party will use the Confidential \nInformation solely for the purpose of assessing the \nproducts/services of the disclosing party to determine \nwhether those products/services meet the receiving party's \nneeds (\"Permitted Use\"), and for no other purpose. The \nreceiving party will not disclose Confidential Information \nto any third party without the prior written consent of the \ndisclosing party. This Agreem ent shall not be construed in any manner to be \nan obligation to enter into a subcontract or contract or to \nresult in any claim whatsoever by one Party against the \nother for reimbursement of cost for any efforts expended. Except as specifically set forth he rein, this Agreement does \nnot: (i) restrict either Party from developing new products, \nimproving existing products, or marketing any new, \nimproved or existing products; or (ii) commit either Party \nto disclose any particular information, or to develop, make , \nDocuSign Envelope ID: 7B7BFB2B-38B6-4A1A-AD79-3B4CACB0A43A\n \nPage 2 of 3 use, buy, sell, or otherwise dispose of any existing or future \nproducts, or to favor or recommend any product or service \nof the other. To be binding, any such restriction or \ncommitment must be in writing and signed by both parties. 3.",
        "id": "qa_155"
    },
    {
        "question": "What is the Vendor\u2019s recovery time objective (RTO) for software product authorization codes and Vendor\u2019s standard software technical support?",
        "options": {
            "A": "24 hours",
            "B": "48 hours",
            "C": "72 hours",
            "D": "12 hours"
        },
        "correct_answer": "A",
        "explanation": "The document specifies that the Vendor\u2019s recovery time objective for software product authorization codes and Vendor\u2019s standard software technical support is 24 hours.",
        "source": "s3://ml-legal-restricted/contract-docs/70684/Lorica Health - Services Agreement (final) 11.2020 (1).pdf",
        "client": "AIA Health Insurance Pty Ltd",
        "document_type": "MSA",
        "context": "For purposes of this section, the term \u201cDisaster\u201d shall mean an y unplanned event that, in \nVendor\u2019s reasonable judgment, is anticipated to significantly d isrupt Vendor\u2019s operations \nand its performance of the servic es under this Agreement; and  \nb. allow Customer to inspect such BCDR Plan (excluding any conf idential aspects) on its \nreasonable request. 11.2 In the event of a Disaster, Vendor will use commercially reason able endeavours in accordance \nwith these plans to recover resources necessary for Vendor\u2019s co ntinued performance of the \nservices under this Agreement. Vendor will notify Customer in the event of a Disaster and, \nupon Customer\u2019s request, Vendor will advise Customer of the sta tus of recovery. 11.3 Vendor will regularly test such BCDR Plan in relation to the se rvices and all facilities used by \nVendor, and at a minimum undertake a full implementation walkth rough of such plans as a \npaper exercise on the basis of a hypothetical major incident. V endor will provide Customer \nDocuSign Envelope ID: 91DF90F9-CA35-4758-BD71-ADE44095F63F\n \n \n#224395v1 with a writing signed by an authorized representative indicatin g that the testing is complete \nwith no material problems, or the testing surfaced a material p roblem and if so a summary of \nthe problem and the plan to rem ediate it. Vendor shall provide Customer with an executive \nsummary of such test results, whe re requested by Customer. 11.4 Vendor\u2019s recovery time objective (\u201cRTO\u201d) for Vendor\u2019s critical business functions is: \na. 24 hours for software product authorization codes and Vendor \u2019s standard software \ntechnical support; and  \nb. 72 hours for other critical business functions.]",
        "id": "qa_156"
    },
    {
        "question": "What rights do individuals have concerning their protected health information under the BAA?",
        "options": {
            "A": "The right to obtain a copy of their information in an electronic format",
            "B": "The right to delete their information permanently",
            "C": "The right to financial compensation for their information",
            "D": "The right to prevent any disclosure of their information"
        },
        "correct_answer": "A",
        "explanation": "The BAA provides individuals the right to obtain a copy of their information in an electronic format, among other rights.",
        "source": "unknown",
        "client": "Crumdale Partners - Better Benefits",
        "document_type": "unknown",
        "context": "The BAA will govern and supersede the terms of this Agreement with respect to any protected \nhealth information disclosed hereunder, and will include, but will not be limited to, the following provisions: \na. Individuals' rights to obtain a copy of the individual's information in an electronic format;  \nb. Individuals' rights to have the individual's information transmitted to another entity or person \ndesignated by the individual, provided the request is clear, conspicuous, and specific;  \nc. The right to audit and monitor activities that involve protected health information; and \nd. The process for notification and reporting of unauthorized disclosure or protected health information \nbreaches. 7. Term. This Agreement may be terminated with respect to subsequent disclosures upon thirty (30) days' prior \nwritten notice to the other Party. This Agreement shall automatically terminate two (2) years after its Effective Date. The rights and obligations accruing prior to termination as set forth herein shall survive the termination of this \nAgreement for a period of five (5) years provided, however, that Receiving Party\u2019s obligations respecting Disclosing \nParty\u2019s \u201ctrade secrets\u201d (as such term is defined in 18 U.S.C. 1839) shall continue for so long as such information qualifies \nas a trade secret. 8. Compensation. The Receiving Party shall not be obligated to compensate the Disclosing Party for \nConfidential Information (except as may result from a breach of this Agreement) and the Receiving Party acknowledges \nand understands that no warranties of any kind are given by the Disclosing Party with respect to the accuracy or \ncompleteness of the Confidential Information. 9. Ownership. Confidential Information shall remain the sole and exclusive property of the Disclosing Party. Nothing in this Agreement shall be construed as granting to the Receiving Party any right, title or interest in or to any \npatent, trademark, license, copyright or other right of the Disclosing Party. 10. Relationship of the parties.",
        "id": "qa_157"
    },
    {
        "question": "What should the Receiving Party do when required by law to disclose Confidential Information?",
        "options": {
            "A": "Ignore the subpoena or order and maintain confidentiality at all costs.",
            "B": "Disclose the information immediately without notifying the Disclosing Party.",
            "C": "Notify the Disclosing Party and seek protective orders or relief.",
            "D": "Disclose the information without seeking the highest level of confidentiality."
        },
        "correct_answer": "C",
        "explanation": "The document specifies that the Receiving Party should notify the Disclosing Party, cooperate in seeking protective orders, request the highest level of confidentiality, and maintain confidentiality as much as possible.",
        "source": "unknown",
        "client": "Albertsons Companies, Inc.",
        "document_type": "unknown",
        "context": "Neither \nDocuSign Envelope ID: 8C793239-188D-4F97-84B8-3A353BD94257\n2/24/2022 | 13:21 EST\n10897 S River Front Pkwy, South Jordan, UT Cotiviti, Inc.\n \n3 | P a g e     V020520  \n party shall ex port, reverse engineer, disassemble or decompile any prototypes, software or other tangible \nobjects that embody the other party\u2019s Confidential Information. 5. Disclosure Required by Law . In the event any Confidential Information is required to be disclosed \nby the Receiving Party under the terms of a valid and effective subpoena or order issued by a court of \ncompetent jurisdiction, or by a demand or information request from an executive or administrative agency \nor other governmental authority, the Receiving P arty shall, unless prohibited by the terms of a subpoena, \norder or demand : (i) notify the Disclosing Party of the prospective disclosure as soon as practicable; (ii) \ncooperate with the Disclosing Party, as appropriate  and at the Disclosing Party\u2019s expense , in seeking such \nprotective orders or relief from such disclosure as may be available; (iii) request the highest level of \nconfidentiality available for such information under the terms of the production order and any applicable \nprotective order; and (iv) m aintain the confidentiality of such Confidential Information in accordance with \nthe terms hereof to the fullest extent practicable under the circumstances. Disclosure in accordance with \nthis paragraph shall not, by itself, vitiate the status of such infor mation as Confidential Information. 6. Maintenance of Confidentiality . The Receiving Party agrees that it shall take commercially \nreasonable measures to protect the secrecy of , and to prevent unauthorized disclosure and/or use of , the \nConfidential Information of the Disclosing Party.",
        "id": "qa_158"
    },
    {
        "question": "Under the agreement between Blue Shield of California and the Consultant, what are permissible uses of Confidential Information?",
        "options": {
            "A": "Only for internal management purposes",
            "B": "For commercial purposes unrelated to the Primary Agreement",
            "C": "For de-identifying Personal Information in accordance with Business Associate Agreements",
            "D": "For disclosure to unauthorized third parties"
        },
        "correct_answer": "C",
        "explanation": "The agreement allows for the use of Confidential Information to de-identify Personal Information in accordance with applicable Business Associate Agreements, as stated in section 2.6.3.",
        "source": "unknown",
        "client": "Blue Shield of California",
        "document_type": "unknown",
        "context": "Title to the Confidential Information shal l remain solely with Discloser  to the \nextent it had title to the Co nfidential Information at th e time of the disclosure  \n2.6. Nothing in this Agreement is intended to limit any permitted uses and disclosures \nof a Party in respect of Conf idential Information that ar e consistent with the terms \nof this Agreement, includi ng, without limitation, the ri ght to use or disclose \nConfidential Information: \n2.6.1.  to perform services for authorized th ird parties under the Primary Agreement \nin accordance with applicable law, including HIPAA; \n2.6.2.  for the proper management and administ ration of a Party or to carry out the \nlegal responsibilities of such Party in  accordance with applicable Business \nAssociate Agreements; \n2.6.3.  for the purpose of de-identifying th e Personal Information in accordance \nwith applicable Business Associate Agreements. 2.7. Security Assessment Once per calendar year or in the ev ent of a security breach \nincident, BSC has the right to perform a s ecurity assessment on the Consultant (a \n\"Security Assessment \"). Upon BSC's request, Consultant shall provide \ninformation and documentation in Consulta nt\u2019s  electronic data room on the \nsecurity of its environment and of any Services to BSC under the Primary \nAgreement, so as to allow BSC to perform such a Security Assessment, and to determine the overall security of the Consu ltant and Consultant's ability to comply \nwith NIST 800-53 or HITRUS T. If BSC determines that  such initial Security \nAssessment indicates security concerns or issues which require mitigation, in BSC's \nsole but reasonable opinion, BSC shall noti fy Consultant in writing of any such \nconcerns and/or issues with a request for Consultant to provid e an action plan for \nmitigation and/or correction of such concerns and/or issues.",
        "id": "qa_159"
    },
    {
        "question": "What is the duration for which the rights and obligations that accrue prior to the termination of the NDA survive?",
        "options": {
            "A": "Indefinitely",
            "B": "5 years",
            "C": "1 year",
            "D": "2 years"
        },
        "correct_answer": "B",
        "explanation": "The NDA specifies that the rights and obligations accruing prior to termination survive for a period of five years after termination.",
        "source": "s3://ml-legal-restricted/contract-docs/68895/Atrio - Cotiviti - NDA - AR - 07192022 - Dynamics_68895.pdf",
        "client": "ATRIO Health Plans",
        "document_type": "NDA",
        "context": "Individuals' rights to have the individual's information transmitted to another entity or person \ndesignated by the individual, provided the request is clear, conspicuous, and specific;  \nc. The right to audit and monitor activities that involve protected health information; and \nd. The process for notification and reporting of unauthorized disclosure or protected health information \nbreaches. 7. Term. This Agree ment  may  be terminated with respect to subsequent disclosures upon thirty (30) days' prior \nwritten notice to the other Party. This Agreement shall automatically terminate two (2) years after its Effective Date. The rights and obligations accruing prior to termination as set forth herein shall survive the termination of this \nAgreement for a period of five (5) years provided, however, that Receiving Party\u2019s obligations respecting Disclosing \nParty\u2019s \u201ctrade secrets\u201d (as such term is defined in 18 U.S.C. 1839) s hall continue for so long as such information qualifies \nas a trade secret. 8. Compensation. The Receiving Party shall not be obligated to compensate the Disclosing Party for \nConfidential Information (except as may result from a breach of this Agreement) and t he Receiving Party acknowledges \nand understands that no warranties of any kind are given by the Disclosing Party with respect to the accuracy or \ncompleteness of the Confidential Information. 9. Ownership. Confidential Information shall remain the sole and exc lusive property of the Disclosing Party. Nothing in this Agreement shall be construed as granting to the Receiving Party any right, title or interest in or to any \npatent, trademark, license, copyright or other right of the Disclosing Party. 10. Relationship of  the parties . Nothing in this Agreement shall be deemed to create, either express or implied, \nthe power in either Party to bind the other.",
        "id": "qa_160"
    },
    {
        "question": "What is the data sharing requirement for Licensee under the Agreement?",
        "options": {
            "A": "Licensee is not required to provide any data.",
            "B": "Licensee must provide claims and enrollment data monthly.",
            "C": "Licensee must provide claims and enrollment data semi-annually.",
            "D": "Licensee must provide claims and enrollment data annually."
        },
        "correct_answer": "C",
        "explanation": "The Agreement requires Licensee to provide claims and enrollment data on at least a semi-annual basis, in accordance with HIPAA requirements.",
        "source": "unknown",
        "client": "Capital Health Plan, Inc.",
        "document_type": "unknown",
        "context": "Licensee shall allow\nLicensor to enter its premises in order to inspect the Licensed Program in any reasonable manner\n(c.g., with 48 hours notice) during Licensee\u2019s regular business hours to verify Licensee\u2019s\ncompliance with the terms of this Agreement. Licensee shall provide Licensor with complete records at the same time the Annual Fee is paid or\npayable pursuant to Section 3 of this Agreement which substantiate the number of Unique Individuals\nas to which the Licensed Program is being applied. Licensee acknowledges that Licensor collects from its customers annual extracts of de-identified\nmedical and pharmaceutical claims data and enrollment data to update and refine the Licensed\nProgram, develop normative databases and for general product development. Licensee agrees to . provide its claims and enrollment data to Licensor on at least a semi-annual basis pursuant to and in\naccordance with HIPAA requirements. The.claims and enrollment data will be provided in the format\nprovided in Exhibit E.\n\n11. INJUNCTIVE RELIEF. Each party acknowledges that, in the event of its breach of the\nprovisions of Section 8 regarding proprietary protection, or upon any other breach of this\nVerisk Health, Inc.\nLicense Agreement with Capital Health Plan\nPage 6 of 30\nVersion 1-23-09\n\f\n \n\n12. A)\n\nB)\n\nC)\n\nD)\n\nAgreement which would be appropriately remedied through injunctive relief, that the other party\nwill not have an adequate remedy in money or damages. Such other party shall therefore be\nentitled to obtain an injunction against such breach from any court of law of competent\njurisdiction and the breaching party hereby consents to the imposition and reasonableness of such\ninjunction. Licensor\u2019s right to seek injunctive relief shal! not limit its right to seek further\nremedies. LIMITED WARRANTY AND LIMITATION OF LIABILITY. Substantial Conformity Warranty.",
        "id": "qa_161"
    },
    {
        "question": "What must the Receiving Party do with Confidential Information upon termination of the NDA with AdvantMed?",
        "options": {
            "A": "Retain all copies of Confidential Information indefinitely.",
            "B": "Deliver all documents and materials to a third party for safekeeping.",
            "C": "Destroy or deliver all documents and materials, retaining a single archival copy for dispute resolution purposes.",
            "D": "Destroy all copies, including the archival copy."
        },
        "correct_answer": "C",
        "explanation": "The NDA specifies that the Receiving Party must destroy or deliver all documents containing Confidential Information upon termination, but may retain a single archival copy for dispute resolution purposes.",
        "source": "s3://ml-legal-restricted/contract-docs/74554/AdvantMed - Cotiviti - NDA - SK - 05102024 - Dynamics_74554.pdf",
        "client": "AdvantMed",
        "document_type": "NDA",
        "context": "Subject to Section 3, \u201cExceptions,\u201d above, promptly following the \nearlier of (i) the termination of this Agreement, or (ii) the written request of Disclosing Party , the Receiving \nParty  shall destr oy or deliver to Disclosing Party  all documents or other materials furnished by Disclosing \nParty  to the Receiving Party  constituting or containing Confidential Information, together with all copies \nthereof, including all electronic and digital copies in th e possession of the Receiving Party  except a single \narchival copy that may be retained by the Receiving Party 's legal department for dispute resolution purposes \nonly. Upon receipt of such a request, the Receiving Party  shall destroy all other documents and  materials \nconstituting Confidential Information in its possession to the extent reasonably practicable. Upon request, the \nReceiving Party  shall certify such destruction in writing to the Disclosing Party . 6. Term. This Agreement may be terminated with respect to subsequent disclosures upon thirty (30) days' prior \nwritten notice to the other Party . This Agreement shall automatically terminate two (2) years after its Effective \nDate. The rights and obligations accruin g prior to termination as set forth herein shall survive the termination \nof this Agreement for a period of five (5) years provided, however, that Receiving Party\u2019s obligations \nrespecting Disclosing Party\u2019s \u201ctrade secrets\u201d (as such term is defined in 18 U.S .C. 1839) shall continue for so \nlong as such information qualifies as a trade secret. 7. Compensation. The Receiving Party  shall not be obligated to compensate the Disclosing Party  for \nConfidential Information (except as may result from a breach of this Agreement) and the Receiving Party  \nacknowledges and understands that no warranties of any kind are given by the Disclosing Party  with respect \nto the accuracy or completeness of the C onfidential Information. 8. Ownership. Confidential Information shall remain the sole and exclusive property of the Disclosing Party .",
        "id": "qa_162"
    },
    {
        "question": "According to the legal document, how is \"Personal Data\" defined in relation to B2B Information?",
        "options": {
            "A": "Personal Data includes only publicly available information.",
            "B": "Personal Data excludes all B2B Information under all circumstances.",
            "C": "Personal Data includes B2B Information unless excluded by applicable Data Protection Laws.",
            "D": "Personal Data includes only consumer-related information."
        },
        "correct_answer": "C",
        "explanation": "The document specifies that Personal Data includes B2B Information unless applicable Data Protection laws exclude it from the definition.",
        "source": "unknown",
        "client": "Albertsons Companies, Inc.",
        "document_type": "unknown",
        "context": "For this DPA, Personal Data includes business contact information (\u201cB2B Information\u201d) consisting of a work or corporate email, address, phone number, unique identifier, that is regulated as \u201cpersonal data,\u201d \u201cpersonally identifiable information,\u201d or \u201cpersonal information,\u201d under Data Protection Laws and the Standards, regardless of the medium in which such information is displayed, unless applicable Data Protection laws otherwise exclude B2B Information from the definition of Personal Data or Personal Information (as such term is defined by the applicable Data Protection Laws. 1.3 \u201cProcess\u201d or \u201cProcessing\u201d means any manual or automated operation or set of operations performed on Personal Data or sets of Personal Data. Operations include collecting, recording, organizing, storing, adapting, altering, retrieving, consulting, using, disclosing by transmission, disseminating, combining, blocking, erasing, or destroying. 1.4 \u201cSell\u201d means selling, renting, releasing, disclosing, disseminating, making available, transferring, or otherwise communicating orally, in writing, or by electronic or other means, information by the business to another business or a third party for monetary or other valuable consideration. \u0010\u001b\u0015\u001d\u0014\u0018\u0017\u001a\u0001\u0011\u001a\u001e\u0016\u0019\u001b\u001c\u0016\u0001\u0013\u0010\r\u0001\u0004\u000f\u0004\u0003\u000e\u0005\t\u0007\u0002\u0007\u0012\u0004\f\u0002\u0007\u0003\u000f\u0003\u0002\f\u0003\u0004\u0003\u0002\f\n\f\u0003\u0006\u000b\u000e\u0005\u0005\b\u0012\u000e\u000e\u0018\u0012\u001a\u0011\u0015\u0014\u0017\u0001\u000f\u0017\u001b\u0013\u0016\u0018\u0019\u0013\u0001\u0010\u000e\u000b\u0001\r\u0003\u0007\u0007\u0004\u000e\n\u000f\u0002\u0007\r\b\u000e\u0002\u0007\u000f\u0006\t\u0002\f\u000f\f\u0007\u0002\r\r\t\b\t\u0003\u0005\u0003\u000f\r\b\u000e\nPage 22 of 24 1.5 \u201cShare\u201d means sharing, renting, releasing, disclosing, disseminating, making available, transferring, or otherwise communicating orally, in writing, or by electronic or other means, information by the business to a third party for cross-context behavioral advertising, whether or not for monetary or other valuable consideration, including transactions between a business and a third party for cross-context behavioral advertising for the benefit of a business in which no money is exchanged.",
        "id": "qa_163"
    },
    {
        "question": "Under what circumstances does this NDA become inoperative regarding Confidential Information?",
        "options": {
            "A": "When the information is independently developed by personnel who have had access to the Disclosing Party\u2019s Confidential Information.",
            "B": "When the information becomes generally available to the public through no fault of the Nondisclosing Party.",
            "C": "When the information becomes available on a non-confidential basis from a source bound by a confidentiality agreement.",
            "D": "When the information is disclosed by the Nondisclosing Party to the public."
        },
        "correct_answer": "B",
        "explanation": "The NDA specifies that it becomes inoperative if the information becomes generally available to the public through no fault of the Nondisclosing Party.",
        "source": "s3://ml-legal-restricted/contract-docs/73385/7-Eleven - Cotiviti  - NDA - MS -  11152023 - Dynamics_73385.pdf",
        "client": "7-Eleven",
        "document_type": "NDA",
        "context": "This Agreement shall be inoperative as to such \nportions of the Confidential Information that: (i) are or become generally available to the public, \nother than as a result of a disclosure by the Nondisclosing Party or the Nondisclosing Party\u2019s Representatives; (ii)  become available to the Nondisclosing Party on a non-confidential basis \nfrom a source other than the Disclosing Party or its Representatives, provided that such source \nis not, to the knowledge of the Nondisclosing Party, bound by a confidentiality agreement with \nthe Disclosing Party or its Representatives or is otherwise prohibited from transmitting the \nConfidential Information to the Nondisclosing Party or the Nondisclosing Party\u2019s  \nRepresentatives by a contractual, legal, or fiduciary obligation; (iii)  were known to the \nNondisclosing Party on a non-confidential basis prior to their disclosure to the Nondisclosing Party by the Disclosing Party or its Representatives; or (iv) are developed independently by the \npersonnel of the Nondisclosing Party or any of its Representatives who have not had access to \nthe Disclosing Party\u2019s Confidential Information. 5. No Offer. This Agreement is not an offer, an acceptance, or a contract to \nnegotiate or enter into the Potential Transaction or any other transaction, nor is it intended to \nrequire the Parties to proceed with or continue such negotiations, the Potential Transaction, or \nDocuSign Envelope ID: 86A93AC8-1F25-4263-BD06-DE620137B060\nConfidentiality  and \nNon-Disclosure  Agreement  \n143467808.3  4 \u00a9 2019  7-Eleven,  Inc.  any other transaction. This Agreement shall not give rise to any obligation for either Party to \ndisclose any information, including the Confidential Information, to the other Party or its \nRepresentatives.",
        "id": "qa_164"
    },
    {
        "question": "What is the fee for requesting paper copies of electronic documents after the initial 30-day period?",
        "options": {
            "A": "$1 per page",
            "B": "$5 per page",
            "C": "$0 per page",
            "D": "No fee is charged"
        },
        "correct_answer": "C",
        "explanation": "The document states that after the initial 30-day period, you will be charged a $0 per-page fee for paper copies.",
        "source": "unknown",
        "client": "Self Insured Services Co",
        "document_type": "unknown",
        "context": "Described below are the terms and conditions for providing \nto you such notices and disclosures electronically through your DocuSign, Inc. (DocuSign) \nExpress user account. Please read the information below carefully and thoroughly, and if you can \naccess this information electr onically to your satisfaction and agree to these terms and \nconditions, please confirm your agreement by clicking the agree button at the bottom of this \ndocument. Getting paper copies   \nAt any time, you may request from us a paper copy of any record provide d or made available \nelectronically to you by us. For such copies, as long as you are an authorized user of the \nDocuSign system you will have the ability to download and print any documents we send to you \nthrough your DocuSign user account for a limited per iod of time (usually 30 days) after such \ndocuments are first sent to you. After such time, if you wish for us to send you paper copies of \nany such documents from our office to you, you will be charged a $0 per -page fee. You may \nrequest delivery of such pap er copies from us by following the procedure described below. Withdrawing your consent  \nIf you decide to receive notices and disclosures from us electronically, you may at any time \nchange your mind and tell us that thereafter you want to receive required notices and disclosures \nonly in paper format. How you must inform us of your decision to receive future notices and \ndisclosure in paper format and withdraw your consent to receive notices and disclosures \nelectronically is described below. Consequences of changing your mind   \nIf you elect to receive required notices and disclosures only in paper format, it will slow the \nspeed at which we can complete certain steps in transactions with you and delivering services to \nyou because we will need first to send the required notices or disclosures to you in paper format, \nand then wait until we receive back from you your acknowledgment of your receipt of such \npaper notices or disclosures.",
        "id": "qa_165"
    },
    {
        "question": "Which of the following is NOT considered an exception to the definition of \"Confidential Information\" under the agreement?",
        "options": {
            "A": "Information that becomes publicly known through no breach of the agreement.",
            "B": "Information already known by the Receiving Party at the time of disclosure.",
            "C": "Personal information of customers and employees.",
            "D": "Information independently developed by the Receiving Party without reference to Confidential Information."
        },
        "correct_answer": "C",
        "explanation": "Personal information of customers and employees is always considered Confidential Information under this agreement, regardless of other exceptions.",
        "source": "unknown",
        "client": "Albertsons Companies, Inc.",
        "document_type": "unknown",
        "context": "The Purpose, the existence of this Agreement and any \nnegotiations and agreements entered into by the parties in connection with the Purpose shall also be \nconsid ered \u201cConfidential Information.\u201d  \n3. Exceptions . Confidential Information shall not include any information that the Receiving Party  \ncan establish : (i) was publicly known and made generally available in the public domain prior to the time of \ndisclosure by the Disclosing Party; (ii)  becomes publicly known and made generally available after \ndisclosure by the Disclosing Party to the Receiving Party throu gh no breach of this Agreement by the \nReceiving Party; (iii)  is already known by or legally in the possession of the Receiving Party , without \nconfidentiality obligation,  at the time of disclosure by the Disclosing Party; (iv)  is lawfully disclosed to the \nReceiving Party , without confidentiality obligation,  by a third party; or (v)  is independently developed by the \nReceiving Party without use of or reference to the Disclosing Party\u2019s Confidential Information ; provided that , \nnotwithstanding the foregoing exce ptions,  personal information of customers and employees of either party \nshall be deemed Confidential Information hereunder to the full extent required by applicable law, and \nprovided further that no damages shall accrue with respect to information unlawful ly provided by a third \nparty unless the Disclosing Party can demonstrate that the Receiving Party knew or should have known \nthat such disclosure was unlawful . 4. Non-use and Non -disclosure . The Receiving Party agrees: (i) to use Confidential Information \nsolely for the Purpose, and for no other purpose;  (ii) not to disclose any Confidential Information except as \nexpressly permitted by, or to enforce, this Agreement and (iii) to disclose Co nfidential Information only to \nits Representatives who need to know the Confidential Information for the Purpose and who are bound to \nkeep such Confidential Information confidential consistent with the obligations of this Agreement.",
        "id": "qa_166"
    },
    {
        "question": "Under what circumstances can the Recipient disclose Confidential Information according to the document?",
        "options": {
            "A": "When the information becomes generally known by third parties.",
            "B": "If required by law, with prior notification to the Owner.",
            "C": "When the Recipient independently develops the information.",
            "D": "Upon termination of the agreement."
        },
        "correct_answer": "B",
        "explanation": "The document specifies that the Recipient may disclose Confidential Information if required by law, provided that they promptly notify the Owner to seek a protective order or similar remedy.",
        "source": "unknown",
        "client": "The Standard",
        "document_type": "unknown",
        "context": "These obligations do not apply to information or materials that: (i) are or become \ngenerally known b y third parties other than as a result of an act or omission by the \nRecipient; (ii) were already independently known by the Recipient prior to receiving them \nfrom the Owner; (iii) are developed independently by the Recipient. Recipient may disclose \nConfide ntial Information if required by law, provided that Recipient promptly notifies the \nOwner of such requirement so that the Owner can seek to obtain a protective order or \nDocusign Envelope ID: B527775C-3F59-4071-AFAF-15FC96A5A319\n \n \n similar remedy. The Recipient shall promptly notify the Owner of any breaches of \nconfid entiality under this Agreement, to the extent Recipient has obtained knowledge of \nsuch breach. 3. Termination . Either party may terminate this Agreement with respect to future disclosure of \nConfidential Information by sending the other party 30 days prior written notice. This \nAgreement shall automatically terminate two (2) years after its Effective Date. The rights and \nobligations accruing prior to termination as set forth herein shall survive the termination of \nthis Agreement for a period of three  (3) year s.   \n4. Return of Confidential Information . Upon written request, the Recipient: (a) will exercise \ncommercially reasonable efforts either to return to the Owner all documents and materials \n(and all copies thereof), to the extent that it can legally do so, c ontaining any Confidential \nInformation of the Owner, or to destroy all such items, again to the extent that it can legally \ndo so, and (b) will certify  the same  in writing . Latent Data, which is Confidential Information \nshall be subject to destruction in du e course but shall remain Confidential Information of the \nDisclosing Party until it is destroyed.",
        "id": "qa_167"
    },
    {
        "question": "What is the procedure to withdraw consent for electronic notices and disclosures from DocuSign?",
        "options": {
            "A": "Call the customer service hotline",
            "B": "Send an email to customer support",
            "C": "Use the DocuSign \u00f4Withdraw Consent\u00f6 form on your account",
            "D": "No procedure is required, consent can be withdrawn automatically"
        },
        "correct_answer": "C",
        "explanation": "The document specifies that consent withdrawal must be done using the DocuSign \u00f4Withdraw Consent\u00f6 form on the signing page of your DocuSign account.",
        "source": "unknown",
        "client": "Self Insured Services Co",
        "document_type": "unknown",
        "context": "To indicate to us that you are changing your mind, you must \nwithdraw your consent  using the DocuSign \u00f4Withdraw Consent\u00f6 form on the signing page of \nyour DocuSign account. This will indicate to us that you have withdrawn your consent to receive \nrequired notices and disclosures electronically from us and you will no longer be able to use  your \nDocuSign Express user account to receive required notices and consents electronically from us \nor to sign electronically documents from us. All notices and disclosures will be sent to you electronically   \nUnless you tell us otherwise in accordance wit h the procedures described herein, we will provide \nelectronically to you through your DocuSign user account all required notices, disclosures, \nauthorizations, acknowledgements, and other documents that are required to be provided or made \navailable to you d uring the course of our relationship with you. To reduce the chance of you \ninadvertently not receiving any notice or disclosure, we prefer to provide all of the required \nnotices and disclosures to you by the same method and to the same address that you hav e given \nus. Thus, you can receive all the disclosures and notices electronically or in paper format through \nthe paper mail delivery system. If you do not agree with this process, please let us know as \ndescribed below. Please also see the paragraph immediat ely above that describes the \nconsequences of your electing not to receive delivery of the notices and disclosures \nelectronically from us.",
        "id": "qa_168"
    },
    {
        "question": "What is the legal requirement for handling Evaluation Material after a written request by the Disclosing Party?",
        "options": {
            "A": "Retain all copies indefinitely for archival purposes",
            "B": "Destroy all copies except a single archival copy retained by the legal department for dispute resolution",
            "C": "Make copies available to third parties for analysis before destruction",
            "D": "Return all copies to the Disclosing Party without retaining any copies"
        },
        "correct_answer": "B",
        "explanation": "The document specifies that upon a written request, the Receiving Party must destroy or return all Evaluation Material, retaining only a single archival copy in the legal department for dispute resolution purposes, which must be destroyed after four years unless subject to a legal hold or litigation.",
        "source": "unknown",
        "client": "Maryland Physicians Care (MPC)",
        "document_type": "unknown",
        "context": "As \nReceiving Party eac h of the parties agrees that neither the Disclosing Party nor its Representatives shall have any \nliability to the Receiving Party or any of its Representatives resulting from the use of the Evaluat ion Material, except \nas may be expressly provided in any subsequent written agreement between the parties. 6. All Evaluation Material shall remain the property of its Disclosing Party and the Receiving Party \nshall upon written request promptly destroy or redeliver to the Disclosing Party all Evaluation Material a nd will not \nretain any copies or other reproductions, in whole or in part, of such Evaluation Material  except a single archival \ncopy that may be retained by the Receiving Party's legal department f or dispute resolution purposes only . Such \narchival copy will be destroyed after four (4) years unless subject to legal hold or the Parties are in litigation . Receiving Party  shall continue to be bound by the terms and conditions of this Agreement with resp ect to such \nretained Confidential Information. Upon receipt of such a request, the Receiving Party shall destroy all other \ndocuments and materials constituting Confidential Information in its possession to the extent reasonably practicable. Upon request, t he Receiving Party shall certify such destruction in writing to the Disclosing Party . Latent Data, which is Confidential Information shall be subject to de struction in due course but shall \nremain Confidential Information of the Disclosing Party until it i s destroyed. \u201cLatent Data\u201d refers to data that is \nstored by a party on routine back -up media, including but not limited to deleted files and other non -logical data \ntypes, memory dumps, swap files, temporary files, printer spool files and metadata that can customarily be retrieved \nonly by computer forensics experts and is generally considered inaccessible without the use of specialized tools and \ntechniques . Latent Data will be destroyed within the normal course of business pursuant to each Party\u2019s informatio n \ngovernance and destruction policies. 7.",
        "id": "qa_169"
    },
    {
        "question": "What is required of each Party upon termination of the NDA regarding Confidential Information?",
        "options": {
            "A": "Retain all Confidential Information for future reference",
            "B": "Share Confidential Information with all Affiliates",
            "C": "Disclose Confidential Information to legal authorities",
            "D": "Return all Confidential Information to the Disclosing Party and destroy any materials containing it"
        },
        "correct_answer": "D",
        "explanation": "The NDA specifies that upon termination, each Party must return all Confidential Information to the Disclosing Party and destroy any materials containing it, while legal counsel may retain one copy for archival purposes.",
        "source": "s3://ml-legal-restricted/contract-docs/73385/7-Eleven - Cotiviti  - NDA - MS -  11152023 - Dynamics_73385.pdf",
        "client": "7-Eleven",
        "document_type": "NDA",
        "context": "In such event, each Party will \nreturn all Confidential Information to the Disclosing Party and destroy all drawings, data, \nmemoranda, and other written materials, including any copies thereof, embodying, containing,  \nor relating to the Confidential  Information, in the possession of the Nondisclosing  Party  or its \nDocuSign Envelope ID: 86A93AC8-1F25-4263-BD06-DE620137B060\nConfidentiality  and \nNon-Disclosure  Agreement  \n143467808.3  3 \u00a9 2019  7-Eleven,  Inc. Representatives and certify such destruction in writing to the Disclosing Party. Notwithstanding \nthe foregoing, each Party\u2019s legal counsel may retain, for archival purposes, one copy of any \nwork product that may contain Confidential Information, and neither of the Parties nor any of its \nRepresentatives will be obligated to delete or erase any Confidential Information that is \ncontained in an archived computer system backup or other electronic backup in accordance  \nwith the Party\u2019s records retention, security, and/or disaster recovery procedures, as the case \nmay be. (d) Both Parties acknowledge and agree that neither Party nor its Affiliates or \nRepresentatives makes any representation or warranty as to the accuracy or completeness of \nConfidential Information provided under this Agreement, except as may be subsequently \nprovided in a definitive agreement between the Parties or between Vendor and one of 7-  \nEleven\u2019s Affiliates. Neither Party shall be liable to the other Party as a result of such other \nParty\u2019s use of the Disclosing Party\u2019s Confidential Information, it being understood that only  \nthose particular representations and warranties that may  be made to  the Nondisclosing Party  by \nthe Disclosing Party or its Affiliates in a definitive agreement, when, as, and if a definitive \nagreement regarding the Potential Transaction is executed, and subject to such limitations and \nrestrictions as may be specified in such definitive agreement, shall have any legal effect.",
        "id": "qa_170"
    },
    {
        "question": "Under the agreement between the Parties, what type of information is excluded from disclosure?",
        "options": {
            "A": "All types of information are included",
            "B": "Trade secrets",
            "C": "Proprietary information",
            "D": "Protected Health Information (PHI)"
        },
        "correct_answer": "D",
        "explanation": "The agreement specifically states that information disclosed shall not include PHI as defined under federal regulations, unless it has been de-identified according to regulations.",
        "source": "unknown",
        "client": "Wellth, Inc.",
        "document_type": "unknown",
        "context": "The Parties agree that \ninformation disclosed and received in the course of di scussions concerning a Potential Transaction shall \nnot include information defined as Protected Health Information (PHI) under federal regulations at 45 \nC.F.R. \u00a7 160.103, except insofar as such PHI may have been de -identified within the meaning of regulati ons \nat 45 C.F.R. \u00a7 164.514. 8. Miscellaneous . (a) No License . The disclosure of information under this Agreement shall not be \ndeemed a grant of a license, by implication or otherwise, under any of the Disclosing Party\u2019s trade secrets, \nproprietary or other inte llectual property rights. (b) Entire Agreement . This Agreement contains the sole and entire agreement \nbetween the Parties with respect to the confidentiality of the Confidential Information and the con -\nfidentiality of all matters concerning a Potential Transa ction. This Agreement may be amended, modified, \nor waived only by a separate written instrument duly signed and delivered by or on behalf of both Parties. (c) Severability . If all or part of any term or condition of this Agreement, or the \napplication of any term or condition of this Agreement, is determined by any court of competent jurisdiction \nto be invalid or unenforceable to any extent, the remainder of the terms and conditions of this Agreement \n(other than those portions determined to be invalid or unenf orceable) shall not be affected, and the \nremaining terms and conditions (or portions of terms and conditions) shall be valid and enforceable to the \nfullest extent permitted by law. If a judicial determination prevents the accomplishment of the purpose of \nthis Agreement, the invalid term or condition (or portion of terms or conditions) shall be restated to conform \nto applicable law and to reflect as nearly as possible the original intention of the Parties. (d) Attorneys\u2019 Fees .",
        "id": "qa_171"
    },
    {
        "question": "What is the minimum period for which operational, financial, and administrative records must be maintained under the agreement?",
        "options": {
            "A": "5 years following contract termination",
            "B": "Until the completion of an audit",
            "C": "As required by law or regulation",
            "D": "10 years following contract termination"
        },
        "correct_answer": "D",
        "explanation": "The document specifies that records must be maintained for a minimum of ten years following the termination of the agreement between CMS and the Client.",
        "source": "unknown",
        "client": "Martin's Point Health Care",
        "document_type": "unknown",
        "context": "Such executives shall use all reasonable efforts to confer\nin person or by telephone within forty-eight (48) hours\nafter referral of a dispute, and thereafter as they\nreasonably deem necessary, to exchange relevant\ninformation and to attempt to resolve the dispute. (b) Subject to the provisions of this paragraph 9.15, in the\nevent of any dispute under this Agreement, or if it\nbecomes necessary for a party to bring legal action to\nenforce its rights under this Agreement, the prevailing\nparty in any such dispute or legal action or other\nproceeding shall be entitled to recover its reasonable\nlegal fees, costs, and expenses from the other party. 9.16 Records & Government Access. Verisk and\n\nClient shall maintain operational, financial, and\n\nadministrative records, contracts, books, files and other\n\ndocuments as required legally or pursuant to prudent\nbusiness practices in connection with Services performed\nunder this Agreement (\u201cRecords\u201d). Such Records shall be\n\nmaintained in a timely and accurate manner and shall, at a\n\nminimum, be maintained for a period of the longer of (i)\n\nten (10) years following the termination of the agreement\n\nbetween CMS and Client, or (ii) completion of an audit, or\n\n(iii) such other time period as required by law or\n\nregulation. | Upon request, Verisk and Client shall\n\npromptly give the HHS, the Comptroller General of the\n\nUnited States, CMS, and/or their designees the right to\n\naccess, audit, evaluate, and inspect any books, contracts,\n\ncomputer or electronic systems and the Records that\npertain to any aspect of the Agreement that the Secretary\nof HHS (or CMS) may deem necessary to enforce its\ncontract with Client.",
        "id": "qa_172"
    },
    {
        "question": "What is the required action for a Business Associate if it receives a request from an Individual to access their PHI?",
        "options": {
            "A": "Restrict access to the PHI",
            "B": "Provide immediate access to the PHI",
            "C": "Deny the request and notify the Individual",
            "D": "Forward the request to BCBSNE within 5 business days"
        },
        "correct_answer": "D",
        "explanation": "The document states that if a Business Associate receives a request from an Individual to access their PHI, it must forward the request to BCBSNE within 5 business days.",
        "source": "unknown",
        "client": "Blue Cross and Blue Shield of Nebraska",
        "document_type": "unknown",
        "context": "Upon request by an \nIndividual, BCBSNE  shall determine whether an Individual is \nentitled  to a restriction on disclosure of his or her PHI \npursuant to 45 CFR \u00a7 164.522. If BCBSNE  determines that \nan Individual is entitled to such a restriction, BCBSNE  will \ncommunicate the decision to Business Associate. Business \nAssociate will restrict its disc losures of the Individual\u2019s PHI in \nthe same manner as would be required for BCBSNE . If \nBusiness Associate receives an Individual\u2019s request for \nrestrictions, Business Associate shall forward such request \nto BCBSNE within 5 business   days. 2. Access to PHI. Upon request by an Individual, BCBSNE  \nshall determine whether an Individual is entitled to access \nhis or her PHI pursuant to 45 CFR \u00a7 164.524. If BCBSNE  \ndetermines that an Individual is entitled to such access, and \nthat such PHI is under the control o f Business Associate, \nBCBSNE  will communicate the decision to Business \nAssociate. Business Associate shall provide access to the \nPHI in the same manner as would be required for BCBSNE . If Business Associate receives an Individual\u2019s request to \naccess his or  her PHI, Business Associate shall forward such \nrequest to BCBSNE  within 5 business days. DocuSign Envelope ID: 80DEFD2D-BEF2-43BF-A5C1-FC75FCB75F86\n4 \nVersion 02_2023  3. Amendment of PHI . Upon request by an  Individual, \nBCBSNE  shall determine whether any Individual is entitled \nto amend his or her PHI pursuant to 45 CFR \u00a7 164.526. If \nBCBSNE  determines that an Individual is entitled to such an \namendment, and that such PHI is both in a designated record \nset and under the control of Business Associate , BCBSNE \nwill communicate the decision to Business Associate. Business Associate shall  provide an opportunity to amend \nthe PHI in the same manner as would be required for \nBCBSNE .",
        "id": "qa_173"
    },
    {
        "question": "What is the duration of the Survival Period for confidential information after the expiration or termination of the NDA?",
        "options": {
            "A": "5 years",
            "B": "3 years",
            "C": "1 year",
            "D": "2 years"
        },
        "correct_answer": "B",
        "explanation": "The NDA specifies that the Survival Period for confidential information is three years after the expiration or termination of the agreement.",
        "source": "s3://ml-legal-restricted/contract-docs/63453/19902_ACTmd HMS MNDA 05302019.pdf",
        "client": "ACT.md",
        "document_type": "NDA",
        "context": "The restric -\ntions in the preceding sentence shall not apply, however,  to employment resulting from any solicitation \ndirected at the public or any public advertisement of employment opportunities (including, without \nlimitation, through the use of employment agencies) that are not specifically directed to any individual \nemplo yee, agent, long -term consultant, or other person. 7. Term, Period of Non -Disclosure and Termination . This Agreement will terminate if the \nParties enter into a definitive agreement containing provisions restricting the disclosure and use of the \nConfidential  Information. Unless earlier terminated under the preceding sentence, this Agreement shall \nexpire two years after the Effective Date, provided that either Party may terminate this Agreement at any \nDocuSign Envelope ID: D4C10AD0-BE5C-4B1C-878D-DC3C97B5A4FC\nNDA -Mutual (12 -19-2017) - CONFIDENTIAL   5 \n time by providing written notice to the other Party. Notw ithstanding anything to the contrary herein, each \nParty\u2019s rights and obligations under this Agreement shall survive the expiration or termination of this \nAgreement for a period of three years from  the date of such expiration or termination (the \u201cSurvival \nPeriod\u201d), provided that for any trade secrets of the Disclosing Party, the Survival Period shall last for as \nlong as such Confidential Information qualifies as a trade secret under applicable federal, state and/or local \nlaw. Each Party agrees that the othe r Party shall have the right, in its sole and absolute discretion, without \ngiving any reason therefore, to at any time terminate discussions concerning a Potential Transaction. If a \nPotential Transaction is not consummated or discussions concerning a Pote ntial Transaction are terminated, \nthe Receiving Party shall take action as required by Paragraph 3(f) above.",
        "id": "qa_174"
    },
    {
        "question": "What is the requirement for destroying Confidential Information as per the NDA with ACT.md?",
        "options": {
            "A": "Destroy all Confidential Information within 5 business days upon request",
            "B": "Destroy all Confidential Information within 3 business days upon request",
            "C": "Retain all Confidential Information indefinitely",
            "D": "Destroy only if instructed in a subsequent written agreement"
        },
        "correct_answer": "A",
        "explanation": "The NDA specifies that the Receiving Party must destroy all Confidential Information within five business days upon request from the Disclosing Party.",
        "source": "s3://ml-legal-restricted/contract-docs/63453/19902_ACTmd HMS MNDA 05302019.pdf",
        "client": "ACT.md",
        "document_type": "NDA",
        "context": "At any time upon the request \nof the Disclosing Party, the Receiving Party shall promptly (and in no event  later than five business days \nafter such request) (i) destroy or cause to be destroyed all Confidential Infor mation in the possession or \ncontrol of the Receiving Party or its Representatives confirm such destruction in writing to the Disclosing \nParty, pr ovided, however, that the obligation to destroy such Confidential Information does not extend to \nautomatically generated computer back -up or archival copies generated in the ordinary course of Receiving \nParty\u2019s information systems procedures, provided that  Receiving Party shall make no further use of such \ncopies and shall extend the protections of this Agreement to such Confidential Information for so long as \nthe Receiving Party maintains such Confidential Information. Notwithstanding the destruction of \nConfidential Information hereunder, the Receiving Party and its Representatives shall continue to be bound \nby their confidentiality and other obligations hereunder relating to such confidentiality for the term of this \nAgreement and thereafter, without limitat ion. 4. No Representations or Warranties . Both Parties understand that the other has endeavored \nto include in the Confidential Information the information that it believes to be reliable and relevant for the \npurposes of the others use and consideration. Th e Parties acknowledge and agree that (a) no representation \nor warranty, express or implied, is made by the Disclosing Party or any of its Representatives as to the \naccuracy or completeness of the Confidential Information, and (b)  the Receiving Party shall  be entitled to \nrely only on those representations and warranties (if any) that may be made in a subsequent written \nagreement regarding a transaction, signed and delivered by both Parties, and then only to the extent, and \nsubject to the limitations, provid ed therein. Subject to the foregoing sentence, each Party and its \nRepresentatives expressly disclaim any and all liability to the other and its Representatives that may be \nbased on any Confidential Information, the use thereof, errors therein, or omission s there from.",
        "id": "qa_175"
    },
    {
        "question": "What remedies are available for a breach of the NDA according to the document?",
        "options": {
            "A": "Exclusive remedy of specific performance",
            "B": "No remedies available",
            "C": "Only money damages",
            "D": "Specific performance and/or injunctive relief"
        },
        "correct_answer": "D",
        "explanation": "The document states that specific performance and/or injunctive relief are available remedies for a breach, in addition to other legal or equitable remedies like money damages.",
        "source": "s3://ml-legal-restricted/contract-docs/63453/19902_ACTmd HMS MNDA 05302019.pdf",
        "client": "ACT.md",
        "document_type": "NDA",
        "context": "5. Remedies . The Parties understand and agree that money damages  may not be a sufficient \nremedy for any breach of this Agreement by it or by its Representatives and that the Disclosing Party shall \nbe entitled to specific performance and/or in junctive relief, either temporary or permanent, as appropriate, \nto remedy such breach. Such remedy shall not be deemed to be the exclusive remedy for any such breach \nof this Agreement but shall be in addition to all other remedies available at law or in e quity, including but \nnot limited to money damages. The Parties further acknowledge and agree that the covenants contained \nherein are necessary for the protection of legitimate business interests and are reasonable in scope. No \nfailure or delay in exercis ing any right, power, or privilege under this Agreement shall operate as a waiver \nthereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the \nexercise of any right, power, or privilege under this Agreemen t. \n6. Solicitation of Employees . Unless otherwise provided in any subsequent written agree -\nment regarding a Potential Transaction, for a period of two years following the Effective Date of this \nAgreement, each Party agrees, on behalf of itself and its Repre sentatives, not to directly hire, employ, or \notherwise contract with, any of the other Party\u2019s, including any parent companies or subsidiaries, \nemployees, agents, or other persons who then have, or who have had within the preceding three months, \nemployment  with the Party or its parent or affiliates, and with whom it has had contact or who became \nknown to it in connection with this Agreement or its consideration of a Potential Transaction.",
        "id": "qa_176"
    },
    {
        "question": "Under what circumstances can either party assign their rights and obligations under the Agreement without prior written consent from the other party?",
        "options": {
            "A": "When the assignment is part of a merger",
            "B": "When the assignment is for a temporary basis",
            "C": "When the assignment is to a successor in ownership of substantially all of the business assets",
            "D": "When the assignment is to a third-party vendor"
        },
        "correct_answer": "C",
        "explanation": "The Agreement allows either party to assign its rights and obligations to a successor in ownership of substantially all of the business assets without prior written consent, provided the successor assumes the terms and conditions in writing.",
        "source": "unknown",
        "client": "Ochsner Health System",
        "document_type": "unknown",
        "context": "BH 546 \nNew Or leans, LA 70121  \nAttn: Scott Posecai  \n \nwith a copy to:   Office of Legal Affairs  \nOchsner Health Plan  \n1450 Poydras Street, Suite 2250 \nNew Orleans, LA 70112  \nAttn: General Counsel  \n \nAny notice given pursuant or with respect to this Agreement shall be deemed received (i) on the date such notice is hand -delivered to an authorized representative of the P arty receiving such \nnotice, (ii) on the first business day following the date on which such notice is sent prepaid for \nnext-day delivery by nationally rec ognized overnight delivery service, or (iii) on the third \nbusiness day following the date on which such notice is sent by prepaid registered or certified \nU.S. mail, return receipt requested. 13. ASSIGNMENT . This Agreement shall be binding on and shall inure to the benefit of the \nparties hereto, their respective successors and assigns. This Agreement may not be assigned in \nwhole or in part by either Party without the prior written consent of the other Party. Any attempted \nassignment without such prior written consent shall be void and unenforceable. Notwithstanding the foregoing, either Party, without the prior written approval of the other Party, may assign its rights and obligations hereunder to a successor  in ownership of substantially all of the assets of the \nbusiness, provided that the successor expressly assumes in writing the performance of the terms and conditions of this Agreement. 14. COUNTERPARTS\n. This Agreement may be executed in two  or more counterparts, each \nof which shall be deemed an original, but all such counterparts together shall constitute but one and the same Agreement. 15. ENTIRE AGREEMENT\n. This Agreement contains the entire agreement of and \nsupersedes any and all prior understandings, arrangements, and agreements between the P arties \nhereto, whether oral or written, with respect to the subject matter hereof . 16. MODIFICATION.",
        "id": "qa_177"
    },
    {
        "question": "What does the NDA between Abarca Health LLC and the other party specify regarding product development and marketing?",
        "options": {
            "A": "Each party is free to develop and market new or improved products unless otherwise agreed in writing.",
            "B": "Both parties must disclose all product details to each other.",
            "C": "Both parties are restricted from developing new products.",
            "D": "Neither party can develop or market products without mutual consent."
        },
        "correct_answer": "A",
        "explanation": "The NDA explicitly states that it does not restrict either party from developing or marketing new or improved products unless such restrictions are agreed upon in writing by both parties.",
        "source": "s3://ml-legal-restricted/contract-docs/72710/Abarca Health - Cotiviti - NDA - MS - 08312023 - Dynamics_72710.pdf",
        "client": "Abarca Health LLC",
        "document_type": "NDA",
        "context": "This Agreement shall not be construed in any manner to be an \nobligation to enter into a subcontract or contract or to result in any claim whatsoever by one Party against the other for reimbursement of cost for any effor ts expended. Except as specifically set forth herein, this Agreement does not: (i) \nrestrict either Party from developing new products, improving existing products, or marketing any new, improved or \nexisting products; or (ii) commit either Party to disclose  any particular information, or to develop, make, use, buy, sell, \nor otherwise dispose of any existing or future products, or to favor or recommend any product or service of the other. To be binding, any such restriction or commitment must be in writing and signed by both parties . 13. Notices. All notices or other communications contemplated by this Agreement shall be in writing and shall \nbe deemed properly delivered when (i) delivered personally or (ii) mailed by registered or certified mail, postage \nprepaid, to the address of the other Party set forth in the first paragraph of this Agreement. 14. Assignment. This Agreement shall be binding on and shall inure to the benefit of the parties  hereto, their \nrespective successors and assigns. This Agreement may not be as signed in whole or in part by either Party without the \nprior written consent of the other Party. Any attempted assignment without such prior written consent shall be void \nand unenforceable. Notwithstanding the foregoing, either Party, without the prior wri tten approval of the other Party, \nmay assign its rights and obligations hereunder to a successor in ownership of substantially all of the assets of the business, provided that the successor expressly assumes in writing the performance of the terms and cond itions of this \nAgreement. 15. Modification ; Waiver. No modification to this Agreement shall be binding on either Party unless such \nmodification is in writing and signed by an authorized representative of each of the parties .",
        "id": "qa_178"
    },
    {
        "question": "How is a notice considered to be received if sent by email according to the MSA with ACA Health Benefits Fund?",
        "options": {
            "A": "Only upon receiving a delivery confirmation",
            "B": "Immediately upon sending",
            "C": "Four hours after sending or upon receiving a delivery confirmation, whichever occurs first",
            "D": "At 9:00 am on the next Business Day if sent after 5:00 pm"
        },
        "correct_answer": "C",
        "explanation": "A notice sent by email is considered received when the sender receives an automated confirmation or four hours after sending, unless an undelivered message is received.",
        "source": "s3://ml-legal-restricted/contract-docs/73278/ACA - Cotiviti Australia - MSA - JK - 10052023 - Dynamics_73278.pdf",
        "client": "ACA Health Benefits Fund",
        "document_type": "MSA",
        "context": "Notices \n17.1 All notices must be: \n(a) in legible writing and in English; \n(b) addressed to the recipient at the address or email address set out in the Commercial \nPrinciples or to any other address or email address that a party may notify to the \nother; \n(c) signed by the party or, where the sender is a company, by an authorised officer or \nunder the common seal of the sender or in any other way permitted under the \nCorporations Act 2001 (Cth); and \n(d) sent to the recipient by prepaid post (airmail if to or from a place ou tside Australia) \nor email. 17.2 Without limiting any other means by which a party may be able to prove that a notice has \nbeen received by the other party, a notice will be considered to have been received: \n(a) if sent by prepaid post, 3 days (if posted within Australia to an address in Australia) \nor 10 days (if posted from one country to another) after the date of posting; or \n(b) if sent by email, when the sender receives an automated message confirming \ndelivery or four hours after the time the email is sent (as recorded on the device \nfrom which the sender sent the email) unless the sender receives an automated \nmessage that the email has not been delivered, whichever occurs first; \nbut if a notice is received by the recipient's email, on a day that is not a Business Day, or after \n5:00 pm (recipient's local time) on a Business Day, the notice will be considered to have been \nreceived by the recipient at 9.00 am (recipient's local time) on the next Business Day. 18. General provisions  \nAssignment and sub-contracting \n18.1 Client  must not assign, novate, sub-contract, or otherwise transfer or dispose of this \nAgreement or any of its rights or obligations under it without the prior written consent of \nCotiviti.",
        "id": "qa_179"
    },
    {
        "question": "Under what condition is information NOT considered Confidential Information according to the NDA with AdvantMed?",
        "options": {
            "A": "If it is publicly known due to a breach by the Receiving Party.",
            "B": "If it is known to the Receiving Party before receipt from the Disclosing Party.",
            "C": "If it is disclosed by the Disclosing Party with consent.",
            "D": "If it is independently developed by the Receiving Party."
        },
        "correct_answer": "B",
        "explanation": "Information is not deemed confidential if the Receiving Party was aware of it prior to receiving it from the Disclosing Party, as specified in the NDA.",
        "source": "s3://ml-legal-restricted/contract-docs/74554/AdvantMed - Cotiviti - NDA - SK - 05102024 - Dynamics_74554.pdf",
        "client": "AdvantMed",
        "document_type": "NDA",
        "context": "Information will not be deemed Confidential Information hereunder if such information:  \n(a)  is known to the Receiving Party  prior to receipt from the Disclosing Party  directly or indirectly from a \nsource other than one having an obligation of confidentiality to the Disclosing Party ;  \n(b)  becomes known (independently of disclosure by the Disclosing Party ) to the Receiving  Party  directly or \nindirectly from a source other than one having an obligation of confidentiality to the Disclosing Party ;  \n(c)  becomes publicly known or otherwise ceases to be secret or confidential, except through a breach of this \nAgreement by the Rece iving Party ; or  \nDocuSign Envelope ID: A10BCA03-7EE5-49EC-9661-7F70F4B781D6\nDocuSign Envelope ID: DBA17575-23F0-4B9C-9009-F7484DB71C65\n(d)  is independently developed by the Receiving Party  without any use of or benefit from the Confidential \nInformation and such independent development can be documented by the Receiving Party  with \nwritten records. Each Party  has the rig ht to refuse to accept any trade secret, Confidential Information or similar proprietary \ninformation prior to full disclosure. 4. Latent Data. Latent Data which is Confidential Information  shall be subject to destruction in due course but \nshall remain Confidential Information of the Disclosing Party  until it is destroyed. \u201c Latent Data \u201d refers to \ndata that is stored by a Party  on routine back -up media, including but not limited to deleted fi les and other \nnon-logical data types, memory dumps, swap files, temporary files, printer spool files and metadata that can \ncustomarily be retrieved only by computer forensics experts and is generally considered inaccessible without \nthe use of specialized t ools and techniques. 5. Return of Confidential Information.",
        "id": "qa_180"
    },
    {
        "question": "What remedy may be sought if a party breaches the agreement according to the legal document text?",
        "options": {
            "A": "Money damages only",
            "B": "Mandatory arbitration",
            "C": "Specific performance and/or injunctive relief",
            "D": "Termination of the agreement"
        },
        "correct_answer": "C",
        "explanation": "The document specifies that specific performance and/or injunctive relief may be sought as a remedy for breach of the agreement, in addition to other remedies such as money damages.",
        "source": "unknown",
        "client": "Wellth, Inc.",
        "document_type": "unknown",
        "context": "Subject to the foregoing sentence, each Party and its \nRepresentatives expressly disclaim any and all liability to the other and its Representatives that may be \nbased on any C onfidential Information, the use thereof, errors therein, or omissions there from. 5. Remedies . The Parties understand and agree that money damages  may not be a sufficient \nremedy for any breach of this Agreement by it or by its Representatives and that the  Disclosing Party shall \nbe entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, \nto remedy such breach. Such remedy shall not be deemed to be the exclusive remedy for any such breach \nof this Agreement bu t shall be in addition to all other remedies available at law or in equity, including but \nnot limited to money damages. The Parties further acknowledge and agree that the covenants contained \nherein are necessary for the protection of legitimate business i nterests and are reasonable in scope. No \nfailure or delay in exercising any right, power, or privilege under this Agreement shall operate as a waiver \nthereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the \nexercise of any right, power, or privilege under this Agreement. 6. Solicitation of Employees . Unless otherwise provided in any subsequent written agree -\nment regarding a Potential Transaction, for a period of two years following the Effective Date of  this \nAgreement, each Party agrees, on behalf of itself and its Representatives, not to directly hire, employ, or \notherwise contract with, any of the other Party\u2019s, including any parent companies or subsidiaries, \nemployees, agents, or other persons who the n have, or who have had within the preceding three months, \nemployment with the Party or its parent or affiliates, and with whom it has had contact or who became \nknown to it in connection with this Agreement or its consideration of a Potential Transaction.",
        "id": "qa_181"
    },
    {
        "question": "What does the agreement specify regarding the binding powers and obligations of the parties involved?",
        "options": {
            "A": "Neither party has the power to bind the other to actions or debts.",
            "B": "Each party can bind the other to contracts.",
            "C": "Both parties share profits and liabilities.",
            "D": "The agreement creates a joint venture or partnership."
        },
        "correct_answer": "A",
        "explanation": "The agreement explicitly states that neither party has the power to bind the other, is liable for the debts of the other, or shares in profits, emphasizing independence and lack of formal business organization.",
        "source": "unknown",
        "client": "Crumdale Partners - Better Benefits",
        "document_type": "unknown",
        "context": "Nothing in this Agreement shall be deemed to create, either express or implied, \nthe power in either Party to bind the other. Neither Party shall be bound by the actions of the other, shall be liable for \nthe debts of the other, or shall have a right to share in the profits of the other. This Agreement is not intended to be a \nCotiviti, Inc. CONFIDENTIAL AND PROPRIETARY 3\njoint venture, partnership or other formal business organization, and neither Party is under any obligation to enter into \nany further agreement with the other Party. 11.Mutual Representations. Each Party represents that it has the right to disclose its Confidential Information \nin furtherance of the purpose set forth above without violating any agreement with or right of any other person. Confidential Information may include information of a third party provided that the third party has authorized such \ndisclosure. 12.No Further Obligation or Limitation. This Agreement shall not be construed in any manner to be an \nobligation to enter into a subcontract or contract or to result in any claim whatsoever by one Party against the other for \nreimbursement of cost for any efforts expended. Except as specifically set forth herein, this Agreement does not: (i) \nrestrict either Party from developing new products, improving existing products, or marketing any new, improved or \nexisting products; or (ii) commit either Party to discloseany particular information, or to develop, make, use, buy, sell, \nor otherwise dispose of any existing or future products, or to favor or recommend any product or service of the other. To be binding, any such restriction or commitment must be in writing and signed by both parties. 13.Notices. All notices or other communications contemplated by this Agreement shall be in writing and shall \nbe deemed properly delivered when (i) delivered personally or (ii) mailed by registered or certified mail, postage \nprepaid, to the address of the other Party set forth in the first paragraph of this Agreement. 14.Assignment.",
        "id": "qa_182"
    },
    {
        "question": "What is the protocol for handling Latent Data as described in the legal document?",
        "options": {
            "A": "Latent Data can be freely shared with third parties.",
            "B": "Latent Data remains Confidential Information until it is destroyed.",
            "C": "Latent Data must be immediately destroyed upon receipt.",
            "D": "Latent Data is exempt from confidentiality and can be retained indefinitely."
        },
        "correct_answer": "B",
        "explanation": "Latent Data is considered Confidential Information of the Disclosing Party until it is destroyed, even though it is stored on routine backup media.",
        "source": "unknown",
        "client": "Maryland Physicians Care (MPC)",
        "document_type": "unknown",
        "context": "CONFIDENTIAL  AND  PROPRIETARY  2  \n documented  by the Receiving  Party  with written  records. Each  Party  has the right  to refuse  to accept  any trade  secret, \nConfidential Information or similar proprietary information prior to full disclosure. 4. Latent  Data. Latent  Data,  which  is Confidential  Information,  shall  be subject  to destruction  in due course  but \nshall  remain Confidential Information of  the Disclosing Party until it is  destroyed. \u201c Latent  Data\u201d refers to  data  that is \nstored  by a party  on routine  back -up media,  including  but not limited  to deleted  files and other  non-logical  data  types, \nmemory  dumps,  swap  files,  temporary  files,  printer  spool  files and metadata  that can customarily  be retrieved  only  by \ncomputer  forensics  experts  and is generally  considered  inaccessible  without  the use of specialized  tools  and techniques. 5. Return  of Confidential  Information. Subject  to Section  3, \u201cExceptions,\u201d  above,  promptly  following  the earlier \nof (i) the termination  of this Agreement,  or (ii) the written  request  of Disclosing  Party,  the Receiving  Party  shall  destroy \nor deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party \nconstituting  or containing  Confidential  Information,  together  with  all copies  thereof,  including  all electronic  and digital \ncopies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving \nParty's legal department for dispute resolution purposes only, and except for electronically -stored Confidential \nInformation contained in an archived computer system backup in accordance with Receiving Party\u2019s generally \napplicable  security  and disaster  recovery  procedures. Upon  receipt  of such  a request,  the Receiving  Party  shall  destroy \nall other documents and materials constituting Confidential Information in its possession to the extent reasonably \npracticable. Upon request, the Receiving Party shall document such destruction in writing to the Disclosing Party. 6. Protected Health Information. If any part of the Confidential Information disclosed hereunder is protected \nhealth information pursuant to the Federal Health Insurance Portability and Accountability Act of 1996, Pub. L. No.",
        "id": "qa_183"
    },
    {
        "question": "What does the agreement state about the ownership of Confidential Information?",
        "options": {
            "A": "Confidential Information remains the sole and exclusive property of the Disclosing Party.",
            "B": "Confidential Information is jointly owned by both parties.",
            "C": "Confidential Information is owned by the Receiving Party.",
            "D": "Ownership of Confidential Information is determined by a separate contract."
        },
        "correct_answer": "A",
        "explanation": "The agreement specifies that Confidential Information shall remain the sole and exclusive property of the Disclosing Party.",
        "source": "unknown",
        "client": "Maryland Physicians Care (MPC)",
        "document_type": "unknown",
        "context": "The Receiving Party shall not be obligated to compensate the Disclosing Party for \nConfidential Information (except as may result from  a breach  of this Agreement)  and the  Receiving Party acknowledges \nand understands that no warranties of any kind are given by the Disclosing Party with respect to the accuracy or \ncompleteness of the Confidential Information. 9. Ownership. Confidential Information shall remain the sole and exclusive property of the Disclosing Party. Nothing  in this Agreement  shall  be construed  as granting  to the Receiving  Party  any right,  title or interest  in or to any \npatent, trademark, license, copyright or other right of the Disclosing Party. 10. Relationship of the parties. Nothing in  this Agreement shall  be deemed to create, either express or implied, \nthe power  in either Party  to bind the other. Neither Party shall  be bound  by the actions of  the other, shall be  liable  for \nDocusign Envelope ID: 0243AB36-D266-4668-848F-C357D504BCB4\n\u00a9 2018  Cotiviti,  Inc. CONFIDENTIAL  AND  PROPRIETARY  3  \n the debts of the other, or shall have a right to share in the profits of the other. This Agreement is not intended to be a \njoint  venture,  partnership  or other  formal  business  organization,  and neither  Party  is under  any obligation  to enter  into \nany further agreement with the other Party. 11. Mutual Representations. Each Party represents that it has the right to disclose its Confidential Information \nin furtherance of the purpose set forth above without violating any agreement with or right of any other person. Confidential Information may include information of a third party provided that the third party has authorized such \ndisclosure. 12. No Further Obligation or Limitation. This Agreement shall not be construed in any manner to be an \nobligation  to enter  into a subcontract  or contract  or to result  in any claim  whatsoever by  one Party  against  the other  for \nreimbursement of cost for any efforts expended.",
        "id": "qa_184"
    },
    {
        "question": "What does the Agreement specify about the relationship between the two Parties?",
        "options": {
            "A": "The Agreement establishes a joint venture.",
            "B": "The Agreement explicitly states no formal business organization is created.",
            "C": "The Agreement implies a partnership between the Parties.",
            "D": "The Agreement requires the Parties to share profits."
        },
        "correct_answer": "B",
        "explanation": "The Agreement explicitly states that it is not intended to be a joint venture, partnership, or other formal business organization, and neither Party is under any obligation to enter into any further agreement with the other Party.",
        "source": "unknown",
        "client": "Crumdale Partners - Better Benefits",
        "document_type": "unknown",
        "context": "Nothing in this Agreement shall be deemed to create, either express or implied, \nthe power in either Party to bind the other. Neither Party shall be bound by the actions of the other, shall be liable for \nthe debts of the other, or shall have a right to share in the profits of the other. This Agreement is not intended to be a \nCotiviti, Inc. CONFIDENTIAL AND PROPRIETARY 3\njoint venture, partnership or other formal business organization, and neither Party is under any obligation to enter into \nany further agreement with the other Party. 11.Mutual Representations. Each Party represents that it has the right to disclose its Confidential Information \nin furtherance of the purpose set forth above without violating any agreement with or right of any other person. Confidential Information may include information of a third party provided that the third party has authorized such \ndisclosure. 12.No Further Obligation or Limitation. This Agreement shall not be construed in any manner to be an \nobligation to enter into a subcontract or contract or to result in any claim whatsoever by one Party against the other for \nreimbursement of cost for any efforts expended. Except as specifically set forth herein, this Agreement does not: (i) \nrestrict either Party from developing new products, improving existing products, or marketing any new, improved or \nexisting products; or (ii) commit either Party to discloseany particular information, or to develop, make, use, buy, sell, \nor otherwise dispose of any existing or future products, or to favor or recommend any product or service of the other. To be binding, any such restriction or commitment must be in writing and signed by both parties. 13.Notices. All notices or other communications contemplated by this Agreement shall be in writing and shall \nbe deemed properly delivered when (i) delivered personally or (ii) mailed by registered or certified mail, postage \nprepaid, to the address of the other Party set forth in the first paragraph of this Agreement. 14.Assignment.",
        "id": "qa_185"
    },
    {
        "question": "What is the Receiving Party permitted to do with the Disclosing Party\u2019s Confidential Information according to the NDA?",
        "options": {
            "A": "Use the information solely for exercising rights and performing obligations under the Agreement",
            "B": "Use the information for any business purpose",
            "C": "Share the information freely with unauthorized persons",
            "D": "Disclose the information to a Third Party without permission"
        },
        "correct_answer": "A",
        "explanation": "The NDA specifies that the Receiving Party may only use the Confidential Information to exercise rights and perform obligations under the Agreement related to the Potential Transaction.",
        "source": "s3://ml-legal-restricted/contract-docs/72710/Abarca Health - Cotiviti - NDA - MS - 08312023 - Dynamics_72710.pdf",
        "client": "Abarca Health LLC",
        "document_type": "NDA",
        "context": "\u201c Confidential Information \u201d means this Agreement and all information disclosed \nto, or otherwise acquired or observed by, a party and its employees and ag ents (\u201c Receiving Party \u201d), from the other \nparty and its employees and agents (\u201c Disclosing Party \u201d), relating to the business of the Disclosing Party, whether \ncommunicated in writing, verbally, electronically, photographically, or in recorded or any other form, including, but \nnot limited to, original and copies of all information disclosed under other contractual arrangements between the \nparties  and their predecessors, subsidiaries and affiliates, intellectual property and trade secrets, sales and operating \ninformation, existing and potential business and marketing plans and strategies, financial information, cost and pricing \ninformation, data, media, know -how, designs, drawings, specifications, software programs, software documentation, \nsoftware source codes, technical information, concepts, inventions, reports, methods, processes, techniques, operations, \ndevices and the like, whether or not the foregoing information is patented, tested, reduced to practice, or subject to \ncopyright. No information of the Disclosing Party will be considered Confidential Information to the extent that an \nexception is provided for it in Section 3 herein. 2. Use and Disclosure of Confidential Information. The Receiving Party acknowledges that it will have access \nto the Disclosing Party\u2019s Confidential Information. The Receiving Party agrees that it will not (i) use any such Confidential Information in any way, except for the exercise of its rights and performance of its obligations under this \nAgreement in relation to the Potential Transaction, or (ii) disclose any such Confidential Information to any Third Party \nwithout the Disclosing Party\u2019s prior written permission. The Receiving Party agrees that it will not allow any unauthorized Person access to the Disclosing Party\u2019s Confidential Information, and that the Receiving Party will take all action reasonably necessary to protect the confidentiality of such Confidential Information, including implementing \nand enforcing procedures to minimize the possibility of unauthorized use or copying of such Confidential Information.",
        "id": "qa_186"
    },
    {
        "question": "Under what circumstances can the Receiving Party disclose the Disclosing Party\u2019s Confidential Information?",
        "options": {
            "A": "When the information is known to the Receiving Party from a source with an obligation of confidentiality",
            "B": "When the information is independently developed by the Receiving Party using the Confidential Information",
            "C": "When required by applicable law, with prior written notice to the Disclosing Party",
            "D": "When required by applicable law, without notifying the Disclosing Party"
        },
        "correct_answer": "C",
        "explanation": "The NDA requires the Receiving Party to give written notice to the Disclosing Party if disclosure is required by law, allowing the Disclosing Party to protect its interests.",
        "source": "s3://ml-legal-restricted/contract-docs/72710/Abarca Health - Cotiviti - NDA - MS - 08312023 - Dynamics_72710.pdf",
        "client": "Abarca Health LLC",
        "document_type": "NDA",
        "context": "In the event that the Receiving Party is required by applicable law to make any disclosure of any of the Disclosing \nParty\u2019s Confidential Infor mation, by subpoena, judicial or administrative order or otherwise, the Receiving Party will \nfirst give written notice of such requirement to the Disclosing Party, and will permit the Disclosing Party to intervene \nin any relevant proceedings to protect its  interests in the Confidential Information, and provide full cooperation and \nassistance to the Disclosing Party in seeking to obtain such protection. In addition, except as expressly permitted herein, \nneither Party will disclose the terms of this Agreement  to any Third Party without  the prior written consent of the other \nParty. 3. Exceptions . Information will not be deemed Confidential Information hereunder if such information: (a) is \nknown to the Receiving Party prior to receipt from the Disclosing Party directly or indirectly from a source other than \none having an obligation of confidentiality to the Disclosing Party; (b) becomes known (independently of disclosure \nby the Disclosing Party) to the Receiving Party directly or indirectly from a source other than one having an obligation \nof confidentiality to the Disclosing Party; (c) becomes publicly known or otherwise ceases to be secret or confidential, \nexcept through a breach of this Agreement by the Receiving Party; or (d) is independently developed by the Rec eiving \nParty  without any use of or benefit from the Confidential Information and such independent development can be \nDocuSign Envelope ID: 32A31026-DCD7-4F16-8BB6-2BC6BBBCBB05\nDocuSign Envelope ID: 1DEE5668-B8FB-46FA-AC28-81978C0F8267\n \n\u00a9 2018 Cotiviti , Inc. CONFIDENTIAL AND PROPRIETARY  2 \ndocumented by the Receiving Party with written records .",
        "id": "qa_187"
    },
    {
        "question": "Under what circumstances can Confidential Information be disclosed according to the agreement?",
        "options": {
            "A": "Under no circumstances",
            "B": "If required by any government authority, law, or to establish rights under the agreement",
            "C": "Only with the explicit consent of the client",
            "D": "Only when both parties agree in writing"
        },
        "correct_answer": "B",
        "explanation": "The agreement allows disclosure of Confidential Information if required by a government authority, law, or necessary to establish rights under the agreement, with prior notification and cooperation in limiting the scope of disclosure.",
        "source": "unknown",
        "client": "Blue Cross and Blue Shield of Nebraska",
        "document_type": "unknown",
        "context": "In addition, both parties may use or disclose Confidential Information if and to the extent: a) required by\nany request or order of any government authority; b) otherwise required by law; or c) necessary to\nestablish rights under this Agreement; provided that, in each case each party will first notify the other\nparty of such requirement, permit the other party to contest such requirement if reasonably appropriate,\nand cooperate with the other party in limiting the scope of the proposed use or disclosure. lV. Return of Confidential Information\n\nUpon termination of this Agreement or upon request, both parties shall promptly return all documents and\nother tangible materials representing Confidential Information\n\nV. Remedies\n\nIt is agreed that the unauthorized use or disclosure of any Confidential Information by either could cause\nsevere and irreparable damage. In the event of such unauthorized disclosure, the non-breaching party is\nentitled to obtain from any court of competent jurisdiction preliminary and/or permanent injunctive relief,\nas well as any other form of relief permitted by applicable law. The disclosing party shall notify the non-\nbreaching party immediately upon discovery of any loss or compromise of Confidential Information. Vi. Entire Agreement\n\n \n\f\nThis Agreement constitutes the entire agreement between the parties and may not be amended except in\na writing executed by both parties. This Agreement shall be governed by the laws of the State of\nNebraska. Vil. Relationship of the Parties\n\nBCBSNE and COMPANY are independent entities and nothing in this Agreement shall be interpreted to\ncreate any type of partnership, joint venture, or other similar business relationship. Vill. Term and Termination\nThis Agreement shall commence as of the date set forth above and shall remain in force until terminated\n\nin writing by either party.",
        "id": "qa_188"
    },
    {
        "question": "What types of information are considered \"Confidential Information\" under the NDA with 7-Eleven?",
        "options": {
            "A": "All non-public, proprietary information, regardless of labeling",
            "B": "Only information labeled as confidential",
            "C": "Only product information and customer lists",
            "D": "Only financial and employee information"
        },
        "correct_answer": "A",
        "explanation": "The NDA defines \"Confidential Information\" as all non-public, proprietary information, whether or not labeled as confidential, including information obtained from various sources and analyses related to the Potential Transaction.",
        "source": "s3://ml-legal-restricted/contract-docs/73385/7-Eleven - Cotiviti  - NDA - MS -  11152023 - Dynamics_73385.pdf",
        "client": "7-Eleven",
        "document_type": "NDA",
        "context": "(b) \u201cConfidential Information\u201d shall mean and include all confidential, non- \npublic, or proprietary information, whether or not such information is labeled or otherwise \nidentified as confidential, including that obtained through documents (whether written or \nelectronic), observations, inspection of facilities, or discussions with the Disclosing Party or its Representatives, and all analyses, compilations, data studies, or other documents prepared by \nthe Nondisclosing Party or its Representatives containing or based upon, in whole or in part,  \nany such furnished information or reflecting the Nondisclosing Party\u2019s or its Representatives\u2019 \nreview of, or interest in, the Potential Transaction; whether disclosed before, on, or after the Effective Date, including but not limited to (i)  the terms of and pricing under any agreement \nbetween the Parties or between Vendor and one of 7-Eleven\u2019s Affiliates; (ii)  business and \nmarketing plans, strategies, and programs; (iii)  financial information, budgets, projections, and \nresults; (iv) employee and contractor lists and records; (v)  business methods and operating and \nproduction procedures; (vi) product information, product development specifications, or technical, engineering, and scientific research, devices, and processes (for example, recipes, ingredient lists, formulas, chemical compositions, blueprints, designs, drawings, trade secrets, and software development tools and documentation); (vii) pricing, sales data, prospect, and \ncustomer  lists  and   information;  (viii) supplier   and   vendor  lists  and  information;  and \n(ix) information about franchisees  or licensees  or a franchise or licensing program. (c) \u201cDisclosing Party\u201d shall mean the Party (or, in the case of 7-Eleven, its \nAffiliate, if applicable) that supplies Confidential Information to the Nondisclosing Party.",
        "id": "qa_189"
    },
    {
        "question": "What is included in the definition of \"Confidential Information\" under the NDA with 7-Eleven?",
        "options": {
            "A": "All information disclosed only after the Effective Date",
            "B": "Non-public business methods and operating procedures",
            "C": "Public information shared between parties",
            "D": "Only information labeled as confidential"
        },
        "correct_answer": "B",
        "explanation": "The NDA specifies that \"Confidential Information\" includes non-public business methods and operating procedures, among other types of information, regardless of whether it is labeled as confidential.",
        "source": "s3://ml-legal-restricted/contract-docs/73385/7-Eleven - Cotiviti  - NDA - MS -  11152023 - Dynamics_73385.pdf",
        "client": "7-Eleven",
        "document_type": "NDA",
        "context": "(b) \u201cConfidential Information\u201d shall mean and include all confidential, non- \npublic, or proprietary information, whether or not such information is labeled or otherwise \nidentified as confidential, including that obtained through documents (whether written or \nelectronic), observations, inspection of facilities, or discussions with the Disclosing Party or its Representatives, and all analyses, compilations, data studies, or other documents prepared by \nthe Nondisclosing Party or its Representatives containing or based upon, in whole or in part,  \nany such furnished information or reflecting the Nondisclosing Party\u2019s or its Representatives\u2019 \nreview of, or interest in, the Potential Transaction; whether disclosed before, on, or after the Effective Date, including but not limited to (i)  the terms of and pricing under any agreement \nbetween the Parties or between Vendor and one of 7-Eleven\u2019s Affiliates; (ii)  business and \nmarketing plans, strategies, and programs; (iii)  financial information, budgets, projections, and \nresults; (iv) employee and contractor lists and records; (v)  business methods and operating and \nproduction procedures; (vi) product information, product development specifications, or technical, engineering, and scientific research, devices, and processes (for example, recipes, ingredient lists, formulas, chemical compositions, blueprints, designs, drawings, trade secrets, and software development tools and documentation); (vii) pricing, sales data, prospect, and \ncustomer  lists  and   information;  (viii) supplier   and   vendor  lists  and  information;  and \n(ix) information about franchisees  or licensees  or a franchise or licensing program. (c) \u201cDisclosing Party\u201d shall mean the Party (or, in the case of 7-Eleven, its \nAffiliate, if applicable) that supplies Confidential Information to the Nondisclosing Party.",
        "id": "qa_190"
    },
    {
        "question": "What is the duration for which the obligations regarding the use, protection, disclosure, return, and destruction of Confidential Information survive after the Effective Date?",
        "options": {
            "A": "5 years",
            "B": "2 years",
            "C": "1 year",
            "D": "3 years"
        },
        "correct_answer": "D",
        "explanation": "The obligations regarding Confidential Information survive until three years after the Effective Date, as specified in the document.",
        "source": "unknown",
        "client": "Ochsner Health System",
        "document_type": "unknown",
        "context": "To be binding, any such restriction or commitment must be in writing and signed by both parties. 7. NO WARRANT Y\n. Each Disclosing Party makes no representation or warranty as to the \naccuracy and completeness of any Confidential Information provided by it to the Receiving Party , \nand no liability shall result to a Disclosing Party from its use, except as set forth in a definitive agreement for the Purpose . Only the representations and warranties that are made in a definitive \nagreement for the Purpose , when, as, and if it is executed, and subject to such limitations and \nrestrictions as may be specified therein, shall  have any legal effect. 8. OWNERSHIP. Confidential Information shall remain the sole and exclusive property of \nthe Disclosing Party. Nothing in this Agreement shall be construed as granting to the Receiving Party any right, title or interest in or to any pat ent, trademark, license, copyright or other right of \nthe Disclosing Party. 9. TERM; SURVIVAL OF CERTAIN P ROVISIONS\n. Except as otherwise provided \nherein, t his Agreement shall be effective as of the Effective Date and applies to the discussions \nbetween the P arties that occur, and all Confidential Information disclosed , during its t erm. This \nAgreement shall expire on the third  (3rd) anniversary of the Effective Date. This A greement may \nbe terminated earlier by either P arty by giving the other P arty thirty (30) days advance written \nnotice of termination. Notwithstanding the foregoing, the obligations of each P arty regarding the \nuse, protection, disclosure, return and destruction of C onfidential Information of the other Party \nshall  survive until three (3) years after the Effective D ate. Any expiration or earlier termination of \nthis Agreement shall not release a P arty of breaches of this Agreement by it or its Representatives \noccurring prior thereto. 10. REMEDIES\n.",
        "id": "qa_191"
    },
    {
        "question": "What legal obligations must the Business Associate comply with when handling PHI?",
        "options": {
            "A": "Only the HIPAA Security Rule",
            "B": "All applicable requirements of HIPAA Security Rule, HIPAA Privacy Rule, and HITECH Act",
            "C": "Only the HITECH Act",
            "D": "Both the HIPAA Security Rule and the HIPAA Privacy Rule"
        },
        "correct_answer": "B",
        "explanation": "The Business Associate is required by law to comply with the applicable requirements of the HIPAA Security Rule, HIPAA Privacy Rule, and HITECH Act when handling PHI.",
        "source": "unknown",
        "client": "Community First Health Plans",
        "document_type": "unknown",
        "context": "Sensitive Personal Information means an individual\u2019s first name or first in itial and last name in \ncombination with any one or more of the following items: a) social security number; driver\u2019s \nlicense  number  or government -issued  identification  number;  or account  number  or credit  or debit \ncard  number  in combination  with  any required  security  code,  access  code,  or password  that would \npermit access to an individual\u2019s financial account; or b) information that identifies an individual \nand relates  to: the physical  or mental  health  or condition  of the individual;  the provision  of health \ncare to the individual; or payment for the provision of health care to the individual. J. Use means, with respect to PHI, the sharing, employment, application, utilization, examination, or \nanalysis of such information within the entity that maintains it. II. Purposes  for which  PHI May  Be Disclosed  to Business  Associate  \n \nIn connection with the services provided by Business Associate to or on behalf of Community First \ndescribed  in this Agreement,  Community  First  may  disclose  PHI to Business  Associate  for the purposes \ndescribed in the underlying Agreement executed by and between the Parties. III. Obligations  and Activities  of Business  Associate  \n \nA. Legal Obligations . Business Associate is required by law to comply with the applicable \nrequirements of: (1) HIPAA Securit y Rule (45 CFR 164.302 through 164.318), (2) the use and \ndisclosure provisions of HIPAA Privacy Rule (45 CFR 164.502, 164.504) and (3) the applicable  \nDocuSign Envelope ID: CC6F7891-FCD3-4A9F-B775-815EC2BFDD28\nPage  3 of 12 \nBAA  2023  -6.2023   provisions of the HITECH Act.",
        "id": "qa_192"
    },
    {
        "question": "What must AdvantMed ensure before requesting records containing sensitive information such as mental health or HIV test results?",
        "options": {
            "A": "Only a general authorization is required.",
            "B": "Authorization from the healthcare provider is sufficient.",
            "C": "No authorization is needed if the records are used for research purposes.",
            "D": "Specific patient consent and compliance with federal and state laws are required."
        },
        "correct_answer": "D",
        "explanation": "The document specifies that AdvantMed must secure specific patient consent and comply with federal and state laws when requesting sensitive information.",
        "source": "s3://ml-legal-restricted/contract-docs/74579/Advantmed, LLC - Cotiviti - MSA - DM - 08302024 - Dynamics_74579.pdf",
        "client": "AdvantMed",
        "document_type": "MSA",
        "context": "A general authorization \nfor the release of medical records will not be sufficient for the release of mental health, psychotherapy notes, alcohol \nand substance abuse, sexually transmitted disease rec ords, AIDS or AIDS related condition, HIV testing and related \ninformation, and genetic test results. Such information and records are protected by federal confidentiality rules (42 \nC.F.R. Part 2), HIPAA Privacy Rule (42 C.F.R. Section 164.051), the Genetic Information Nondiscrimination Act of \n2008 (\u201cGINA\u201d) and state laws and rules governing the privacy and security of such information, and may further \nrequire specific authorization that comply with state laws. The requirements of complying with federal and state \nlaws and rules governing patient consents remains with the Client, as the party requesting such information. Client \nis hereby advised to have all authorization/s and other necessary legal documents including specific patient consent \nfor mental health, psychotherapy notes, alcohol and substance abuse, sexually transmitted disease records, AIDS or \nAIDS related cond ition, HIV testing and related information, and genetic test results, reviewed by legal counsel prior \nto requesting any such records , and Cli ent further represents and warrants that, to the extent it utilizes Cotiviti  for \nretrieval and/or processing of any records containing this type information, it has secured all necessary and \nappropriate authorizations in order to comply with the for egoing federal and state laws and regulations. 7. LIMITATION OF LIABILITY  \n7.1 Limited Liability. Even if advised of the possibility of Losses or if such Losses are reasonably foreseeable , \nneither party is liable for any indirect damages, including any lost profits, data, business, goodwill  or reputation , \nanticipated savings  or recoveries , opportunity or use or other incidental , consequential , exemplary or special  \ndamages, which Client or any third party  may suffer as a result of or in connection with this Agreement .",
        "id": "qa_193"
    },
    {
        "question": "Under the NDA agreement between Abarca Health LLC and the other party, how can a party legally assign the agreement?",
        "options": {
            "A": "By obtaining prior written consent from the other party.",
            "B": "By either party notifying the other through personal delivery or certified mail.",
            "C": "By either party assigning its rights and obligations without consent.",
            "D": "By mutual verbal agreement between the parties."
        },
        "correct_answer": "A",
        "explanation": "The agreement specifies that assignment requires prior written consent from the other party unless it is assigned to a successor in ownership of substantially all assets, which must be expressly assumed in writing.",
        "source": "s3://ml-legal-restricted/contract-docs/72710/Abarca Health - Cotiviti - NDA - MS - 08312023 - Dynamics_72710.pdf",
        "client": "Abarca Health LLC",
        "document_type": "NDA",
        "context": "This Agreement shall not be construed in any manner to be an \nobligation to enter into a subcontract or contract or to result in any claim whatsoever by one Party against the other for reimbursement of cost for any effor ts expended. Except as specifically set forth herein, this Agreement does not: (i) \nrestrict either Party from developing new products, improving existing products, or marketing any new, improved or \nexisting products; or (ii) commit either Party to disclose  any particular information, or to develop, make, use, buy, sell, \nor otherwise dispose of any existing or future products, or to favor or recommend any product or service of the other. To be binding, any such restriction or commitment must be in writing and signed by both parties . 13. Notices. All notices or other communications contemplated by this Agreement shall be in writing and shall \nbe deemed properly delivered when (i) delivered personally or (ii) mailed by registered or certified mail, postage \nprepaid, to the address of the other Party set forth in the first paragraph of this Agreement. 14. Assignment. This Agreement shall be binding on and shall inure to the benefit of the parties  hereto, their \nrespective successors and assigns. This Agreement may not be as signed in whole or in part by either Party without the \nprior written consent of the other Party. Any attempted assignment without such prior written consent shall be void \nand unenforceable. Notwithstanding the foregoing, either Party, without the prior wri tten approval of the other Party, \nmay assign its rights and obligations hereunder to a successor in ownership of substantially all of the assets of the business, provided that the successor expressly assumes in writing the performance of the terms and cond itions of this \nAgreement. 15. Modification ; Waiver. No modification to this Agreement shall be binding on either Party unless such \nmodification is in writing and signed by an authorized representative of each of the parties .",
        "id": "qa_194"
    },
    {
        "question": "According to the NDA, under what conditions can the Nondisclosing Party share the Confidential Information?",
        "options": {
            "A": "Only after the Potential Transaction is completed",
            "B": "With any Representative without restrictions",
            "C": "Freely with any third party",
            "D": "With prior written consent of the Disclosing Party"
        },
        "correct_answer": "D",
        "explanation": "The NDA specifies that the Confidential Information can only be disclosed with the prior written consent of the Disclosing Party.",
        "source": "s3://ml-legal-restricted/contract-docs/73385/7-Eleven - Cotiviti  - NDA - MS -  11152023 - Dynamics_73385.pdf",
        "client": "7-Eleven",
        "document_type": "NDA",
        "context": "Each  Party  agrees  as follows:  \n \n(a) Except as expressly provided in this Agreement, the Confidential \nInformation shall be kept strictly confidential and shall not, without the prior written consent of  \nthe Disclosing Party, be disclosed by the Nondisclosing Party or the Nondisclosing Party\u2019s \nRepresentatives, in any manner whatsoever, in whole or in part, and shall not be used by the \nNondisclosing Party or the Nondisclosing Party\u2019s Representatives, directly or indirectly, for any \npurpose other than evaluating the Potential  Transaction. Moreover, the Nondisclosing Party  will \ntransmit the Confidential Information only to those Representatives who need to know the Confidential Information for the purpose of evaluating the Potential Transaction, who are \ninformed by the Nondisclosing Party of the confidential nature of the Confidential Information, \nand who have agreed in writing to be bound by provisions no less restrictive than those \ncontained in  this Agreement. The Nondisclosing Party  shall be responsible for any  breach by its \nRepresentatives of the terms of this Agreement. (b) Without the prior written consent of the Disclosing Party, the \nNondisclosing Party shall not, and shall direct the Nondisclosing Party\u2019s Representatives not to, \ndisclose to any other Person (including any Affiliates or Representatives to which disclosure is \nnot expressly permitted by this Agreement) that the Confidential Information has been made \navailable, that discussions or negotiations are taking place concerning the Potential  \nTransaction, or any of the terms, conditions, or other facts with respect to the Potential Transaction, including the status thereof or the terms of this Agreement. (c) If either Party determines that it does not wish to enter into the Potential \nTransaction, it will promptly advise the other Party of that fact.",
        "id": "qa_195"
    },
    {
        "question": "What is the procedure for resolving disputes under the AdvantMed MSA?",
        "options": {
            "A": "Disputes are referred to the Chief Executive Officer of each party",
            "B": "Disputes are resolved by the court within 48 hours",
            "C": "Disputes are resolved by a third-party mediator",
            "D": "Disputes are resolved through arbitration within 15 days"
        },
        "correct_answer": "A",
        "explanation": "According to the document, disputes are referred to the Chief Executive Officer of each party with authority to resolve the dispute.",
        "source": "s3://ml-legal-restricted/contract-docs/74579/Advantmed, LLC - Cotiviti - MSA - DM - 08302024 - Dynamics_74579.pdf",
        "client": "AdvantMed",
        "document_type": "MSA",
        "context": "It incorporates and \nsupersedes all written and oral communications  relating to the subject matter herein . This Agreement may not be \namended, supplemented or changed in any manner except by a written instrument executed by an authorized \nrepresentative of both parties . Each party acknowledges that it has not relied on or been induced to enter into this \nAgreement by any  warranty,  representation or statement (whether mad e by either of them or any other third party) \nother than those warranties,  representations or statements expressly set out in this Agreement and any other \ndocuments incorporated into this Agreement (including all SOWs). 10.15  Dispute Resolution. (a) Any dispute arising out of, or relating to this Agreement,  not resolved between the parties within fifteen (15) \ndays shall be resolved in accordance with the following procedures. The parties shall refer the dispute to the \nChief Executive Officer of each party, who shall have authority to resolve the dispute between the parties. Such \nexecutives shall use all reasonable efforts to confer in person or by telephone within forty -eight (48) hours after \nreferral of a dispute, and thereafter as they reasonably deem necessary, to exchange relevant information and to \nattempt to resolve the  dispute. (b) Subject to the provisions of this paragraph 10.15, in the event of any dispute under this Agreement, or if it \nbecomes necessary for a party to bring legal action to enforce its rights under this Agreement, the prevailing \nparty in any such dispute or legal action or other proceeding shall be entitled to r ecover its reasonable legal fees, \ncosts, and expenses from the other party. 10.16  No Third Party Beneficiaries . There are no third party beneficiaries of this Agreement and nothing in this \nAgreement is intended to confer any righ ts or remedies upon any person other than Cotiviti and Client,  and their \nrespective successors and permitted assigns.",
        "id": "qa_196"
    },
    {
        "question": "What remedies are available to the Disclosing Party in case of a breach of the NDA?",
        "options": {
            "A": "Specific performance and/or injunctive relief only",
            "B": "Specific performance, injunctive relief, and money damages",
            "C": "No remedies are available",
            "D": "Money damages only"
        },
        "correct_answer": "B",
        "explanation": "The NDA specifies that the Disclosing Party is entitled to specific performance and/or injunctive relief, in addition to all other remedies available at law or in equity, including money damages.",
        "source": "s3://ml-legal-restricted/contract-docs/63453/19902_ACTmd HMS MNDA 05302019.pdf",
        "client": "ACT.md",
        "document_type": "NDA",
        "context": "5. Remedies . The Parties understand and agree that money damages  may not be a sufficient \nremedy for any breach of this Agreement by it or by its Representatives and that the Disclosing Party shall \nbe entitled to specific performance and/or in junctive relief, either temporary or permanent, as appropriate, \nto remedy such breach. Such remedy shall not be deemed to be the exclusive remedy for any such breach \nof this Agreement but shall be in addition to all other remedies available at law or in e quity, including but \nnot limited to money damages. The Parties further acknowledge and agree that the covenants contained \nherein are necessary for the protection of legitimate business interests and are reasonable in scope. No \nfailure or delay in exercis ing any right, power, or privilege under this Agreement shall operate as a waiver \nthereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the \nexercise of any right, power, or privilege under this Agreemen t. \n6. Solicitation of Employees . Unless otherwise provided in any subsequent written agree -\nment regarding a Potential Transaction, for a period of two years following the Effective Date of this \nAgreement, each Party agrees, on behalf of itself and its Repre sentatives, not to directly hire, employ, or \notherwise contract with, any of the other Party\u2019s, including any parent companies or subsidiaries, \nemployees, agents, or other persons who then have, or who have had within the preceding three months, \nemployment  with the Party or its parent or affiliates, and with whom it has had contact or who became \nknown to it in connection with this Agreement or its consideration of a Potential Transaction.",
        "id": "qa_197"
    },
    {
        "question": "Under the MSA with AdvantMed, what are the conditions under which Confidential Information can be disclosed to Optum Health - CDO?",
        "options": {
            "A": "Only periodic status reports, minimum volume commitment, and fees can be disclosed.",
            "B": "No Confidential Information can be disclosed to Optum Health - CDO.",
            "C": "All Confidential Information can be disclosed with prior written permission.",
            "D": "Only periodic status reports and employee details can be disclosed."
        },
        "correct_answer": "A",
        "explanation": "The document specifies that Optum Health - CDO can be informed about periodic status reports, the minimum volume commitment, and fees under SOW #1, provided they agree to hold such pricing in strict confidence and not further disclose it.",
        "source": "s3://ml-legal-restricted/contract-docs/74579/Advantmed, LLC - Cotiviti - MSA - DM - 08302024 - Dynamics_74579.pdf",
        "client": "AdvantMed",
        "document_type": "MSA",
        "context": "The Receiving Party agrees that it will not (i) use any such \nConfi dential Information in any way,  except for the exercise of its rights and performance of its obligations under \nthis Agreement  or for the purpose for which it was disclosed , or (ii) disclose any such Confidential Information to \nany third party  without the Disclosing Party\u2019s prior written permission . Notwithstanding the preceding sentence , (i) Cotiviti may disclose  Confidentia l Information to its  Representatives  \nand subcontractors who are required to have access to the Confidential Information in connection with the provision \nof a Solution  to or on behalf of Client , provided each  has agreed to restrictions no less stringent than Cotiviti  with \nregard to the use and disclosure of such Confidential Information , and (ii) Client may disclose Confidential \nInformation to employees of its wholly -owned subsidiary Advantmed India LLP  to the minimum extent necessary \nfor implementation and provision of the services under Statement of Work #1 for Risk Adjustment between the \nparties, to be executed contemporaneously herewith (\u201c SOW #1\u201d), provided such Advantmed India LLP employees \nhave agreed to restrictions no less stringent than Client  with regard to the use and disclosure of such Confidential \nInformation . Notwithstanding anything herein to the contrary, except for permitted disclos ures to Advantmed India LL P \nemployees pursuant to the preceding sentence, Client  may disclose only to the Optum Health \u2013 CDO business \nsegment only the following information: (i) periodic status reports  for the services performed under SOW #1 , strictly \nlimited to the number of records retrieved by Cotiviti under SOW #1  at a given point in time ; (ii) the minimum \nvolume commitment under SOW #1 ; and (iii) fees set forth in SOW #1 , provide d that Optum Health -CDO agrees to \nhold such pricing in strict confidence within the business segment and agrees  not further disclose such pricing.",
        "id": "qa_198"
    },
    {
        "question": "Under the AdvantMed MSA, what is a condition for disclosing Confidential Information to third parties?",
        "options": {
            "A": "Disclosure is allowed with the Disclosing Party\u2019s prior written permission.",
            "B": "Disclosure is allowed to anyone as long as it is for the purpose for which it was disclosed.",
            "C": "No conditions apply, free disclosure is allowed.",
            "D": "Disclosure is only allowed to Optum Health-CDO business segment without restrictions."
        },
        "correct_answer": "A",
        "explanation": "The legal document specifies that Confidential Information may not be disclosed to any third party without the Disclosing Party\u2019s prior written permission.",
        "source": "s3://ml-legal-restricted/contract-docs/74579/Advantmed, LLC - Cotiviti - MSA - DM - 08302024 - Dynamics_74579.pdf",
        "client": "AdvantMed",
        "document_type": "MSA",
        "context": "The Receiving Party agrees that it will not (i) use any such \nConfi dential Information in any way,  except for the exercise of its rights and performance of its obligations under \nthis Agreement  or for the purpose for which it was disclosed , or (ii) disclose any such Confidential Information to \nany third party  without the Disclosing Party\u2019s prior written permission . Notwithstanding the preceding sentence , (i) Cotiviti may disclose  Confidentia l Information to its  Representatives  \nand subcontractors who are required to have access to the Confidential Information in connection with the provision \nof a Solution  to or on behalf of Client , provided each  has agreed to restrictions no less stringent than Cotiviti  with \nregard to the use and disclosure of such Confidential Information , and (ii) Client may disclose Confidential \nInformation to employees of its wholly -owned subsidiary Advantmed India LLP  to the minimum extent necessary \nfor implementation and provision of the services under Statement of Work #1 for Risk Adjustment between the \nparties, to be executed contemporaneously herewith (\u201c SOW #1\u201d), provided such Advantmed India LLP employees \nhave agreed to restrictions no less stringent than Client  with regard to the use and disclosure of such Confidential \nInformation . Notwithstanding anything herein to the contrary, except for permitted disclos ures to Advantmed India LL P \nemployees pursuant to the preceding sentence, Client  may disclose only to the Optum Health \u2013 CDO business \nsegment only the following information: (i) periodic status reports  for the services performed under SOW #1 , strictly \nlimited to the number of records retrieved by Cotiviti under SOW #1  at a given point in time ; (ii) the minimum \nvolume commitment under SOW #1 ; and (iii) fees set forth in SOW #1 , provide d that Optum Health -CDO agrees to \nhold such pricing in strict confidence within the business segment and agrees  not further disclose such pricing.",
        "id": "qa_199"
    },
    {
        "question": "What is the duration for which obligations related to trade secrets survive after the termination of the Agreement?",
        "options": {
            "A": "2 years",
            "B": "For as long as the information qualifies as a trade secret",
            "C": "5 years",
            "D": "1 year"
        },
        "correct_answer": "B",
        "explanation": "The document specifies that obligations regarding trade secrets continue for as long as the information qualifies as a trade secret, according to 18 U.S.C. 1839.",
        "source": "unknown",
        "client": "Crumdale Partners - Better Benefits",
        "document_type": "unknown",
        "context": "The BAA will govern and supersede the terms of this Agreement with respect to any protected \nhealth information disclosed hereunder, and will include, but will not be limited to, the following provisions: \na. Individuals' rights to obtain a copy of the individual's information in an electronic format;  \nb. Individuals' rights to have the individual's information transmitted to another entity or person \ndesignated by the individual, provided the request is clear, conspicuous, and specific;  \nc. The right to audit and monitor activities that involve protected health information; and \nd. The process for notification and reporting of unauthorized disclosure or protected health information \nbreaches. 7. Term. This Agreement may be terminated with respect to subsequent disclosures upon thirty (30) days' prior \nwritten notice to the other Party. This Agreement shall automatically terminate two (2) years after its Effective Date. The rights and obligations accruing prior to termination as set forth herein shall survive the termination of this \nAgreement for a period of five (5) years provided, however, that Receiving Party\u2019s obligations respecting Disclosing \nParty\u2019s \u201ctrade secrets\u201d (as such term is defined in 18 U.S.C. 1839) shall continue for so long as such information qualifies \nas a trade secret. 8. Compensation. The Receiving Party shall not be obligated to compensate the Disclosing Party for \nConfidential Information (except as may result from a breach of this Agreement) and the Receiving Party acknowledges \nand understands that no warranties of any kind are given by the Disclosing Party with respect to the accuracy or \ncompleteness of the Confidential Information. 9. Ownership. Confidential Information shall remain the sole and exclusive property of the Disclosing Party. Nothing in this Agreement shall be construed as granting to the Receiving Party any right, title or interest in or to any \npatent, trademark, license, copyright or other right of the Disclosing Party. 10. Relationship of the parties.",
        "id": "qa_200"
    }
]